<SEC-DOCUMENT>0001104659-12-030581.txt : 20120430
<SEC-HEADER>0001104659-12-030581.hdr.sgml : 20120430
<ACCEPTANCE-DATETIME>20120430161155
ACCESSION NUMBER:		0001104659-12-030581
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20120611
FILED AS OF DATE:		20120430
DATE AS OF CHANGE:		20120430
EFFECTIVENESS DATE:		20120430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			H&Q HEALTHCARE INVESTORS
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		12795191

	BUSINESS ADDRESS:	
		STREET 1:		2 LIBERTY SQUARE
		STREET 2:		9TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		2 LIBERTY SQUARE
		STREET 2:		9TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a12-6485_3def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="23%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:23.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UNITED STATES</font></b></p>    </td>
<td width="27%" valign="top" style="padding:0in .7pt 0in .7pt;width:27.14%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:23.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>    </td>
<td width="27%" valign="top" style="padding:0in .7pt 0in .7pt;width:27.14%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:23.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>    </td>
<td width="27%" valign="top" style="padding:0in .7pt 0in .7pt;width:27.14%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:23.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" valign="top" style="padding:0in .7pt 0in .7pt;width:27.14%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="23%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:23.74%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" valign="top" style="padding:0in .7pt 0in .7pt;width:27.14%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">SCHEDULE 14A</font></b></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy Statement Pursuant to Section 14(a)   of<br>   the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by the   Registrant&nbsp;&nbsp;</font><font face="Wingdings">&#253;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Filed by a Party other   than the Registrant</font>&nbsp;&nbsp;</font><font face="Wingdings">o</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate   box:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preliminary Proxy   Statement</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> </p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Confidential,   for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></b></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Proxy   Statement</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Additional   Materials</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Soliciting Material   Pursuant to &#167;240.14a-12</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">H&amp;Q Healthcare Investors</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name of Registrant as Specified In Its   Charter)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name of Person(s) Filing Proxy Statement,   if other than the Registrant)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="6" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment of Filing Fee   (Check the appropriate box):</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&#253;</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No fee required.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee computed on table   below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title of each class of   securities to which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate number of   securities to which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per unit price or other   underlying value of transaction computed pursuant to Exchange Act Rule 0-11   (set forth the amount on which the filing fee is calculated and state how it   was determined):</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proposed maximum   aggregate value of transaction:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fee paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.34%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee paid previously with   preliminary materials.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font> </p>    </td>
<td width="95%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:95.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check box if any part of   the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify   the filing for which the offsetting fee was paid previously. Identify the   previous filing by registration statement number, or the Form or Schedule and   the date of its filing.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amount Previously Paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form, Schedule or   Registration Statement No.:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing Party:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" colspan="4" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:90.64%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date Filed:</font></p>    </td>   </tr>
<tr height="0">
<td width="37" style="border:none;"></td>
<td width="33" style="border:none;"></td>
<td width="2" style="border:none;"></td>
<td width="105" style="border:none;"></td>
<td width="367" style="border:none;"></td>
<td width="203" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105981\12-6485-3\task5295534\6485-3-ba.htm',USER='105981',CD='Apr 25 15:13 2012' -->


<br clear="all" style="page-break-before:always;">
<!-- Document name: 12-6485-4.aa-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>H&amp;Q HEALTHCARE INVESTORS<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2 Liberty Square, 9th Floor<BR>Boston, Massachusetts 02109<BR>(617) 772-8500</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</b></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">To the Shareholders of<BR>H&amp;Q HEALTHCARE INVESTORS:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">An Annual Meeting of Shareholders of H&amp;Q Healthcare Investors (the "Fund" or "HQH") will be held on Monday, June 11, 2012 at 9:00 a.m. at the offices of the Fund, 2 Liberty Square, 9th Floor, Boston, Massachusetts 02109, for the following purposes:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(1)&nbsp;&nbsp;The election of Trustees of the Fund;</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(2)&nbsp;&nbsp;The ratification or rejection of the selection of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2012; and</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(3)&nbsp;&nbsp;The transaction of such other business as may properly come before the Annual Meeting and any adjournment(s) or postponement(s) thereof.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders of record at the close of business on April 30, 2012 will be entitled to vote at the Annual Meeting or at any adjournment(s) or postponement(s) thereof.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">By Order of the Board of Trustees,</font></p>
<p align="left"><img src="j1264854_aa003.jpg">
</p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D.<BR>President</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">May 1, 2012</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Please complete, date and sign the Proxy for the shares held by you and return the Proxy in the envelope provided so that your vote can be recorded. No postage is required if the envelope is mailed in the United States. It is important that you return your signed Proxy promptly, regardless of the size of your holdings, so that a quorum may be assured.</i></font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='12-6485-4.aa',USER='bvanmeta',CD='Apr 21 02:17 2012' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">This page intentionally left blank.</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=2,FOLIO='',FILE='12-6485-4.aa',USER='bvanmeta',CD='Apr 21 02:17 2012' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 12-6485-4.ba-->
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>H&amp;Q HEALTHCARE INVESTORS</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PROXY STATEMENT</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">This Proxy Statement is furnished in connection with the solicitation by the Board of Trustees of H&amp;Q Healthcare Investors (the "Fund" or "HQH") of proxies to be voted at the Annual Meeting of Shareholders of the Fund to be held on June 11, 2012 (the "Annual Meeting"), and any adjournment(s) or postponement(s) thereof, for the purposes set forth in the accompanying Notice of Annual Meeting, dated May 1, 2012. This Proxy Statement, the Notice of Annual Meeting and the Proxy Card(s) are first being mailed to shareholders on or about May 1, 2012.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Proposal 1 relates to the election of Trustees for the Fund and Proposal 2 relates to the ratification of the selection of the independent registered public accountants of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund will furnish, without charge, a copy of its Annual Report, or the most recent Semi-Annual Report succeeding the Annual Report, if any, to a shareholder upon request. Requests may be sent to the Fund at 2 Liberty Square, 9th Floor, Boston, MA 02109 or be made by calling (800) 451-2597.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Proposal 1<BR>ELECTION OF TRUSTEES</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Declaration of Trust provides that its Board of Trustees shall be divided into three classes with staggered terms. The term of office of the Class B Trustees expires on the date of the 2012 Annual Meeting, and the term of office of the Class C and Class A Trustees will expire one and two years, respectively, thereafter. Trustees chosen to succeed the Class B Trustees whose terms are expiring will be elected for a three-year term.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Declaration of Trust provides that a majority of its Trustees shall fix the number of the entire Board of Trustees and that such number shall be at least three and no greater than fifteen. The Fund's Board of Trustees has fixed the number of Trustees at eight. Proxies will be voted for the election of the following three nominees to serve as Class B Trustees until the 2015 Annual Meeting: Lawrence S. Lewin, Daniel R. Omstead, Ph.D. and Uwe E. Reinhardt. Each of the other Trustees is presently serving as a Class B Trustee and has consented to continue to so serve. On December 10, 2011, the Trustees, upon the recommendation of the Nominating Committee, nominated Michael W. Bonney to stand for election as a Class C Trustee at the Annual Meeting and appointed him as a Class C Trustee to fill a vacancy on the Board of Trustees until the Annual Meeting. Proxies will also be voted for the election of Michael W. Bonney to serve as a Class C Trustee until the 2013 Annual Meeting. Mr. Bonney is presently serving as a Class C Trustee and has consented to continue to so serve. In the event that a nominee is unable to serve for any reason when the election occurs, the accompanying Proxy will be voted for such other person or persons as the Board of Trustees may recommend.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Class C Trustees serving until the 2013 Annual Meeting are Michael W. Bonney (if elected), Oleg M. Pohotsky and William S. Reardon. The Class A Trustees serving until the 2014 Annual Meeting are Rakesh K. Jain, Ph.D. and Lucinda H. Stebbins, CPA.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Board believes that each Trustee's experience, qualifications, attributes and skills on an individual basis and in combination with those of other Trustees lead to the conclusion that each Trustee should serve in such capacity. Among the attributes or skills common to all Trustees are their ability to review critically and to evaluate, question and discuss information provided to them, to interact effectively with the other Trustees, the Fund's investment adviser, the administrator and other service providers, counsel and independent registered public accounting firm, and to exercise effective and independent business judgment in the performance of their duties as Trustees. Each Trustee's ability to perform the duties of a trustee effectively has been attained and enhanced through the Trustee's education, professional training and other life experiences, such as business, consulting or public service positions and through experience from service as a member of this Fund's Board and that of H&amp;Q Life Sciences Investors ("HQL"), public companies, or non-profit entities or other organizations.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Michael W. Bonney:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Mr. Bonney is the President, Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc., providing the Fund with valuable insight into operating matters relating to biotech companies and the overall healthcare industry. He serves on the Governance and Nominating Committees of the Funds. Mr. Bonney is also a Director of NPS Pharmaceuticals, Inc., is Chairman of the Board of Trustees of Bates College and is a Board member of the Pharmaceutical Research and Manufacturers of America (PhRMA). He holds an BA degree from Bates College.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Rakesh K. Jain, Ph.D.:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital, providing the Fund with a valuable perspective on emerging life sciences technologies. Dr. Jain co-founded XTuit Pharmaceuticals, Inc. in 2011 where he also serves as a board member. He serves on the Governance and Nominating Committees of the Funds. Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 520 publications. He serves on advisory panels to government, industry and academia, and is a member of editorial advisory boards of ten journals, including Nature Reviews Cancer and Nature Reviews Clinical Oncology. He has received more than 50 major awards and lectureships, including a Guggenheim Fellowship, the Humboldt Senior Scientist Award, the National Cancer Institute's Research Career Development Award and Outstanding Investigator Grant, the Academic Scientist of the Year Award from the Pharmaceutical Achievements Awards, the Distinguished Service Award from Nature Biotechnology and the Innovator Award from the DoD Breast Cancer Program. He is a member of all three branches of US National Academies &#150; the Institute of Medicine, the National Academy of Engineering and the National Academy of Sciences &#150; and the American Academy of Arts and Sciences.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Lawrence S. Lewin, MBA:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Mr. Lewin serves as Chairman of the Board of Trustees and Chairman of the Governance and Nominating Committees. Mr. Lewin was the Chief Executive Officer for 30 years of the Lewin Group, which he founded in 1970. The Lewin Group, a healthcare public policy and management consulting firm, delivers objective analyses and strategic counsel to public agencies, nonprofit organizations, industry associations and private companies across the United States. Mr. Lewin provides the Fund valuable insights into healthcare economics and reform. He has served on the Boards of a number of healthcare companies, including Intermountain Health Care, Medco Health Solutions, Inc., CardioNet, Inc., and CareFusion, and is currently a member of the Board of Regents of the Uniformed Services University of the Health Sciences. Mr. Lewin is an elected member of the Institute of Medicine since 1984. He holds an BA degree from Princeton University and an MBA from the Harvard Business School.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Daniel R. Omstead, Ph.D.:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Dr. Omstead is President and Chief Executive Officer of Hambrecht &amp; Quist Capital Management LLC (the "Adviser"), a registered investment adviser that serves as investment adviser to HQH and HQL. Dr. Omstead is also President of HQL and HQH. Dr. Omstead is portfolio manager for the public and restricted/venture portfolios within HQH and HQL. As part of these responsibilities, Dr. Omstead is a member of the Board of Directors of several portfolio companies including Magellan Diagnostics, Dynex Corporation, Tibion Corporation, Celladon Corporation and Palyon Medical. Prior to joining the Adviser, Dr. Omstead was President and CEO of Reprogenesis, Inc., a private development stage biotech company which developed therapies in the field of tissue engineering and regenerative medicine. Before joining Reprogenesis, Dr. Omstead was Senior Vice President, Research and Development, at Cytotherapeutics, Inc, a public biotech company. Prior to entering the biotech industry, Dr. Omstead was employed for fourteen years in positions of increasing responsibility within the pharmaceutical industry at Ortho Pharmaceutical Corporation and at the R.W. Johnson Pharmaceutical Research Institute, both divisions of Johnson &amp; Johnson, and at Merck, Sharpe and Dohme Research Laboratories, a division of Merck and Company. Dr. Omstead provides the Fund with insights into both pharmaceutical and biotech companies. Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He is a member of the Board of Directors of a non-profit agency that provides emergency shelter, housing and supportive services to homeless and low-income individuals and families in the Boston area. Dr. Omstead is also a member of the Board of Visitors of the Columbia University School of Engineering and Applied Science and an Overseer at the Joslin Diabetes Center.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Oleg M. Pohotsky:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Mr. Pohotsky is a corporate finance and investment professional with over forty years of diversified experience gained both in industry and in financial markets. He serves as Chairman of the Fund's Audit Committee and Valuation Committee. He has over 45 years of cumulative board experience in the full range of organization types: publicly-traded, privately-held, venture-backed and non-profit. He has also served as a director of a healthcare services company listed on the Nasdaq NMS where he was a member of the audit committee. In his various directorships he has also served on investment, compensation, personnel and executive committees. His career spanned over twenty years in the investment industry, both as an investment banker and as a venture capital and private equity investor, and included serving as chairman of the valuation and fairness opinion committee of a NYSE-member firm. Mr. Pohotsky also currently serves on the Board of Directors of Avangardco Investments Holdings, an LSE-listed agribusiness enterprise based in Ukraine, and on the Board of Advisors of Kaufman &amp; Co., LLC, a Boston-based boutique investment banking firm, and is affiliated with GovernanceMetrics International, Inc. as a Senior Advisor. He provides the Fund with valuable experience in valuation and the financial industry. Mr. Pohotsky holds a BSChE degree from Clarkson University, a JD degree from the University of Miami and MBA from the Harvard Business School of Business Administration. He has also been awarded an honorary doctorate by Clarkson University.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>William S. Reardon, CPA:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Mr. Reardon's personal experience as a Life Science audit partner at PricewaterhouseCooper ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides the Trustees of the Fund, and especially the Valuation Committee with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. Until 2002 Mr. Reardon was a business assurance partner in PwC's Boston office and leader of the Life Sciences Industry Practice for New England and the Eastern U.S., working closely with many of the Firm's public clients in SEC-registered equity, convertible and R&amp;D limited partnership offerings and many initial public offerings. He serves on the Valuation Committee of the Fund. From 1998-2000 he served on the Board of the Emerging Companies Section of Biotechnology Industry ("BIO"), and from 2000 to 2002 he served on the Board of Directors of the Massachusetts Biotechnology Council ("MBC"). He has been a frequent speaker at BIO conferences and MBC Industry meetings on issues affecting biotechnology companies. He currently also serves as a board member and audit committee chair of two development-stage public companies, Synta Pharmaceuticals and Idera Pharmaceuticals. Mr. Reardon is member of the American Institute of CPAs and the Massachusetts Society of CPAs, with an MBA from Harvard Business School and a BA in East Asian History from Harvard College.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Uwe E. Reinhardt, Ph.D.:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Dr. Reinhardt is the James Madison Professor of Political Economy at Princeton University, teaching economics and public affairs since 1968, and has been a member of the Institute of Medicine of the National Academy of Sciences since 1978. He serves on the Audit Committee of the Fund. Dr. Reinhardt is recognized as one of the nation's leading authorities on health care economics, a prominent scholar in health care economics and a frequent speaker and author on subjects ranging from the war in Iraq to the future of Medicare. Dr. Reinhardt provides the Fund with valuable insights in healthcare economics and reform. He is a past president of the Association of Health Services Research. From 1986 to 1995 he served as a commissioner on the Physician Payment Review Committee, established in 1986 by Congress to advise it on issues related to the payment of physicians. He is a senior associate of the Judge Institute for Management of Cambridge University, UK, and a trustee of Duke University, and the Duke University Health System. Dr. Reinhardt is or was a member of numerous editorial boards, among them the Journal of Health Economics, the Milbank Memorial Quarterly, Health Affairs, the New England Journal of Medicine, and the Journal of the American Medical Association. Dr. Reinhardt received his Ph.D. from Yale University.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Lucinda H. Stebbins, CPA:</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> Ms. Stebbins brings to the Board over twenty years experience working in the fund industry, providing valuable perspectives on a variety of technical and industry matters. She serves on the Audit, Governance and Nominating Committees of the Fund. She started her fund career with the investment management firm of Scudder, Stevens and Clark, which was later merged into the U.S operations of Zurich Financial Services, and then finally acquired by Deutsche Bank. She served as a Senior Vice President at Scudder Investments and subsequently as a Director at Deutsche Asset Management and was an officer of approximately 200 funds in these complexes. Ms. Stebbins' expertise is in the accounting, tax, and regulatory side of the business and she continues to act as an independent consultant to the fund industry. Prior to joining Scudder, she was a Senior Manager at Price Waterhouse and is a member of the Massachusetts Society of CPAs. She also serves on the Board of Bald Peak Land Company and has been on a number of non-profit Boards. She holds an MBA degree from Babson College and a BA in economics from Wellesley College.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Trustees and their principal occupation for at least the last five years are set forth in the table below.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="146" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Age <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Address</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>with HQH and HQL</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Term of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Office and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Occupations(s) <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>in Fund <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Overseen by<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Director or <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Nominee for<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Director</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1427" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Directorships <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Held by Director <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>or Nominee <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>for Director</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="3370" align="left" valign="top" style="padding:6pt .7pt 1pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INDEPENDENT TRUSTEES AND NOMINEES</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Michael W. Bonney (53)<BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor,<BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee of HQH and HQL; Member of each Fund's Governance and Nominating Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Since 2011</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">President, Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1427" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, NPS Pharmaceuticals, Inc. (since 2005); Chairman of the Board of Trustees, Bates College (since 2010); Trustee, Bates College (since 2002); Board member of the Pharmaceutical Research and Manufacturers of America (PhRMA) (Since 2009).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Rakesh K. Jain, Ph.D. (61) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square,<BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee of HQH and HQL; Member of each Fund's Governance and Nominating Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">years; since 2007</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1427" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Advisory Committee Member, Department of Biotechnology, Government of India (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (Since 2011).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
</table>

<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="146" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Age <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Address</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>with HQH and HQL</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Term of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Office and <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Occupations(s) <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>in Fund <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Overseen by<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Director or <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Nominee for<BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Director</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1344" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Directorships <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Held by Director <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>or Nominee <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>for Director</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Lawrence S. Lewin (74) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee of HQH and HQL; Chairman, HQH and HQL (since 2000); Member of each Fund's Governance, Nominating and Qualified Legal Compliance Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 years; since 1987 (HQH) since 1992 (HQL)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Self-employed Executive Consultant (since 1999).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:3pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:3pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1344" align="left" valign="top" style="padding:3pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, CardioNet, Inc. (2001-2007); Director, Medco Health Solutions, Inc. (2003-2007); Director, Care Fusion, Inc. (2005-2006).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Oleg M. <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Pohotsky (65) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee, HQH and HQL; Member of each Fund's Audit, Valuation and Qualified Legal Compliance Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">years; since 2000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Consultant and Managing Partner, Right Bank Partners (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1344" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Adviser, Board of Advisers, Kaufman &amp; Co. LLC (since 2008); Organizer/Incorporator, EmprendMex (since 2009); Director, Avangardco Investments Holdings (since 2011).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">William S. Reardon (65) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee, HQH and HQL; Member of each Fund's Valuation and Qualified Legal Compliance Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">years; since 2010</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">None.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1344" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, Idera Pharmaceuticals, Inc. (since 2002); Director, Synta Pharmaceuticals Corp. (since 2004).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Uwe E. Reinhardt, Ph.D. (74) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee, HQH and HQL; Member of each Fund's Audit Committee.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 years; since 1988 (HQH) since 1992 (HQL)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Professor of Economics, Princeton University (since 1968).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1344" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, Boston Scientific Corporation (since 2002); Director, Amerigroup, Inc. (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Lucinda H. Stebbins, CPA (66) <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Liberty Square, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">9</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">th Floor, <BR></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Boston MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee, HQH and HQL; Member of each Fund's Audit, Governance and Nominating Committees.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">years; since 2006</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Independent Consultant, Deutsche Bank (since 2004).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1344" align="left" valign="top" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, Deutsche Asset Management (2002-2004); Director, Bald Peak Land Company (since 2008); Trustee, Massachusetts Hospital School (1997-2008).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="146" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Age <BR>and Address</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held <BR>with HQH and HQL</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Term of <BR>Office and <BR>Length of <BR>Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal <BR>Occupations(s) <BR>During Past 5 Years</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of <BR>Portfolios <BR>in Fund <BR>Complex <BR>Overseen by<BR>Director or <BR>Nominee for<BR>Director</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="1427" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other <BR>Directorships <BR>Held by Director <BR>or Nominee <BR>for Director</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="3370" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTERESTED TRUSTEE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
<tr>
<td colspan="3" width="146" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Daniel R. Omstead, Ph.D.* (58) <BR>2 Liberty Square, <BR>9th Floor, <BR>Boston, MA 02109</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="701" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Trustee, HQH and HQL; President, HQH and HQL (since 2001); Member of each of the Fund's Valuation Committee.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="200" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3 years; since 2003</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="808" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">President, HQH and HQL (since 2001). President, Chief Executive Officer and Managing Member, Hambrecht & Quist Capital Management LLC (since 2002).</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:0pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="64" align="center" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2</font></td>
<td colspan="1" width="8" valign="top" style="padding:0pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="1427" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Director, Magellan Diagnostics, Inc. (since 2006); Director Dynex Corporation (since 2012); Director Celladon Corporation (since 2012); Director, Palyon Medical Corporation (since 2009); Director, Tibion Corporation (since 2011).</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr height="8"><td colspan="24" height="8"></td></tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&nbsp;&nbsp;*&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser. </font></p>
<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following table sets forth, for each Trustee, the aggregate dollar range of equity securities owned by such Trustee in HQH and HQL and in the aggregate in HQH and HQL, as of March 31, 2012. The information as to beneficial ownership is based upon statements furnished by each Trustee.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name of Trustee or Nominee</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Dollar Range of Equity <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Securities in HQH</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Dollar Range of Equity <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Securities in HQL</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="149" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Aggregate Dollar Range of <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Equity Securities in Both <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Funds Overseen by <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Trustee in Fund Complex</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="15" width="572" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Independent Trustees</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Michael W. Bonney</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,001-$50,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,001-$50,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,001-$50,000</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rakesh</font><font face="Symbol" style="font-size:10pt;"> </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">K. Jain, Ph.D.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">None</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">None</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="120" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">None</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Lawrence S. Lewin</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$50,001-$100,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$10,001-$50,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="149" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Oleg M. Pohotsky</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1-$10,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1-$10,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="120" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1-$10,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">William S. Reardon</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,000-$50,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,000-$50,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="120" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,000-$50,000</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Uwe E. Reinhardt, Ph.D.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$10,001-$50,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="105" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$10,000-$50,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="120" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">50,000-$100,000</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Lucinda H. Stebbins, CPA</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="105" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$50,000-$100,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="149" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="15" width="572" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Interested Trustee</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="149" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Over $100,000</font></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Although Trustees are encouraged to attend the annual meetings of shareholders to the extent they are able, the Fund has no formal policy with regard to board members' attendance at annual meetings of shareholders. Last year, two Trustees then in office attended the annual meeting of shareholders.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders wishing to send communications to the Board may communicate with members of the Board of Trustees by submitting a written communication directed to the Board of Trustees in care of the Fund's President, Daniel R. Omstead, Ph.D., at 2 Liberty Square, 9th Floor, Boston, MA 02109.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Trustees &#150; Leadership Structure and Oversight Responsibilities</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Overall responsibility for general oversight of the Fund rests with the Board. The Board is comprised of eight individuals, seven of whom are not "interested persons" of the Fund as defined in the 1940 Act ("Independent Trustee"). The Chairman of the Board is an Independent Trustee. The Chairman presides at meetings of the Trustees, participates in the preparation of the agenda for meetings of the Board, and acts as a liaison between the Independent Trustees and the Fund's management between Board meetings. Except for any duties specified herein, the designation as Chairman does not impose any obligations or standards greater than or different from other Trustees.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Board holds regular quarterly meetings each year to consider and address matters involving the Fund. The Board also may hold special meetings to address matters arising between regular meetings. The Independent Trustees also meet outside the presence of management in executive session at least quarterly and have engaged independent legal counsel to assist them in performing their oversight responsibilities.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Board has established Audit, Governance, Nominating, Valuation and Qualified Legal Compliance Committees to assist the Board in the oversight of the management and affairs of the Fund. All of the members of these Committees are Independent Trustees. From time to time the Board may establish additional committees or informal working groups to deal with specific matters.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund is subject to a number of risks including investment, compliance, operational and valuation risks. Although the Adviser and the officers of the Fund are responsible for managing these risks on a day-to-day basis, the Board has adopted, and periodically reviews, policies and procedures designed to address these risks. As part of its regular oversight of the Fund, the Board, directly or through a Committee, interacts with the Fund's Chief Compliance Officer, the Fund's independent public accounting firm, and legal counsel to the Fund. These interactions include discussing the Fund's risk management and controls with the independent registered public accounting firm engaged by the Fund, reviewing valuation policies and procedures and the valuations of specific restricted securities, and receiving periodic reports from the Fund's Chief Compliance Officer regarding compliance matters relating to the Fund and its major service providers, including results of the implementation and testing of the Fund's and such providers' compliance programs. The Board's oversight function is facilitated by management reporting processes designed to provide information to the Board regarding the identification, assessment, and management of critical risks and the controls and policies and procedures used to mitigate those risks. The Board reviews its role in supervising the Fund's risk management from time to time and may change the manner in which it fulfills its oversight responsibilities at its discretion at any time.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Board has determined that its leadership structure is appropriate for the Fund because it enables the Board to exercise informed and independent judgment over matters under its purview, allocates responsibility among committees in a manner that fosters effective oversight and allows the Board to devote appropriate resources to specific issues in a flexible manner as they arise. The Board periodically reviews its leadership structure as well as its overall structure, composition, and functioning and may make changes at its discretion at any time.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Standing Committees</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Audit Committee.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has an Audit Committee comprised solely of Independent Trustees who are "independent" as defined in the New York Stock Exchange ("NYSE") Listing Standards. The Fund's Board of Trustees has adopted a written charter for the Audit Committee. The Audit Committee charter is available at http://www.hqcm.com/Reports/AuditCommitteeCharterFebruary2007.pdf. The principal purpose of the Fund's Audit Committee is to assist the Board of Trustees in fulfilling its responsibility to oversee management's conduct of the Fund's financial reporting process, including reviewing the financial reports and other financial information provided by the Fund, the Fund's systems of internal accounting and financial controls and the annual independent audit process.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Audit Committee's role is one of oversight, and it is recognized that the Fund's management is responsible for preparing the Fund's financial statements and that the Fund's independent registered public accountant is responsible for auditing those financial statements. Although each Audit Committee member must be financially literate and one member must have accounting or financial management expertise (as determined by the Board of Trustees in its business judgment), Audit Committee members are not professionally engaged in the practice of accounting or auditing and are not experts in the fields of accounting or auditing, including with respect to auditor independence. Audit Committee members rely, without independent verification, on the information provided to them and on the representations made by management and the Fund's independent registered public accountants.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The members of the Fund's Audit Committee are Mr. Pohotsky, Dr. Reinhardt and Ms. Stebbins. Mr. Pohotsky is the Chairman of the Fund's Audit Committee. The Fund's Audit Committee held four meetings during the fiscal year ended September 30, 2011.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Governance Committee.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has a Governance Committee comprised solely of Independent Trustees who are "independent" as defined in the NYSE Listing Standards. The Fund's Board of Trustees has adopted a written charter for the Governance Committee. The Fund's Governance Committee's mission under its charter is to review, evaluate, and enhance the effectiveness of the Fund's Board of Trustees in its role in governing the Fund and to oversee management of the Fund in accordance with the Corporate Governance Guidelines, which have been adopted by the Fund's Board of Trustees.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Governance Committee reviews, discusses and makes recommendations to the Board of Trustees relating to those issues that pertain to the effectiveness of the Board of Trustees in carrying out its responsibilities in governing the Fund and overseeing the Fund's management. The members of the Fund's Governance Committee are Mr. Bonney, Dr. Jain, Mr. Lewin and Ms. Stebbins. Mr. Lewin is the Chairman of the Fund's Governance Committee. The Fund's Governance Committee met one time during the fiscal year ended September 30, 2011.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Nominating Committee.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has a Nominating Committee comprised soley of Independent Trustees who are "independent" as defined in the NYSE Listing Standards. The Fund's Board of Trustees has adopted a written charter for the Nominating Committee. The Nominating Committee charter is not available on the Fund's website and is included as Exhibit A to this Proxy Statement.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Nominating Committee requires that each prospective trustee candidate have a college degree or equivalent business experience and that each candidate is not serving in a similar capacity on the board of a registered investment company which (i) is not sponsored or advised by the Fund's investment adviser or its affiliates and (ii) the Board in its discretion has determined to be competitive with the Fund taking into account such registered investment company's investment mandate. The Fund's Nominating Committee may also take into account other factors when considering and evaluating potential trustee candidates, including but not limited to: (i) availability and commitment to attend meetings and perform responsibilities of the Board; (ii) relevant industry and related experience; (iii) educational background; (iv) financial expertise; (v) the candidate's ability, judgment and expertise; and (vi) the overall diversity of the Board's composition.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Nominating Committee may identify prospective trustees from any reasonable source, including, but not limited to, the consultation of third-party trustee search services. The Fund's Nominating Committee will consider potential trustee candidates recommended by shareholders, provided that the proposed candidates (i) satisfy any minimum qualifications of the Fund for its trustees; (ii) are not "interested persons" (as that term is defined in Section 2(a)(19) of the 1940 Act) of the Fund or the Adviser; and (iii) are "independent" as defined in the NYSE Listing Standards. In order to be evaluated by the Committee, trustee candidates recommended by shareholders must also meet certain eligibility requirements as set out in the Committees' charter. Other than those eligibility requirements, the Committee shall not evaluate shareholder trustee candidates in a different manner than other candidates. The standard of the Committee is to treat all equally qualified candidates in the same manner.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">All recommendations by shareholders must be received by the Fund by the deadline for submission of any shareholder proposals which would be included in the Fund's proxy statement for the next annual meeting of the Fund. Each shareholder or shareholder group must meet the requirements stated in the Nominating Committee's charter in order to recommend a candidate. A shareholder or shareholder group may not submit more than one candidate per year. When recommending a trustee candidate, shareholders must include in their notice to the Fund's Secretary: (i) the shareholder's contact information; (ii) the trustee candidate's contact information and the number of Fund shares owned by the proposed candidate; (iii) all information regarding the candidate that would be required to be disclosed in solicitations of proxies for elections of trustees required by Regulation 14A of the Securities Act of 1934, as amended (the "Exchange Act"); and (iv) a notarized letter executed by the </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">trustee candidate, stating his or her intention to be a nominee and be named in the Fund's proxy statement, if nominated by the Board of Trustees, and to serve as a trustee, if so elected. Once a recommendation has been timely received in proper form, the candidate will be asked to complete an eligibility questionnaire to assist the Fund in assessing the candidate's qualifications as a potential Independent Trustee and as someone who is "independent" under the NYSE Listing Standards. The Nominating Committee will make such determinations in its sole discretion and such determinations shall be final.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The members of the Fund's Nominating Committee are Mr. Bonney, Dr. Jain, Mr. Lewin and Ms. Stebbins. Mr. Lewin is the Chairman of the Fund's Nominating Committee. The Fund's Nominating Committee met three times during the fiscal year ended September 30, 2011.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Valuation Committee.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Board has delegated to the Fund's Valuation Committee general responsibility for determining, in accordance with the Fund's valuation procedures, the value of assets held by the Fund on any day on which the net asset value per share is determined. The Valuation Committee may appoint, and has appointed, a Sub-Committee made up of employees and officers of the Adviser to deal with day to day valuation decisions, subject to oversight by the Valuation Committee. The Valuation Committee shall meet as often as necessary to ensure that each action taken by the Sub-Committee is reviewed within a calendar quarter of the occurrence. In connection with its review, the Valuation Committee shall ratify or revise the pricing methodologies authorized by the Sub-Committee since the last meeting of the Valuation Committee. The Valuation Committee is charged with the responsibility of determining the fair value of the Fund's securities or other assets in situations set forth in the Fund's valuation procedures.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The members of the Fund's Valuation Committee are Dr. Omstead, Mr. Pohotsky and Mr. Reardon. Mr. Pohotsky is the Chairman of each Funds'  Valuation Committee. Each Fund's Valuation Committee met four times during the fiscal year ended September 30, 2011.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Qualified Legal Compliance Committee.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> The Fund has a Qualified Legal Compliance Committee ("QLCC") comprised solely of Independent Trustees. The Fund's Board of Trustees has adopted a written charter for the QLCC. The principal purpose of the Fund's QLCC is to review and respond to reports of Evidence of a Material Violation (as defined in the QLCC charter). Reporting Evidence of a Material Violation is required under the Standards of Professional Conduct for Attorneys adopted by the U.S. Securities and Exchange Commission (the "SEC") under the Sarbanes-Oxley Act of 2002 (the "Standards"). Under the Standards, if an attorney appearing and practicing before the SEC in the representation of an issuer, such as the Fund, becomes aware of Evidence of a Material Violation by the issuer or by any officer, trustee, employee or agent of the issuer, the Standards provide for the attorney to report such evidence to the issuer's QLCC forthwith. In discharging its role, the QLCC is granted the power to investigate any Evidence of a Material Violation brought to its attention with full access to all books, records, facilities and personnel of the Fund and the power to retain outside counsel, auditors or other experts for this purpose.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The members of the Fund's QLCC are Mr. Lewin, Mr. Pohotsky and Mr. Reardon. Mr. Pohotsky is the Chairman of the Fund's QLCC. The Fund's QLCC did not meet during the fiscal year ended September 30, 2011.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Attendance.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> During the fiscal year ended September 30, 2011, the Fund's Board of Trustees held four meetings; the Fund's Audit Committee held four meetings; the Fund's Governance Committee held one meeting; the Fund's Nominating Committee held three meetings; and the Fund's Valuation Committee held four meetings.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Each of the Trustees attended at least 89% of the aggregate number of meetings of the Board of Trustees and the Committees of the Board of Trustees on which such Trustee served during the fiscal year-ended September 30, 2011.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Compensation of Trustees and Officers</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">For the fiscal year ended September 30, 2011, the Fund paid an annual fee of $18,000 to its Independent Trustees, $500 to its Audit and Valuation Committee members, and $250 to its Nominating and Governance Committee members. Additionally, the Fund currently pays each Independent Trustee $1,000 for each Board and Committee meeting attended in person and $250 for each Board and Committee meeting attended by telephone. Currently, the Chairman of the Board of Trustees, the Chairman of the Audit Committee and the Chairman of the Valuation Committee of the Fund each receive an additional annual fee of $2,500. Currently, the Chairman of the Nominating Committee and the Chairman of the Governance Committee of the Fund each receive an additional annual fee of $1,250. Independent Trustees are also reimbursed for travel expenses incurred in connection with attending such meetings. For the fiscal year ended September 30, 2011, the Independent Trustees as a group received $187,597 from the Fund for fees and reimbursed expenses. The Fund did not directly pay any additional compensation to the Trustees for the fiscal year ended September 30, 2011. The Fund has entered into a Services Agreement (the "Agreement") with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the fiscal year ended September 30, 2011 these payments amounted to $82,527 for the Fund. Trustees and officers of the Fund who hold positions with the Adviser receive indirect compensation from the Fund in the form of the investment advisory fee paid to the Adviser. The following table sets forth information regarding compensation of Trustees by the Fund for the fiscal year ended September 30, 2011, but does not include expenses.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Compensation Table</b></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">For the fiscal year ended September 30, 2011</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name of Person, Position</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="101" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Aggregate <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Compensation <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>from the Fund</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="117" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Pension or Retirement <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Benefits Accrued <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>as part of the <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund's Expenses</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="86" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Estimated <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Annual <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Benefits upon <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Retirement</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="123" align="center" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Total Compensation <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>from both Funds <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>in Fund Complex <BR></b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Paid to Trustees</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="590" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Independent Trustees</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Rakesh K. Jain, Ph.D.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Lawrence S. Lewin</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">55,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eric Oddleifson</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">44,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Oleg M. Pohotsky</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">34,750</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">69,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">William S. Reardon</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">54,000</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Uwe E. Reinhardt, Ph.D.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,250</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">44,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Lucinda H. Stebbins, CPA</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,250</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">50,500</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="590" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Interested Trustees</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="139" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D.</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="72" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="101" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="94" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Executive Officers</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Set forth below is information for at least the last five years with respect to the executive officers of the Fund who do not also serve as Trustees. Each officer has been elected by the Board of Trustees and serves at the pleasure of the Trustees.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Laura Woodward, CPA (43), 2 Liberty Square, 9th Floor, Boston MA 02109: Chief Compliance Officer, HQH, HQL and Hambrecht &amp; Quist Capital Management LLC (since 2009); Secretary and Treasurer, HQH and HQL (since 2009); Senior Manager, PricewaterhouseCoopers LLP (prior to 2009).</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Required Vote</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Declaration of Trust states that the Trustees shall be elected by a plurality of the Fund's shares voting at the Annual Meeting. The Trustees recommend a vote FOR all nominees.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>INFORMATION PERTAINING TO THE ADVISER</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Adviser is a limited liability company organized under the laws of Delaware. Under the Fund's Investment Advisory Agreement, the Adviser is responsible for the management of the Fund's assets, subject to the supervision of the Board of Trustees. The Adviser manages the investments of the Fund in accordance with its investment objective and policies. The Adviser is also obligated to supervise and perform certain administrative and management services and is obligated to provide the office space, facilities, equipment and personnel necessary to perform its duties. Except for a portion of the salary of the Funds' Chief Compliance Officer, the salaries of all officers of the Fund and all personnel of the Fund or of the Adviser performing services relating to research, statistical or investment activities, and of all Trustees who are "interested persons" of the Fund or of the Adviser (as defined in the 1940 Act), are paid by the Adviser. The Adviser is located at 2 Liberty Square, 9th Floor, Boston, MA 02109.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead Ph.D. serves as President and Chief Executive Officer of the Adviser. The address for Dr. Omstead is c/o the Adviser at 2 Liberty Square, 9th Floor, Boston, MA 02109.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>REPORT OF THE AUDIT COMMITTEE OF THE FUND</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Audit Committee reviewed and discussed the Fund's audited financial statements with management for the Fund's fiscal year ended September 30, 2011, and discussed with the Fund's independent registered public accountants, Deloitte &amp;Touche LLP, the matters required to be discussed by ASC 950, </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Communication with Audit Committees</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">, which includes, among other items, matters relating to the conduct of an audit of the Fund's financial statements. The Fund's Audit Committee received written disclosures and the letter from Deloitte &amp; Touche LLP required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees) and discussed with Deloitte &amp; Touche LLP its independence. Based on its review and discussions with management and Deloitte &amp; Touche LLP, the Fund's Audit Committee recommended to the Board of Trustees that the Fund's audited financial statements for the Fund's fiscal year ended September 30, 2011, be included in the Fund's Annual Report filed with the SEC. The members of the Fund's Audit Committee are Mr. Pohotsky, Dr. Reinhardt and Ms. Stebbins. Mr. Pohotsky is the Chairman of the Fund's Audit Committee.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Proposal 2<BR>RATIFICATION OR REJECTION OF SELECTION OF INDEPENDENT<BR>REGISTERED PUBLIC ACCOUNTANTS</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Audit Committee has approved the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants for the fiscal year ending September 30, 2012, and a majority of the Board of Trustees of the Fund, including a majority of the Independent Trustees, subsequently ratified the appointment. The Fund has been advised that neither Deloitte &amp; Touche LLP nor any of its </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">partners has any direct or material indirect financial interest in the Fund, nor has had any connection during the past three years with the Fund in the capacity of promoter, underwriter, voting trustee, director, officer or employee.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accounting services to be performed by Deloitte &amp; Touche LLP for the Fund will consist of the examination of the annual financial statements of the Fund, consultation on financial, accounting and reporting matters, review and consultation regarding various filings with the SEC and attendance at some meetings of the Board of Trustees. Deloitte &amp; Touche LLP also will perform non-audit services consisting of review of income tax returns of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">A representative of Deloitte &amp; Touche LLP is expected to participate in the Annual Meeting and to be available for questioning and have an opportunity to make a statement.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The following tables set forth the aggregate fees billed for professional services rendered by Deloitte &amp; Touche LLP to the Fund during the Fund's two most recent fiscal years:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="71" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fiscal year</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="85" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Audit Fees</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="115" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Audit-Related Fees</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="77" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Tax Fees</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>All Other Fees</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2011</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">92,000</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="86" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,500</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="70" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2010</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">74,500</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="86" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,500</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></td>
<td colspan="1" width="70" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; height:18pt;">&nbsp;</p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">All of the services described in the table above were approved by the Audit Committees pursuant to its pre-approval policies and procedures (the "Pre-Approval Policies and Procedures") which are summarized below to the extent that such services were required to be pre-approved by the Audit Committee.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The aggregate non-audit fees billed by Deloitte &amp; Touche LLP for services rendered to the Fund and to the Adviser, or an affiliate thereof that provides ongoing services to the Fund, amounted to $4,500 for the fiscal year ended September 30, 2011 and $4,500 for the fiscal year ended September 30, 2010.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's Audit Committee has adopted Pre-Approval Policies and Procedures pursuant to which the Committee pre-approves all audit and non-audit services provided by the Fund's independent auditor (the "Auditor") and any non-audit services provided by the Auditor to the Funds' investment adviser and service affiliates ("Service Affiliates") during the period of the Auditor's engagement to provide audit services to the Fund, if those services directly impact the Fund's operations and financial reporting. Audit services include those typically associated with the annual audit such as evaluation of internal controls. Non-Audit services include certain services that are audit-related, such as consultations regarding financial accounting and reporting standards and tax services. Certain services may not be provided by the Auditor to the Fund's or the Fund's Service Affiliates without jeopardizing the Auditor's independence. These services are deemed prohibited services and include certain management functions; human resources services; broker-dealer, investment adviser or investment banking services; legal services; and expert services unrelated to the audit. Other services are conditionally prohibited and may be provided if the Audit Committee reasonably concludes that the results of the services will not be subject to audit procedures during an audit of the Fund's financial statements. These types of services include bookkeeping; financial information systems design and implementation; appraisal or valuation services; actuarial services; and internal audit outsourcing services.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Pre-Approval Policies and Procedures require Audit Committee approval of the engagement of the Auditor for each fiscal year and approval of the engagement by at least a majority of the Fund's Independent Trustees. In determining whether to engage the Auditor for its audit services, the Audit </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Committee will consider the Auditor's proposed fees for the engagement, in light of the scope and nature of the audit services that the Fund will receive. The Pre-Approval Policies and Procedures also permit the Audit Committee to pre-approve the provisions of types or categories of permissible non-audit services for the Fund and its Service Affiliates on an annual basis at the time of the Auditor's engagement and on a project-by-project basis. At the time of the annual engagement of the Fund's Auditor, the Audit Committee is to receive a list of the categories of expected non-audit services with a description and an estimated budget of fees. In their pre-approval, the Audit Committee should determine that the provision of the service is consistent with, and will not impair, the ongoing independence of the Auditor and set any limits on fees or other conditions they find appropriate. Non-audit services may also be approved on a project-by-project basis by the Audit Committee consistent with the same standards for determination and information.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Audit Committee may also appoint a member of the Committee to pre-approve non-audit services that have not been pre-approved or material changes in the nature or cost of any non-audit services previously pre-approved. The member may not pre-approve any project the estimated budget (or budgeted range) of fees of which exceed or may exceed $15,000. Any actions by the member are to be ratified by the Audit Committee by the time of their next scheduled meeting. The Fund's Pre-Approval Policies and Procedures are reviewed annually by the Audit Committee, and the Fund maintains a record of the decisions made by the Committee pursuant to these procedures.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Required Vote</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The selection of Deloitte &amp; Touche LLP as the Fund's independent public accountants for the fiscal year ending September 30, 2012 is submitted to shareholders for ratification and requires approval by a majority of the Fund's shares voting at the Annual Meeting. The Trustees recommend a vote FOR the selection of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>INFORMATION PERTAINING TO THE CUSTODIAN AND ADMINISTRATOR AND <BR>TRANSFER AGENT, DIVIDEND DISBURSING AGENT AND REGISTRAR</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund's securities and cash are held under a custodian contract by State Street Bank and Trust Company ("State Street"), whose principal business address is One Lincoln Street, Boston, MA 02111. State Street is also the Administrator of the Fund and also performs certain accounting related functions for the Fund, including calculation of net asset value and net income.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Computershare Inc. serves as Dividend Disbursing Agent. Computershare Trust Company, N.A., a fully owned subsidiary of Computershare Inc., serves as (1) the Plan Agent for the Fund's Dividend Reinvestment Plan and (2) the Transfer Agent and Registrar for Shares of the Fund. Computershare Trust Company, N.A. and Computershare Inc. have their principal business at 250 Royall Street, Canton, MA 02021.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Section 16(a) of the Exchange Act and Section 30(j) of the 1940 Act, as applied to the Fund, require the Fund's officers and trustees, investment manager, affiliates of the investment manager, and persons who beneficially own more than ten percent of a registered class of the Fund's outstanding securities ("Reporting Persons") to file reports of ownership of the Fund's securities and changes in such </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ownership with the SEC and the NYSE. Such persons are required by SEC regulations to furnish the Fund with copies of all such filings.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Based solely upon its review of the copies of such forms received by it, and written representations from certain Reporting Persons that no year-end reports were required for those persons, each Fund believes that during the fiscal year ended September 30, 2011, its Reporting Persons complied with all applicable filing requirements.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OTHER BUSINESS</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As of the date of this Proxy Statement, the Board of Trustees is not aware that any matters are to be presented for action at the Annual Meeting other than those described above. Should other business properly be brought before the Annual Meeting, it is intended that the accompanying Proxy will be voted thereon in accordance with the judgment of the persons named as proxies.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PROXIES AND VOTING AT THE ANNUAL MEETING</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders who execute proxies may revoke them at any time before they are voted by written notice to the Secretary of the Fund at 2 Liberty Square, 9th Floor, Boston, MA 02109, or by casting a vote at the Annual Meeting. Instructions on how to attend the meeting and vote in person can be obtained by calling (800) 451-2597. All valid proxies received prior to the Annual Meeting, or any adjournment(s) or postponements(s) thereof, will be voted at the Annual Meeting and any adjournments or postponements thereof.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The representation in person or by proxy of a majority of the outstanding shares of the Fund is necessary to constitute a quorum for transacting business at the Annual Meeting. For purposes of determining the presence of a quorum, abstentions and broker "non-votes" will be treated as shares that are present. Broker non-votes are proxies received by the Fund from brokers or nominees when the broker or nominee has neither received instructions from the beneficial owner or other persons entitled to vote nor has discretionary power to vote on a particular matter. Proposals 1 and 2 to be voted upon by the shareholders involve matters that the NYSE considers to be routine and within the discretion of brokers to vote if no customer instructions are received.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Proposal 1 requires the approval of a plurality of shares voting at the Annual Meeting (i.e., the three nominees for election as Class B Trustees receiving the greatest number of votes will be elected and the nominee for election as a Class C Trustee receiving the greatest number of votes will be elected). </font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Proposal 2 requires the approval of a majority of all votes validly cast at the Annual Meeting.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Abstentions and broker non-votes will not be counted in favor of, but will have no other effect on, the votes for Proposal 1 and 2.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Matters on which a choice has been provided will be voted as indicated on the proxy card and, if no instruction is given, the persons named as proxies will vote the shares represented thereby FOR all nominees for election as Trustee and FOR Proposal 2, and will use their best judgment in connection with the transaction of such other business as may properly come before the Annual Meeting or any adjournment(s) or postponement(s) thereof.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In the event that sufficient votes in accordance with the Trustees' recommendations on any Proposal are not received by June 11, 2012 or the necessary quorum has not been obtained, or if other matters arise requiring shareholder attention, the persons named as proxies on the enclosed proxy card may </font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">propose one or more adjournments of the Annual Meeting to permit further solicitation. Any such adjournment will require approval by a majority of the votes validly cast on the matter at the session of the Annual Meeting to be adjourned. When voting on a proposed adjournment, the persons named as proxies will vote FOR the proposed adjournment all shares that they are entitled to vote with respect to each item, unless directed to vote AGAINST an item, in which case such shares will be voted AGAINST the proposed adjournment with respect to that item. A shareholder vote may be taken on one or more items prior to such adjournment if sufficient votes have been received and it is otherwise appropriate. Abstentions and broker non-votes will be disregarded for purposes of voting on adjournment.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As of April 30, 2012, there were 26,006,087 shares of beneficial interest of the Fund issued and outstanding. Shareholders will be entitled to one vote for each share held. Only shareholders of record at the close of business on April 30, 2012, the record date, will be entitled to vote at the Annual Meeting. As of April 30, 2012, the Trustees and officers of the Fund individually and as a group beneficially owned less than 1% of the outstanding voting securities of the Fund. To the best of the Fund's knowledge, based upon filings made with the SEC, as of April 30, 2012, no persons or group beneficially owned more than 5% of the voting securities of the Fund.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>PROPOSALS FOR 2013 ANNUAL MEETING</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholder proposals for the Fund's 2013 Annual Meeting must be received at the Fund's executive offices at 2 Liberty Square, 9th Floor, Boston, Massachusetts 02109 no later than January 8, 2013 for inclusion in the 2013 Proxy Statement and form of proxy, unless the meeting date is more than 30 days before or after June 11, 2013. Submission of such proposals does not insure that they will be included in the 2012 Proxy Statement or submitted for a vote at the 2013 Annual Meeting.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In addition, shareholder proposals for the 2013 annual meeting of shareholders (other than proposals submitted for inclusion in a Fund's 2013 Proxy Statement) must be submitted to the Fund's Secretary between February 11, 2013 and March 13, 2013, unless the meeting date is more than 30 days before or after June 11, 2013.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>GENERAL</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund will pay the cost of preparing, printing and mailing the enclosed proxy card(s) and Proxy Statement and all other costs incurred in connection with the solicitation of proxies, including any additional solicitation made by letter, Internet, telephone or telegraph. The solicitation of proxies will be largely by mail. In addition, certain officers of the Fund and certain employees of the Adviser, who will receive no compensation for their services other than their regular salaries, may solicit the return of proxies personally or by telephone or facsimile. Banks, brokerage houses, nominees and other fiduciaries will be requested to forward the proxy soliciting materials to the beneficial owners of the shares of the Fund. The Fund may reimburse brokerage houses, nominees and other fiduciaries for postage and reasonable expenses incurred by them in forwarding of proxy material to beneficial owners.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">A number of banks, brokers and financial institutions have instituted "householding". Under this practice, only one Proxy Statement may be delivered to multiple shareholders who share the same address and satisfy other conditions. The Fund will deliver promptly a separate copy of this Proxy Statement to a shareholder at a shared address upon request. To request a separate copy of this Proxy Statement, write or call the Fund at the address and phone number set forth above.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY<BR>MATERIALS FOR THE SHAREHOLDER MEETING TO BE HELD ON JUNE 11, 2012</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Proxy Statement for the Annual Meeting of Shareholders of H&amp;Q Healthcare Investors is available at www.edocumentview.com/HQFunds.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">H&amp;Q HEALTHCARE INVESTORS</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">May 1, 2012</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>EXHIBIT A</b></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b><u>Nominating Committee Charter</u></b></font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Committee Membership</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Nominating Committee (the "Committee") of the Board of Trustees (the "Board") of the Fund shall be composed entirely of trustees of the Fund who (1) are not "interested persons" (as that term is defined in the Investment Company Act of 1940, as amended ("1940 Act")) of the Fund or the Fund's investment adviser and (2) are "independent" as defined in the New York Stock Exchange ("NYSE") Listing Standards. The President of the Fund, although not a member of the Committee, will cooperate with the Committee by recommending candidates and recruiting them for the Board of Trustees (the "Board") of the Fund and for executive offices of the Fund, and otherwise assisting the Committee to discharge its responsibilities.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Mission</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The mission of the Committee under this Nominating Charter is to promote the effective participation of qualified individuals on the Board, Committees of the Board, and as executive officers of the Fund.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Nominating Function &#150; Board</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.&nbsp;&nbsp;The Committee shall make nominations for trustees and officers of the Fund and submit such nominations to the full Board. The Committee shall evaluate candidates' qualifications for such positions, and, in the case of candidates for independent trustee positions, their independence from the Fund's investment adviser and other principal service providers. Persons selected as independent trustees must not be "interested persons" (as that term is defined in the 1940 Act) of the Fund or the Fund's investment adviser. The Committee shall also consider the effect of any relationships beyond those delineated in the 1940 Act that might impair independence, </font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>e.g.</i></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> business, financial or family relationships with the investment adviser. In determining nominees' qualifications for Board membership, the Committee shall consider factors which may be delineated in this Charter or the Fund's bylaws, and may consider such other factors as it may determine to be relevant to fulfilling the role of being a member of the Board.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2.&nbsp;&nbsp;The Committee may consider potential trustee candidates recommended by shareholders, provided that the proposed candidates: (i) satisfy any minimum qualifications of the Fund for its trustees; (ii) are not "interested persons" of the Fund or the Fund's investment adviser within the meaning of the 1940 Act; and (iii) are "independent" as defined in the NYSE listing standards. In order for the Committee to evaluate any nominee recommended by a shareholder or shareholder group, potential trustee candidates and nominating shareholders or shareholder groups must satisfy the requirements provided in Appendix A to this Charter. Other than the requirements provided in Appendix A, the Committee shall not otherwise evaluate shareholder trustee nominees in a different manner than other nominees and the standard of the Committee is to treat all equally qualified nominees in the same manner.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3.&nbsp;&nbsp;Once a nomination has been timely received in proper form, the nominee will be asked to complete an eligibility questionnaire to assist the Fund in assessing the nominee's qualifications as a potential independent Trustee and as someone who is "independent" under the NYSE Listing Standards. The Committee will make such determinations in its sole discretion and such determinations shall be final.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4.&nbsp;&nbsp;The Committee may identify prospective trustee from any reasonable source, including, but not limited to, the consultation of third-party trustee search services.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5.&nbsp;&nbsp;The Committee requires that each prospective trustee candidate have a college degree or equivalent business experience. In addition, the Committee considers whether trustees on the Board may not serve in a similar capacity on the board of a registered investment company which (i) is not sponsored or advised by the Fund's investment adviser or its affiliates and (ii) the Committee in its discretion has determined to be competitive with the Fund taking into account such registered investment company's investment mandate. The Committee may take into account a wide variety of factors in considering prospective trustee candidates, including (but not limited to): (i) availability and commitment of a candidate to attend meetings and perform his or her responsibilities on the Board; (ii) relevant industry and related experience; (iii) educational background; (iv) financial expertise; (v) the candidate's ability, judgment and expertise; and (vi) overall diversity of the Board's composition.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6.&nbsp;&nbsp;The Committee shall evaluate the participation and contribution of each trustee coming to the end of his or her term before deciding whether to recommend reelection. The Committee may seek the views of other trustees to assist them in this evaluation.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7.&nbsp;&nbsp;The Committee shall periodically review the composition of the Board to determine whether it may be appropriate to add individuals with different backgrounds or skills from those already on the Board.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.&nbsp;&nbsp;The Committee shall periodically review trustee compensation and shall recommend any appropriate changes to the Board as a group.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9.&nbsp;&nbsp;The Committee shall periodically review issues related to the succession of officers of the Fund, including the Chairman of the Board.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Nominating Function &#150; Committees</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.&nbsp;&nbsp;The Committee shall make nominations for membership on all committees of the Fund and submit such nominations to the full Board, and shall review committee assignments as necessary.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2.&nbsp;&nbsp;The Committee shall review as necessary the responsibilities of any committees of the Board, whether there is a continuing need for each committee, whether there is a need for additional committees, and whether committees should be combined or reorganized. The Committee shall consult with, and receive recommendations in connection with the foregoing from the Board and Fund management, and shall make recommendations for any such action to the full Board.</font></p>
<p align="left"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Other Powers and Responsibilities</b></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.&nbsp;&nbsp;The Committee shall normally meet yearly prior to the meeting of the full Board, to carry out its nominating function, and at such other time or times as the Committee or Board may determine appropriate or necessary, and is empowered to hold special meetings as circumstances require.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2.&nbsp;&nbsp;The Committee shall have the resources and authority appropriate to discharge its responsibilities, including authority to utilize Fund counsel and to retain experts or other persons with specific competence at the expense of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3.&nbsp;&nbsp;The Committee shall review this Charter periodically, but such review will occur no less than on a triennial basis, and recommend any changes to the full Board.</font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><u>Appendix A</u></font></p>
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Procedures and Eligibility Requirements for <BR>Shareholder Submission of Nominee Candidates</b></font><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><sup>1</sup></font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">A.&nbsp;&nbsp;Nominee Requirements</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trustee nominees recommended by shareholders must fulfill the following requirements<sup>2</sup>:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.&nbsp;&nbsp;The nominee may not be the nominating shareholder, a member of the nominating shareholder group, or a member of the immediate family of the nominating shareholder or any member of the nominating shareholder group.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2.&nbsp;&nbsp;Neither the nominee nor any member of the nominee's immediate family may be currently employed or employed within the last year by any nominating shareholder entity or entity in a nominating shareholder group.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3.&nbsp;&nbsp;Neither the nominee nor any immediate family member of the nominee is permitted to have accepted directly or indirectly, during the year of the election for which the nominee's name was submitted, during the immediately preceding calendar year, or during the year when the nominee's name was submitted, any consulting, Advisory, or other compensatory fee from the nominating shareholder or any member of a nominating shareholder group.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4.&nbsp;&nbsp;The nominee may not be an executive officer, director (or person performing similar functions) of the nominating shareholder or any member of the nominating shareholder group, or of an affiliate of the nominating shareholder or any such member of the nominating shareholder group.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5.&nbsp;&nbsp;The nominee may not control (as "control" is defined in the 1940 Act) the nominating shareholder or any member of the nominating shareholder group (or in the case of a holder or member that is a fund, an interested person of such holder or member as defined by Section 2(a)(19) of the 1940 Act).</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">B.&nbsp;&nbsp;Nominating Shareholder or Shareholder Group Requirements</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The nominating shareholder or shareholder group must meet the following requirements:</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.&nbsp;&nbsp;Any shareholder or shareholder group submitting a proposed nominee must beneficially own, either individually or in the aggregate, more than 5% of the Fund's securities that are eligible to vote at the time of submission of the nominee and at the time of the annual meeting where the nominee may be elected. Each of the securities used for purposes of calculating this ownership must have been </font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;Appendix A applies only to trustee nominee recommendations made by shareholders to the Nominating Committee. Refer to the Fund's By-laws regarding submission of shareholder proposals.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Unless otherwise specified herein, please refer to the Securities Exchange Act of 1934 and regulations thereunder for interpretations of terms used in this Appendix A. Calculating this ownership must have been held continuously for at least two years as of the date of the nomination. In addition, such securities must continue to be held through the date of the meeting. The nominating shareholder or shareholder group must also bear the economic risk of the investment and the securities used for purposes of calculating the ownership cannot be held "short."</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">held continuously for at least two years as of the date of the nomination. In addition, such securities must continue to be held through the date of the meeting. The nominating shareholder or shareholder group must also bear the economic risk of the investment and the securities used for purposes of calculating the ownership cannot be held "short."</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2.&nbsp;&nbsp;The nominating shareholder or shareholder group must also submit a certification which provides the number of shares which the person or group has (i) sole power to vote or direct the vote; (ii) shared power to vote or direct the vote; (iii) sole power to dispose or direct the disposition of such shares; and (iv) shared power to dispose or direct the disposition of such shares. In addition, the certification shall provide that the shares have been held continuously for at least 2 years.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">C.&nbsp;&nbsp;Deadlines and Limitations</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">A nominating shareholder or shareholder group may not submit more than one nominee per year. All shareholder recommended nominee submissions must be received by the Fund by the deadline for submission of any shareholder proposals which would be included in the Fund's proxy statement for the next annual meeting of the Fund.</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">D.&nbsp;&nbsp;Making a Submission</font></p>
<p><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders recommending potential trustee candidates must substantiate compliance with these requirements at the time of submitting their proposed trustee candidate to the attention of the Fund's Secretary. Notice to the Fund's Secretary should include: (i) the shareholder's contact information; (ii) the trustee candidate's contact information and the number of Fund shares owned by the proposed candidate; (iii) all information regarding the candidate that would be required to be disclosed in solicitations of proxies for elections of trustees required by Regulation 14A of the 1934 Act; and (iv) a notarized letter executed by the trustee candidate, stating his or her intention to serve as a nominee and be named in the Fund's proxy statement, if nominated by the Board of Trustees, to be named as a trustee if so elected.</font></p>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">This page intentionally left blank.</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">
<p align="center"><font face="Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">This page intentionally left blank.</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='',FILE='12-6485-4.ba',USER='rwaldoc',CD='Apr 27 16:07 2012' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g64853bgi001.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Using a black
  ink pen, mark your votes with an X as shown in this example. Please do not
  write outside the designated areas. X 01GKUF 1 U PX + Annual Meeting Proxy
  Card . Authorized Signatures &#151; This section must be completed for your vote
  to be counted. &#151; Date and Sign Below C NOTE: Please sign this proxy exactly
  as your name appears on the books of the Fund. Joint owners should each sign
  personally. Trustees and other fiduciaries should indicate the capacity in
  which they sign, and where more than one name appears, a majority must sign.
  If a corporation, this signature should be that of an authorized officer who
  should state his or her title. Signature 1 &#151; Please keep signature within the
  box. Signature 2 &#151; Please keep signature within the box. Date (mm/dd/yyyy) &#151;
  Please print date below. + B Non-Voting Items For Against Abstain Change of
  Address &#151; Please print new address below. Comments &#151; Please print your
  comments below. For Withhold For Withhold IMPORTANT ANNUAL MEETING
  INFORMATION 2. To ratify the selection of Deloitte &amp; Touche LLP as the
  independent registered public accountants of the Fund for the fiscal year
  ending September 30, 2012. 3. In their discretion, on all other business that
  may properly come before the Annual Meeting and any adjournment(s) or
  postponement(s) thereof. H&amp;Q HEALTHCARE INVESTORS A Proposals &#151; The Board
  of Trustees recommends a vote FOR all the nominees listed and FOR Proposal 2.
  01 - Lawrence S. Lewin 02 - Daniel R. Omstead 1. On the election of three
  Class B Trustees and one Class C Trustee: 03 - Uwe E. Reinhardt For Withhold
  Class C: For Withhold 04 - Michael W. Bonney Class B: MMMMMMMMMMMM
  MMMMMMMMMMMMMMM 000000000.000000 ext 000000000.000000 ext 000000000.000000
  ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000004 MR
  A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6
  ENDORSEMENT_LINE______________ SACKPACK_____________ 1234 5678 9012 345
  MMMMMMM 1 3 7 7 3 6 1 MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140
  CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND
  MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MMMMMMMMM C
  1234567890 J N T C123456789 qIF YOU HAVE NOT VOTED VIA THE INTERNET OR
  TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION
  IN THE ENCLOSED ENVELOPE.q Electronic Voting Instructions You can vote by
  Internet or telephone! Available 24 hours a day, 7 days a week! Instead of
  mailing your proxy, you may choose one of the two voting methods outlined
  below to vote your proxy. VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE
  BAR. Proxies submitted by the Internet or telephone must be received by 1:00
  a.m., Eastern Time, on June 11, 2012. Vote by Internet &#149; Log on to the
  Internet and go to www.envisionreports.com/HQFunds &#149; Follow the steps
  outlined on the secured website. Vote by telephone &#149; Call toll free
  1-800-652-VOTE (8683) within the USA, US territories &amp; Canada any time on
  a touch tone telephone. There is NO CHARGE to you for the call. &#149; Follow the
  instructions provided by the recorded message. </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105981\12-6485-3\task5295534\6485-3-bg.htm',USER='105981',CD='Apr 25 15:14 2012' -->


<br clear="all" style="page-break-before:always;">


<div>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="92%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" color="white" face="Times New Roman" style="color:white;"><img width="680" height="880" src="g64853bgi002.gif"></font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:4.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">. Proxy for the
  Annual Meeting of Shareholders to be held June 11, 2012 This Proxy is Being
  Solicited on Behalf of the Board of Trustees The undersigned hereby appoints
  Daniel R. Omstead, Ph.D., Oleg M. Pohotsky, and Lucinda H. Stebbins and each
  of them, proxies of the undersigned, with full powers of substitution, to
  vote at the Annual Meeting of Shareholders of H&amp;Q HEALTHCARE INVESTORS
  (the &#147;Fund&#148;) to be held on June 11, 2012 at 9:00 A.M. Eastern Time, at the
  offices of the Fund, 2 Liberty Square, 9th Floor, Boston, Massachusetts
  02109, and at any adjournment(s) or postponement(s) thereof, all the shares
  of the Fund outstanding in the name of the undersigned as follows on the
  reverse of this card. THIS PROXY WILL BE VOTED AS SPECIFIED. IF NO
  SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS 1 AND 2. PLEASE
  VOTE, DATE AND SIGN ON OTHER SIDE AND RETURN PROMPTLY IN THE ENCLOSED
  ENVELOPE. Proxy &#151; H&amp;Q HEALTHCARE INVESTORS qIF YOU HAVE NOT VOTED VIA THE
  INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE
  BOTTOM PORTION IN THE ENCLOSED ENVELOPE.q </font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105981\12-6485-3\task5295534\6485-3-bg.htm',USER='105981',CD='Apr 25 15:14 2012' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g64853bgi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g64853bgi001.gif
M1TE&.#EAJ`)P`_<```0!`0D%!@L'"`X)"A$,#1,/$!81$AD5%AL7&!T9&B$=
M'B,?("4A(BDE)BLG*"TI*C$M+C,O,#4Q,CDU-CLW.#TZ.T$]/D,_0$5"0TE%
M1DI'2$U*2U%.3E)/4%524UE65EI76%U:6V%>7F)?8&5B8VEF9VIG:&UJ:W!N
M;W)O<'5R<WAV=WIW>'UZ>X!^?^<`;N<`<N@`=ND`?(%_@.H`@^P"B^L)A^P*
MC>P,D>P2C>T3E.T;E>X<F.PAC^TDENXDF^TMENXKG>LPE.XSGNXYG^\MH.\T
MH^XZHO`VI/`ZIO`_J.U"I.U*I.I,JNI3I^I3K.I:KNE=L?!"IO!#JO!*I_%+
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M_@``````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````"'Y!```````+`````"H`G`#``C^`+D)'$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FRI<N7
M,&/*G$FSILV;.'/JW,FSI\^?0(,*'4JTJ-&C2),J7<JTJ=.G4*-*G4JUJM6K
M6+-JW<JUJ]>O8,.*'4NVK-FS:-.J7<NVK=NW<./*G4NWKMV[>//JW<NWK]^_
M@`,+'DRXL.'#B!,K7LRXL>/'D"-+GDRYLN7+F#-KWLRYLV>QV@2&YC::M.C3
MI0F.+IW:M.O7KUFK/CTP]>K6M6GG=AUZ]6S2N&GW-JC-]^?CR"T'3\Z\>=1J
MD;9%XC8,BR-N9\[X$C4,%+5)W'K^91%5#4ND4KW2]R+%S5.58,"JD`+5G1HH
M8-P:::DFJHJO2=!)MPTW9)#!S2-:_$*)-9-L\P@WU&CQ(!G:B2*-=^")1UX6
MD9BBWGKM50%,,/*)T@LE#D(H(8%G_,(=AN')9PV''JK''B@BQD?*)]T-(PI^
MC6#!WQ6]`'C8-<XEF5-HU%!1S1'<^"(#$MO4P,,G9/@RQB]7<"/)"V50$T,5
MCD@B2222H,'-&"^0(LH+C(RAI9;L#1'#,&>\X`D63?:YC0TV:).$#*1D0<T4
MU2P190Q):&/##J!D*2<6W$0")C4PD$G))&:J.08,;KZ`1AF2\"E%E#(T^J@G
MDG+I)0S^90PSIB.;1D*)IS"(0HJHDM+)S1`R4%,&#'M28]@UQ"BI[$W45%'-
M%-S\0H,2VN#`@RAG]$+&+UEP0XD,9PPC0Q:/>$+)N8RL22@I,C"2999EL(=$
ML&?(`(H6S5;C[#8XZ*"-$C60@J\5PT`K+;76@J+=EMU^>P8U-%SQR+F3>)+N
M&.O&P,@9D^QG\+3<W'#MPMQZ"RXU,DA\[KF>9NRN+]N2(2^],GBBQ3#+YJPS
M1,T>&BT-2'!C)2AE^"*&+]U.<K(,54P\R22W<B.&#+K&@,:[,,],3;V>&%I%
MS]O<@(.@A!IJQ;/1IAHV#PIK6;+2X3)-Z]-13^VF#&APC*_^$J@V.K1V8KP-
MKKA-KUPWU:1838:VO\C,31$RX%ES%CCO;/GE!O7,M[1^LZW=M@T/SO3$FWJB
MYM15N]M+X&>0H@T2-$@."I]??UTM#MLD48,H`U/#MR]`APRI=MI9P0W<*&?1
M",6'DY)XWAW[##RU5E+RN>!Q6^$TRU(CWJZ<1XLQL^R&8FX^YOG^GJK0;&<9
M>-)+%[YRRVXJ;K31\L9>QN0].WO[O[LS%*(V-RUM_.U^QG,8X9;W---UKW[0
MVP\!$>:Y^\'O8:,SW.EB`$&LG4$4W(#=UNQ%N?.94&<%0]LO4E4MSVD+:<=;
MFO8VQ3TQ<)!=5[L?&4!H!)J!0H#^^J+&_Y)``X'U#%K3:Z$HL';!8=#`"@R$
MVND09S6]26]:5:H@Z$P6JR=NKWG/<Q_,3/$Z&0B#:^4[H1J3E+Z?-2IAGX/A
M)&)P!F%DD&Y3K%H.6[1#;A@A=O7Z8;ZF0(TJC8V(HJ"<LS8G`R5D,5(PPQ[*
M9EBZ=-E05W@[@R3V]C/J\<!Z%O22Z&:(1ZG%('58<]R\MA:#KE5NC;#\#),&
M&*4"#LU]DI0!*2N6QS#>[X-^I,$(NT:-LR&*7S7@!A$+=2@5TN"-U\)EZ#!8
MA>71<(/.JV+TD/A,`VI1CO$C70TSML=>`%.$]:($%EX9RW9R9I!I<R0<80;.
M[$41C!K^$R,93.''R''M9L8L)`YJ(*@B>JT:OWOF(]_U-CHFCW12[!XF(^@[
M-[*O;0R+8;B>R,`:GC)QC`B?+SZHC1Y*SF;L=*=*+S.,KQ$P"8\$'/:<2$E>
MFO)N<:)G'TUZAE92#E%G^Q_`C/@U;E*P;4=K(M,Z&C6,0="*+]6&R"+%N-"9
M89+WG&(V\W8_\;T.D/Q;J5@O`\\D3I6A2MUE4ZF8PZ/M,X0T(V9`A4J#1+;Q
M8%GT1!R5JCR*.="&SLOD-FM)K:D"#IRQTN47>VFU\/WBG#XLX7+&2MG$-%-]
M1Y6I\9!W1X\&-J0ZU%H@@4C(L-V@H$1%J!M;J+#5Y;*F^*3^:$([%ZG'(DT;
M"LS@_-1UMQR^BST]E,;^?IC2RAI7,7>U907?9[(ZZC:BJ,.A&%L'UY.:+5_\
M.F1=29LV:!(MDM.<Y&(?*(I,;M)G*TQ"R%S(7(>A3'[CS.;+W`K<N);PN/A%
MKDOC:<#A&2V7U60>-D4!`S2X%68\]*=/^R?0&RC3H)I#E2?;EJ6DT5%<L*6?
M*+3)2<Y)M7VA5%IBX7LX/::ROB,D;GY7?!AJ9$%?T:K!%+2A@Q\H[+&_T(+)
MT.!$+43"7)3P1",(1`-3F$(&C2#>2/D),&J@@6KX>O&+:>RO*01L/UZ+\8QK
MC*U(ZOA;:(`8AU8&BB&385U(1@/^)<0`XU_(F,8_$`4:1IKC]N!-S+8Z5YD)
MA.8D1_(,I>`&P(;Q9%"(P5@L3O1@!C0@;5C#&MQXM#88S0U&5V,;VKAT<39M
MZ>)<FM*8CG0U)CUJ4`O$&M6H=*DKS>I,#^C1VS"UJ[GQ:4P7I].NCC6E:3V@
M:E@CUI6>-&DNS6M;WUK5GHZUL$.]C5);0]B*CK:TITWM:L]DL@G!MK6WS>UN
M>_O;X`ZWN,=-[G*;^]SH3K>ZU\WN=KO[W?".M[SG3>]ZV_O>^,ZWOO?-[W[[
M^]\`#[C`!T[P@AO\X`A/N,(7SO"&._SA$(^XQ"=.\8I;_.(8S_A36L-QV,Q&
MVP7Q37'^/*Z;W7Q<-]H>#D*",_*.JSSD)D<YS%%3\I?3W.8D%PW+2Z[Q<W><
M,R#O>;CUH(?2$+TTJJB#'91A$%7D00]YF`5"_E`'I@OD#TOGQA^>3G2H2WT@
M5%\%0:Y1AZ\+9!9/ST/:\W"-5\PA%Z9911W@'AIEI/T5!@D[0>3>]3S$8B!\
M[[O854-TTA`=20+)@]C[D'710)T;N:A#UZ'^AX$X70]\0#S:H:YVJ"/>[I0W
MC=VYGH<_I.;R>D"\T/.KC`0D`/'7.``"K-X"`DC``!Q031L2```!`.`!>3@(
M!@`@]M`,7^P6$(```A``W\O!-,AH``!(X!I7`*`.IY%#[P7^8`#E`V`6+;@^
M-Y"D`O%S(Q##]ST"GC\093!@^JXY`0`(T'P`'``.`I$_`;8/`!.\YAJNAPW7
MH```P`("<0T"4`+<4'XN8!JJ```8P`US```&P'\3(!!UX'O*5P%X%P?;UWV^
MIPKGEW[SIP),IPH"0`#*UWP?8'49V'L`4`%2%W2KIT;7\``08'77``$/@"37
MP``7J'UZ8!IZ```0$`BQD`<'<`!X5Q`=8`"N8!H>`(7<P`$&D`>OH`JKH`I6
MQPU*V``,@'>A\0H#$'RCH0RH,`LG(`!M,`NIP`UI``#!AR3A-X<2``!L@'8'
M(`#%YX4'`(9BR`TM$`!L``NN4`?^##``?2"(`I"'6J@*<#=V/(@-V``!"J``
M4O>#*\`-LY``%H!X<?A\=1``)S`+CXAWG1@!J0`+=0``&<`-:*B&C6B*VG`-
M$8"'L[`*&P``:<`-KF``&>`*6KB+U->)$)`*L]"*$5B#QW6##@![#_",`D$"
M!B`'(9``37B#"M"'>2``'F`0'3``@1B.>,<!!!"%P@<!*P``;V`:KB``V#<;
M=3A^@BB'W(`-]8A]'MB+H<$&+&!V&``!+,".IC&/H>$"`/!\`VF&"'&##7`-
ME:@`!O"-`+B)W.`!!/"&VH`!3.B%`-`"L#$+!+`!3*<->2`'2!(:!EF/O2@0
MRC`!!I#^"R*9>P*Q"@80@2))DHDG!S3(C";DD'9`=';0`#TH$'9```;0`$TX
M?@T@`2G)#:^`>[!AA6_0!WG0!Q9`A5:(`1N@`1C@`8CW"@10`LJ@`!00E@'`
MD*<QCW08`"RP=7X0`O"X@/8X<@0AEB10EA.`>(.X`E:9!Q"0`'#'`@-0`5VY
M`19@=J3AC!#9E'+Y?`A@D=K7BZL@`">`@0(P`8=9`8NX@`)P`!L`!UT8&@M)
MC^$WA"/W`0+P"B)I`7SP="8``/C'#6L(FJ+ID\>E#(&Y@@*0`!"`)+$0F`P@
M`<HP"U$X"P9`?:-Q#17@E+G!`0>P?[[G>F*W`0=``190`17^H`&(IP(",(0D
M(`"5!Y4"H):F49I(P@(&4('J9P#8%W[Q:!`H\)W<$)Z!(!#JR9X'@`'!QPTL
M0``38`$".@%+>8`.X``"Z``2H`H)\`"SP``J<'8)4`%P"`!^@($#$`'9:0$0
MP`>B@0)928'M6)!UR0TA@`"*V08)F0L'D`#*1P#JN!HJ4`$%(**X65D.>0JN
ML`JI0)37H`T30`!^L(XD`(3CQP!%B21BN0$&88Y^IPJOD`%:20`%&AK7,`$(
M``>!T`(#(`("\0IS^90"$7YV0**..`NQB7WKR)#*$(E7F@!P\`=<ZJ7UF(<:
MX)XD:IX%X9`0Z0`-P`UO$``F`*'^IF&.JH`!TL@-=O"1LW$-*>D*:<``"E"2
M]1A\^+BFXQ<:'2``LY`+!(`!L[`&!``"L(>/V@"IDMJ%-ZI2U^"C!OJG(@F2
M"V@`"3"$5WH`(N@!+/`&`A`"34JE`]$!YUB%PUH0?V``>]A["=``4@>F_9D;
M*QFM`%"F<6B`H>&=P><'R+I\O<D`4C>/Q/``<UFI"G&##U`<!XHD3U@`UNJ%
M!K`!"7"9H9$'C%H0?7``V!<:)D``E:>2):H&`'"99P<!!T`,LS``'8"?`.`!
MH7&OSQ<:)\"O.;>J)V2N.O@`Y_J#$/`'JZ`"2'D">/<'F5D')5``+=JO!.$!
M!1"%FKK^LE5H`%69=I4G`@10![&@"K-0`@*P!KY(`"O@!VG'ER7*EN2J#<G7
M`H&P!K0J=2+@GEF(I@+0BZ7IA0,``5+'`@+``D`+=7R0&N;JJ`[PFUJWA"!I
MI1*0``9PH?,J`"*PM9Y7#`F@`'+@!THKC?[*D!L)`"H`M!-`D*Y``-\(BQ4@
M`,^7"W%;!W2;E*I'L>TT@`P`>Y>()'J0B"JX`B1@C]R@!])G``CP``80`LE"
M$!D``*U@&AI`?-R0`=[G?1A0#+97&E$9`3T[`,T7@@*QCOG*#;A+C[O+B2#0
M>P'P`$,HDA(`NP8``?XYK:81FQ^P@`&@@O5G`*HZ@`I0BPK^\+AC"@";.'+R
MYYRAT8H@"(,BN'O*)P#`=QJ[.QJS$`+UAP!O@"36IP&FT0><&X5O0(#*)[R,
M*U:KL`JET;]GJ`JJ\'=V1Q"FN(7$D`;,6A"OD`JJU\!*JH7]NX6SH`RG$(FC
M`<'8(,$3C'BY$`A=.`NGT(4?W(77T+^I8'7*$`@8_*6IH`TE/!`G'`C7D`NI
M,,']BXZUL86D`<`N>0J*^<$%J@PWC,.KX,%:F,(%$<-CIPK"N)37D`H%.@N!
M\'6YD,2JNK^*]G-CYQ,]Z11?G&U:_&W&01&R01PSIQ!AG'/+<<83F\8/4<:_
M$1$IM\9C?,=XG,=ZK!0@9\=<O'+^,7<0=HS&@AS'#.'&JI%RA[S'C,P4@]S(
MW%8-9V`-!A(,16`@4U`%I1`)P?`(PJ`FI,`#`/(#9P`*SN,\E'`@/)`>G_0(
MP=`(PO`(O2`U/U`-D\`#I(`&DFP-DZP-F:P-9%`$O:#+DVP@PG#)OIP%F]S)
MG\P-H3S*'P0*Q/QL4P`M8B#,TVS,R#P%5F`*G.S)H"S*U$#*NJ(KI``>C[#*
MO=#*KQS+LRP&M7S+I3#-O5S-VG`&1C#,DKP-E;S-ROS-P1#.T"P*G@#)+-8G
MIR(EC7(#D((U7?(E83(F3B,)E'`Q;4(*!=8KC@,LPS`LQ$0%33)J.'!:2E!7
M^`+2C.3^-SN`)?=#*9,`*V+2-/K1,]5R6H-B5TZ2T%/"#?WR74?CTB]P59W5
M5*"R*V8@!JN3-;\B`\)%+'SB)(A2TV0C"D^M6@HM50V=U-TB"3!@!M(P.NGR
MR`9M.2VE0HW$6M=S02BC,KME-QOV,G(2+W"58K031'256J>"5]8B"D6S1>ZE
M6`B2+T-T9?"T0IE%3WPE3FM5/QL36M452+0S#%8@1#AP2`'C->AUUO/4(DJ%
M!8\P9&.-7V6E4%:R1/^EUDNE03?UUB<60F!%3$4E4)9M5T552]Z%5AJ%89^-
M+[93V0^66E%5/3)E87'35]=$7E64U([#4R24+_Y3V;FS76W^!#SJ926A4#1)
ME=M,`PEA'=K&%6%ZS39]/5-W!%WDM#B_]=C-[2S[,E"H=5`O=5&'A=K:$]BV
M4P/:Q4RT1-WR?=H:]5Y,Q5@A94Z^(-?HQ#]5(-F435`E72A!]#'09-K,Q5E5
M,`F@[=V5-=W==$O^+6)?;=PV%5UX(U++'5G-1$A"1=BU?=4)@]MP0SB[W4S5
M4@/1S4R+M%KSM$4O_ER+C4/90E_]1#Z'4DR4C3O+Q-L5Q3GL`TK9O>/:,V1B
MC>'*<D06=4`5]M^I74I.55[9H5/C$TB]T]O:E4AE'=]_\T*H7>$S/=E#!&&U
M[6'"W>&BTU=04S<<M&$&YMBK-%K^@U3D[SW:WI76HC1BGRWEE57FMJU$TO3?
M-%`X#81-SW-@JF1&:$3D7X-,`*3?:$/=W@1).NY03&/A`S,,*<X[)XXJ09/C
MDM3H`8[<H)7>/91B!W7I[EW2M*U:<%Y!&:4T5]7HD]#="Q'EA/S&ADX85,[B
MND[>E#1.J2-3D\Y*KL3>LHU:O(WK:B,R73;A,E`&7RW3^%):T-W@0#1!G3[?
MVDTN`O9`SW-8RPU6Q%4[LEWCWX[K"M7B<IX]A8YMOK8;S18:S?9Q^^YHH8%J
MD,9KIR;LQ2X79?TQ$S;<QP/JCNY9K/U"DWY2D7TVV94[`11AP!,T#(U4`!8)
M@3W9&;_^3/!M48858J)#8@+>VO,BY$5U:="M.[1]18'>X0[5Z/F>$&@0!%,`
M"@*1!;-,!D8P'60@R@+1"/PT!450!03R`Y8T!3_@"9:L8Z2`!&@P(`G?8C>>
M1#60U8&30"L/4;'E\I$S7-<EY@!DZL["\.5^[[H]TU%=V5]EXYN^X2!VY10^
M7ENN.,J=/[+NW$*$W_]21-4>5=;"Y.1=!9&0+@GA"]!B#3,V"3<0#.+!#?*A
M)E00:\*<'P/2"SJ&!@7_'F,@'5TC':F\]89!Y7J]`TMD6_`3)N7]5][35DI]
MX+!MUS=@TVZ>Y`5D[^^#6S(4XPF>76LO0.C537#D6O!C!C#^OBGF+5^MW4-G
MQ#^$A/%T;_*754M!8^7U)"[D<N$PQPAA_6O!H`7\%&M.P@V?\"!HP`C#X`M!
M0`:3``R-(`;!(!"E(`;<\$/[$08`P0T4)&[:N!U$F%#A0H8-'3Z$&%'B1(H5
M+5[$F%'C1HX=/7X$&1*D-FI5JBGA]HN&$FTU>(`ZXTO,KRS<)LDX,TQ&ED:4
M*$VBA(:;F!BD1,5@1*87&5]E2'%#(F/8&1F@L)0<5H7:-APXM"6A(2I+R9/<
M?,E0LLTE3%]D:'*CA',8#2N/&FFA9J4:5QS;E-`@-=8D2I5)U+Z,Z;;FS3/4
M9%1YY-.G4**B2,5`PU1,VZ=1J9W^B0%*<+4IU;1U_1IV])24:%ORH!1SYF*<
MCB$S*KC08*-&N;5IRV+JX!2A-L_T8M2K%#4TU;2(TD*J-+<S3R.A$4/MT9@J
MDT1^!Q]>_'CRY<V?1Y]^8TEJK'^YQH&X[5O&MB,#I81;C`Q2I&0D;8LSJ&3X
MK*K1M#H-!VZ2J"$PLMR#3SZF:&ML)[OP,BE!;?X*K!J36/-E)6UN>(FI,>C#
M21@+?YIL*/[\`Y`I,CJCH4"KV+."&@T9A(X]]T2,CZT)X9)+!BLFZ<VA2<XX
MB(QJN-&B%(&$JD88;L@00XDB2J.&&U(B"8,;1W04PR`SN`'&$VI^>>21W-2#
M,TXYYZ3^LTX[[PR)&BK*>@\);F[8`103?5DLAC*D>2PR22;Q1*@Q8K#L!33&
M\(72&;DQ@L`R8O`D"]+(:LF&`1VD@AHIS)(!B1%Y^$2I$['@)A(8RK`-DD>N
MTDJM&K[B;ZQ2"9,A"6UL"%2V7Z[@1I(8S+"/DD6#XN91HV#(K-*E.I-J4TI6
MV^L&!:,BM:RSA'5)%!/?4K8,G:IH!#>#&-(&"33.J.(@+'JA9@=&?;F"IFVX
M*<67K'[12@Q1JM"F&BH.BHX14V8D`Q@\)Z:X8HLOQCCCAJ@APQHMN`F&!RVT
MV;*41X!A))@RN!$%AT>HT8$,3T2A612"&+G!%%-JB*01E(/^:42X+'30#@=2
MRJA&#&O$V`L)5;7@P12DQU@:9)%)5H*41X)!(Q@F6WXY9D]B2WHO(_R$VI0S
MDJXZY(^WU#J8E%<&&V8R*#&*YDBXP5EGGGU.^1&AB7[$Z+7'8#O>IZ->6VDQ
MK'Y["JU_IMMENT'Q[B%ASLCI(%*HJ::1,W#SY1$KN:&FRUX<&8:;7M!HW9I@
M#K(F$E&XV:814#3FO7???P<^>-_?%3X]XHN'%WGEEV>^>>>?AS[ZAHY'Z+?J
MDR^(^NO?E-XB;`RR/GS?Q@<?_(/*/S_[]*WW[=WRV8=?_?;/=W]^\LD/W_SY
MW4<???7U]U\`\T<_^@EP??4;8/?^%+A`!C;0@10Q2!X:\``&,*`!%FQ`!BMX
MP0I:L(,:Y.`%,RA"$6X0@R0T80E!Z$$/CA"#+.3@"TO80A.F<(0SW"`.2;C"
M'+;0A3\,(0UYJ$(9PO"$,FR``M)`'NII;WL*<:(3'SA%*E;1@7400`A.8`(3
M;)&+6SP!&+L8QBZ6L8Q>Y.(7U8C&-)[1BV048QK9J,8SUM&,<1SC&MOX1C&^
MT8YUQ&,;!2E'0.JQD'8,I!I+H(('J(![QL/>]*PX24I64GIY$,`K+&E%@W`Q
M/-L`1C!^\2^$".,7OVA=*4\Y#.(-XQ?`2.5!A@$,5")D&Z3<9"YUN<LX&02+
MKI#?;X3^F3UA#K.8Q,S?^XB)3&.^#W[%'&`"F[G,9!X3FNTSWS6=64!H-K.;
M__-F.*F)OA*4X)$>V082:K!.))#R$>M<YU.X\4X<K%,XW&@$/!MTD'S>()Y-
M(H/\>#E0@A;T(YC4I$$7Z,GO3,('VZC&,&K0"]S=@!3;T`85D+4-BUHCHQLU
MVK^J4"^.DN))54`6-ZZ`+%*@1*$OA6E,H<@-.P@`F`IIP2O2X`%NS"(#<E#%
M!D+`@5EP8P4<(`$PX\"!$&1`%778@`@\(`=N;``.!UE!&[B1AQ8$H@,A^,`2
M#^('#!1U%D3EQ@D"48<3<",6)%`&"5;!#39HM0\6*.HK2J#^C(0$H@)_,.H'
MB'&"#X1`!'X000A`<()5A$"Q*VC!'XJ!UA/X01DF\$`:^&J0-OR!K=S0:Q\\
M,`(.`/:H2>7&4D60@5-PXP.._$,%^L"--G1`&]<@`0BTN(:KOD&HL_4#"'XC
M@J+FQI-2Q(A!'O&#@ZB%HM6X@2\.DH6:5`,'%.4&=;E1C1I(-[O5O0%VM9O=
M>C&"N3)%;WH'ZLM,*N0:">B#!B:@C18`P`\H^``W2-""-#2`&&RH`#<DH-4*
M>.`::7@`,;@A!P:T]1H&L``W0M"":^CA`*NXQOD^X``_<*,.`*C#-1J@#`P4
M@+8AF`4!,BQ;;GB@`;-]PP.NUP+^!>0AQ2%810**<0ULL&$"W%`&,F;AB@/D
M@1L/J(,?0'R-!ZR"`FVXA@78D!L(R,$#)F:#"50``B`;U;\`%K!6*7""630@
MOQLP@"NN08$)$`,9N8!`"UQ;60.HP@\*,"H`7I&*"%SON".9YWFA2U'G3K=>
MUICH=&MBC?`>I`K@Q:X5:I)=*P1:O9?&M"41>CT]6"`5':AL!SR@BA*<(!49
M6($$BKH*!A`#`VH(!`2T&@<1`)D#$M3&*S@@6P_H@1NIP$!"Y,""%9"`&R[0
M@`?^@`%E?,`"<%C!&_J07V4P(!=U6$&QC6ILXI7@`WE800?2\(<)Y`&H:=@`
M'^0P5V7^3$`9Q!CQ&I+M!P^T@*?7($:&>PJ!58C@V2M@PPE(H`<^O*(!J[;V
MJP.!Y#YL(`UYV$`'KM&"-W#@JE7M\`3T4`$C7X,!JE`!!E10AQ#XV03@>00/
MFIMH[GHW"X=N-'FWF^COSER\D]9"$$J1A;Y0DGC(?>3/$])$W10]?4>/))Z(
MCG2FG_.)W),B^R(B]*=G&H(T;:_YWB`"MK:``VOPP"L>$`%9!Z(!&>[#!%*A
M`!80X.(8>`,W1&!J":0V!'7(P`84C`)N<X,8$/C#"MI:;A$X_!44Z`,&,C`+
M@7O8`LIX0.#;*H$X)(08'6B#!XK-50K4(0T^!8$<V*#@.OS^.!40X`8&\D`"
M#:Q!\-?PP`1F^^N_6B#Q&^B#!%3`!CF8/<-^F(`JV$X`K9X@#81-`PE.\8!7
M=*#RJSC[-2"@"GYS(Q<-2`4%_*"!#5`U(0P%]')IEVA&WU.[T+WG%19-\Y=S
M@]$W/P@:=,`#'=1`8E;'?_Z[5].$(F0#=G"!.(B].NB`6:B`=WF%.FLW.=`#
M#N"&->`R;J"`/Y@%!E@!%5"`4V@!.+@&`CA`N5LB@UB!"G`!#Z``$KN&.```
M/%@]`2L`;0BY:Z"\-*"`G:H`9:@`5<`&OOHU$,@#`.@T5P"!.CB(-4LH@V`#
MGEH!<Z(`;%!!KHHP50"`N3*J%=#^`V.#``9X@_DZB`1<A7:K`SWH`&Y(@Y+C
M@#Y0@!)(`Q4@`0YP`0S@*7+;J@A+`")<K%D(-A(`@-8RGW)R.HX0/_>[+O>+
MN?.++D7;KD.L.>Z"/^()Q`:R!GIY$FK0`C(PB$C4BX)X!"7X!?<K`T\I"$A0
M@OL3!26X'6V(!$X\B%*\'5LJ`Y,(Q5%T/TDLB%0D15/41%D\'J*SAE@*CT>8
M@EML15^8`C=A&5PTBV*4I2P(*-=11FX8ADILKE=\$H3H!2I($E8\B%YXQFAL
MQEZ`#%F2QIE"NFTXG4QCK_X[B`_0`Q58!1)X@SS(@VE+GS3(``R0LQ9P`2##
M@%P@A@W^X`8UV$<)TP,3L`-NX"]N@+V$N@8.F"M7Z(!3NRUF2P,YJX-:RP4/
MP``34`:'Y`97X(!4L`"IDC,/8X,_T(!94(%KV(`/``',$RH00"L2,#*`RP4,
MN*V45(8-\``/8`,>9($W8`.+5`$]*+EWL4=\Y`86V$=E<"H2R`4-\(,X:(,0
MX*L\R*\UV$>2\S`,8*JMXK)5V`!L,#GP\`0;$`,QT`(:(+0=H`(Q((,<^)AM
MT(&W)`,=F,NZA$L=")-M<,N]_!CS>00?^$/G,8@P8`12^!@D((5&$`HM0(/`
MX`9(N()@8`W$E,Q'R`++=)TA:(]MF(3*7)A>\,PIL))_"8/^R*P)2-C,RTS,
MU:Q,$"E-:PA-RXRBZVF3PMP(@X@$T>S,]AB&;?"!8!"#4@B&("@)8=B&(`B&
MYX"*QL2-X0R#VV%,T8&2Q`Q,]V/.X@R&T@S.X308J!`%1^@-Z;R=(6A,H8BZ
M@S"%,`$ZF,(D8!(?AY"Z[8D?Z[F&73PZ_#2(_+3/_3P@A?RY^5R?_1&?^IQ/
M_7PZ``+0)P(?__2?_^0?@R#+$CBY]\0(1DB"*9@",B"E7E""*:""*L`N$.50
M$MW&$!71$E51%$V(S7$@:X#%*H`.U)F";:""?YD"CY$N+0`%+;`&;MA1+:"H
M+/@%1J`$OGD$I<@N7V@$[V"$),'^41WU&(IZ#BUX$BFHTB9]4FY`@TA@TNA(
MB$;(`BM1$Y;Y!3&`%?'(@B(]TB1%`[RAFS)X!.]``TDX&B\9`VI`%F'``D]8
M&5(0@V%`EF'(T1L5TBZ!BZ^A4RB=A#P5U&&H"4D%A4#-CIIHCQ?-`MP0A=DI
M!5-X!"0(4G3TL/;2O]_I)'/"T%,5"5-QM$9X'&I(`D,]""4(ABIH'3%@A$E#
M@F"X@M;)@J.YG48H`RRPDF"]E$9HQDSE!EO%52@ATX/HU6=%UMMAA#/``F#U
MA-P@5F&H`FLH!2D@A2"XDF8,#RH`5E(@`VOM":%0S#%@5V@)C%Z8U"I`@]Y0
MS%Z`%6K^4()A8(UF[42^P8UWO1TTJ%-W)5)8\=9[]9(VS0*2:*?SF8)>6))J
M*`)3>"A0J)?\RP,"B(,_(#@^X(,^&%D](%F1[0.3-5F19=F63=F3A=F7#=F4
M75F4/5F49=F7S5F3O=F8S=F=I=D^D%F85=F>K=F1!5J45=FC;=F2_5FE%5J7
M!=J;;5JH+=FHU8-4V`!'`H_Z&3J!LI_KV47]F20]J56X1)T?,(6-#8+`F!TM
M@%N#:-LL:!UV.8-AG0(ML!+(N-MY^E=F+0*QL!*X_1AN*(+`.-9'Z%M@+-/L
M8A*#4`)&*(4A<!,MT`&*X@W=Y(@IJ%O%'58MF`3<*`4D$%/^1@!=T36"4O@8
M:C`",7"34C`"Q=PNM=W8P#V(1Q!=TGT*TPU=@&',U2T"UP48(S"%CZD&'C@=
M4V#,2/`!5*R!))7=536H#Q,``0B```"`Z@6`Z\5>[KW>[;U>`0#?[/U>Z[5>
M[B7?\,5>ZP7?`!!?]/7>\&W?]E7?\Z5?\W5?[=7?]_U>[A7?_>U>^:W>_LU>
M_MW>`M[>_U7@`@Y@]T7@`6Y?_HU?[S5?`'`DZ675CV#6+)B$QQ&&TOC7/4%7
M;@B#;1D.K,BN7UA7)=7;%%[AS$6=C2V-9Q6#29BT*6`/**F4W;V5UA%3@^C0
M,WB$W25,,7&7<^T2+5#AIXC3_&#^F3,H@X(%BH%EBH]I3MSU$K?XF*Q0F!,^
MB"AE&3)P"K[Q"4YU"UBY8C/VA2U&&/8L@FM]!&L(D2>1W?PCAD!8A550A3WF
MXSQ6!3W>XSS68T#V8T(&Y$!&Y#].9#_N8T4>9#Y&Y$$^9$A.9$JV9$B>Y$FV
M9$W&9$7N9$Z^Y$J^9$;VY$-^9$P^A>+*8/30AB'HQ"HPA2$@B84I@DY,B^[@
M!BQH*>F2@FVX@KTQTD<($S28A#``9E]PA#'@F][XC2*0KEL&9E.0`E[VY6-^
MA,<AYC`@B"C)#260+DKHA6TX@BH(*##N6FZH@F-VA&&>A%[P$U$08G;NA2/P
M$J4)`I+^R()2K.=J^(%M,-L@D"X</HA/0`E2B&<O;6<_$51KN&=JR.>"1IP?
M(`G6,`A36)AJ>`1MN`*4\I+L7.6/!NF!FH0B(.<K40(EV)N1KH+'Z84BR`+6
M4.F`ZH4?T`+6J(8@T()V^@6:MFF7%E4/L0F2EFF:7IB8=AV7[NF<WH:=?NF$
MF`0D$(-^IE-MV(%J^(0?J$;PF.FFMMB<?I(118)P+@(L0((NF8(L0`+A((,I
M0`+OF((J,`**(H,D0&EM,&JM$-(L,`)?6$ZT[A*P-@5M.(.3=FNT%H[!3H+,
M<30M,((R^%%,^9P=P*Y35=!Q4J9A0B9P8J9ENI]MTNP#A3K^`NJ?T$8Z!:4Z
MJB/MTO[:U-[L8,+L;");HPOIC^@%4/@7;>@/:[3M@PB&,W6=W089WZ8&2I@=
MD*$$1:4&3YB=;?"N7O`$4NIM'7&=YRZ(8#CN@QCN^PL&4%!4A/"%Z[XHUY$&
M+\EJ\(AN[*:$^]L&4,"NX2[N]<8NW):G];XG+Y&GZ?X77S`(^,9NY6XN3XCO
M_MAO]CZ?W!XZR^`&4QCO7Y@=4SC'V8;P"-<_#-;<2P,Z"K\(#->_;:@"#JT)
M,:`H7X"$:D""*E!%@>#03@Q5$^]$44"")+@=%Z^"MN;7(`4&UB`#):`")<#H
M;:4&R4V"#L\"7!*(W3&(W=W6:CC^`P[W<"+W'1E%`G/-CH/XA1(?5HH28N5]
MM$E\'(-P\3;E!D_85DHH7`F'H,J6NLJN\-5^B`&ESZK[3_50\SE'\SF7;=5F
M\Z5;;=26<&HH:V&PDB"H%W7]A5[V!(4N:U\H`FT(`TE8[S"A`E,ZE4<H@VT(
MAJ6N"B^A`1S%E[>5:#W9AF&`A.6H'T8XXKT)`QZ8Y9.@AF%@)>`Q"##&@MT!
MAA](TG@1!6HX@FH(`U.X\7D:@VV(#9;A`>D:AEH&47S*Z"DH;C._NJ:S\P6M
MGO=$4#:'.C>G&&PG(*:+=FB7;03E\S1W]HHP6XR"$BP0A:7XA<)58C*0$BA1
MX=OI!63^81<TF2?<^!=34`))$),BD-'3Y(9/9(1M^%=0\$7E<A.#\`YL9009
MU1-M,'?A\832J!*^\00F*5XJOQ)&$(-_R5Q34&:9$0ISIBC%)8-F'_?QD%X-
M3_F6%XGCU1(W(5%X+8.WT.%+$0B5^0&G:1V'Y@$WB00=8&MJH%=&`(9'&(PB
M@&HH(84Q*(6--?B%:)?<0/6F-X4AYP$M21+A62Z$T89[N8J,-W<QJ('&A80B
M0(,I`(5JN!=DR5QSGX0:H(+)=GF'H(25*8A&,,9%18A2F'*^/PB_KT;B]"[!
MYVTE5HB[[_N_'_;`9QK>G@G'[VXXQQTG_P[#!YG(WZX5!IG^,`C8:L#Y;6`$
M8P3]5A3]O8^-XRE]R/]\SC_]@P#]^1[]Y*&>40V>A*F&W,]]T-%]W=\*.2F)
MA+C11[@"1B`4>UEBY!_C?M4&X=B&(9A,-_D7=;UX!\'K?]$"7WCZPA6%!U<N
M9DX6*.F%P,"+?T4>?+F22*"&(1`#]%SC@YB$;7@.47@<S2R%(#WT,/#,WM4&
M-U%<;P4(;@('$BQH\"#"A`H7,FSH\"'$@MJXE0G3J`PW*8S(3**HA1%&2DHH
M9?%XD1LE*22Y`0L"B@JW3R-+M@15I1JWB15/>IKI$21*GS5ARER9<*)`2H]R
M1FPX$910EU.V:1M",M@PEU6H!B'^Z8L;E49B/'$+,BG+5RJ,Q%"B:!'CQ&U6
MJP23)I6JU2MIUY+MFJ47V(UM!R(E.+$7&:9-%S,VS&U8E2R1)6>I''GR%%.-
M-W.CAJ17KZ]3J&VK00:8$FJ/E'`S9<27J"K<L)#BQDBV#U'`IG![%$:8*6NE
MQ@SS48U*-2FB?&G64MM($(&?A"G>QLV1F&"_N$7BYIP;]&U(?(6>6#AGX?,"
MTZ\GW/Z]>\7PM9U'.G$,%FIC1#E:VNL*-TH\\@L2VXSQG"^1,,+4%8!%8H8V
M19`BBA2V+:@%&NC%IYY\[,UG$'OVQ<<9B24ZI,T5U'!312\E"2-;%2I*86!M
MM&DQ3$;^-'*313`*<H,&)6?4=@4PD33RXU(YI9BC&#66HH6,.E[1XX)H3"+D
M;)H-1`H:5)EBW2_#D#&&B0B%,621CG!S!B6^A!$3FPN>X4DO;WY"QC:R"8/%
M<-R(0H8U,`D#4XS<3($3-Z20*<H9DLC9YIM_YLG-GHK&A*>>,`VT#2.B<-.+
M-8\%,\D4')9Y*D'6@"****NRNJJKK'J"(ZH.;1.&9%IHTPA.I$Q2S66TDIH%
M=9%LMXT8V_0R116:F3)%%E/,.LDV2S&R#1J754/)=L&<(5`O*A9D2A55?%L*
M=]L!DZ$65V2AA76URKNI&%4LR`BBUPYCQ10=&<O-+Y1,*)#^-0MR4\V"I3"+
M[L#4,&+JO!%++#$U%>X8B1B/45&Q0*-5@:,8D6#1,34?[XA8;8PPH@5U?Y%1
M6R,&<VQHR=2%/#+-)KL,\\HX?C>1)U6LY(D6P02!;,814X'CSK9)0DF&?Y+A
M*2.1..JG&+Z,+$P6CBQ("AF^E`39S%/0JG*B9+SL--2)9NWB1U^__1AO3&7Q
M"$?!I!;$J$K$._&IOL@P..&%%PZ#)/(!OGB9O4Q"R23!1&3-XY.0XNLD=#X>
MB2^_1`)Y+YY,8CGFFD-NBBBCBV)*Y;U`/DDIPWP^">JJLPZZZ)9+M/A$OK3N
M">27/VXZ[:E/(@HUE`3OJ_*.BU[^BO&K_SXZ*;=/0@THHX,",>.`4Z-I$EHD
M1@T/I<A6EBC$>O>N0$6`HKZ]9WC:"!7J9\&(_-PTPEIG=?\@2M'65Q)N_,]^
M()D?M%J6F(DH9QM2(`L5?M`61AR)>YPQVX[P-[\L3")#I2C"=QC!P0690D):
MZ$P1Q+"4#Y+BA.0CET""0);>>-`(6MA@![G!0A<&(0Q+*6$+#Z8#R7U*"M7H
M!1"X088=?"N(%NS>0ZBA!3%0L8I6I"(9M``8*.Y./2)R#_?,0Y@O*H8^\#'(
M-JRQ#:HPQ53V,8\:U;A&.<9QCFF\8S7F*,<TTE&.>:RC&K7Q1S[Z\8[6..3?
M-'24,^[^#D0'(20DMS%(1!+2&MJ@I"$S"<E#]E&/H4IC'KDH2FKP1AM9H$3&
M(',<DIE,#&>9R,9T]HNIV>81+-N1+VA)08%\CY4@,PIR=`:,M3'"EI+[CD"4
M`*U3]L8'$XF9Q):VHUEZ"DB46!"CRI`RY44M;"<,AA8>@4TR_&)D9-/4:`32
MB".)H@QEJ*;RQJDU2H5SG.6DVT!ZP8-<5>,7-NC5"47)&4%6HZ`&/:A!22/0
MA3*TH0Y]J$*>"-%Y62,(.+J"*%CSO6U8-$#;H(*GM``5',UH"I["@B_.D*&J
M80$4TS3#M]#&C6T4`4=3"%1(94(=)1S'4UGX11EB^@@LA+3^-LFD3B^`8:@@
M6$M-$FW*1)1PTI1F"`V2((5LVGD&,_S(<K)1E#"&T!D.?I4X1N@,%6AJ4W%%
M`D!@0\.WK(K51!$G.M0X94D410V[EE*'`-J&I\3@@\0X<:(,Z9T,:*#8Q2XV
ML3*P@0P2]]13/76RDV7D(C=S6<PB9+.;/0@93V38T3YT(FB@`AH`5`4J?NL,
MJ"V)*,R"A!^]UD]!B,1LA?$#W`Z#%+=5@C:&\8-)("$8MUK3%&YC6]S:9@IH
M@.UOM:%;W%*C%+^USD3.4(5)[$!V8Z#&#KA3JHC%EKFZ):[D@L`(*I"B&KLM
M;EENX]+5BB%#1;@-6>C;6N>61`S^.!D"_4A!C>'"5[U5F"\5,V1@!(OA6P+A
MZ",J8XJT!N$7OPB"N$BK$&#PX`<_*(*'02SB#Q=!!R[]K(93C.(4L[C%+BX(
M),B`(VN@`0VAXD:,:24*,6PQ$C*>R(ZWV`LQ>`IK0B8R-ZPQ&!_KF,<Y8;)`
M@@PN)!M9/J!P\B-4%#EMH"'#\I+RIZ@LID@<1LQD('.2:QRJ,1.LQO'"&XXH
ML>8SE[G(;)ZIFBE%YS3;F"#4J+$VVN2GVCQBBR\6K>*XN`T!+21/O/D@=3BT
MFD1.$2';F,*1Q&`$ZJ!Q"DOAD"/\1A!2%('3`H&$A&Q5A4>7&B&3)@@5+<UH
M39O:,$K^<*I!5A/5(Y&ZU@?I]:&#+>S,#GNB'%IQ9XM=JVV8`C3.[H4IF@T:
M\IC"RXS;!@T"FA!KV,`&*(G!=G87!AHDT@<^L'2VP2.#KZ`QW?7AQKCC-1%*
MR&`[2!E##-HBT6W<H`;<\$2]'1D&&6!7(.9&]PF'L.Y'TN!-[]:"#.B3;DD$
M/-GT9K>R,\X8,ZXG/>_NN&'>.$;'2.3CBIP/QT^^H49*S.,A!_F(4#YRF+_\
MC"F_><USWAYD-W086I@BT+5PAI\370Q_$65I,L:];>``!_^NN$'$4`-Y<Z,(
M1;!T#3*&A("K)^F.E#K5Z4W$B9!!!F39=]-1`O6"A&'J!+'^.M;?A`0:V+L@
M7M^=U+7A]4FL_2#T5BK/-2[XP1.^\(3?1C`2KWC%"V/QP4`4%$NC;814(^T`
M#[=CM.#V@8`8ZR<T`MT?F77%343SB9Q$Z)E2]L$PA.G^IC?FW6-Z@@2A"*:2
MO+ICOZG1<RCOVJC!"?E>=X10(O6&/SYH:;YRB9H\T3('H\U=W'PQDM[YS@\1
ML:T??>0GQ.=$_S[XZZ6ER/-^1!.I_.ME(#F<@UU#M?^0UT$_?*3@7HQF;#MV
MYUUQLLN@+8F$/P[XFR>$'L>94?N9T8>=7%P`7]41H'O4'WMH'GTP(.K-W\C!
M'O=EX(/]S1IMRM_HG0<2QHT]F'W^))(E280)BB!A)!(;Y<0(0I3>%48+SI0,
MUF`(DN`-YL3_S10'RB`'_F`.:N"#)1XP.)X1_@+D=4_])83KJ9WN,848D)MB
M=)[HG5`1]-V#C=Y!M!]38*`9C4'_V0H.W,#3/>%$X-_;_8#SX9X18.%,U8##
M[1PW^!X%&I\C"9\0(E\P9$$2;`>Y6`%.[.$4;$<UD`$2>,H>*H%248,AUH8V
M,((1+$4UB,$AY@0C($&2"$0B$B(E(F*T?$4A5N(C8N+!C`$2."+TN<<P/.&I
M5(,I.N(E)@DE)$%BV`8IHD02G,%$*$P6X`0E($$M\F(@9H$2Q-XOUF(L)@4P
M"H3"W`3^2BRC#D%+$E*?&%7#^`V;SUG1%%71-AJ=H2DA`XI"JXG!"0E#$:#+
M#9#AY7E'QIAC;6B>#A4!)!"0&KJC_@#7[WT>#00#-:1:J.D=`Y(:-7A&QDA@
M@!P)'I*C$ID=-R`!KXUC.:9:#9#AQ;'C8Z0:/'[04B3@,*1:(Y2*U\T=/Z::
MKN&>0'I&8D@@[N'ASW''#Z`+H^%A'A+>1&3!K,A&<5W9CE#"H-A&QK"&%E#"
M,/"&6`2(-IA"$JR(,$#"3VI#+R0EB]B-)[R(3P:(=PBE;*R%4?;";%6!,#S"
M3R;A3.G@@UF(]FF6_C2E*;!&%?@"1ZT)*/C";%F!6ZKA&73^Q!`$`RB<P3;8
M94>4FD[:)&0,Q%[!I5RNB%M&QQETAQ$$0SN]Y5V"AV,NT*:4Y4`\R5FFF&H\
M`F=VIF<V`F<V@E(I&@-&PL(=W"_D&S=,I!-R`VK&0.)H`0W\6PR0B8<!C`QT
MAVQ.H-S)@#`(0VYZ!PU,8/#%P&_*@%A)H#;(0/"=IAJ"(5DP)W><YKD)3EOT
M6QFZYKG]0G#"HR?`0,;<)G?J9L3E8T/NHS#$@&[6`'%R@R08)W`F)WN:)QX>
MW!C``%FD&QX&WDPZ5,E,Q!7HY#`@AZ88$8_`&R7H2D94PX&B1?X44W;@TH.J
MR<'4C8%*#ELHZ(5.TX."I>3PR4#^5(,6*$%M1()2,<(O:$$5\*="T,5LI%0U
M'4^&D$)0N10C4`*CT-4>!A<62,*,CL$>HI4UC-?&G%K4E`$:N)25Y*BB!.DP
M9$$D=).3UHU`D((2P`LHU`8DD$(C%(&U'9HOP$`,C"F9EJD,C.D+2!;Y->=V
MP!UWDH7E!5P11`=W=D3;<0,HR$!B!`&=RD!'Y%UIR!T-'&=;T.$)T=MOTL!L
MT>&;5&#514?9N=3HX:&;,N089F>E=H1WZFE9T"D-_.E\CM[<"<,P^*EWX`!O
M<@/?)>ILW:EY8B#<E1U9P*&JJE]_$EXO&<H9D(EG_$+=?(;)"-T``2O3@`(M
M-0*NM(S^L<),0)&20!C!?U"'L`H$L>Z(L<Y/LGK'IU%$=W@E,!S!(QS!FF1(
MQ&!0%ERK;=SEC*Y6RMSEUS2+"TU!&?`:O':&$0##^2"!EJ`-5C5)ND["NYK"
M"0WE&2P%5@DL"B%*-8R&P&J#$5!"=)#"`!4;-3R-\@#/Q2K/Q4Z"KRW.-DCG
M>VX':C)DM]'F5_A`GY+GO\$`F;QF;`ZG-J1;$*B?,,!`=V`!N2WG"44"?"(G
MO)5GNO'L=@3!N=UG=.XLN&DG-_B":MJ``,;`R5:G>GJ'#*QLRTHM>=*'="I<
M,*2G;L*L=)IFX_DLQ$D<TD8M-Q@M-X1MTMZJX#FKH:A-9P3^@2^<SSEF@<^,
M04`9@2G@[<5@22.\2\M<R0;QDJ;PK?IH@=ZV3RG8CR3D3^#>2`8Q!1)\Q`\L
MR!CH@(JL4V9NAC1Q$)8PPAA<4Z),@;^*+NDJ#,*BY)&L)6;N5=T^JU&)4^F>
MB6V,[M=,P>O2X@HIP>K^@+CTP@^@`1GH`&#1`&`@+(M&WK.!AK0U;[6)DBEU
MA\+@"!E@A#!DQHZ<T+/@2!DDQE"B2R3(1B\H04?(;?BJ:A;49$>XUD#J+G>4
MQ/3J$$^1$D:T54W.8_<J46(0%V!D@?YB$/HJ`6"TY+-0QQF`+Q6(+X"4;T=\
M+]V(K_QRT)IL#"DQ,'U`:30.)!7^?$LDK"^*=$3U\J^J)@%@6`'U8I#;:AS<
MGM*;G%/'`,LO#="AF`P64%,MW=)/':O,U$T-@\Q9Q+`L$9,M2:M1&<HD9"E@
MH($./-.1E"O3Y!+5<%.BN!,\M<V?_`+<T"[8:/%CQ$C=%*E9TN@[V085=[&+
M8`$7AXTYP<0NLE>6;@,I#&IKG-#R\L[2QH#A[/'@($[GKC`@![(@;X81U`85
M&`TU4&4A6Z70<4.#*$=&:$,CT\4DP$09>,+U.O*HP,1B4@IX>(H42/*W_`4D
MAW*#.3(P5#)%8/(H`P8#U<89]$(U'($9``C:W+%!8,&W3(DJEP$E!,.Y[24E
M6+(G`(/^&MX)-_!`(O_%U1FK-@#O8"[RH:B(*43'7GJ")?_R,2>&,@\#%O1"
M=""S,E,EN,P6-22+%*"!N`:1LKU(9;PS/,-SLPB4AY31A[R'AQR;^>'S/=MS
MA^RS/U]?/Y-1:-US/J\</QLT0M?S(`N;==U7;\RIIY#:?047$E1N/$+T,""!
M#<U4%2"!1EWT">4)2/=/:UC=D6QT1W^01HNT1Y?T,!A!1S-%*8`T<(D4`0$'
M#]"*O*CT2'\T<"E1$6S:BH"T=1AB$4A.)%A=8`VU4H/81%O=@J23(1+U%(`T
MV2%!4N,84\^A5C]U$7@*4I"!$@S7(V"$%(""->@`*C:T6[_^-5S'-2\1T6/P
M-#70M34`0[S<-5)4@UX/H<+^]4P!0Z@(TESWM7'-]4#D=;P@7F#_'S7\M3!,
M!#6LV0ZV8F+/U.,-!#\^&&&O1V<+!*FNQS"HR$0,@UT'P_F91V@[-FAGV#!P
MFC:$-J7P-&?CR#!81S6HR#"\8+!5PR-,`B1X9F=.`F="@FC*M7(O-W,WGXEX
M%LGEH1M%-ZJ$T0IOYB.`YF=Z)B.,)G-_-WB'MWA+WW@7A*JP"GJC=ZRTBFV7
MMWN_-WS'MWR;B,.LDWW?]WVCZ!_/-W_WMW__MUR?=WH/.'K/"H`?.((GN(*[
M[9_5&!HP@H,_.(0_^!FPXH)?.(;^+X1Y,/2\6%!]>/BAX7*&"X3W4='/<>.)
M&]TUCCB+M[B+O[C$"`X?[S%L[C>,W_A[^X$+K$$:K`$+O,(LL(`R.,4U0%4:
M]$'RK0(+S,)`R`$<@%:1QT$<1-1!R($<G$B1-\4U1/F5XSAC;,,O*!XP%.&8
MEWGB_8)O>[F:Q_=$G```'(`!'```]($>`(`KM%%T7\,'U$'U"?0U#,`)J)Q`
MP`(`J(!`$(,`@(#BS((&J`(W3,`$)#1U<X,$1#KUG9&>\_FEQQQ3,+JC5WI`
M)YJ(Q[?#$#=Q:W=WK[FJ\S<+*``Q7(,R#'D>",`K"$26#P2L"X0K```>M-&0
M<T.N&\;^KY^<,JB'!SQ`D0>"`"!YKD]$'0!`K6/#>0P[-V`#M3-%!F0`KE-[
MK.LZ`-C!MB=$L#][K1?@M0,[M;^ZE_?.F)[IF;:['A-.FMKXJM?[($_$"BA`
MECM[`,R"-I@`!'@`DW.#'5```ZR`,G1``D2`,LC!&GQ`I*="!B@`"A2Y"N0!
M"1B`&N0$"5SY+(!``FA`*K1'"Q@`DZN`OJO"Q)^`-LS"!"3`!G!#"[``-[3!
M&Z1!`9A`D3.Z`J2!!_P!06"`MI-`'V```X#[-:!``B!`'6C#!BR\,L3!PUO`
M+&P`T,<!"$P$&SR``[R!R\.\S--\+)#``8``D[^""?1!`TC^P,A_O`$\0""H
M>:G?=VBNDR.`)AIX][!-]Z3;N]]#!`L0`-<W``1P0QX`0"Z4?!Q```9P@S(D
MP`?``0"\`1L0@**K``%`0!I<0P)(@!P80`=P@P4<@!J$0`"L`C<(0*";P`'4
M`01$`$&H`@#P.0,$^@%(`!P8P`=<0P@80`MP`P5(`#><@`"L``L`P)5K0`+4
M007,OF((/3<HP`.T@04H@#;(@0#40;[G0AH8P.5G/AO,`O)S@PD0`#>L@@"T
M0`O,N0D4P.]30*1CP`'(`00X@#:\@@!DP!LH0..3@`+T`4!TH*"-6T&#!Q$F
M5+B084.'#R%&E#B18D6+#@E>5)C^46-'CQ]!AA0YDF1)DP<)LC!`@L0($]SR
M"%C50`6W.@)R^3E`3)N<7+,"U.&F(L$U;FP,S.+6Q@"W#1:XO1)@AUL"%MP:
MJ.'6IP]';1!.%!-01T[2I0=@"GC%#0,&;BP2:-.68,4U`VRX^1&0AUM&#!FJ
MUK0#8-:;L;F411W+;451Q4(;<TOS@%LN.==BNF+K(94`/]P""8@U:_$*M"(2
M_*%E]&1KUR>':1&C1?9LV[3%B,EBZO7";<,*;A.V#5@O7]8.6D-NT%JO7P6U
M42-(K5I!ZM5\^0)>;?FV[+V`]Q8_GGQY\^<;-F9-\&8J"@D>-,"IWJ`K`7*&
M.C[AV!7^@3X>H+*/KP/2F`4`OK!!B1L/)&!*&?KL^Z,/`%9A"RH5%-#FF@32
MR`4`H5;9JZ^"_@K,)@%FP:8#``C0X!JI\,/0**F$(HJ;"MQB[:8*+?@@,VZN
M42`-8A8[00%N8ID`@`-(0,_))[<IQ90I39&2RBM+H<8\@GRA`1AN3-&!%!ZT
M0"(+Z+@98XP1N<F"BA\HX6:;('QI<XB"JA#CC!_<M.811@J"A$PE(F'SR4,1
M3511]`A:00'6"LIC@%0:$&&6//B*XP"EZO"#QJ$>Y>8-L_0P@)BGN!&0FP-:
MT.8`K5YY(S&#ZC```K?:V)0;/@A01@\!-&LK/[D2:)5`;D+^I,HO#4R\::U<
M6EE#@#>(^3"_&1>SL80("(KCE1\MX$`5`?B(ZH`_JJTQU%E4,<$S0Q>-%R1J
MSC@#C7K1R/=>>^TEHQ?T?,'A$VXBX4$4,0K"HI3@S!ACFX)\N8(;:A`N90Q(
MN!'#B.J**.,,4KBAY!-*`.6FD4;@E5?EE5ENF:%&#4B#C358R$4/PE!%`2J@
M3E`%@!5(^^`:N(PB#80_)'!+6*D&K(F#!%[IP(!9"U+&`0%6X,;H/VX]D05M
M,K@PKKEJTB"!-S80T:`2$SC!)@"(D8,`54)<(Q<!A"8:60!:^".!!O("0(X\
M#M0C@*R%;6""/SS(,)8B$^"F!`;^E,'C0)<QG\@:4DKAO///2PF=<U*T/,\4
M)<[@!HTJ0$'"$TJJ6*Z4228!N:`R17GX#%_*X.:,*4RAI@I&RO"$FRI>+_F1
M*4!YI+K,H8]>>O-:,.```Q``0(\_4(R%@00.$`HF\#%(#`,`UF##,9BN;T`5
M;C)PBVEN%,@Z%PL.8("OC`@JP8!`"F*'`QS`?5I[@/9``!5'$:1^W%!&!@B@
M`@,()2,9V`#]LF8'%"G#`@DP``CZL@'TK2%4VB"!`#80@@9<0QMIL%Z39G%`
M/7S`+:IHP`"I\BE'<4,5#_!@&J871(10`PV,R!<CC%A$(RYQ=^@AA1@>(0I1
M:`$416#^A`_J1!`R7.$*9!B1-BB!A#-HPPAG"((PSL`(1Y3"$?<B$\K^5)!(
M&`$-9`B/$/&81SU.Y!K$4,8?>8(-GCC0CQQ1!C%8<\AK]/$@RD#&K/[8EUP8
M!9$%Z2/5#G*-8A@RD@7QXS4B>4A/)B8/2OF402+I1R`-LH_%2"0B&6E)6!(#
M.H?,B#)<V<E#SDH;E13E*I7!D3U"KQJ4,.8QD3D)8WIB$L,09F\(0@HR_$(+
M%IL$PD!1A>`@+YL/ZP4:N#&,*WQ""Z8H0R3(0`I(,`(4'A/%B!KQB(*<+&7#
MM.<]\8D1B#Q3GQ'AYT,HL!(,($`I(ODG2`Z:SW@1)!@_*$+^$8SP4(A*-*)%
M,%@]7V,Q:NQ@&UB01!@*8H1WBF)-:7HG-7Z@&T>,`63"T,(5?G&&,OB"#&4`
MV<,>$00R3"(203@#%14:5*%&+Z$+*2I"/?(*$#P``Y\AR5&/.E0\=JD&5:T!
M#6A@5:W*8!(8=8TU@J$-X/R"&L$HR"^>$PQA%$089IT8)42AC5X01!N_Z,4V
MML&=8`3C>1,3!25,40U0@((2=9+J81&;6,4N]K#:P.MC(1O9AT$OJHRU[&4Q
M>Y[*9I:S#!E&%:Q@A2IDH0J@S4)H2^NFA3&*37*!#EV]TEJ#\`]-KIVM:W&K
MH-E:9+.=]2WF8IO'WOZ6N`WQA0S^D)M<Y2HW!I+P:G$?(LSA0I>ZU1W)=*V+
MV6V0`DNA\^Z4.E<Z\P1C"E50@EE%.X4S/0()5!!&-7C3BRPHX9V@*-D9JG.&
M8%`B"568PAFL$=\L3`%D9*B3+^1)$%!08V%DF((2%D:0;\X3%!-CQ"/J1(U&
M4$*\V?6PHHB1!Z-HHP^:P>Y)KJ&'7#A$&7XX,4*&>]!;NK@AVO`#)B?2!QQ_
M&*F'*@45MD$)*E`#"<,(1EFKL`U)C*$:`\M"EJK0"U#48*U+D(X8MQ$,1OBB
M&L(@136*$#PD]**]W""%%@H2#"\Z]Q%M78[)@E`=+?P@.E<HA3;-$(E>))C'
M?7:2,@C^T`(>"B`5Y\E#&^!%D%=8ZY\$404"(%409*A@QQ%A@QXD0@Q*[U85
M!X`4/^U2Z-X2Y!H'J)"?(Q(,)4R!U:UV-:NK@`20O5@CI4`S-\)`B3,1I!I*
M`)E:32$*1[!U&Y/(PIJ4L`U01`*_W)C$PX+1BTB4K!&.*,,51.&+6YMB8''J
M*D?HI4QND`$+C-B&$KBA!4>007>H=K=YV$`9#WC`@7\X*C$T4Y!`_*&1*S;(
MI_MRXX*$8`15.W5!:/0*HP"\(*MX`&MF8914>+H@J8"4*VC)#556G#40@$-K
M_T"U:[RO()UFS2F,XG"C*./4!%E%8J[Q`%4$LVKV1M,D+5G^:"`]X.#O9LAO
MJ$&-80Q]&$(/^M"%/EGSV+H@8@!%$)10!)21^0>]H(8IIATR+6SC$9$P`RFR
M8(TRB,*FSH8VUDLFY7*R]-9D6)AS8YWD@I#"IFO2`BG&8`IM5F,'_^+&D'T>
M>-<H@R8,J)`(+:"4#O"E`B:6#`,0D#6D*"`$,*G`"!*P/\G0.Q"`80$`&N"*
M/@RP#S%40$T(XHH#3,`!$[B&"*[RAB8UG`$F_$`%+'`_`WR`&R%0P`2(\0H/
M$.`-;\!`!PS?^]\K0PWYR_=;0,]O-EC`+->@P`%X[_L)*,,5#$`6!!3@MO15
M0`&OT,8#0H!^(*TH\;W_@`4J`$K^"RC``QI*/JVI^]DL['__5MC_:/EO"E:+
M/*+IUL1`UPR"&@Y,"H:A<^1)&JZ`F=H,"[(@&*@@"Z3`#,R.&X1!VJCM$;2@
M&AXA"WHGW1:FJ[KJ80B"$90@"XX`UWR!%*[@UJA`&@IB"CI,\'00J=H``$J@
M]QQ@%C:``[A!`O`C`4XM%PX@#^1@`ZY!#6+!#YJB#KS/`YHD0:3P&DQ`!>I@
M`%1A!1Y`&3C@@CH`B"2`Y*2B#;1!`>(@#BBC`A#-Y;RO`EQ`&0I@%?(`"?L`
M`H9B!7+!`##M!"ZH`>H@%2AC!4X@YK*F(-B@`+X0<$X``_R-&^1``42/#U?`
M#X_$`X#^"`)F8068)0,J3P'\(!!.XP&$D`@IH`X)8!;8@`@W`#\:H.=VT"!^
M@^AP,1>-3.G*PQ2&[!&J@,CL:AAZ(0A^`>RHX9V,X,NJ@!0D`9RT0`<DP8NH
M00JX01(>1AARIPA(@;RH8<BVH09`:MQ.4!NZRA9Q,$U*(9VX(0B"H""DH'2R
MH*]JL1X[0AD8`(`FX.-2(4,P0!9/;298B""4@00D@`_EH`*XP01>@M0@@`\D
MP!54H$F400$^L4F.#PXJH"8>@QM(X`2LY@\4X.!F@BV$@@%F81:.I`X:@`U.
M@`(,,3$8DALF0`_T@`'80`4<@!LL`#^,@@1^L"(_\0<S8A7^O(\E79("3J$!
MM$$#."`.*&`-6J!)X@`J+'(6O,\"/DX5C@0#A$(!<J$%)N`-/@`P1(#?\`^Z
MAB$+:*,MW;(MQ<`*>.,\]*\*@$,+4LO9U(L:FH,;M&T*>N<3WJD:TNA+N`$2
MBN-AJN%?2*&\>`,-JD,4Y`E,C&=A!I`;?@%C_/)UG@,84D=UJF,84"8M[;$6
MKV$6>1*(;M(DL>+47"$!9D$;X$`9)D`.*,4F%-($W"8C5B!<N.$$B'`6$D#3
M?G`C4P$.\NU3-N`E-D`#-H"ND`5P_I$;&.`57L'[Y(#GY.`/8O(W7X(";'(6
MY:!<IC-!3J`#M&8X5^`'#:(DLU/^%>0@$`R1+50@%:CE!)JD!=RB`5[!>]C"
M!;AA-:>3`7)A!39@%>(`@.1@+4JS(*Q!%$@!0B$T0J6H0B/TCLHCN)Y$&]A-
M(PCB$6RG0464CPZ@T.;@`-B`)FB2`TH@``X.`S8`-8BA`=J@>KC!#7M/!`["
M9^AM%0S`!3``*HR$&%8``M@``G0N1#+`-"I$#M"'33J-)N.`&PI@-`)`#E1/
M#3)`#50O,42@\AZ@#F;!`+0T:W!D5E:!58(T1_O"Y>[C%5YE2UVA*53`2%$Q
M#0@D?+C!`/IS"@V@#53T`?"C%?/@`-I@`H2"`AC4'KE$JQS546G@VS1+MBA5
MMIXIJJ#^DR&"IY\2(B-(@1='-%1K[`0*B@TT0`6,(@\XH`5(=41R(01"X'WJ
M8`/>H`5F(16R!@ZFE'].@-]@8@-(8,5480,"01N`5'RT9@7\(`/X`B9<]"!F
MP6WZ9B&5X@2N0@\VX`2T(1<2D1O@X.-8@-^PM5M552D((@^`=<5T%25.(&O&
M=5M-0$..]3>!52NPP02(@1BZE0TR`%6Y85I-0"F,3RNN@00*JD&!@0=^8&&+
M8&$=]F%UH,)$=6(IUIY,2`$J+7I$0$=)LV)KZ[D0!:\R0F0]MF3W*+90%L92
MME+11+?:M&55]E_5QF7K24-AUK92IJAHB[9>RUL_[E)O"\;^>I9B?T$'>.!H
MD39IC_8'<$!BT2,+WLD3?F`*BF`8@&%J@^"=,@(-)-5DO1:Z7NR7OM:RN"2K
M'O51N0ID3Z(:KJ!WC$CKY`LSD6"R2D$'"F5L\;:Z^*EC6Z/1HLLD^+:SHB/H
M"+<:"I<Z@@Y4Q8,@)L$3QN@1AJU-*`%ATLUV@N$,)C-O-?=)KJ$"!`VC7(XR
M/D!91B0-7&]$6$#0_@DN0H`UY(#>#,(.Z$W&7#93]6D%KD*Z%B(/(2!I`,X5
M+"#26':S@+9E4^(J4A5V!4\NF!>WFC=P*P(+'L'.)`%0M"$+)O=V(LQD1G-S
MO=<\N(<!A#<A<J$F*F!*T40%*([^(%AB(5J@`4IE2J^A:T8$*E^#?6=/GQCG
M!!J`]Q!B%4+E/-JW6RA`;:MK&)(`UE;MU5HM"4*T/(:!"M!`W2(!9;:!BB@W
M"_Z%(!R!S[[W@WOC)2-`#Y3!!6@)#MZ'`QC@XY0!/WJ2&U3X#1@C`4I``]ZG
M!%Z"#22@60M"#S[#`K)&!0@`=@DB(=E`!%;L&CB@`BJ$&/`"0;GA#S22&-*`
M`4#@8*\!^63XWU0`0-S&#Q0@`UZ!&%R@&&Y4YS))`D2MAS%`!!Y`&_I1C*GX
MA%>!&#*@)3E")#7@X/Z`*N0`/]9@YN9-6"T`!60251.Q#J`B\+2A&ASYD2$Y
MDA57/![^00.M`0O*H`I*`0D>`1B"X,S.9$20"(1)V36T`7X_(`2T80!TS`!R
MP05`X%=F02IX,@_6P`-^)1?20`#BP`,`IP16(!`@H`](T5!B[@]R`0+T\R#J
M(/,:P&TT8`)`(`&XCP!NE#),@$/JX`%>H01DF"!4(`1^Q?'2H`#R``*RY@'R
M(`0L0!L$0,<2X/E05WFUA@!88`4:@!@DP`[8>95U[`!>M6<VP-_F=YT5DB#^
MH"DHH`*TP0!6(014P`4HX!HD(`Y`H/),@`122%04\MT(0AA6S;\8V-62@#>@
M%R)$8:W,3!3.@`Q0AE[JA1Y[P>]*N:9#`J%A4PTB1P16(`_^#EH5U.`JI1,_
M4B$-P#(-XB)(RC=UZ>T$>(]_8/0WW\"GT20A)6<%B$0S+*!#CC(W?_`F2`!9
M^P*H[^]&$`V'N:$8^,`#`",$>IHI$V*'V20.)B`Z04D/V)H;0&`%]`!P.$`!
M6H#DJ@:OF:5J*J`.%*`"C.\:&*`/D$$"U,`3N?(:=KF=0:.P?2XZ#/>1KV.S
M'WD;3MJF11MZ5*(!&F```J$/,H`$@$@.+.!]K3,KZX`//+<!9L$%QL8B56`%
M(AL1\<(@2.!1_A!`SF9$K)H$@"942N`$B.%(Y*"`2X`]JU(`\((]7IOG#.)\
M/=)M0@`$1,`M[$`#/A)>!/(@WD#^(6>B(#^`!-RB#L3;;?25`2S2DD0`!$8`
MLYW"`DC`B[G!`42@7=O@`4Y@P)6A!2"@`OA"&=PF\(;!__C/P?GOM`;L,C?4
MMI@W9D<[PR_BE.N"@TC@*Y"0&QX@#DHM);/2#BS@#4H\#0#@%.0`+4J@!=A@
M(%J@#PQ"%0@@!-Y`#=J`#50(+2E1(<?[;)0!`4H)`7*A!*"B!)HD%5I`B=VB
M(!X`#C:D0@CB!.)/`FS5FME`(95!`@Y`%:Z!#:`S.]>#APQ`%0+\#]"BRQU(
M`A``@-B@E`B@65.A*=S<N`$@#M8``*A"`>K@%?K&U/H`0&-<A[FAJ`7/&D"A
M0AW]T47^`10P=$LTO-)?(Z$9M`V\KP0DP"C:(`$8Q`^PLI:;V0,@X!1<8`@G
M2')00!LJP``D8"U2P@`8(`"BW+6K.C=?HIFQKS+BXP$N:"9G`0+@XWT(H@WH
M3P+*A2"(H0(8@`0`M`(D@`,RP"@R@`]]=,2V.R'2(,=#(!>NG=J-0@.X150.
M0`%$(".P`0.FO=H-(J%G`1!@TR8\R&W2``%05'*T-<SK0`($[[B6BP:6"[F:
MRX!-HAH>9AM^03OD)!A\P:T,8J\L?>(AXAIB4Y96R9)F01GZJ)<<B(4B[H]`
MJ>,=".9P#I7RM1@@"1DRB98ZB1A.?I<20Y<0(Y,B+I9D"93^'"@V*ZD"+D@9
M5("3.A619I[GC:("B-"33KYJ8G/I-4XN,HZ0,B)?JR8Q8"EC>6PMWW+KM2`,
MJF`NT4,)V(Q,>,`4@D$'YJQ[18$*J,"D*?[M@RJA]O9OM2%MQ!6`]JE3TP;O
MY?YO2Y8[N,,:'EDY"#^O0CO5R$`#Z<D7L.#,N,$:J"`\Q,"NL,#@X?[R7P9F
M=TMZ&FT-;#PMM6$-,`WNC^NJL,JJL"JKLDH&XN3P'0)$T8#K2B8+KNEV'E@2
M/A/S=7_W3?87EE9A?T!A@1_X<4!K,_1XQD#6)@&<))=RJVE$3&$'<I#WJ=^W
MH-?UJ[\C@*$9K:V")P8+IJ@@8"K^..PH^\W__'?0.[)C_=G?%Q8^.^B1/-1(
M3L(@^1GA!SP!&':`$9)@31YF#`!"R1E/W+1Q.X@PH<*%#!LZ?`@QHL2)%"M:
MO(@QH\:-'#L^O%8PH4%NR@R.''E0&S*&RERE1(CRX"QE-)6%A-DPIK:8+V^>
M['ESX<^<.!GN),D3*$J>2Q^.S)7KX#6:/D7:#(I5H4EEQ*X.]0AVXK`L6LJ6
M)4M62]HJI<)6]%7M(#!?HBBUW597%$I@H";Y<@LXL.#!A`L;/MS1#LB%ROP\
M)!9"*[<Z*K")7)@GD(H_?Q![9@C"9M+`UT[4.?AG5N2&KU)A5!8H5>?/A+<)
M&Q8L&.[^8;QWZQZVC;;PX<2+&S^.'+`=97GR].'F:L6U-AZNG7H#LLX;@ZG4
MC$"HC$VN5Q@<<_NCYU2N-P?7Y.&62I4)5Z[\Z+'#[5J=."ZY];EV31[:R!$(
M-^^MLDH?=8"DWQNS#/A<<]S@]TH?G>6B!T+_!3A@@>^IHLI!J^3AAS)PV"0'
M>QN^=U`J<6@C0AWO=5@0@22M\$I^<1284ARG&*C'C&_,=E`@<G##1FC<K+*!
M'"202!(;.1YT`@FG_=C'+*O(,=(K(>J1BRIQ("G"'Q7>EY]V_25'D3!HO9E%
MG')J,45;HQ5F4DH[C;3-43#YR6:@@@Y*:*$'Y4$,!'F4<$K^&GFDH4<:U_F1
MQQ\M].%"'RVPL8%43W*@F6O<D'`""RNP$8<<J<K!0AQIL/&&!VVL@&D>&+#'
M31M]O)*&"W5XT$<(U[SQ1@@E$$.2`W:<$,@$<*0!QPEP!*G"*R[DDL>8!NG*
MJZ\=!*O-&VP<]`8'Q<K1@A_IIA&''K.T(*((:;0!PJQ^^.K!'[YRT`<;>IS`
M#1Q^\'>0"G;DNT$;F]71!QS]Z;'I"7U(QTTN)_QA01XDO,)&*FU<U<8::ES#
MP2MUL/$J"3*9P$T:;Z2QQ@E\H!SKK+7>:NA#V^1V6VZ[X:9;;L'E3'311A^-
MM$=YY!+9"7Z\H<8JLZ1B!P=MG'#^32!KD`#F-:MA>]XJ?%QCD`JKM+8*P'Z<
M\&H=+J1ZPH!K9/@&'`>YPD9S[\WR[S6JJH`L29&I\B\W<I!]Y`3LZ:'=+"%Q
MG$>0W/"-M:KD'J[8!]AH'<(L;-AA7AT%7@."X6H\-XL=>_>11Z;<<)"&:?D=
MR;<)VL0!!PFQG\:-NY/-\IQ!2T>F0A[FAA`B?*_(84<+>OCK.)<%M:`*&WXX
M;H>7^\4MQ]S<O*%MTMP,HX489IE?EOGJ9V&*<8STP@TI2E21Q3;#3%'%%,$@
M9(T650PMO@`*<("#`E-D5O`'94!L:I%"SQ]V=`([K,)K!\E%&R:DBK$53!6O
M\)(+@E3^AS6PP6URD$/EP)<K7)7F8^-2A1U(,"`YJ"`JW(!,[_+`LH\I@ST8
M&)<K2'`DA)2&#>&!C\8&9+>`':X/RF#6CDBPPJO4815+"L&`VG`D5=3!;JE8
MT!].H`P5\,$.KM'&&KBA"ASZS57W$54=7-,&OB'$@-Q8@1U88"3'*6\6)XA#
MOO3@FC6,1`XA6`4@<Z6].*C`;R@DE@"K\8A(0&(2DX`$)"0YB4=<,A*/V!]Q
MMH&$,G"#$6+8!AG.X`LJ5&,22D!(&4#A"$9DA8"TK*4M!5.'672`&R?06!W`
M6((\L.$/,BI>"5*A@CATBDI_,($R%',0$J2"/J=801O8P`;^-;1`#M9\`Q3K
M9@<56.`T!DF#REJ0AQ6L@ETA<%+@E&$!&:KB`X9K0QOR``=5.(\;'H@#5<IY
MSG2N,PXAP%4;XA`@95BI>/1,0PE"$@@6Y*$%(`B7'-I@!W6N(:/RJ8,5U_"T
MY*%S!:FH*/CBT(<W)"^BCV).2%X5&1/X(0VK4$/@4@%&#%P#`ZI8Q0HFBA!7
M4``^/TW#-52P@CC`L&Z4B:<`?0$#&<1`!E*E:E5C,-472&*6A_%$)$3YB$84
M)`N4$,-!M$"*@U1C&Y\`Q2W?"M>X;D09UZ"B*ZX1BSI$10_7>(4>#*('5=AD
M%68"#YAJB)!7`&@JLPC0*Y01"V+^S&(6Q,@15%:A3[L9I`ZGN48?6E$Q/JB"
M&'<]B#(RL#1M4)$;L=%&B%K2,K[I<3*=[0,5<R':P$%%&S8!;6"1Q=F$N*(/
MVG`)5/SC$FU\MF)V<(EG5UN0/KCDME'A`W2A\YRI!#40.7IL@&:K##ZH]AJN
M,,AP8T+#!!G$#ZNH;,6(@:`6A"]IU9AD)"(Q"?SF][Z4S*0GAS,&4I#!%Y&0
MI3;(:E9N:,%.W*#&%(#!5;E*>,(4KLB=/.("-7Q,1!^X"D3"2!2$:&QRBUE%
MAR]#$1.OY#,7)HX+UK#AI!ED&[ZH<8U[8>,<^Z(7U/BD%+*`!$E,0I;<0/!9
MV\*-X/C^@@P5;K*3G\P4IUPD*=H(!$IF,:6@M-@A!EF%APV"98QT*1:2$4I1
M(HQF%)M9S5(.\9FOX8<M&ZH74[6JG>\,@ZW*.2P&\<08&JP%1HS!E&?XA12J
M$8E6'N0,I2@%DY\,Z4C+6"E2^2=+\H1BE$RE)+,]LS86PXT5]\0K9<Z/:*3,
M6ZP,!=.8+K6:]RQI0=TO"_2K@JUM36M<UXDXCX`P-RC1""K03QOWL_7^#$(-
M-*`A+K%NMK.+9I`_Q$($1N$ECR)BIA)<(XD-(4;I:K@:E!1C-0])1:?7S-IS
M/WO=[&ZWN]_ME@#Q(1=^>$YXQJ,!)T%)&6T@LS+J\(%5Y(+^!1[F]X/>@QX/
MR,$$U_B#(>5@DT"\"(UKH#9)^NFX\,R$GJ?@DH!<H8Q6_$@95N-&'$15C,ZH
MPC7Y)-D%X<`C8JC<-2<WT)(2M*`T.4@;#`.2-O;6AASQ0=WP1DY]^ZO?_2:]
MD\DQR4]@7?2H2WTBRGA`'3;PPE>TX3JK4($?,E8"5?1R`VG+0P7^X"@62"68
M&PB$!W@I!Q?DX02Y`*(&ZH"C-E!*79PR[03L,)^MOR%MFHK9&YJH!SUTYJA\
M8,&O,J2-R*1!G[]Z5!_DT`>":>.ADV_!K_Q@TF(=BR0/6%8@)``'%[Q!6LWQ
M/+Q.$+BI(R?9C:A](\)Z>]O7'@W^OY"][W\/5QN.Z:?'(ZQJN*$".3C&A<^Y
MV!O6("JPI4(/#U5!*JY'`F0DDTM`[,"L]-"5U2`C,M/?@#?UL`+?Y:&$:ICH
M5;)TFEFPR`6K<('?N/&*/P2"&!]0@^R^UP=KH`RTTS<E!#BF17YS-QD`,@?<
MH#C<T`)_<$90!WR`80VB(`JD0`H9B($=N($;V&--UR<I,8(5:((G"!Z1<1H2
MA4!RD`M9$AF.UX",<R2;H4`J4$$7E`<OQ`TH(!NS0`)AE"JE80=J\`=\,$77
M8''C=T,()#H&`T?$8$TF,('^,0L7I$6H(0)'D@;PD1ZSD'YD=!!\<`(9H@9H
M=$1_0T/^-A0D.403/'1&"B,J*.@9R(8&C'"'C<`(C:!L>HB'>/@7%!@66B`*
MW.`)/S`%18`;/U`%/U"("+$-9T"'DPAOQ,`!AL-+?9`&J6!4V!09)6`I?7`"
MLU`\&L`'5J(RS$1WP60!KO!\)$`,)4`L7M,=1M)U<:`!IB4!)O0NJ]`&JB!-
M$N4"W*`!?'1!!G%1[8='4E$!+C%2KR!,>E=S!7%V$"A0[.0D-`1/\D1/%]4&
M6Z1/?9`HUZ`*UT:)A8$7&LB!&$@*IL".(%@<U5`%HH2'OR8&O9`%W.`+2!`<
M!@$*2'".`?ELJH58=_5=2\)=^$=7OM,8JM!7>F5843%<#NG^"JF!5\=%16(#
M$H2597^P-"21!XX3(N>U)-<P$P@Q"XXA70F1"R:Q7"G)#:*5$"L@&K95,;^E
M6*:%`1^Y6JWE&LHP$S@89@))&-1P!LJF;$>)E$LY8,-A$)'@"6>@#6%U$%DP
M"0FV8`<Q#&(P"0!$E%\ID((X*&PPC!+11!+Q?V`Y&-2@!6,P!F)`!F]Y!F5Q
M!F])!EH`/\2!!9"`!:8P9&-55F>55MR`!KW@"=:@EHD9:1>V%'O&F*ZF:F4V
M&JV&:@EQ"J#6%!,1$]:AF(/A"W5V9W<6`R\0"6DF&-1`!7/I"),@5MN0!:"0
M8%@`/]N@!%/``X]@FIVIF[O)FU/^MPTX9F._H&.^\`N_T`O,QF+<\`AFP`W5
MH`5EP!93X`C`,`2D(`95`(G<``F(V9O=Z9VV));?N1"0M%^7M$F;=%],-QR@
M,`P'00J@<`9D(%9&>4K(>1"^$)[BJ9_[R9](`U5V!IH`JE6Y&1CYV9\'&D"3
MF16`8A0Z`10/BFY<5A5NQE6MEIFN1ID1$641*A)1MJ%L!IDA8:#'893*]H<F
MBH<FBDILTB=#TZ(("J.%,J(Q^IU>2:,W2HFJ,!M\<`H>>1!$=!`.67$@$$3*
M,(P`5P(AP`9>-ADAH`+:,`ME*0=3XE$B,(R!\`$F``)PP`(B4`(>D`K7T(5H
MQ&]7H1K^'L`[!R$YJO&EIV$")$`JBP&D!^%1B\0-L1`")#`;RI`&VE`E)?`!
M'I.G(O`**D`"']`9Y92GCH&D@7HB".%1:N,2;\`')C<EJ:`,+6`3>H`Z>3H"
M)S`D/WH-:V`L(N`X?P`")2`"*T`?*R`"</H&:9H&>=HY^7$"(G`"4_(&H%4:
M)!`"8QI`;'D&9R`&Q6JL<$D&8C"7>4D<:Y5D<]&>VB`,OS`,2Q$,/(:CV3H8
MN6!Q+``+77H0'A`X2X.HNO0C?B`!,_$*T,<<_Q:$=5`"JV``G:&G!V$"_L0U
ME-$24/$TC?4'$^`2B!("@:,"X+<!LW4"D?$''?9#J<`!6#;^6^)Z$$KU3)'Q
M`2'YL-S@!Q/@97X01]>0+Y,U"P<;"!MP%:`R"RQS`G)`6B`;.!0+>'_`'A[`
M'G-:!\J0`#4[+B;)66)Z0=S0`<H0LCD)E&_`1+&A#'WP,0IH$"B;D\2P`;GP
M!VI',EU(#!DP"Q:3J.*3CAEH"NU("J6@@>I("NWIE-Q`!9/`#9'``UK``[T0
M##J@!3_@""'A"SQ0!:4YH]K*MPE!`HW5`JXX>-P0`BLFCJ/W12V3![B2!R#!
M!\0`B]$T=RJ#0`53(!:3(B_Q@@?1?HL#N8&3!EUXDDOR!G'4=='4!RRC$"%P
M%0,;391Q-\C2N9/S'-P@`E=A0]_^@RNWBR3<L(P'P;K`&S@DT"^YH`)K0`P6
M9R`I2P*YH!TAL0JNX4B1IU#%L!!9@D:N@5OG@8,&$;PI&"4&(@<CHPRKX7D"
M1`VZI[[JRWO%(0QCP)QZR`V]@%9:T)Q38+:E\(A]R[\>\0:!$`B<54+L\0&!
M\[C->Q[2$:^VLX`Q";DTE`<A-`=UD`:S@0*=P4=U``$BD+&S4*E\M`HJ(XZ1
MFQ\J4`%G:!!P4$*Y]``B0`&-.P$?L`'AX[J$.ZYU0+5@=@*K\%`8<A`=D`$<
MX`+E2RZXT@$:H`$`LP(5``)6)`*!4\.Y=$\=MX,BQD=H][S<\2-R(`&'.@'8
M(,,=H';^(>$[J>`:<I2X!N$!&R#&ID4!((`!%[09+O`'VC`!(5`!P"H^U/`(
MCY!)?=S'F00)?1P)C>!KM/&4I(`&V_`(1&:56#F86B!L@]F_E8P1OM@&T1$"
M7DJX5\$'Q1"Y^O('&*`"&>`2T'3`@=-+:E<"TF2Y%9-\N%)!E9H'&:`"&""U
MD&N])<E//&("(1`")`4P+:`8Y(80(K!B-6P"Z70HGF7+6*M`P'L51*R[!_'$
MW#`?%7S,@0,"W,P<S9L*).`8@,6M=60"Y)2]`7-!V,"Z)/P2?1`5(!):K(6#
MUAQ[W%`,%M<Y'W`"5J,-]%0'\")`Y'.L!6VL9Y`%\+.W%T'^!62`!*0P"6A0
ME5<IF.X9#+X@B9:LT1;A`:;Z;2`P"R!06.!7KAO@"B?@&NC2P'G@KO\V>2HS
M!P+0'_>J#"/`.#3I"L@B?X3+<FR@'H@:"]<PP]?@RJ[P;26@,!7#L0_["@]R
M$!Q06$[R;RO`3W8PLLIP3":W!@'RU($@LL58LBL&*KF`RRO`LG?E`0DIU;#[
M*TN"`:=FU;NT"@)P)-S1&6SPLQP@M%[]"GGB.Z?P(SN]L.[EM""A#&"M<&HG
MM+/P=MQP=JE&7QTH"J`@V90]V75AML(!#%<@"HU@!H7<8%@@"@EV!;W'#<"P
M#9"TT:L]$942")7J'W_0!B$``AS^I`Q#6@?:,"[A&P@@(5@M`P(H@']CTC)4
M"@(B`"]NIZ5'H@RKH-NF!0=>I@8B$*C*(`(AP#M]4+L2B!\!@\.OBC4'D0;7
M72`N``(J8!.S0-UV8$:F=7C),ZMP&@N&*M((,=[M9#@@8`*!.ML@4"`M\`%V
MZ@KP<E2@AJF[C5(H*72URP;7H`:E.EN_'6;*<,;@W3)Y^K>V>J@CTA]RD`JX
MH@<$$CQ&8Q"^8%4T$)HG'@-ZEIR,4+?;H`4.W0@_X`G`L`.,D`1F91!^*%8+
MS=H_#N1?*0Q5H!9J$2=&/B=5T#[#@:VGW0N?,`EI50UY$1-A&^17+A$,JF40
M(6<.2A'^7Y'E$>J@C@FA7W&A$.H16L[EE^'E$J8-J;T-VV`-<FX-<S[G<3[G
M6*[G>\[GA&'B-0#H-$`#-3#HA0[H,J"V/O[E'>HG>Z(0<=[GD2[I8!FW/&#I
MEX[IEOX#..!6AJ+HDP[JH;[1C0`_I(`_64!L4T!K_^6:]2/JKP[K4;<-OQ`,
MQ5GKMG[KM>X+W#D<H,1D@F8-9%`&OG!HD3`%".$(CT`*DOCIL2Z0Q+!;6RZB
M%6.A8DX2BT&9#_)I^?&@UQ`XVD`,JR9$GW;/,4$5-P$@%;H09)-I"L'N3\%J
M(7'N/='E57$2(P%JEK:@>N(0\_X5W@X>I$:@A^$F<F+P!^_^/PPF'%X%5F)5
M9(&I8$CV"*+`K,Z.H]<``0IP`&7I$-?0C!AA`?.5$-<P`>_B"JD`+TTA!Q8@
M%0U`14E!U)/!\F9F`BR#[R7@86YV#3@O97PT\@YP72]1\P-O$=\8$D,OB#^A
M`MW;$*O0`(OA5,W>$?8S#-30&U>/]3;Z&6/@:+]08$EF9`HVF(\P!E5`"1:?
MK=?```C"`+,P+9_V!I)E-\Z1!HWE()-#4B\1""N0"_PV&:_``7U47!V'#/K7
M,G5P`"Q@`>EJ."&B7">0`5(!`6JP(#K4!B`A!P(0P17@!XMW]P91`F:S@\10
M!W3=^!/"LG^@.CERA88C`,1-$G#^T))QL!Q4<@!UW`:Y@`TN'RXM"0?$Q$LA
ML"LU0D4,<[/P$42HH0J'$Y([-!GEY3S7H`!Z324>``>.,PO8(6)R8/>.<PW#
M1!)WOT40QV_*E2&LE080L!@8T$=^XQ*YGQS"@#_X<VOU?VM*0,FTL0U+`&22
M\/4/#Q!BN''30FH@EE+;&''3-M#A0X@1)4ZD6-'B18P9-6[DV-'C1Y`A18ZL
M>*U!'3D/_A#X$&@#!@S*)*3),$N!JQ48/"CS<"+#M8&S-I`XX<H`MPAR0EAX
ML*(.!!`2/#!P!2$-`PT3%*AZ8P%#L381,&P8>.U!!P5Q.NCI4V%@&P%I\B@(
MH4#9"9W^0+F1:-%"@88-;`BD>0,S%P8%?E0PV&#A6@<,+.`(6#$P5P8,&90I
MJ'!J((D"=7+N;/!*!88/RA)X4%`G#00-%K2%R`"!F(4*$DKD\LJ&&U"\C;VF
M.BI!3HL2&O@\F#!KX`H(&!Q#-L&06X4&>4YSV%NA@JK39$F8Z-!'CX8_%BP$
M"O2`PP.]F)NN:$',@5Z2^?7G;PAJ##=JL$!CC&W(.*.7*:R91`GK'@&%%#+V
MDW!""BNT\$(,,Q3)K`:R>Z4!;MX@82]59@&@#FX>\`,#-B18T8,V&N+&E09(
MR.-#;C#(@X,ZKBFA#L<XT&8#/BH(!()95BB!FPS2P"".$J[^J<.MWQB8)946
MZE"!A38&<H4!;N2P@)L&_,B`#0A2&:B$OE3(Y8'VM.'`!0SJ\`".O5:8144+
MV*C@#_C>&O$$/B98Q3HY,-!F@C8F\,-1%AV58)8_6F#!S0?ZP(`;-N3P((\\
M-*AC@Q8V;<@$%6(AX1H,`,VQCA(L2(-5.:PSH3H1]&`1`F4&L@!%1B?(8X3?
M9JF@C0>29*&.$U2HPP420F"AA4!F84"O"GH4(1`0Y!A1PXMD%'?<@60$]Z%'
M?!EHDD:JJ"(+;829H@HJ@G%H&S'*J.9<?OOU]U^``^;(K$.Y607$.-+@QH-5
M5@'@C133RZ,.2N-HH.!<^DCC3Q#^)["C`SER`:$.S4+@9H6V`,WEA"4Q>*..
M7#H@1@XJK[&RCQ.4L4`#Y[A110%NZE!4)0LF[I6;$EQH`859)/@#1`W:J(,8
M#2`F04^G*_!#CU0:T`L.A3_H8P(U&RI,&PDFSB4"B6%N(!8L6U"AZ3Y&9,%3
M4#T8]0\];&7AE1.X,4$/$"N`8Y6G\M@@#NM.J(Z#/"SP`T5?:TV;X@VTN;*"
M/&IM]AH()KA&A1/RF.6$/FS2ZU=BR/)`<H%CEWUVVFNW_7:!KSE`E8%4.4`;
MLT+`8!8,])!`#P92(0H#53!H00)7>I^`A0IRD6"%7SD8:XTZ1"?K!,)7\0"$
M-K9*0_C^0-;`0`2R?DN`A`IJW6`"AY1I((TX).#F@%6(LJ#G$*Q`!268Q0'V
MI#018"`0%N@2"$XPBP0(Y00;(,8#5#`093Q`>!`L&S=2D0!OX6456QD/!EH!
M`1)L`&>[,8`V,N`!"L3"8]U[!09*,**&A.`$KQA1!UQQ/0QXRP05X$,:DC40
M$]0H-1F8H(P@`+&>_"\$=0D$42K@(Y.I)TP=\$`<^B"!$TS@:!7`0`<NF(8"
MX`=W:W1(0\QEG8>\D8USI&,=[?B1/QQ-&7]H2"SDH`QB_&%&JPC$-:0D2%?(
M04T."80<7L&-0/QA%KE812KZP(U<I$(;AWI%,?YPC5GHX1K^><@%-_2@AX9P
M[9$,"40J!,F-OL`Q$*<@AIH^*:5`.*05KXC%*[3A!P\*,@]\T$8JG..*5UQ#
MD+FH0_0BZ9!73(T;GWP('URAC3KD\I9U.(7-N,F-75X#F,5H)B2)H8Q<)K)G
M,TKF(P_ERDDJHPY\X`8Q[*"75ZBB#[UB9O0&DHI2XO(WWSSD(+DQBYX%H@Z]
M^L,??-D[?3:D#A^`XQTM>E&,9E2C&_67'#/B@@?TRJ-VO(8%_,E1C^0A`05#
M:4M=^E*8QA0C<A17&]]X4XC4-"(>Q6FY;)I3@QTMCFT,ET\K>M2*FDL;2P4J
M38W*4Z/NE"(Z16I4&3+2I/YT(DK^E2I"9?I5L(95K'<TY$.4H4>A6I6K$;E&
M+HB1"[V0ZS=/]:FYB''7<Y:RJB.M*4V5H=.>.J2LW$AKN8@!%&W`M2R(5>Q8
M'?M8R$96LO[Z`.,:DHL&,``9Q6!``_3J$3L4H`$$J(Q'_=""JD($=`IH0`)8
M\!.2-.1@:B2J1"I[4#%"A`4"`$&(!!`X;MQV!0((`58G>USD)E>YR`T!`5#$
MAVNL0(!I2(,*!&B=0*Q`K[,(1!Z0F0>@TNPW0&D#XT($,0P@B1AON(8RWK!/
M.?R!<L!;@QA=D0;N>M<5X,7F(A]RC3<00QMQ^(,=WKB*9#&N#J_(0Q\6ZL%:
ME:NY?)C^10,@H$9E:&`56M/1!%Q1`@&`-P.NH$`NEWMB%*=8Q2A5AAW6`#$1
MK*(%JU"%"UR@BE4`5R@;J$!#4O$`$4`@!`<0Y!OK\+X-=(X##9!#'$(@J@TP
M0`_"6X$K!."!5S"@`PSH4D/$VS4_:%#(!EA%'&`2"S@2`S,Q24`'&M`EZZC"
M:0?@AG$V0($)G(`8,/$-8>O`O57H@03$8"L%4B$";JB@P6K`TV\FM6)(1UK2
MDX[=&R#6*Q6H0A74Q3$*''):"?1J%0S`Q@>(H0(X/Z0.#%"#"OH@)0VT@`T6
MO(N>)N"G/UQ8&PT@Q@IP&":WR+EKU_A`,500![ZX[*K<:,/^B`8W@5RL`-$.
M604$XH0!.T`N#W4BU::L8^F!A(#0$#E!"XC-C1,($MSHOB"EW?UN>,?[(PV!
M`YZ`4H(WM,%2Y5W203LP)5'#1P3::#(<O3RFAK"!!2MXX+:K.S='Y6&VV+"2
M"JIS<(-)X$C7&+@<Y$`^BCT$;-P`P1=G8?&W+!@#J0`3Y[2MMPUL3>00XT8(
M"LL&LBBC.2L_+S?4T#YY!UWH0X]W0]K@&Q4T#"8-\XJ)5:$!-33@/'](P#4\
MH(WRBB`/)*"<'`(P`02\(0TH&(H+/-"!-.A!`1\[@0=2<8!K:,,`*S,94-X`
M`0\R@.I6Q[H<V""\/W`=@QH<W@'^Z#Z0/S!@`B[0Q@-:8`$[_"H/$ZBA";YE
M]#YS8)0>P&`"&/"`7)2*\YR"&`(8$(%46("E1&=]ZUT_6:^N@J&O;.A#_-`'
M'.=1D(>:!3$"H0P6V&$@Q#CEC:2DBE0H`U2&)*4R'"G.AGSR%2S-12[WN$>#
M';24ISR9\!L234+[X1K3=T@J[@G)/^0BDW=-IQS6>5!:],YGT\X%'_J0!T/"
M+"BY4`9;]*`,/RBLUQM``BS`2),#VOH7!.27/_`O`WQ`"(S`QS*NK)(JH+I`
M@YNWIL+`G8*JU)((IK(J$/Q`"2Q!$SQ!%$Q!%5Q!%FQ!%WQ!&(Q!&9Q!&JQ!
M&[Q!',S^01W<01[L01_\02`,0B$<0B*$M%R``'KBAC2X/`SB':3:D[YQ(ZJJ
M(<0R%U5`K*&JJRR<A54J0B_\0ARD@+KC,J*ZH:IRA1.QB!&BK5$3P(RH`(BA
M0#"<0SI\K%F3@`K`#?50CSSD0S[LPPJ```BHCIGB%+Q;!0)X!5=P/-RJ`.?(
MB>CY/@-((<:1`V!:A0@SF`;0!E`Q`<99`1#BAK:`F(SY-\1I`1<`BE&<I@9(
MC3I\15B<0,%AGA9H%A6X15Q$`5S<Q5L,A!.@DHQ8B5R(`PM0!0;P@`8X`6-D
M@%5@@PR``P88-U=@"38`@%4H@4WI">L8-6Z@@`V`"U4(`0/^8`%B8``[@`#W
M(X`,R#$&J(,04X9V1$<[0(#FB$5[O$>9.H$38(/.8@!__$=_S*S,ZL<&.(`Z
MR`-@G"D'J!OZH`"#,0!E4($1N;4<Z;-7$``4"0$5R+)<<`#^TL0<F0-N8(!8
ML(DPT1\QH1'@J(X*T(,\0$G]B1]\G$F:S*B&.($0D(`#8``%6(`%4`"@Y$F@
M',J@)`"]24B,P`N5&*#?4(`D&9',.`'!XX:+1!$26!(*2(,($*J#R9%:<<I7
M`)I58YDT"(0&Z)426!)AX0,%<)S*L(!:D<.:G$NZ#!B<S``$^$F>Y$F?5`"^
M%$I_+`"N0\J*:(A3&(`'P*:JDP/^.CL!BL(`%(BN@KE(%=@,/!DNX)(M$(%+
M;@#+JIN+:X@#B?,:I%'+/-@[C[N./JM+UFS-@+E)X3F`!>#+GO1)O=3+O32`
M$9@2CB"&]_D-#TB`4&P#`.B#+SF`F!@(!#,!`_``H,B#XGP(;OR5SGP%94``
M[O"``T@`/\@RM)S(6NF``U``\"*!`7@DN71-]5Q/DL!)##`]V_1)OK3-GO1+
M!B@`$>!-CN"_LIBD<ID%H%`&`!4LN!K0,!&`]TLL3`**66B(NV*(WH-0#"J&
M!870<0.E]&1/#=U0C8#-]_S)^/3+VA31O11,_12)#$44`?@6#FU1%Z4C]]Q)
M$9U-O^S^R[V4STD\T=C*B#Q(`P$,K!<-4B&]$`^5S?FL3_D44?LT@/PD3`VT
MD!0=4BF=4HMP3],;409(TKXD4=W447Z)4BH-4S'="`^%3_JTT=K$31-UTHX0
M4`QT*H\2L(@XJX>R*F6(*X88-ZJ*JO:JK1"TC,_*0+,2J3$MU!JTTI^L3Q+%
MTB5M4A2=)N`"B6)(0HC@@U@8/8E(!0=L!0>T"#]X/ZEJ@RZS"/PS5%.-0=C$
MRW^<3;VTST5E@!QETXR@4$@J+6XXA8TDK#50`<\@K#1`D3;(-X<H%>)K@:,Y
MA6,A`39`D9,K,@]BL#;PT1`0`0#S#3MP`3YH`S40I%-@&IW^<8&@R!5F$U9E
M:`.]<8@\6($NR0-C_2<(R(-B2+=3G5<6/(&H,``%2(!\W5?AU-=^U5<%N#(O
MW8@ZX#5([1UEU(!K,`%5^`":(P%5(`$]Z(`>C3"%J@,VR`.3^8TU6`75*X%4
M<(%<8`.].H63DPL7Z`,^.,C;NT4@<848<P%B2`-M>`,3TQ.Y@)Q?78%#,R^,
MS8-/60,]Z*W?4`-5*`%7V(!(I%>FC<";!)\)@``)F%JJK5JKA8!B'-A"3`.#
M#81V0SY3F@7P>@-[8]8^*`&"HSGNDJ2@T0L]F`63430.4($/*!B3G;%58(%>
M2@,/(`$Y<(%5:(4+DMC(``%MZ`/^O2(&.-";$R`X-KBD==.#<T(=Y^B1@7A;
M>DH%)VQ:SGW`$H@`9BF!6TE+T4W+T3U=$E@6#I#5B^A32/(T2((8D46M-<`3
M;6`!;IB<*)$#M4V%!CL9=!69D\D#<C2=?YH%%L"Q%NBEQVV%4U@!'`L<&_'1
M6D'<YQA9.3B!:^!=WX`#FHLO8O@18*J,@3`=<+79SDW?`90H#N``#_B`#P"!
M^`4!^9W?^:7?$/"`#>``A1F)50`C%2"&NP'7K>/,\V*!6>@XFE.&$.B#%@"W
MAD@#:$&W0'B#'CT:8V*!AD%@$<C6-E`%#<ZQFGL%N5"#H&FW$V@#14/;.)"#
M'NV6X2O^@0\(`>2%8%B*@TY9`3=47QZ6MU]<,Y@(8B$>XB#.``N(U)#0G%6(
M'F58A>><V0C3!E<@-$*[4VBZ!F)8/6*8A5ZYTVM0!:&*NSO5AK]Z)"XDK*7J
ME2J^0L+JF296!FP@M#Y]A</RDD`(1TPZJ7K*A4W:X1[^8TK[@P.`WP_P@/:%
MW_9]7T/N@$).9$0F`&`"TZ)Z@Q.0`S"59`[<#U<@`?PB04#^9'D;"V[@@#P[
M*/5PCA-X`(CYHJO3!@\HY<R`4E"59$RV$`,M3%#.Y4G[`P$0)!'X``OX@+'8
M@`P`Y@^H`!"P``\89IVH##WHY4?5*A&<J@ZUP*'B*RTLJFS^!@ELUF5OCJD1
M<(MKX+$*@)8)F`!.]@X,6`,8FH!;/.<E40U;I9V&4!J?0L7]J(/5LV:)4`87
MR`.*6H5-D;,&0"TT>8`K*@D-Z,)O;FB4N@8%\(UKT(,Z$"3ELX->:23>JX.^
M,:4Z`"9N<`&'#(E5`%!W>C4`O097*"0N'C\,BIY<<`7UFR9#*C.1_`//F(-:
MN89#4894(`8T6V*@4`5LN%5EZ$)7$+59<(4$8)P&?(@K*8N>YL+V>J0\:(.7
M-!B[J(`6Z`,%2(6<L"2?]IEBD.ED^@UC/)0\&#>';NN+LIE]_@@QX6:?4P$]
M>(`?@H!5T(`U6`,3<#L-8`,UB&?^#8"3/#``#+@B"D"^#3B!%?B#]P!K[>6`
MB)X%`MB`!I@%#C#(-TA&B,X`\E1"".@Q#&@`#$B`(/H`"+@D<((`!?@CRF8#
M5Z@`#5B?!'`O2V0`2J:`/[@/3FF!\VD(WZDS3YD`!U`#;<`S9FR!VDY`MWYN
MW#$+?3Z%4V`/39VEZ\9NZFZE5*CN5`@$5V`!;P.)/[A%J6L!-8B#!$B#Y$T#
M.5"`-&B!OHD#_N41V8B@-=BW%6`!\5Z#NT#%RN@`0+F&^/D`/)D`.8``/X`>
M+=F3D[$3/''*TV"#53J!.M`&53`!U/*`Q!MG5P@!.5@P/3@`#ZB`"6@/AJ(N
M!P`!/*C^L!S9D3JP@SJIC`;(M16(@UJ&;AW/D,T`@`#X\1\'``$(`!\7<B`G
M<B`O\@`0```8[WG+`!)8@^SXL;^C@&MHC[^K`$*+@PUX+Z$A$X2B``V(-A,@
M!A<P#OI(`V#J8+S3$0^HE5MK@SV9!55H@4WF%#GX@*]TA5E(@PE8@X&05\$1
MI!'H@POK.&^1DC$1-EY3GO@F1&.\CAW)&][M3%7P`Q)`DAW?]-NYO=OK`S\(
M=5'_]#XH]4\?=4_G@UX-B=75`P#@8@`(%?TA!@"P`\RHE!41NP3G!@)0$PG`
MNQ!0UB6LQ1(X$C58N>)(E"ZI@#@0@45L`1,`=`BHKT"`0V[^@`"&4X.K\;@W
MX(`3$($^B``G(0YL$)(X6`$3?H,'\*"C(`$+BW43(-H*FX,'B+PZF))`D`"+
MT5@[>(!.Y72`AS15^*,%C(.5!FF#/P7-!70[`-E6P!.2G29@:K"3(\?[8S8W
M409`-_@Z4)-70($V4`:KB)%;+1UN@`/>*:)5D"YBF!B,=PX5YK\UX$0IKH-+
M2@4\(0;?4(8T:`.IO/B!D(,V"`3$02:(<0U2RH,3H+F`;_K77#9RB?IR<:-I
MABFX]N0*45"GW_H4[*MMCBHI5"JOWT+\"$&N^M-EHZO:$M2U^GJJRG&NCWNY
MGWNZIS2XKWN\5\&[/Y>]SWN__WO^P`]\C=+V$#"QANB#/_BCJF_C<J+`)N9G
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MAQL;%:[^D+4`\>$AMS@D5A##L&*%-F[:/)@X6$)ABQ:Y'FK\$$A9"Q;*B(D@
M\8<$MQ5Z8EZTNFI%!A8/V;SJ`^=5FU0GY%RK4$(-1!(J9JEP@6%6&Q6K>`(.
M+'@PX<*&#R-.K'@QX\:.'T..+'DRY<J6+V/.K'FSY*(M`+QZ2((#B6LKN,G1
M4^=-BSIPN+&HDT>.G#Q_1,YJX2<5"S9Y`J5YF.:/'F6K+MJ&TT)/KC9MB,\2
M/DM5FY.K6KRZ6*=%'#771-1)<U&.'V0>'A(SFT;/3A.WN:6:M:+/2-^G@L-/
MXRI5FN1L^LQ2!U<MA7!-2W^\T48N?9SPT!]VT):''B,HDT;^'R!PTX8K;/Q!
M7PFYI)*'"\0TR)F))Z*8HHHKLMBBBR_"&*-D?9@U4!W7X%@'-].MYH(>?_6A
MBAH,C?C0*;FMHHH+;Y"F(S?8J*#"-:J\PH8'(O310B#<V,%-E,H\9(<VU_CA
MUW6OO))&>''`=4(>&Y``1Q_$4/10+GI`I$<)7FX)'Y*KI,$D"3H6E<<'JE@I
M0AYYA$3,3BSD80(W:7A`PJ+<!*(">BYPJA\($IW"52JJ>+G"*B?,$@@?<`HD
MHZNOPAJKK+/26JNME5WC)#<B*/-&'W6PL4(>IXEPS0FK96`4IH&@H,I(;YR2
MBY-OY-*"*J[XL49\6>H1R!IUY.+^@A\/L9!*(&RDX8<>*[SR!PMRL-#&&]H,
M*H<VL\$QRP8/U2DLANX9^<<)JSP;B+0/K9*'DFT<V<<:IZBB0@G:B&"'"-RX
M$)\?:02BAZ1%E;`:!]=(^AL'VM@$KIHFY))''7+TQ(U#M])<L\TWXYRSSK)J
M\QXWKJ31!C=Z]-'&-7FDRTT=@00R4U&SG,!&+K/$<8T::LS<QT_:S/(ANM>T
MH,$:9))@%;]L>(>7"^">\$8@J?4Q*3=OI/%7&R[0Y6!_&G$#ARL/X=7&++/`
M874:3W&CS`GN68VU,FN,O5VY0C^>!C$:M0!S478PK:,?:]-[[-`DM#`+&_2^
M(H<+KES^T^K.K\,>N^RSTTY[49=I`_)MMP?&NV*^RPA\[<,37[SQQR/_JO"+
M^;X\PF`6YGSOTP,FO5'65_]0\\!C;QCWR8,?OOCCDU^^^>>CG[[ZZ[/?OOOO
MPQ^__//37[_]]^.?/_W=,Q\9__H#,(`"'"#X_O<_`B(P@0I<H/N6EZI4I.(4
MJ5C>`7,1@E,\)#S*XLG,>%<48H``@]931DB*4I1<G,"$@BF*L:)#F`,R,(8R
MG*'\KA&+[E@``QEH0`$,X,,#8""(&GB#''(1$L8P0%/<>$`+E.69$@G&%0#0
M%6%F,0'H*6L5!SCB!@%SC0/\!88T'",9RVB^7,3!!!-0``'^#("``QR``0V0
M8P,:D``$X+&-"JA`W?[G@@EPXQ4$",0U2,"'@6Q@9-S(`PM*&$@#I"%CF(H.
MB'@BAP2D8I&-A(@#<`0IP&ED)M>`@![BX,)4B.`O/Z-:)KEQ"E29,9:RG*7L
M7L%#`R1``76<(P-\Z$LWRI$!<E0``@Q0`*XD)@\&4$8>()`+"RC``&_PPP$,
MH*X'>&`"1W2%`2SP`0'DX@/M0>8U)G#,9GX`D*Y@@#8ZX`$F<N,$(3A!`&;2
M@!%@P`$0D2,"9E(!"XA@`,2P)0D8$!I:(C2A"E4>-TA```<(4P$,4$`!#J``
M#X0`!"'8Z`:*:0`&+&`!PF1``7S^9IAK*$`524D#`[C1!P-HXR#<J,!K,."D
M5PA`1QG0$@-&J3ENJ**E&'@#-RR0AUD\(!4-T(8K'A#/$,`&`]Q00'84P`T,
M<&!2$"@JS!0@GXN90%-B7"A9RVI6Q2A#`@I8ZT09D(`T*`.+/-&&,OP@@@2`
M5`$B+4"#K%>4C5+`#BO8$TIGP8(]94`N&\@;3G4D$6U(``X->$I15M$`;FQ`
M+AEX`U(#P8!/64`9*N!*'"S`#8.^HJ46@-DJK+K:J>8B#0T@0:7.:MO;XK8Q
M+^6E,`4`5U6L8BH#D5D@5O&*N!``I!&5`!<-HX<XMFZK?S"`L21%@31H0W`/
MP:E`(!#^'!$HX&(\L6Q179!=8KA"`JE(0"Y4`;,39#4$YV'`X%KJ@9VPP:DV
M/6TN5K`O.;0RMP(>\(!7((!J&N``#=B`*S8`@`,(((Q*`T`"!)`6:!(3EPI0
MY6%F`8"L*@,"$$B`ICYS"F5"X`$'5<4!.-``"("I#E/<($Y-8(<#1*`!Z-VB
M!^;(%18<8`()^%L!T$0`B"1@`@;0T0/BP(TBQR(!:HT;@:MLY;+F`0,DV*@)
M7&`!/9!`P0JHPRI.`30%(V`6;[#`3S)`@@E\@,.'^8,+`]2'HBBC#M%9!;AX
M4M<\NS`/`O@;8/XP+CY'1QEZR)T>]!`2E?R!5-K@`X[N_+/^.KSG#T_A`Y@"
M).<K@SK48RP*"QK@`0YX`)H"R`,(/LH`.%83KPP@P!\^TX`]II,`5$31*1X@
M5<?\5;R=$36QB[W`HJA```E(@$41(`$])&`!=YPH7A40QP-LH`\"D*BU%T"`
M<75O>X/Y7NXRM!?OK7"\$N[B7-M-/6/#.]X!K$,;?4@`!<CA`P;8HP62G`$%
M/&"'O6Q#'1Y0;P-`E3+"&RMDFN?NAWOPA==KMPK9#?'L:<_B$L_XQ@^C0H;+
M.^2Y)0[1\J`,.1#`CG6@MPL"D0`0K*+?:YT%,_O0+9`__'>3P;G_1.[SGX?O
M%=4&^`-T6?0&/*"M!M@79J[1!C;^8+$H@9B%SV;!N^.\0I77D)H3"[,*.<?A
M-3UQ,E!=@+B!K`%/0$M#:-*N+$(^Q-'*8`,;KI%=-K1A.'%8@YIX,@MB$*,%
MK90#V>%`]C@X>17-!0P?<J&,!4%E)H(A1B[&19@_..0:<=/#VOB%)Z"#WLHJ
M)(&K#S"X>G(#`:?90!P;<`"G\9PG)4!!'3P`IML=2[PMF_BW@/40I"T^YT-5
MEA[0]@?@D"!N*U!#7R?5`A6<N"6Y0,$;3D!EWR1N!?JJ0QM.<(WBHT`/<LA`
M'N#P^:[$M@XJF#0)U""'/ZAA#8&(0PNTH@?)"^84BG[%>09B^<#D`?]A7%%H
M!3?D`@C^O,(']$$'=$D@/,#9A5X$"I@=%,!$K96(`9Q:-<`$M)5;/<#,-)PJ
MK<*>+%++=,!,M$`>E,@*5`#5C$`NU$8>",TL4,`:'!8QR`$L59\++5(($,K<
M.,MVM$(JV(2F;(!#:$,+Q!4VN`V8.-D;L,%#^$&#Z($=8!\W>,!M0-X?G`9@
MQ%973$IS*)XVO($JN-<L($,J$)700(30I,'6L0$<U&`(M$`;](H>G(`*M-(?
M0``;A$!O`%4).$U7;`D*"<R.S(2\[)H$,F)9:8,%(,!((<#*$0#')$`(K$(%
M1*(N&0`R`5N&"$!T_(&F8$/BT`4"JDF)O((?O(PKJ$`<V('^#(;)+'0`*[X!
M,;`!'T!=$RG+&Q#5TP01,2R:M+Q")MVB4;S!EBD#!J1!!QS2-7Q`*_`+5SA%
M"[R''F32+,R$*DC`"4A%W,%,&T2`IM@!?,5"4)S;+'Q`=/#*0+3!*XB`*ZB?
MNLP"!HA6':P`')P`,?2?TLQ"!BA.'T@)VSW$"=P&,4`5"S8151!#%S;B0RI4
M4:1!RK%5`KP!'!``"T!;%E9`M+55`GR:SL7!!H#)(4*$-JP""VS`190CX#!-
M=&3+HA`5-_!!,92&'6!`"+`!3HJ`0\Z-DW5`'=@!++S":A2#*ZB!*\","@3"
M!IQ"L?@!S"!B/`5'E'"#&M!(//7^R7#L")X$@D6D`O2TP6M$81STURD00QO8
M02S$@MCY`5U\P,S@'0NL`1^T')TE9!VX`!S`#(;\WBPDI*&(0`@<5!QLB:/D
MCN*HP2M,``E8``A"9&3.$@;@54A)%`$DEP$(P*LIFP5RXL=,!D%$!PF4"3>,
M`-`(B$LNBC:X@%K:`1OF`4)BP\II@_CIB%06A2]R`S)@S'&%QZBL`0HU%`G%
MD^;1YJ+H@=","9BL`@7H2!TT"#2"R9UPPR'R#A%I`PHL$EL<R=,=EQSHF7QP
M`PAD#0D$0@0TY"GXP2R<APILQQO$P5'PQ%&UIQV811[$@I$$!_?E@:;X00NL
M!TV\1NS^26:!RD]E59MGSI%$\=*MA=0"2-0!:(!EZ`%6N4!#I<%=M`$C084'
MI,*0G$(=Z`$?2*4?%`,*Q%4:J(&CI8';*8L<S$$61=(K5(@:1$<<](>RI`+I
M'$TD4<0'<(!)=8`+G<`&>(#E51XWM$(%B``'\&+JS,T:T`6)H,HK<,HKK)TT
M1N%#Q(+W80AVO,%03$H>])XV[$E1J`$+G,9)D.D:W(XVI`$'F``)@0`'B$#$
MA,0L9`QD&FB?+A"]112W=2!;":I$O5I66<8U*(,)R17OV)VBYMP&0>I`%,-A
MQ!6_0,^D^MD1$6?B+.H+X<A@*&JG8@R8(`.G<BKT7&H>=,G^7+VI4=C=!KVJ
M]L0J!S5/IXY)2)2BLN0!!/KIKPK0YB176Q4JH4*H!8I4BP7/BE`09_@!J21&
M4=2!7%D&R-4JL&*K`%'@K1&K!7JK94;4JS&=PO7.`4E/N*6;SA!HMK*K615*
MRHT4H7:KH(Z4LA+0NK9KOC)B'6S;LN62OZZ5`BR;P`KLP"Y=911E!N5"*X0`
M"4#KCO"@8(1G!_%$'1S4"[FHG93`"4@:QF5/PJ;K8<0"GW4=NG'<8$Q-I-[.
M&\C5X&B<OL+L`EU#=L3"X,Q"S=ZLS6;'X.SL++R"KT+&'Y"@"4QA*BP@3\0!
MJ1`GCF`#F+A"6CH$$BZJ*X#)IW+^3<:E!@M(6`C$08,]A1$-Q*2"[>\UR"PT
MUS4@H:+B2$A\*BX.5*[*#*96S^VI+6"8+4_`@=*&Q#64XMZ"B0?<[4/D[4"`
M"8Y\JJ;&;.+&6Z8\Q`HP"YZH0DCD`A^]@@JH@39\@`BL@03TP1NHP6KE04\J
M@P4\GRL$PEN@A@=(Y<^(0'P:28FDPC6D@@<XA0N(0`GL!^UBZ0HPXRIX@`MH
M75+\"`:H0&K,Q$2@1@6H07>$P`K(`0FT`E4X!53X8=<*Q9:BADY^+1_Y@0F0
M@#;0!L6@C`<\Y>)LKPM0Q0?\P9NX"4TTB^+"+_XX7*2RV[J:9+,H@P=4P"$5
M17&00.K^Y`$)J%D3G<`IT)EZZ`$(&`N858@>E(ZN_`%-#1?CEENOVD$+N$"0
M%'"`K`!G\0$+3%VD`(ZC>4``C^<?H,6%#D0?`$<+]($?)&UOY,%]/,2Y=(4)
M<\#,W$@=/@0?&!9J\(%K:(.-V:&A*$,<L*&CU4$?+`0<O.&@6`X4Q>\46UDN
MS*3U.<3H0H\>D$C#A@HVR`%1G4`J_,$K')(JZ`EL!#`)D``Q^*Z3*,,'7$,)
M;.GI]K`R($,:E$#>?5U&Z+&%8$HCZ?&%Y@X^6LIIA(!HQ4$K70,?W$<:4,DK
M*(F@.(FS5&<=F`4(0`^@^.!#`,A,S$(J$-X0^_!#@`#XBEW^<:PG-_@!&]B+
MF\`)]E+Q+`^8";B"*Y2`,E"`*E`$].3!*JB`,C!-"&@#'`@$"81(1-PP5+G)
M?0;"M"9<_FH$!MR.!Q0'2:Z`*M!(N8Q$&ACM"K!!T["`-_L!"8XB-WP`=&+6
M-<B!!]Q.KH@("YP"EHX$P^1"JT9,/*D@-^3P0Q1(T/S>*LSI&]P?&P!F'<2!
M,JR`.R?(+"*T0OLBO;S,W-!R10N8*PQF:/3!?8&;2[5`+*3!Z6`7'R0BU<B!
MDC!*<`A.(&0.;)#`3_W!!D"(*KG"!WC`:Y3S<YC2+``8";1!'VA$;.PH04/%
M";S$_$T*4WDB-[1`VLG!+$P-U6C^Q.%4;,;PQ:1`3PZ^02OQ0>D$RD"H0!H$
M!]VX@D#PP><)Y-R(1Q_P`9QF""1;=%P;&[K:#,&Q",CAJUSK-0-]3\=%S_3D
MCO,LW,N^J0F5F\/YSBNP`/?,[\1Y[&-47&/D]5Y3=F5;]F7#+ZYR0RQ$-@M%
M!V.?K)_QP1\8VBN`8,2QFT)TD39$KI(Z!-5=K)WXP6N'!C+0=.9%T!]`#S&L
MLC"3,0\6@R-1SZS.%1.[JI\I@]71;_/\'9]B]G/GS[VTFP<X=W5*L6+D`@N,
M0`CTA=@E!H`$QA<U$03(@3(H@`,<`/\&4ATY``I!U1M(P$"0&%!1)#7[`40A
MP"OD00#^0,`!\*)T!^T^$@8?Q,).+$8NF$!#3S9T,[CQU,$$M((K:!\W)/)8
M4!X&*X,JA(#;P`<+3(US;,E(1.Q#6'(<G(!VB0AKFPHRK$`F%8H;BP#B7,,#
M),`RJF"#U$%\/\0'E-AVD%8%+)($)$LK-``V:,,!I`(&P$P<L$$=F!9@/#A*
M3+C,S(0?E+$*$$.`S`V8!,6\Y"@4@DDJ5$`;D,`;Z(AA!=C<"`TJ46WQ>G>#
MP_G\7`30Y`)=E(`JB,<;_,$$G$H?8$!$E$D@?(`?5,`JQ*-X8%>[F4M/A(#`
MI(*&O$P&J$+I&'1!_B8O*L,$/$`:;$`=<("3'<7,5`#,A,3^"AR`!3#`OKPT
M",2'1:[`!,Q"`T@R&R1,-SE`WL3"&HQB4QZ1"6B#*[/`'X3`/A_A69SN'XA`
M`BMAXD"R!>PH?Y@.XKR!"\1A0YR`'K``'`QHG',[_#1R)KI`(E\[!K2`":S+
M)9^&I9#*'VQ'0U5HN%,K!&6(O80,1[@`F\Q43J@2]$$G(T-`'52``GR%DQ$$
M](QZXG@)!@0""21+`]2>4S#`1&:25]6!`7!`'CS`KVA='P37(KD0'$!((&02
MNYM%"%2J2VGCCC`(".K!+&"(L&P`"X``M++L=K7!Q;<`'/QBM_,\^VB>*EA%
MFXB(,.J!IA#<:0AB.&(R-PCBB$S^:[NI`@;!9TRMQBSX`7:RS%$]A`KT02Z,
M(%0P0"Q\1IEPQ1LHP.VP<4-51]ES@!\H0!J$@+-?EG_-E-"\@0;D`9![49`X
M&5579P@4UVNT@1QHR@=L\45<,BS])52QP`6WC`NQ`9WHI>+H91SL?,]C/OI8
M2G_0!6'ZR!LT)]W9,0*^B_PU"`(N1Q2^`1?)>QO$IPBDB8C*@=`L!UQM/9@Q
M'U10E3(,@!U<PZTIP.[LR(A=T0E<S-W_1.)<UP.`R0/\P2I$XNL)6@-DI+)8
MRMK4R$-@@"IDY^27>6C%W1'#`0M\!!).B@MPQ0D$PH;:_M"$M!R$C*6P@)FO
M`I5E_OW^CP^-*L,I2&[B;,DI`(2'6=>N%>.6BYNR5->T$3N8\-0U;K&T<;-(
M,*&RA[-49>1V[91&B\2N*0LDDMO`E!J5N4)HT6)+B;D<*ILU2^2L7+-&\LSU
MBJ<RH*X<6GRE3*%$B]I42$R:\A6QBA\KJO()\^`LA\6T83N%#.LK5RE7$42F
MK&!1K&O9MG7[%FY<N7/IUK5[%V]>O7OY]O7[%W!@P8,)%QZ\Z@VWJ8:Q+I[K
MN#%CQ6M;M)E\F2]DR9LY=_;\&73HF$A)ES9]VK12T:M9M\:K.;-=V*XQ+Y7[
M:G9LVKMY]_;]N^VU"0P:$#=>G$%RY<B9$U?@`7ATZ:QS3[?^?AU[=NW;^UY[
MH$`"A`@1Q(L??YZ\A/#GU1_8P!U^?/GSZ=>W?Y_WM00JJ&KSKXVA__YC")L!
MN<$``_P4Q*^ZOAI<$,+N+I*HHI)JJPZCCT1:;"IE'/-P,8PX=*LZR/S[*+(+
MX7),FPUA&G$QAPA2S;878;J&)(]JK.TRAFQDJZ(04:KK&@56Z`O!")4,39F=
M*+P(0-NF8I&@V=!::ZH,?YS0115_'+&QHJ+$;$P`IVR,H2??8G''*6E<RD<R
M@9QS2^F0(<$B..*`*98Z[L)`#HOJR,"M:R!89;)K*!AKLA-.8$P9$013Q@^[
MWE#HCR,?//"-:QKXHZX[\?(#U$W^;S221[N27))5PQ8S`00.`K$M#CE64,LM
MH%P`M:TZ7DG5CR'9^F.60/^J,#%ND)%T+5$3PK,MDY0903`2#%J+!&';,M4Z
M8D"PZ(T]TR!&F556^2./BG*I@P^E4FGC20Q8\%.."KC1`]Z4W@"0@5?^`/4:
M%F;)(Y4\N"GAA&OVY*:8/.J0:)8X<$27)ZS^G>45/3YB`]$^_L@E!&[XT.@/
MAOC@)H^Q^N#&%9WLX.F57_\@YA4[N'E#!(+@X&D6-932.)9K7EFE9A'B4*&/
M6&!*A8V&*)[LCPI"P'.J.%;FIHU4L&I#E6L^^&/6:^0H=Q5M<-/C7XV->B65
M/ZZ>2S_^_OA:M=6Z`\O29ICR0#3<$XI1)M`_D,I%F:M58$,%.?2HJ(^5JYK%
M[5,L:F.563AH7!7!E0'5CT`L)YB;50QV!5V-ZC#8HH$-GJ6.7+`9>Y:Q_F";
MFU=PYD:5.BJRG5EB/JC#IK$"0>@-$F81H0^ME8FCXFOTF+6/D[DAYF%N_*BT
M8!SK\$`98N"8:7N1P+[)8&WJZ.B:-7CZ(]DX*N7FC_-3DA@X94*^68Y:6\BC
M!19(2&-L)8B#`S3R"A+\(6$6V4`%&M""0:4"`Q(X@3(@,(%L16`%&Y`1`_[0
M@`TH@'\>`(&Q4N&`.IR`&&S@0QU2`8$ZD(!&%DA#"-YP@C_^I*$.:?A#!TJ@
MBA/D00V3\\,LTI"&-W#@#Q_01AL4]X"5O>)1+8"#"UJP@CR8X!IMZ,,;<@'`
M%E@D#<HX@1[01H(3VL$"+X08"?K0@C]$P`XPG$P("("0BK2!#6\X71Q.H#1N
MU&H%JK"`'$K@BL1]0`Y\6(4(B-&&#:1!!>_+HP?2@(*WQ:5(FEJ+1CX$&[K9
M#91[2<4'E,*&/E2*!7'8P"KJ``<6(+`-)'B#*^20AE;`P2(N>(,*3H##5-2*
M5S^L@!Q(0+TXK*`//X3`&T"PBE2H(!`D.)P*7NB'%;``@!B(@P[9T(*KO6&8
M:ZB#!/*@@CA<[D@K2`4)K.D"@;3^(0]\R)0+WO.1"?"1#RS@Q@D0(@<5Y&*8
MQGM#']K`D@>PP6%RF%4(6N"".*S!C!FT@PK@4(%<F#(.L3`!'"8@$AF&H`TG
M*%@>VC`+)JY@%6E@0QWDD,<ZU&$-(7A4&@A:OQ%4)%QU8$,J_*"&-*Q"%2J(
MQ<I"H)%KB"X#'@4>">20H#R48(1!Q(D$`."GCSP@$!+(!0I0\`8`$*HB@>!/
M'NRP@2OF09\><,A40G"-/.1"#@4-Q`C\*94&?,LBKH"GPVJG!RS"(0]Y2-8U
M5N"*-?3A5W*8A1^T88$X!H(-<=`:-UZZ!CV$T7A_2,6C/("0H^;!`VCE!@?6
MRHT5"*#^8M-+Q0K<F`8]*"4/-)U%R!*G,70A=*5Y.($VXF`9;L!!#BC01EQ3
MQ1;]:!(FLTB`9::BAP3P!#*?#.5T[:("`%2,EV$,E"L"48<WN"`/H`IL3G=J
MD53,H@7FPN;A7&`1%ESQ8#Q-0QZPH8?C<4,%YG)H4.P[QE^15'<A6,7^7@('
M7.9AI6*SW@U=$<8QXN0$=0!!'520AX'<SUO66P4;`I&&U/G!:_BU`P=>J#5B
MA.P$*V`#&UR1F.65!*VK<$6E2I`'LY8`;=P`05':J@>XPH$$;5"!'70ZO'D=
M)14LL*(V4N&"5V`@#T4%3AL<`EYM\"\/:TB#*E+Z"H/M."7^;#A%"(J21OO5
M80.J"($:2+!-EA&#`C*]"`1.`8%9J*`%:<``!RH6"!10EL)DY<.1I`R3MO9!
M;'+(0QM/>!8/(#,F)Z!R8D1'@N&.EQO8^",)3M$'OD'N&B30P\X`=Z3I'<X$
M;.#&"""W66Y(>19BKK$^"QT("'R`:BBS@QST^8?\7D2L?L#3O&RFA]RM0`TB
MB-1P%_8&.20L?W0Y;EO8<(!?U2X!JFZ+=*G;[;@0`U$?R=L2<1>_*=IA98K5
M,@M4,!7/I5<51FQ#'=3V7A/@5VL(G/%L]VFN_:%E%O:M,*+JP$1MA$`;`T8=
M'!)3<#E<(S$I>V')?GB4".]/#W;^<,4U[F>_>]%R!;-*2<D^8-IR"I8G)^9&
M&N8="%6LS*0P3J\K-&:"<NJA#HW3L4@.+;9MUD&RSIO@+-8`ASX`'8?7"$0+
M9F$"/L!!6[1Y=O&X(0(]1#@-ZO2A-OY'`8VD0@2MV(!()I`!2LHAC2)00052
M8<$*7.,`JMA`I?3S!P7,H@0JX&4=[J<*#.A!!;-8P2S>P(=[CSU'W-B`\R`N
M9#^<@)A(^<`LH)-+/"&-!:EP8`CR((<U3&85$X"?-UD0:F6L(!:4(P$?H,6-
M#,RBEXHGA@O8\*@-(`3LJ_B`'6Q?E`GL*P&374%<7:"&9W?$M/[,0\E+T`=U
M9BL.+'C^A004KXTW:)L-L5RBJA^D#51II@0)J`BW84)^;Y__+=?P4T606=BX
MGB`0(L53C;<WF4"P&:@5MH,?\A;AD)%@%8ROC]K@#4H.C])@7M[`V7K+!/Z`
M!?0@LN`E!')(G"Q"#B8LLE2-!%*A!(1B`AHB!`)A!>K@`R!K%11J!#4@)LC)
M!(AA%B1`),3H%3C@8/K`!6(MY=XC#O+`#_1`&3CM!"+K#>Q@!02'C3!`%02&
M#32J#RI`)!8O#R!.`5-!#E+!!*Z.#R"/#=9`#M[`FU0`!%K@&@)/#;3AM7Y#
M#RXE)>!@%5K"%9"B;#RF`XHBL%0"?M`E)2JE#J[GJ-Z`)Z+^$*@4(P^4H5W,
MQ16Z9G&X(14R0`\<XA7&1ADZ8E8LS")F!2%N`JZ.HFNT8592021>ZB-`AW7^
MH!@PYD4J)GLH"RGD`%%2X0VN31'+12-.01L\YE<BPB+(R`41!1>5X0Q3`?D`
M1Q7(Q6I@`G#Z@!-Q!RGJ(.7:$%%FQ113@B.D4=KVPRVPH0)(X`0*(+78POS0
M#QPQ([7<2FN`HB-81R-:YB:,,0\"H20Z@@_4)G1F06M4815/)A4\+2'V4&56
M)A\11156AR<6PF&40@X^@+'6D7J41AN4!B2XX12,31&K)R*1SPP5*R'D1A!S
MH2/L41GJ@%&4SB+Z(!'1D1MTSA[^:Z<=4Z)U5#(0IB(5&D(;;L)\9L5VM(8/
M(%&R;,(/:HAE6A+1XJ/IY,!8V.)X$.8#1*`$9*H$EE(;10`$3&!J2.`#0J`$
ME'(J28`$0B`$0&7IBLLHHBXN*B(60,".J(M;B.3[VF(5#N``1,XMOC$<YY(N
MTG(UB!(L^R)QZ.,-U(!RL@-,:F,5X+)-4`,ISD(9$-,P#7-*`K,N=P0K7"'<
MVF0L(;.X9H--2`0L340S*Q,OILTM^N``$`#YXC)!Z!(UUZ1.4H0U+1,V.%-%
M,/-%-$,V(3,SK^&24J4V+X,SS\0RZ40WI^*M@),W[#(UCQ-(UM)&E`$!5J`$
M'B`WY!+^.:>3.JM3,#*3.%7S-Q]C-3LS.[]D34HD,F`32(Q3-\-33KQS6ZJ1
M/R#C&B0`3W(A`;[(-*W3/I'3/._3+8BFO1+"M_;",>P`=2*C#S`@!'*&:UZ#
M&SA&+BH"W."">=Z0+AXT)GQ+&?0I,OA3-57A\]A"&?X3+CPQ,AC4,#+)0X?C
M$P%@0-=".O7315]4/Y%A!81-)W`G="9S>A#%%?SC5_S`(72B),9"*,:B#2PC
M%7#E9CRL)U^)&]PQ(4#L21T41V>2!#I1-6@BW-:Q#7"I=F;D&EK&!0VI%2"2
M1F*!9PC">Q+C8VR44KZ%0A,"F8P'NA8"*P"'/V+&(M:T(\K^A7#`S2F048S&
M`A>I%"X]AQI%\B!X918($R[BAC=7+@%>HB):P`'>9/Q.$T8S55/U<Q4`)0-<
MX`0,Z!5:H(=B8@W4H&!6B`!5(`U>P0-4(,A(8%TDH`5V30Y<00W8P$44\"2+
MZ!3X0`WVI9?2(!?:``7@90O?AQM<P`4D8,-6X`-$X@1"``7^!5KS8`4L;4%=
M`8A&M0):0-+,"L'VQ2*PU0/$*A56@03`50_`=15*8!6RU0.N(5DMHE/EX%.Q
M*,O(]5Y:8`-:@!C20`T@9P5.8!5,8!54@"N;R@4LHY<.Z^_T(%BQH8@.15!Z
M:>DH(!#F8+XB90W:H(M.P&8:Q$3^U\)"ZK0;L:)%-Y5E6[;;WJKD+BX-9\<B
MCD9=N<$$2J!)B^$$X&"";C4.3D?5WH")2L`/V"!0IJ(.*"`--A"\/.`55.`/
M5H$8/."R`N$$#?;>#N+S(@R7%,HB1"JHY,`%X8!VFI0H7RH/\$2D/F8#HG:R
M=+58X(WI'M$.II::/#'"M%9O<B%F[0`$H&BRUF!SBN@-$$S1\):%Q*@+M<$#
MM.$/D($#VB87WM:*$J,$1*YRO#`-L%8@"DD59K`/TB`5&+50E+,[WV)E799U
M6U=)WBID]N=1GDKD7J@%$D,$)"4-][9P%":P+*,/D-8%5"#S+L-65.*]3J`%
MF,X.WD#^P(@APO)`!%R`2P>&&^8%5%)ALO)KP!#->0+Q(Y@USV)!4E2@;6:!
M!*BH8G3G&OR`>YFN(X1,K/B`7'Y(!*2H;T,F>9=W?>$G#>"@!/8':T).!>B7
M<>7@X"@K#@1LB-:U<U<&FBQ"%=J@,DAW%C[`!=8@34'@&JQP1=\"&Q(`N5:D
M/EW7A$]X27!*#Z`#\J*W"\L5ZN1`%>!@#9X*O8",\9Q-#U!`%6ZW#=)@%OC@
M)"IFQ5#DAUB@)MN*\UKUASK%MZY!!"S'\)2AD"P"`%?K</$EUF""!#J/`ZY!
M!3=0#MR7M_S(M01KWH[F$=5`%5S@A&(K$$`@#;,()MY@A7'^EG^T86?`*`_@
M8/C\(&/8H(=/J%V+1P&UH0.485X]0!7DH`_:38:-9P-$SH;JH(H\YT@49X)"
MJPU\+70PR1I]<SLG8RI6%X5/&96O0[`,1@]6P0?S3"VRC!@:,1?"JP7L2W=P
MXQ2\#`,Z17O3QT_^Q2).858J(@]<,`U.1@[48&0H3`_9X"SUZE)B80U*!66(
M(1<T)@[VA!B0V"+\P%PD)U".N0YIZD:(LB&,*%A(=P4*RD^\RT_L`)HG8Y51
M9B?,^2+B8*!N9E]<H9T_DAN6>0.U)E`\#]$$E(A69A4(\"7\.0\RAB?\8,NX
M80W>0'#88/!F(6_2#U7F!E-3&:3^0_K\[B@Q\M-%22H-\S(T/,5XS,409<Q<
M6D$R6\$0)5,R5R$6*D`%19JG>QHX7O,U:P0VD.([UY,R?U,\63,W=M-&V&2I
M6Q.I;0,.Y/%11QD\@=-4BD0``F"K!0``NEH`MIJKO[JK`V"LO?JC?5JMUYJM
M1=H,`TL/\H",XGJNZ9JNY=JNXYI7VIJO^]JOK\.D_UJP!YNP"SLO3B1('A6Q
MI22Q#=NQ'QNR(UNR)YNR*]NR+QNS,UNS-YNS.]NS/QNTU?JIH;JH4U>EM7,S
M2YNTU?,Q'82$/=.H7[NTL1-`YV13DMJJZX(V4]NT91NV5[M!L42XB_JV6WNU
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MRZ/<QHT<-5P<+6"<R;T\S`V<RTE<RZ4<Q[]\S:V\R8,\Q>?^O,5IO,ZA_,6K
M_+[?A#9<(`$>P`$>0-`''=`)?=`=(-`-7=$)/=$/O=$#'=$%'=$CO=$9'=(/
M?=$+W=`O/=,[W=(U'=09/=,C7=(KW=$G?=--7=0?W=1)?=15_=,E'=`K/=%9
M?=0['=9A/=8]W=-=?=-Q?=%UW=$5W==%_==#G=>+G=>)G=.1G=@Q7=AG7=93
M/=I1_=5!G=6M_=>;/=6=?=:%?=*5O=2!7=NS?=JCG=F7_=F?'0(2H+VN^UBN
M=P`80`'J?0'LO=[K/0'RG=_S?=_Y_=[[7>#[_=\'WN`%ON`5(.`#_N#Y/>$;
M_N`3?N$AWN$I'N(?WN()?N`9GN+^$P#C,Q[D0_[?Z3WD2][D#7[D*_[D_=WD
M/U[D5?[E&][E(9[C8W[E4?[F<Y[A,9[D<Q[F([[A&:``,'0WV$\`%,#CD][C
MD7[?E=[IGQ[IF5[JGW[IJ?[?E9[IH=[JDW[JM][I]?WKK3[KP[[JQQ[KH=[?
ME][LO3[JN=[KJ1[L]QT!XI[LL1X!WM[MJ[[IM1[KZ_WN]Q[NZ_[LWS[KNU[P
M"_[OUS[O!Q_P%5_O\9[P%?[?Y][Q'1_RMUX!$$#S__[O$V#S-=_S.S_T/Q_T
M.?_N3=_C-Q_O53_TG9[T6S_U/]_S9S_U9__T8;_T8U_I23_W69_P%V#RZ9[Q
M%S_PX5[^`/0)W@%C%@"!F(F9^4\!$*(_^IL_$$[!^I^_^@-!^U,!$`H!^J6?
M^;6_^J_?^K-_^Z<?_4^A=+7?^J&__-\_$)Z_$,"?F-F?_*G__,E?^M=__-V_
M^:D?(``5.E4(D$%`IP(I/,408<*$"E,9/'708"J%@1A29)@18RJ*#@]>7-B0
M(\1`$E%5G(A1H\..$4N6]'CJS\.%(1\R_)/Q9L66+WUN!&H2)TB:-F%N'*J1
M9]&?1F\^9!DS*<2E#ID&RNIR9,^E,%&N%-E29L^.,IGJ7-I4X:JW<.&J6L6J
M+EU6=-_.C<MWU5R\>/,&ALL*%:K"=5'U?0MX\>*_=@$/9FS^>+)?P8SS7G;<
MMZ9-C0POCJ7Z-6C9B3-C(L2(\L\L;K!CRYY-N[;MV[6Q+5-VC3>TW\!_7UM&
MO+CQ9<.)!P\^//EQXLZ7+?\-_?GS:].A\49NO?IQX,:'0^L./3NTYN2=F_=N
M/;KQ\<7=AR\.?K[\^.39M\]_7/QX9?KA5QR`W%TGW7CW"<A?==01>%]T";)'
M8'S;I2?=?LI19R!\W2786W[*<*,--H:=@HJ))Z;R$6@LGJ)B*B>66***+)[(
MHHHR,I3BBB;V>".,/1JV8XLMXAACD#2"9J-&+QXI8Y*G+*,--\8I\YN5&N(7
M87(>8KC;-;B%*>:8M"V32S'$H%G^#"W%M-DF+<2D&>><:M(9)YIILHFGG'?.
M::>?>^(IZ)Y^]IEFF\3HN>:;B!8ZIS%U$LIGH8+>^::A=?ZY)Z2`8IIIG,9,
M2FBEASH**C&<_FEJIWR.NBJ=KA8:*J1N2LIJK8[B&6J@KUK*JI^SUFJKJH:R
MNFNNFM[JZZO&<#HLI=#*R2BC<=*R3#%R7##!``$($$"WX(+KK;??ECMNN>A^
M>^ZZZ9H;KKO=DMONMP"H&R^ZYXK[K@``Y"M`OO/*B^^[WS[0@1RP+/-GJL1.
M:BJIDO(JYS)D5FQQ;=<<BJNP''?LL9H?(QKRR"27;/+)*&^<\LHLM^SRRS#'
M+//,--?^;#(QV.1100`0;`#'''/((0?01!,]=-%`#WTTTDD'[;303B,-]=),
M+TUUU5<K'3741C<]!QU<`TV'U$PW??38=(2P```0\*%PR<W:+&R(%]=M<<9N
M:BQWWGH'ZB:<?9]L*<N4[HTKK(+[;?CBC#?N^..0WXP-'@(L``<QUV2N.3::
M=]XYY]AA`_KFUXA>^NF9<R[ZZJ"KKKKGV)R7^NBCGTX[Z:FCCKOGGZ=^7NN\
MF\X[+7,P($`:UT0>,C1V-S^FPLFT>5[CF0N[#.=O*R/ZVRMS3OCUI<?>.#'(
MQ1YXR'?JIOSZ[+?O_OL<+X-'`1:PDLVPH?*9?Y[%[`]L,;S^`!RR:$&+`!(C
M@/OC!2\.2$!@K6J!EPJ5`"'H*/^AJH*]@M6Q&+@FP!7#2K/(``#4`(WS18X8
M='.>"FMS+3?5H0UP,APQY/`&C2GC%&UHPRJ.H0Q4M($-J%"&R9*1L63`P@UX
M6!GY3L$&.,#A#70H!O=LAK-3N`$.=8"&L$SHIF7``HA3A)\8QTC&,MYL&:@P
MP`.LI:@V"1&!;6(&+W9QC&/$D1B[,`8SA+6+\R$#&<4X1C,&V0PA%H,9NT"&
M,H@AR$$^PQG'8*0Q=G'(C^FQ&+MH!JV*T0Q*[K%6E&R3,8[1QT]ZS(YYC&2M
M`NBF03+C&89\D\(R4`!`A'%]Y%O^H2YGD[U3&"``;4C>%DLE*I`UZG!K2@`"
MV)0F;+BA7R-`SAN^Y09LL*F-EZJ5">+`#3\`0`(E'%S'-(:S9Q8````H``9@
ML4AI-8J<>9N6R/*VC#HP`)T#,,$R(HDXOB%J&8``P!NPP44S&O2@"(4<YDA0
M@"CUC9&[P($1[%B,2^B@!DV@Y#$LP0,:9-1-S*@$#1#1C+XA@Y&8:$(4HO`$
M3#Q#$TVX`0\TX0Q$/"$*4'A"$S"!R";0@`>6H"C'-LJ#&FPA;L780@UV8(D]
M\L(94*B!)E#ITQ\$]927*&H3VG@,'AB!&0?$*4O/(-0U+8,5!LA`"]V'N5VZ
ME4IHND;^'1!P``ZL58O'T$V:D"/%X>Q5BX&\*W;>](`U"I$6V)##`19P@6)`
M(P3*E,,U:,$;8;8).5HD1C;2`(`Y:(,5+(##,8CCV-ZXB3=U!"R:L!&'`F2@
M!2IP`#`_Y%C`GN=MTK'C:.&C)NG0DQ8/4,`*6I"!`+2@A,@QK6.O-9Z]9N,/
M!)`#01-*W>I:=V_*`$0!3C!=7"GC&#XUPB@U48,:Z(`&1U#&+G1P`R/(X`BT
M,L819'"(9F`S3LTPA`SV&P-!/&.^0:!!#Y(!A1C00`8UH*\SYLN$'=#@%F5U
M(R]V4`,<>+2.6Z#!>760)F8LHKR;J.,1:("#&T@UPFU:;PW^AO!>.Q*#&8>@
M@7@QB0,9'%@(FT34-4Q@@%?<\H1@>JLNWP:-#S!@`PN`A1UAL0<OM@`06H0%
M'XSXY&N=P@^T.`8L^J`G5#PQ8;1H0`/TA#DY%(`!"3C%-32```/$(7FTL(,=
MLHS"5\R!#W(2P0!:0,##'(,5?8`&(%KP"FC0`AI>?@4L_%"JQ`*@!2.B0P$Z
M<`V5%(,.?KC6'NH0)5KDP0\)8P4?`*$2-BE#U*5:!AL"D`81K2(!(U"&,E91
M!S6L0HBD)@8<.EV'/JQB`&\6YW6'3>QB?PQG<@B`+0-'#)_68*+,^((,$`%>
M&=S"%C(PA#.44`->'!(-Y:UOWY3^@8QC#$$'EUB$(7"Q"?0ZPPLXL(4M#H&(
M1`0!![K@!7J?$>.F"HL6S$`##1+!C"/40!?$P`$/BM$%&BS"&8F@07DST0Q=
MR-C#-(A",SC&#$W0P!#_[78@=6%A\38CQFBP!"(ND>/^+6,5!EA#"=E*,2&O
M4(O*@`4"3K"&`.0!.7`(P!L:`(`$U($;;1"`&XB.`#Q@`P,!^`,WW@``J<MA
M``40@`-808P&.(#,UX!#`1Z``$"P0@$B0``<K'F!;SD`%21JP+<N``TW!,`!
M`#C!*@!0`6Z0(`%NX)8#`)$S`P@@`AA0`-CE```59*/2ZO0[`CX`@!E@0P3=
M&L`,N,'^!@!\0!L=`$`>UM!9+3Y@`K521@8(8$LVL4**@$!``0A@@#Q@@P(0
MN(#HE7$!`1@`!`98>T&-3?SB(Y06UU#!`B@[U$U@E`9%L*,FHJ`+9\18$\K8
M!"^:87!>R%$'/ZC!(9SA;8[_(`@%=(;U:1#B73CCD,QPQBX^[@Q:V.`(_);!
M5875C"=TVQE;,&W%4`-0D']1X`P^<`0.I@ER]`4$QPL$6%(<0PN;`'`&!R?,
ML`4W@`-%H$>(P'[>!U8=0PL)P%WODTLVIT*+)%<`P`:G$``H(!VM-0%R,`,#
M0`+<('8TF`;YI`T:4`!6-P"`H`T>L`"G``<"4`+%(&99MB;^UY!L)>``+`!S
M:F``;Y`-:Z!Y=[``(J`-(A!\<&``;#`+&V``)+`*OK0!W)`"!:`!>'`"0G=[
M"9`'=9``$)`P:?*$`4`"*K$!`:`"W'`"!3`!+7`*+```))`'&2``><`-'G``
M+6``'L`-J$``)L`->S``:V!-EY4!$*`H0G0-+E``>\`'"5`!RL`!KI4&L$!U
M*8`*Q259PV=\M%B+[P,-%7`!DS54EY`)%C=1'_1^7:4#WL8,N!!@7L`,S2`(
M-*`(-'`(JB4LO!!^-$`#7.`,35`#7/!3EW`,WF8,38`#:;)1-_`$.C`$X]0,
M484+SQ"`EF`),J!QG$`#1V4(!4?^`U-5#._G#(8P<"+(,9UD!#1P!F!%"S3P
M!4;P`\<0;31P`S)0!*'$,<J@`2/07>U3<RG8/!GS6`8`"]IP`0\`"]G`>"O`
M#<6@`">0@P%0DL10@MR@`08@=4@(")-5:'70AF'V=3H6!P%P`A*0`FS``(`@
M`'(`#1`P9MEP`@Q0"`FP`;N!`7UWB$?W!VVH#2D``$=W"@,P!\5P`".@#=HP
M`HKG)D]H``DP`-R2`;1@E0%P=+2P`!9P#-SP!P.0DGI`5PX0)<5P`1#@3`)@
M2UUD`1JPBQ_T)JP`4`LP9AU0`'`'#22``+#`#8`0`&^&3;9XF9C)/KBHBQ_S
M#)D@8Q3^Y7U/(`-;`%;95P//V`RV4`-@8`O/N$=]PPR9L%1<$&"7,&(U$`4Z
MH`,:97%@\'[%L`@W4(W7R#&*=`DR``68D`,.MPCQ2'ZYR0S'8`Q#@(]VY'V7
MH&&XD`R`-%2S.7"%U`0[8`P_H)#',&)/``4TL`3_*"P0@`(6J9D9Z3S*8$0.
M``$GH`(44`!XD(,`D`+7``L*<(EP\)_8``L,<`(^2`!2%W@T"0LCD``)8``<
MT'5C1I:,-P,HX``=4`&3*0?'X``)L``+H$9[H``DR@`$@`':<`(```=S20`;
MP)9RH`V3B0=Y```K,!PID`!-B'QR0``10`)T``>P4`S7<)7^<:`-?C``3ADG
M"8H-RA`"`Z`"VH!\:B"$(#!F0J5Z"\`*AK0*;N("RH0`#T`,J@AEP!62@A8`
MLIB9<!JGD',-+/"EL20LQ^!Q1^!B&+<#B$)13T`#G``%-Z":(T5^'6,,NF`+
M+R4#@B`%--`%^8=]S2!PFN`F-W`#MR`(,H`&*'9(SN93BP"/&K<+N?D,62:0
M^:A>/R`##T<,W3E.@:H)[68)SU">SI`F4W6K.N`Q+3D">.,^*32?%X,<<V``
MOP0`R%H"VA!TCD<+`^J?*9`-L^"2M"1U=2``?Y`-&U``<3`_',`+7D=G959Y
M=6```[`"K!``7+D`#^`'I$8+VJ7^`0;!"J^`#2L``$L*71J@#2H``'(@F>Q*
M"P;`74GIHT)4KE9Z'L>`6"G`KADS`1F0/-5:`I0H`0?0`%$"4`.@!A-0D3;$
M`7^)':AP`"&`K\8%"`[@`&AJ`+8$#2*P`$B*"@/PIG)ZLSA+,XB5;(#),>,%
MFL30#):@8?F(24_EFHA`!#3P`Q16`U]@2K@22<K@<4S`C#1U"#+PM,S@?W$4
M<5M02#7P!+FZ1<?@#)BP"6A`7_H&!1!'`UB0J\=0!-8)JP$&!I^**+202=BV
M"(M``S[@`^4U!'0T*ZK:GE*T"@<03/##/,1Z,=I`'")0`"U0!W00!PP``<N0
M;"IPH`O^D))Q(``I@`VS@)+<@`$&<`K8$`(%L`HT.XF`0``=4`PK2Z[7,`?&
MQ0ITQ0;K*ET<X*/8T`(L\`H04`'90`L\=PV`L)5S:0!J^*]P8*-;N0P+\':G
MH``7ZH2VN[E]@@TGH``)4V0*<`I(1Y1A20`,50($!0L2H``&H`<S%U=T(*-B
M.@(!P`+%L`!]^99GF@$6L`P.6P!T@`TS0)3!FK,&?,`I0S[:90*$*2RR"9J3
MY`,T8`OOQPP1=PC/,+2(T`7G5U0X\+3>R0-?\`R8T(SPZ%^((`.;($=AJUL>
M%P7/@`L9![5N9`E,H`G/$`43K`PUL`3/D,**H%N%>PQ=(`/^7>`,W]4Q%EP#
MB9#!`Y<)YQ<$Y74$N_`$0;"0.P`$$89\#`6F)SBLC4LFV/`*">``Q9`-T*`-
M(0``?E`'>:<-LU``(S!U>4>M9L@-/5<!&#L`IT""OP<!`M!8*$IFV%"@*?"6
M`W`8`.`&W,`'`_``NM<!VF!W$S`!`.`"3$H`#,`&>W<!+?JB-BI0VF`"OG=Z
M.AE7C'<"P8HY/,8F`%4`"K!Z%8"\`Z!6%S``378-*%``GVA,'\0!`*``$#``
MRU<,%B``'&`!!;``Q$`!%6!HT,`'!(``%:``<8@J")S-VCPR.U9+#8PH'2=C
MQK",)&8$0?`#UT8#0W`(#L9395O^"P.'JD.E"^:U""RV";M@`SIP"$%P`[J@
M#+1`@.07/;MY"%`@`V!`PX>T"3(0!(>``U=\#%?PC/T<2L=0N+I@8C\P!"*L
MT,?PF49P".=5"9H4?T$0!(/D4U\@;5``M<BW"@50`I;5/B@8QA6C#7DP`6NP
M#`&T#'HP`6_@!Q+`!M:T`:UF!T,]61NPB<5P`A0@`MF"NGC``1/`!BC@`:SP
M`1U`9M"0TT1]`A=0%Q20!]K!!A=P`2&0,$UM`1>0`J,%"R%0U;!P`0K*!A-@
M>Z=0`7A0.G!``7S0`@@;)UU=U9:%.6NP`<P$#7B``1=0`JNP#"F@USA-`2@@
M1;;K`8O^Y%VTT`)G#0*`\%V```(3L`)K4#\G$$W2LP88L`%U<`%[/8O;'-LX
MBT8'\':<F#=Y*LX7+7'5R'[-\`756`.+\$EY2E^&^R:5VMM;H`P>AIHT@`9[
M9'$'"*O*D`BH^9`?<PR!6HV7()VK68T)W2;FQG[\QMLV(`-B&SC,<`8V)MSV
MU2SD^0.C=`O,N;2VH$IK8F@7P)B9S59!9M-DHD7C42N^924MM!N7E=G$D8>W
M=2W$,![P84>D93T*,^%K=2'0H$H<(M[4L5Q2M$\)3@LS0`?:<P(^*BS--3>Q
M1#[&L5<53EK<$`<OFC%]<PP0;N'H\>($;AQW*]L^;L`/G@?^!M``-.G@<T(+
MF:`)<:()F9`)F\#D<&(,FJ`)]WU!B8()E"0KC\+D#`@JM9#DLZ(+F&`+>W(,
MM<#DO``I"V0J3%X+NL+E_O,*F<`FNM#D29X)MY`K;)*G5-XL?C+EH%+GF1!(
M@*,]M&`!`<`&[_L^8`S@N-'?M:(HEF*9(),K_B1*S'9,6^2KY$1,\G1-#P``
M'""('!!A[J0R[]3I>+(,>T`"$)``CWT^GI[J5KY)Q<0^L/WCNDXSF),'!U``
M,W"8J(,-V9`-G%/LSU#LQEXZ8/EXGO,,KJ,[H*/LJ$/MFI/LNI,-T([&MO,Z
MI:/MCZ<ZU*XZUD#LJ:/LQ9X[M9/^.<5>.ZL#[>(>[IGC12Q@S6M0P/[MZ&2"
M[V+4<E340]6,`!P0ZTI4*SD6)R_'``V`!S_F[P>5ZRT#\1[C\"4C\?/D,A2_
MZ[YZ#7S0>PA``2<0!T[T1&\P\B/_!B7O1"AO\B>O\BUO\B6?\B[/\C'/\D\$
M\S=O\SB?\RXO\R2O\S,/]'`@\C)?\W!0@Q9@S7Z]Z"?XW_K^Z`\C0.)T31FD
M*MXV)VL^*5>/*0XC+0TC]:E'0%F&W^5WY+EB07T2,;0P"PIC*E*?06]?]=6"
M0<C2]::"]L3R*:<B]V;/]Q*30<_R*'S?]W+_]W5?+%ROY80O^'4?^'L/^`WS
M*M92#'K^,`(4<`&_]"^:'R__8BZ;'P#<HOFBW_FC7_J;SRV<;_KD,BZES_FI
M3_JHSRT$X/FB__JUS_J;3_J:C_H!`,D>T`=2%/F#W_6TWOAQTNA/3QO)`2`<
M,B''P?P`XB!8<B!?PAT9KAP+0A]5HAS13QS=O_T30B"E15H#\OR[T1TW;AW4
MD3F^P2'T<?U70OW?<?W2X?P7XOWX'_[FO_WG?_[ZK_T`L4S@0&@%#2Z[AG"9
MLH$-'3IDR%"@Q($1'U[$.'$9M(0**6:$N+!BR(\@32)45G#9,8'01HJD6%*F
M1I@O,;HDJ#)AQY@;7;+,A@V;-EBK6!D]RDJI4E1+5STUBC3^Z52E2*U6A8IU
MZ=&L4Z-6]<H5ZE.O9,F*!:OU:]2L;=5&)18T&[1B+5\JPUNS)<Z+!EWNY.O3
M+S1EV+@=1IQ8\6+&C1TSAM7G#R!`DRE?QLP'\V;,?SQ7_N/',F?2E_V8+IU:
M]6K6J%V;]CPY].?6M6VG/OW:=F[7N6/'%HV9-Z#APV]3/IV;M^CBE9T#'TU<
M^/3CTY7#_BQ:=FS0M*LWKXY<.NK?GH/?/I5>??I"ZU&I?[\^/2!4@.3?Q_\^
MOOS]^-/W3R\5`?T[I;_Z3DF%P`+=N^\]^NB[[S+-PC.NN/)F$^]"\V!YK$,/
M/TQ,&VY6"$"!!!)``,43#4@1103^7GP1Q0-F5)'&$U5\\0`8#W!1QQ=9_/%&
M`X0D<L4;C801`2!A7#+'))5\LDDE>3R2RA-YA-'%*YGT<48G<_1Q22\1\'%*
M*@\PH$PHDV3QR`2L3&#(-WELD\8TCY3S1BR?/#'%/*^\TDHVHWS23S?AK/),
M-\G<,LY#`[UQ4$F3=+1*-R]MT<48:51SRDE_S!10(MF$]$X]+SV2TB7%]+&`
M'6=4%%8==;Q3T3F]E#77,64EDT5==P653%DU?97,37$U-MD=DX1U36$;#=;)
M+@.U$<TQC<7ST4,+#173!!008`5N1`2Q7',/$W&%`1CXUD0%W#WQW0426.!=
M>]M]MUW^?>WE-UYW\^7W7W@'WO=??`.^5UZ`Y3T888'W_3;B@"5.&.&&%YZX
M7X<WSMA@$R_>N.""$]97Y(X%YGA@CT?6&.5^36[9Y9`]5AEBC%/&V6&3_:VX
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MOJ!KW(>_?ONSYXC^^_??7W_^Z_<?]9XW0`(6T(`'1&`""T@N!3;0@0^$8`09
M&$$*/F^"%<2@\RZ800YV<($5W*!C0BC"QHSP7"9\(`K#1D)S,5"%+.R@";4A
M0Q"ID%PT=.`+'Z/#%2XFA#ST(&*`>,$)`A&!1BRB`HT81"8VT8E/A&(4I3A%
M*E;1BE?$8A;1):(E:M&+7P1C&,4X1C*6$8LW'%<7@XC"'T(0B3NTX`")*$0X
M=LB%=F3,'4L8HCS"48V*X6(?E4C^QSWRL89X'&$;"9A$0Y8KD2U$EPCGR$86
MVO"$8E.D(!E91SP6DHY_]*`R6+`"4I:R!<K@)"CG>$0#@M*,873E*P<)0PG*
MTI84C.5BZG""4JZ`!2?X@Q-#```#%(``!@!`\T24AC?480(5T,`UN)$'$G##
M%1[01A\D(`$_Y((#VE!&"\*6AN;9P0[<6`4'N-&':HXH#QRH``3:R8<-H),-
MZ,0`!-J@C0Q@0`,90"4;U,`-99#@&GV8`#=S(8$-5.`$@:B`!2#0`A)40`)Y
M"-L),)H*%ZRA><KHP"L.,PN&5D`%?1`!-U+Q!F5@()[MS(,*_K`!;:Q"#G!X
M@`<@X(?^-$B@`A-8Q0@LVH)98&`6UVB!-D`03P^X0`(>D(`>$',""'3@&K/(
M@`4D\(;#\*&J6ZV#!"SP@#^H`*/<\$-$&P`'9T[@!-PH`4;7X`ILZ/2M?:"I
M*UCJ4GE&,JU:/2H'(&`";NBAG=<`@5:E&C976%4;'(@%8MH0`0N(=`-\X`8+
M4$E5#Z"2&VN`@$[]L()SIF$681WK8E5`@0B\01L?L"@'5J$!B7+U`V/=IV#?
M^E=N'B8-`R7!!#:0`36\-0\3F(!42[`&;K!A%9%\PT\)F]9XNL`#%OAG]#P@
MTL(R=!9L:%X=SGH8$F`4%D9%ZFLMD-RPK>"G'N`&')XI@37^8"`##M4H-]1P
MVF=6@!@SM>8]/QM:")2U#MPPK1PFD-K#J*`"#Q`P&R!@@5GXX0$=J$`+;IN!
M#&ACLI7EQ@:8&]U9<.,:L&7O*C!`7VZ\@0+0U`,T3<K.PB84H\MM[G,1#`<Y
M5#,/9PTN!RBPBA"X(K/78,&+(R#2$\>V%1DX*MB4P0$)P($;))"JB/2`7*F^
M8KV>42L<[/#3MQX&L1;]0!H(FX<^M&"C+9#O@\N*42USF1LHB*<<(#I6YC+0
M#\0TI@$$(`%I-G$6$%!``QIP@!`D)@0K<$$%]%`':5Z#`:LHP0DLS08V1)4!
MUU`&?$5$@I1RFALJ`,`JKO$`9;S^P@%_2(`=]."'P]0AU:H@+`5.8(<&2"8$
M#<B#8?PP`6[(H0+*8`"G(;"*/&"``J^0`P/\D(<_-"`-;7``,0ZS!A!<604K
M:+0=`""'PQ###BYU11PB@-85Y,(`>=!#'P[SA@SHX=8GF,4:$K`"95B@!'_(
MPRP8X()FB[L-U\"F`MC0ASX$H@W[SL5A.HU7?!M`#G&P@#2A_8`/$.,$&`A$
M'8A1`2MS(PX-^$,=9G&""OA!`<UNPY55@8++0D`.?$@U*E0PBW?G@=:(B78>
MY*`-$FR@#Q"H0UC-G(!K/R#B(F)!JKF1`%4<Q@\,R,/'KW&`;G/@&F^00!\X
MT&B5/IS^WQ3@*@E<L0(+A+S$W*@`">J0@%0X8.%]2,4!+HX!9#`@#75PA0F,
M_@#Q*H`/&C8Q`BR`5A8<P`YIL(`R&M`&-C2@I0W@!C`38X(*'%V\TJ8V2AMP
MSCR,FQNY:,`;/)`!4C<WYB)Z!0#>V@H`O.'$V&!>&QJ@;;B+X`\8^`/;`Y&'
M5#2[`JN80-K7/H$_A&#AMVZG*LRNC`JD_17"5_EA*E`"563`%:I@@!T^OO$0
MJ((/(F``PQNP2PQ<(]$AEKHR%.#13UM@UPQ8_A](0((^6*`"KH"#8VL`3K,\
M#,`\S>.&$%"!-```;8"#F$.K%DB`.,@%!:@ZK\.`?ZL#5)+^OX7S`U6HO6M0
M)Q+P`#D0`%7``*[B!F(8P,J[!A$H`3O(@#=`.94[@0G0)@%SOX7[`Q,0``^K
M`SF`+Q)8@19H.Y&KOG)KP0*4NP>@JFFK.L4X@0-H``:H0B-K(A&)`P.HP@,(
MA$@J`1=P@6H*I#=@``G0!CG(@,/0@!*H`%`CNU.S@#[P@`,#`1)0`6[P@!\C
M@5E0`#L(N,/(`P$P@5-P@5EP`&DJ@6K"N,2@@%E8@39HML.P`*XJ@1(H-@CH
M@SS(A0=XK@J(@Y&:@&O8@%1H`4S,-/@*&Q/`1#EP@*Q+@PH4K[>+`P[H`P$X
M@51XJVMH@.?"@!.0#&WH16Z8@,K^JX!9*(%58X,\>"Y>?"X1J8`#4P4("(0'
MT(99V+VPL8!0/`$-\`.IP@!RXX8ZT,0#0X%<RP,0"`$]X(!A>RXX,#I"/(46
MJ,`?>SL1D8/%TX9K<``C@\<\J``S&T90-+,0($)NN#3RRD->_`,+2(!7,"@+
M(+=K"`1R<49NP``1T`.C:H$,^`,](!<+.+`&"`0)6,98>`7,FX4'B`4(2`6"
M:@`C>P,.R`,*F"8)F"82R("77`4&*+8ZQ`#MJP,2$(`_2(-@6D5,?(,-R`--
MM`-4RL?#,($3@*\`-+&5PX`^^`!R6Z:/PX97.``+B`42$,9/#$5NV$:,E(,T
MR(!OE";^$R`L@C2!ZZLF%2B!/\O%/!21B\R`=>3(M@3)P\@`$TB%#\@%%=C%
M!J@ZB3P,8_,V$R/)"6``K#H`(^/%67@%"?@#")`F$FB!,3RU#^`&5FRQ.EQ#
MN*N#$BC*HSR,$FB!-@"`.*@#KA*156B`?7P`%ZB#]ML`8$1*9<R#5XB%L(0%
M@TI(5[B&<#R,.#C-"A`_"O`#8HB#<LP\3(P#FS0Q"`LX!F0K.;@&0MN`0'`!
MC\0HQC2YYJR#$N0&"5`!''S*Q2"&!T@T`RBS)[J&"'B3."0O%EB#!O"`LQP7
M!Q"G-W"!P]@`$QA%96BT=$F`#5``/4B%#8@%FR0E%A"Y`ZC^`&!;3@PP`15@
M`U<@.Q.HIC=8/,38@#CX@-,2)[2TLOT;1P/0JFD\!;@31VV@`#W0@,S3M`G(
M!:,*FT4<QP/0`&O+!0Q]Q<.`@P[831.`-)A\R0UH``DP*`B8``-@`>0[`150
M@563@`?X*,5$#`]XKE20@$!@``HP`!6D1*Y2@02(*+0\RSHP@`<CAC0H``4@
M-@YH@`QX`#\``51*TB7UT"*E@",EESI0@*8204#E@#$3R)>L`''T@Y#"`,G3
ML1,X,&4@JU\\`4VS`'@3@`TH-,FKN@UP@`Q0@%Q(@P.@@/8[#`Z8$;)\``EP
M@#:8A028``((Q0;8@!`H3$;-@P3^D``$H+4/R(,U`)M4\$DYX(`Z6%&1-$@2
M>*@5$M$6XP`]F--EBZ^`S(4*Z%9EJ(/%DZ85:%`&.##M<P40\`.2RM(M90!(
M%4?!2H`U9`$$:%54ND2XL[*Y3`,&<(!$7-(B#!M>+-533=55K0!7#;$H58!K
M4(%S(E6X.\LX",A=(Z@'"`0+X(!.E8"JTU0&((`W>`6R(P'^M$((*#$7G4EG
M%4J#G,HOO+(62`,/*`$5X$IT:H#HF56MTH8..,.4,C$(Z-(VB`6WTE*"18RT
M;+$"I5&X(@""@U$(*`852"DX*-%K$-K48P$/P$-RBZIZ:@%[#4H,.$LX8%J1
M%`$TT2C^&(T`([L@%R``!E"`R(HB/3@`IZ,C$Q!#3%2,%0@F.<!.#$"!!!5-
M$3D!PFH#.VB#`RB!!'"%64BH64#$0L/'#7"%`EB#"D0E$B`L.0C*0X6`H'2F
MPZ``<LO7.`A*$W.`YYJ`FW6!!VBT$F"!/R"`$F"`4#3<5ER\/W`!U"NTQJQ#
MRS4`<5*&U45+<5RU51`!-J"%!UC)#Q#&5D",Y-5&KBK)0$#9"A@OM82KMQ(1
MY2PV?<P\$)#<XSTU/RA3;F@##["##5@%`V`#;/Q=H$M=2WO)]<V#JS7>"3A7
M";3=/P"JPSB!:I(\,E4%G<)(KM*#AC4SXTW+$X@%%B`L!L+^@#1X!66X2'1R
MNL[CAF&T7_7=0Z-R7FUX``S8@*"TS9\\+M)]I\<S`.XR7,3=PQ)MS,7+`P,@
M@0?5`YQ<A5TBK#<H.;`$`0E@@95$1.@=QM*EQ#IH@PX8S?K,/,*JQ"MSA5_Z
M@W63@PUHA>&=7@?FQE>08,503A!0@S1H-&1[+O-TS`&&R4#(@!-@@!:H@*I;
MM>#DAE=0`%02@31H`6`:Q>J,KSTD-FZ@@!9.@Q=N31=H@170`P&@,YR=(4],
MP&O(@)N%3!U;!93EN`ZNNC1H*7$<7=1<!7!J@!*HI]QML:N59+AJ@4;&J!:`
MW2<.&_"M`^R<@#SX@!80J7!]C);^$@!+=B(1R0"PH2,0T-)N0R,2H+7O_(`/
MP,D-^``0$+4$%$WP`KX[JR:UX095$`!2&Z@6@P"TK*8.L``3P#_U#>?I[683
MFX!F_N,0Z#8X*(`3$`$:](`/^./#`,%0!`$1C3G'%)$0:+0V>(!UVKENWN/#
M:`,,J(."MH!JN@8#J+H7&^!7<%R!DP,$&!&<3``.F,I]/("JT[(&:`$(>(-9
M.(#"2F<1T:<K8P`5^``5BSNV(@"8]H,36%!N:&D16`7=(]>0*VB'RH5N#H$W
M"(3F`>=Q>@!R!3@"&&!78(![_F.L_4*8A@`.$($\(`8%8+EN(X!8N,7"4@!P
MFP"+/(#^EWR`F./I%5``%0"!&=5I%;R&!.#:%@B$E,X#!U`&!(C"U_WI.G"`
M.PN!9L.&^'2%6"``DPMG"6AFG+0Y90"`61`ZJ1SK!&AJG":W-@AG#>"JJ(2`
M%9B`-#@!T5P#`5,!PCJ%"?"#E%X!G#R`QBXT"+`R!0B^!(#I8(+G<62`-6C8
M$FBT"F"#AA;G@0UI;DAK;A"!*K9M$(#9GV*!!]!J!3`!"Q#-N)ZW<,;CKM:&
M!)"#`^@#!7C)B!9I;KBM$T@`92B!;L,`<<GM-L#)IW)FG8X#91``'5-`%6@T
M`\!==#J`?93H$&LI"D"!/C2Q!.@`UPP$`QB1@I9C%F``;?#^O^72!L:.[PW0
MM0FH5ZKL`[9FZ[.::PX@@9FMI@/@JGUV:9A6,0HP@368\,9>3Q64`_H$@4E3
MT[!IZ/F%HE5XN\2H`SV8-#X*1&NZQ.=2!3STK'$\L%.H`S60IN]J+JDZS`'^
MYE1@KE0X)V)``1&0-Y5BKNEM`>D5<K6K-6GL5!*0@S8042PL-Q;0-CN0@_TR
M,37PK*3CAC^XIU?0`V5`3!+H\D"``U6H<HQ"JHA[@\/M0]-J,7+2!F(8.M&N
MV1FB1W11AC3X1658!1+(!05]9#;X0CV82A%0A3HP@1%X@U;H5(W\<1'A=&ZP
M@Q(SXU`\A8$J/H<]@1&(@X8\C%/^$+!Q>?5M[M02R+>G/HQ<:($F)R></K#S
M4P%ET(9(/SB3"X%3$J)(7W61\X-/AVLV@&ML</0B3BIM8($^0'1>#P%89RYB
M=[-:^P-1XG)K(H$2,+(U^$*6:H-VTH,!#D55Z-01.+!`N"<6B+AK2(-K@,AR
M.K`_@-DU>,GX$O?3BP-M<'0UK_8V\'1Z_D(ZOX8QQ"PZ-T4^N"<K]_*(T_9Q
M)(9KQ^F%+_00%Q&46O9M6WA=/PR69_9#W*]8-+%(%Q$]UT@D5RGCZG?F<H5+
ME%YY-[FWZ_$?SP.8/;UOCW3OE(.I)'"!'V`6>(4")08K@W@Q3_F!"GH2>"X]
M#X%`>(7^3EW':S?SZ15M$G`!.3BPI#\]-B^L3P]U$1TH3(/WSX)K?<=I/K"#
MDDL,95#Z6Q+\P1\I#\A2G!8!G#;(<V6BCR3\)ZH#'4LA65*EQ[=\6WJA.\(A
M0@J;38JDS4\C3>JA1LI\/MJD#0JDT4^B7-JBS]\BU`>D%2HB<L%@SH\DUT_]
M/G(A-`*D1S+]/5JEV+_]T1_^UN<CWNO\3Q+^$/'\Y2?^'@HDU-<CY[?]Y%?^
MXG=^WG]^VV_^T-]^[,]^U8_^Y<_]U;?^W'?]X=?\])_^Y&?]RX?_^)?_^:?_
M^K?_^\?__-?__>?__O?__P<(;@('$BQH\"#"A`H7,FSH\"'^Q(@2)U*L:/$B
MQHP:-W+LZ/$CR)`B1Y(L:?(DRI0J5[)LZ?(ES)@R-VKC5E.@MIPX=0[D:?/F
M3Z`^<PHM:A2G3:1"D_:\J=/IT9U%>S(-VI3@T*53E6)URK0F3Z]6DT;]V72K
MV:M<T^[LZE9J6ZAOQR)MJY9N6K!WV>;-2O5KU:&!PV;U2M@P5;1ZURX>2W1N
MX;>/`9-=6QFNW<N--VO%S#>R6J)R[TX&BS@SY\1G]_K-S#:U99^O#ZN>:?LV
M[MPO@>KN[?NW0M[`?8L1DX42-S1:Q&BA1FVY%C3<*&410T;;-C+&D9NJKF48
M-T9:HG,;MCQ++VYDQHOAUBO+F./^R:$[/V]J>G4RV[1IE]^=.7CBD4>=<>D5
MMYQ[W@4XGG3F&7<?@==EMUURWM7'G'24+"=&3OUQI^!\Y#F('C?,:4%&@F3(
MIQQS%V8!87[8><C-?]^%QR!^!9;(7'OOC6&C@`W:E^-UVAR('(O-/<<<(SF2
M6)Q_("HGXI`$]EA=%I[,9YR+,&IQ1H?&34(CB$%RXPF6!HZ'XGL43BGD@T2&
M&66+2VK1)($DCD%AC>"]65Z5U5WI)GUV9ACCA'3:.&63(Z;W8W$IKHCCB#!:
M-R=RI5AHJ),&\EDFI8&*,4:"A-8)'9[5@<G?IP#>>">@.JZG!:EMRF=FI7(F
M^N&I&';^NB."/BXZ7J.BZL?JI+W"2J`6-=0@0WM&T%`##<$$,RT-1I0X+0[;
M;(/#L^U%(L,--?C"C;39<N/+M#(@5VX--TQ'`PXT1(NMM>U&4J(,-73[;;C<
M3$+##32<FZZV8LB`@[O<P"LO)=@>3(.ZO6"[K\+^>@LNM-P4@>^UU";<[[\<
MMS=PP1-7'&_##\][0\?24ILOM1B3O#&U)TN,+L4C/ZLEN/'.2VUZ"*_;[IAB
M<(MSS"!C6\2V!2,'+@UA"#RMN=P@T;-[2//KK\#D-CUSR#(DO33`'8];KLH^
M-UPOV!'#?*^Z[#Z;],UIGTQN#<"$K*["#+\;,,H&\UR#MA;^W[VMT')7?7BU
M?R>,MLG<K)WUUG5C.[6S$!/<],HP8TPYX>1&CJW;G-M[=<'I9:ZMW68S[OG<
MD--,`]1*:ZQWV*WS7'&[G#=N.MVP>YUQR3E?33;J7\L`=.=#&VZTXK+KGOSJ
M,I\N\M<U>.LM-]]O(Y#X-GU/OK=@?5]3^>&#[S[XV*4/__CPLW\^_>:_7[[X
M]\>/?_O6ES_[#9!_`#R?_.H7P/F5+X'^4R`##[@?_4$0?/W+7P+1M[\(;G""
M"_P?!]7'P0H^4(/C^V`),2A``XZ0@B>48`H%F,'\?7!\,T2A"EN80Q)2,(8M
M=&`!YW=#!$K0AC"DH`DU6$(@UA#^B3M,(@$;R$(>XG"(%EPA$3O(0ROZ$(3U
M&\Y#A`/&,9*QC&8\(QK3J,8ULC$X911C&^.($3C*T21TK"-([HC'/?*QCW[\
M(R`#*<A!$K*0ACPD(A.IR$4RLI&.?"0D(RG)25*RDI:\I$H:@\E-<K*3GOPD
M*$,IRE&2<I0U@0,&.L`!#GC``ZODP`8XH(%9'$2/NUD*0S3)D:W8,HZ][(AL
M>",6-YI1EW:L"C*'N9ICEG*0*@```@YP``($P`#2E"8!7-',;5+DEV$TI6V\
MR4TUUH0%!F@``Q2`@31`0`$,8$`#$J!-H,Q"#G6H0S%J61!A8J6?-LF#,OC"
MD%>\H0[^>9"#'KAAAX#Z<R!^L&<=B)$0?@I$&7F@J$!6T09:*B,.=;##/:]!
MS+J,M"$8[8A%E?F7DM)1&760`TP#>HT\Q(&6W*CG/5.A3VW8X1JJ.(5!4MK0
MB/`F%GQ`R!V%,XNC`I2D=Q3J2A$RBX0.Y`_V?(-.N9&*-_@!)P<UJ$BK:L^N
M&D2/P?3G4@DR"ZR.\X\L(,`[";`&;KRU`>X\@#:1(H<!2```&&`H22UR#0.H
M8B)Z@,`#!/"`$VC#`#J]HP448`$`<*`N9M7J`<)Z$`PH(*&NF,`$!-"`#6AV
MHMQ(0QZ0&56D!K:L0UUM:Y&BBLQNY`2K<.TJ!%`!"T!@%M?^>,`![)K0.`C`
M`@(0@!Q4RXW!YL($(2!+"6;Q"@.(5)P+J<D;'J!<AV!7`MP@0&&!DHH3Z%,5
M!@#L=;GQ!@@@);(8>(`:N+&"`$"``"A8;@(FH`#*$L0"#$@``-JPSXM@E[TU
M>04$&D#8MO;QK>]4@#;_@(!T_C>O`Y$#!K21B@348;E_"&@@`H&468A8(*^@
M*C=R\8:\KE6BO[VM0262!P&\8KD/2(5O!3*+/Q3$`LGU`P%JS(T^6#@5<JCN
M-;JJC4#TX0&E/7%%(8R45P@@M=C0:BZX<>5KU$3%>87`&Y;+!\#^P::Y:(.%
M!^**V^Z8(('(,C>4T5.;8.,:?+C^AC+Z4)-KV!G/>M8QCY>KC5G`6<-^<#(W
M'EI:;@3BR`/ALT"XS`U7'#7.!\BJ'VR:440+I`41R'((&,"-.EB`&\38K5KA
MX.(&Y&(%)DB*,@S@BEDX(!="YH8J"DL0+A-Z('S(JTA3H<U,F_JV?'9%6-M<
MT3]SPZJEQ;!61:I1B;+!NW'F@U-.<6C-=E3(7'X%0Y6Q50PPQ<=)B06'APR`
MKC;@MFT(P#RY@0$Y:$,-"1!I+D0\4XDNM]E9KDD?;JUH@>CAHMR00ZEK<H+G
M1J`%VV4P&LM9@`8<@+1IN$8%$O#.`]Q6KZ56!@/TX(<*".`/J2"``,BK"A*L
M0``KF'3^`RA[C5-O0`%RF(4"'L"`VRH@%BZHP`0R\,T9UU@9#PC!`S:@U0<T
M@`0$P0`+E,&&"HBT#0`P@(#K<(`'1.`:U39`+CR@@`DT0+.SB#EI/6``"&B6
MRAU>!08$$(<TD!<#><#X!A)@!S88`,(B:``$M*D"=/I!&178``/@`&L/((`$
MKVA`T[E1#`E0'!#:P```(D"+63S@`P_P``@,P`+.>Q[T!R#O*73N]!98P`,)
M**P&%$"!!AQ<`AB`@$1K8@<$0"`"#,W#`[1!#`D0X^P`(.T'UBY?R*-X%3M_
M12ZTH0`59/3>=:A`G"7@@:2L0@'MY'FK2Y`4M5L@$`P@00+^J"\'=,9W("VH
M`.-UR@8!%$#`'["`!290@@1K(P\?X,8$B$#2:94#1!XQS)X%:(,<V!X$_-O!
ME5H%S,(J2(`&/,!Z%<#%41X&B%3-40"G*<,$/$`"))<K\98R*(,#0(`#*-U`
MK!,QW%8+W)M`6``;<,/.<<,:"`"<<4,%Q,'!*8`VG`#@<8,)`$!GG58+8,"E
M<8/581TWQ('M/8`RI`$"-$!E(5Q/B!0-0MP>O94#$(`<O`("G!9<,0!>%40=
M&$`%(H`VU$$#%!\!L,%T]<$LG!<?',`L2``(&-T:U$$"$,,?$$,J=%@#)%<#
M_`$#W%R@V02?-:(C$D0="(`V78/^`@3";'$#!]3@!(A836P``B36R_5!`/A!
M'Q!`+NC!AQG`+*P`N>G!`>0;`X25-CR`"!A="^!<:B6%V^%:`O!8"3B=!.1!
M'AP`(,Z",D``&^B!=]&=,BC`->B!!\A!`N1"F3V:S7'#!LR5!+P"&T"`,H2`
M'82`[[72+`"`'/P!`*A"'3"`*@3`.::CUF%B#6[C"E36`]1!*H"=^0'@"2B#
M'@"%'01"K'4<,AR`.F*?`X2`+<Y"`NC!+,1B'Y2:B4T3`&!?R)D8`.A!'QB`
M!6S=8S$:(2:7`H0?]RD`'[S"O;7!!'##`P0",7AC4IA`![!D':C"NI7B+&R`
M!%!B"&#^@P'T01ZL9`)8X@%@HC:^0AK\7S1F0#_^8U)`VS2>`-7IP12R5PN`
M`";BHS[&HH[5(`<XW02HP6#-`AMH%QM(I$!TP'$!P"K.9$U@0`(^P.P=``L0
MQ`8T@`8,@--1`/6E@2JF@0)PPPDH'0>(P"D`P!_H00'D0@4TI3:\`3'X05%>
M7T'P`:MQH1Q)7#R]`C'4P36LP@&\$P)86$W4@0/4`1R(F!Q@GRJ4'3>4P`GD
M0BQ>PR%"@$[%@04<(P!8`"U5FP*D%H2YP-5UF.YM'>1!G@,DP/8E!=$M%P/$
MPD-BHP:L006\7$U8@("M0@+X@1U0@$#TH&!*@`(0PPHXW1O^E%IKAM4UW.!J
M<D.[$025V0$WK()KFH#X48!G/L!NTM($Y`$?*$`+E$`%F-\)M,`#Z$$%5.0.
MTN9M84`VAN4*B)](54!RJ<(#J,(``*=T08`J5)D-S@(L,(`V;,!T3@`;M`!8
M%MQ*JH*HR8$`$(##/=H)4%Z\<4`;>$"8*<!MQ8%%0J<"G``+,$!>==\]_0$V
M'$`:"(0K$&,>-(`;ND!!J.1O<L-(JH#X[=ESXMS!D1LMJL$]QN2K34#!81\/
MU@$(E!H)D%=_YD&I*<`L1*<&E&@:I($$I$$'?$`D#D","@06NBEH!L#_R8%W
MSJ@:<$`(U(%WIN=`Z`$%,,#+54#^AS%`+J"`T\%!P@D$!I``'R37"H@HIM9E
M`Z0!"4P`0]5$!HC`2P44>)+`JU'B*IKG!I#:=QK4<3D<,7B`!+!7>SJ4`'08
M9OH271E``I#;*>C!;57`A(UF56#A4Y::*R0`+'"#!K1`+@`A0ZH"!*06*VI5
M*M!B&BB=!42J*RB#*K0``=B4N*V"*JP"NZKKK7%#<RI#`T@7[5D`"[Q"'-38
M6R87#^9!'S1`3C2`'H3`"M!FJSG=^N&::SJGM@K=>]X$E:56:P:4";P:A6H5
MMBH=!>B!'LQK'03"AJE"'_34*J2"!+#@<CE`857`O<*!,FPK4&K`R^4!!*Q"
MAGXH+$3^P"H00&HQ`(B*&M2]@LN>P'UJI*BQJ#:0:R2F5B>V`(,F11U(0`;0
M$@.D%@L(G<^*82H`95BM@@-HE@AH@$``YJAAWQO06%*P`+@FEZ2ZVJ/-JY9"
MFP+@HQSDGF"^VL;^:\#F00B46L7R(,>26P-`IZC9J]`JPPEP0#VI`KG.@8?6
M!+2]Y]9B71YX9PDH;AC:`>TI*KP&W]]>K*0FH7I)Y+XF12"<81WV+++!Z-/Q
MZUOZX&!R@Q@J@PJ(`#>H@`=T;$XX@'P:697U)WV.VJ7^UG/MV:^VD3D9P!M@
MPW[1'AM,G+(BQ7J9Q?1B(@6<P"O.`@&$P.%Q0PLH@#GYP8;^J0$RIL$$U`$8
M<H-C84`([!]ZN5$=`,`D&L`KO`(!<(,+-``+W-A`5`#+4@#]<H,#M))V;4`(
M6!TMF`!6_I8J-0!@M0`#F%-"+9B:F2-F!900%F$>J$("T.FC6L`?3!\%N,`L
MAL!7Z@$#T&E=[MD2KH`#K,`#S-H!F,`!M(`?B%X"K$$N`(!\!AE*'F:'^;`!
M>&\#K,"\EL!S/8#B-4`#<X,(8,#WQIL&'+``Z%J<&4#P>6\$&T!"'8`($"\K
MW<3)R10WP,(`,*4`U"4;.,!R38`#W`0+3(`=I*\I.E=27,,!E$`^/F$!8X"`
M(D-2A$`2*]X`>X!V48!W@<!S-8#^'=@!>]'O*Q0`_NJO`\2"*QJH'I2`!41Q
M4KR!=YWK&S3`&B0`4"+F)7_I`S3P[_UFY#V`#\I:+AS`J)+;0#R`@$D:!Q@`
M#'_M8(D8&P!`'R0%F/4;-PSSDI[`!"C="IS>`214(;-Q"$`Q.T:`"YS`$,>!
M@7'#+RM8!VC##1ZO&IF3`L`!&R2`"+)!&@37&0+%*<S50`2".R.N"`0SMC+C
M<J4!"/!K''R`K9)`&M3!',A7,;R"")!`FCF50:B"";C8"A##RVK#-;3!!P3S
M0+Q!"92`"918*Y!`"=R6*H3`&[S!*>2!K[X"".A!'0"6-N"S#VH#M1($,91`
M8<V"TT[^FC^G`5#!P0=<W)")0"Y\-`G+[@F<@$3M<QH(Q2TNET13E1^`P!N(
M5!R`0)+&]&VI@#(4PRW:EGPY-`M`]%*/6H>E@8BY0@B@-)Z=``A0M$!\]!O`
M`5D)1$'A!#[SJQPP5BR8`%$/!#&P`6^H`@NL0*"M@@_*;@OP6TS_<X>M@$7Q
MJT#$@0K$@L.=0GP10PN$0,<)Q#UQ@QJ(V"K\HC:QP5QE=AJPZURM`#*0IU?G
M[C]Y@.(1P\(%\TT$0@VR0):E`6O'60ET6!U\P&"[PDFG-$ZTP`GD@8"M@4Z-
MWI"%P!_X*I]>]G*QP0H\M4VP@41APQJH]1J4F$!DMT#T00C^J(!$G8`'J$"8
MV;1!I]C")13?U@$;2&"28O8)K,`)"-@*:!HXOY%\"0`#$``!*$`")``!%(`"
M*("L241-S-:BW7<B70,+L,!0GX!]KH`+N("#FX`*5+@*J$`N-M,UJ,`*J,!0
MXW6!ND`+@'B!JD#%MH`+)+AIB8#M*C@DN4`"0`"-/\`#U+B--\"[MA8NI5A-
M#YA3B9%L?--$"<<P\9,FT5&/P]9K!`9JU$94G10N4=21Q]9B#/EEK%:/\\8U
MG``)<#1'_^*7?[F8_V()>`!S/X66\[AIN<9V"3F0)]5*+3D<Z465RRB9@SD)
MC,"8BWF8B\`)L'@ME29QKKEE]!/^EL,X&?&9,C!ZH^,9HRNZI$\ZI5>Z15B7
MI6=F9=BY9F`Z)G$ZJ&]ZIC.8IX]1J2?2J8^ZJJ^Z1Z0ZJ[?ZJ\>ZK+?$"995
M*J2",B6M0\/6GOW;4N"9D"TY4RA#B>GZ^SY<BOU!/N5"=>F1N`7B0.S8*OS!
M;1EY1577G`,Y,M7Z7YS4-02"L?EZMQ?$*_R!9KD"N%=C,EW[NL^ZN[\[0I"`
MX@&%,@`Z"91W0;3"*BYB0OP!>8E1'^0"<[N1'!3L?.Z[2<FN!>!NJ_%[0@CJ
M"H"`3>4!"70`"=0@4FUX-ZF7@(E3"8``"<B!*OP[0^B!!:Q`+0H$&Y"`!Y"`
MQAN$'FC^EJO#.\W?=TV8_,`S(<9GP'(C%$Z(``NH`!M(-TP!Q2HX;2I07QS0
MM1VH@H]UE1^L@8;501OL(#&D02RX@@7`-M`+?9CQP1H0PRNX0):M`MD/Q`E`
M?1VT`(Z9@#:-/+5U/#?`09@]%%+(Y]4OMS:<0BI<@^,AZ"O0-"UYW5$1@PE4
M.[RJP#7D@AR\06$I@QP<:J2Q03#;$[_VP1J$E1^0US6D@1Z\W`KX:AY8YPI0
ME3:$`"W)P89?0X>I0G9W6!X0@RN4P&=2P-VUP&WE0AH45AWL>,W_?J8_9I@!
MQ0D`U<'U007XP7FKU^BW0!RTP<@"I4`0@PL(K1^X@!_D`2K^YH$*I,$;7+?+
MIP$<J(`<;(`?B-]RD<`?<$`@N$#'O0'WLP#=5_8?J,$K;!362[U`?$!`U43I
MKP!`O#KA)XT?-GKDO-'#C9L<#W5(S&+(L`ZW5!#Z;-#VIDV;/RU2M5B5)I8:
M;FQ.R1D9:,4U;JY4".PS(14(;0,]R&%XH@^(C'):]'G%1M4;AFW@<'/Y)XV<
M/'78S$J31TX</BY<<2,&@INVB0RO57R#(4\';B;LJ/EX;<7(H;G2#`W[ZFM=
MNW?QYM6[EV]?OW\!!Q8\F'!APX<1)U:\F'%CQ&^,>O5Z(A!#IR>XG?C#\-0L
MD:M:I`FA(@W#5!;6F,BC1K2*-G+^<C',,XNGQ#ZON7E@.&MAH%5]7%KTO`IT
MFE6O*J@IP0?#FA#*&((@Q@VZBD#$Y&Q():?M+-?0&SY<4=$KMXJG5'`+H4V.
M'#\\K_5958$-B&L>5I#(TX=G^51M0,AC!6Y`F,4.;B!3JJ)9^BA!&SCJT".#
M-#!#T"B7`DDOCQ,&7"&-7%(YH0Z7M@*K/`41U(DK%?[@[A1N\B`&`S5$\&.#
M-$!8I2O'>.S1QQ^!#%+((8DLTLC$O((CJ:_8,$J]4TC@QCK39F%A%55<>"./
M4Q;BYI059LDCCS2T_.,/.)11)A4^O*NC,LCDT(8K;G)9HR%5^`BN,Y%422.-
M5%Q9(9;^_5J810[P-..FCS?6R(.-7`92Y@\4B)FEC8JX@<.H/J(LKZ(0N>&@
MH3>4<>6$6?Q(!4PYKE$A%3U2(<85$Z9S18U<2A!0/6)*BR.RT@+9\!HX\N"#
M#5<PY2,];5;0(PT[^M`US#24F66%5)0*(;8W,.U*+%9%5<$/23&;[817\LCP
ME3HD.M+==^&-5]YYZ25L!0Q""*Y>OKSJR#RZE-K@!!+>N$94$S;C)L,2KESA
M#VZ[5,;A-_Q@X>$Z_M!CC33T:,.%$U9AH3TYX-!&5(94$-8./55@."07_F#K
M#S:(L;@TAERI@`4,/,N#!#U$Z$.$-EJPXP06\K"L`A<JX./^JXK^*(&;%MCX
M0`[72+CFA#$).BF/-EXIH0T2H%L%!#U(,#K4:SH"02=NU.!NE?7>B",7%Q:=
MB`010&`C%1;>2&/C63Q0(XXU7"`A*Q@M6&$#\)32R5\2Y-!`Z#9,F%J.-?Q0
M@U>FKLD#X'U)+]WTTU%/?:(,!&A`7]7K4J96Z+PJIH]`M-%&HEF"NR85WJ^1
M2!55OLK%CVN"YV9XAI:?997=*T,&NG:5^F,ZR'T'GAABH"-F7*V._XI!'7F?
MY0]E=.\#NE-P9TB90/S0\2OHDG\_EC3[$+X89<+7Y@^ZE)&_B:@B%==01FQF
MX954O`(\V@C$[J@SG5>T#RQF0E[^+K3AAUF4+6;^DQ]#?D,]]T60&[,X12S2
M-[U79/!Z?I`@Y&`70QG.D(8US(M7/&``";S.AJ@[40][]$,@#I&(133B$1?#
M`0,\@(=(')(0!0-%O4AQBGLY$15WQ!`L?F6+2(KB1+#812>.D8QE)*)DO*)$
M"-`NBV9TXQOA&$<YSI&.@E%C$^N81SWND8]]]&.1E"$F0>K!`@=X0!T$^101
M]C!W412C'!L)F/),DHN5O,L5_WBZ1UX2C);,Y!`E0QA,<I*405J%``Q0``.L
M4@&M7.4J#P``\GR2EK6TY2UQ2<95#.``KRQ``AB@@%<:()9O`Z(V*+095K6Q
MDQ/1PPG^6.3'7+!`!23`UB-ST0+EE28/<7"!K)2A!TS=+3BA1&9LS'.@7+HK
M#B<H`1N8J9<U$*\%L"B&&KBEC50@PP7!:<.+,&D'=<)ED^MDS"I0@`(3Q.:1
MI[!3-[EQJ18X\!IOJ$Q7TD"]1A*4(7[SD3+D4(<ZA#0/%3B``T(JTCK$89$S
M]$H:3/`*#Z@B!,6@SD30IQ0VGL`X)9!(09UXRA%\H#*-U`8>P5*!:Z0!`,6`
MI@I:(8%7F"`$S#O`Z[QR#0,03STBB*=!@52!"I#@9N6Y!A950"H`M.`5%F!#
M'=+@4P*<E1L0<)(671*"JEK$`$@%JV.\(@<"G"`$/\VJ7U?^@0%N:,``W,C`
M&MKB.@DXZ1H'P-9$7***JS+$KE_MT1V=J(P/@-!45=(/-_[`@3;`;:8H4^8L
MZK"D/+J"B>XK@01RH8<&D("*%:C#"2"0"A7HH00M($`&2F`!#,`A%@WXP`:0
M1X()9(4!J)H`!%CPUR)90"=>J<,#VJ`-"U3@HI6$@P?R\(`T]`%P*BAD"R;@
M`8UP8`,66,@L-J"!S*1G`Q78H7:')`?%[F8#&8#;`[1YEVL\P`\<P,`K:C0"
M%0A`!/*M0!^T`8$/6(`N:7C`'V;1`&VPH0(-Z!:/S,F-#1A@C5T)Y1"54=7R
MD"!8U\B`,E00ICY$19TKL$`(=+/^O3VV(@$>\*H'6@`'U3Q@%51<`V%=$((.
MT#:]?5`!>AL0"`8$X@%V(,$*XE#5!J1"`W[P`&:`"F#"])<#JO@#!%2!@578
M%89?><7>6A`"#M1!!2<@;"H8\(=#>L`%::!`7?G<AA6LH`THR`,#_*KFQ=0A
M`1_0)@02[8(,M'0B?2[!"D(P@E,\X-&OP("?*L`-!I1E!6_8@(T"$8$XS]F8
M0@(M$DNDO%F4@!AZ6($'KI$+#\!3#A]XD922AILT%]$KJVC`!KG1@32=0`X6
MP(MW&1`7#)Q@P:/.A0IR+(%1<P,#$$E3OA[`J;-D3M)`P@`;7.(O%.AA`A^T
MBS+&JXS^$FC`.RV@9BX80.X\<$!,-S8+4UC`@C2H8A:0;G<0&U(!901;-TQI
M@=0XR0(%Z"$/[YX%!`+A`&Y8(`^$5/6W6]""S?RL`GI(3P6Z.R0E_M>)U#Z+
MR^N@S0U@IU5Z\$UZ,K.0$N@DTFY<10*"0X*W/D0">DD%`-*@#0-P0!L*>#,?
M1'"J0"M`&Q.HPPK44`<#6YT"JNA`YI;]<+](8$E^L,`L)/"',>NE`@G(#`#T
M31H/_,'N7L\`(IMN`2NG`=PN&"[2U0[83#6=(1BP<@M`_56OQ`$`?G@%U!M^
M"@:X8@)YL,,$N'&`69A`!74(@2HH(.A`2&`6*"T2ZUPWQES^?,`#*."&"T:O
MAC6,6`34(L'/&.+J,W.#XWN,!71QAH$-H,JK>;G&!G1TVIT#J-7$^,`J1$4"
M/^3"`AS0T09RT8<,M"`.B5?\:7=B`:-L8'1U\<H:M)D'KJ2A#<1PZWJTKYD_
M5+6D^5J#&DSF!%R@SLPO,=!F1_2@`D3@&MB@-*@(%CK@K/@-O[3!!`;&3*)D
M`XJ!#4S"P?H@%S8@HCB@!9PF[0;#O8`-DIK)LPJP!5WP!6$P!@O0!&6P7FBP
M!DOG!G%P!WFP!WWP!X$P"(5P"(FP"(WP")$P"940Q;3(J)PPDOPB=]#(G(QJ
M"?N""B-)"O^""EUL"EG0"IO0Q<3^D`NCL`FQ4`S!\`AU,`V]B`W=\`WY10U"
MPT_HD`X+S4_:HB]\K0[YL`Y5P-[<,)ON,`T&D0]9H/SXHF8*L0_]Q`588#K@
MD!OBP$,8<1!=H`4@<2_B0.$8D0^;)1+[Z!H20``"``!,\111$0`&``#FX`MW
M0A53,197L=;<\)16,191,0`"8,#VPA9Q,14-0```D0TQ``!*\1=-<0"$L2\L
MP!B1T10%``!L#Q058PV'1!DFX`!21J6X4:3R(`0$(&FJJ`4$8`6>HAM5ZAO#
MT15I*(QHR!4,@"S04:7P@`T,P"SX`AY);AZ]<0T8(`$6YYA*B9%RXP#8X!SG
ML:0.("#^]8(##J!1^!&15D``M,D:J7&&KB$"!B!IL(&36@``DJ:+/C)ILL']
M=N0C\0`.O>(5".!D.(DE1:6+8'(O7"$!`)(=CY`#!J#][J(#"(`G\:(#=O*&
M8&2M>O`:`@$\T@0O,&@%LVB4VHB*W@<0M0&=M.@N7*'H&B,C!Z`BL"$+<Z<C
M60``4M(=/_)`JE`R.G(D<=(P5F%Q)`6/E$$53F%T,*E:LH@8@H,84B$56L$D
M)46C3-*`HI*+K/)'9E(*N=`5"``?]R(QM5`QN>'H;A)(?J<K4N$PP0B=EK*9
MKF@5^I(AN>$54B$0K-(KLA*S,O$I<0I]"#!(.(``LN()Q3#^-F=S+Y1(1R13
M"CL2#XS2(FW)(=BM!&2K+C[@-1.C!$H``]2)(8IAM/9B1(J$*T/2(T'2BJ;F
M.J\M.\711V*A!#;M&DJ`K$Q2#BJ@!9KFJ\+D*Q)%2C!@9Q;B1/K``U0@!(#R
M*T!,+YY32&92+UC2,;>S/_.B)BO31_:O`[0AS#B``*WO*"(C+U0!`JK)3G"*
M`MR)`UYG#ES"*_X`S3CI-6(A%HXD-N_S*TBT+W2R1"<B#WX3!T6+&TA@%?[`
MMUB3(4(`$I7A!'XG:?H`1NR@#93A%08P%TB&>%SA0R8325_"JY0AP1@"&?9*
M*W`O$`KH#[#!/5JA#MZ`JX!$&33^,B7U8BRK<SO9$HO$M"V_"`56@25FP054
M#)U.1%-*:+24)=A(QA6(H4>K0DHN:DIF84ZTR#Y1RP->P2F(@69.(@YL#)[8
MH$<1!-Y0JP6:ST=0LS$?LR7[XA4&P"7M`C5M\C9[!`2P@0U"*D$QY41BS#)0
MH#)Z=$1&:B(R))Z@M*.28@UZ5#ZTU'DHAWA\[1J(02VN00Y(8`U$P"2,Q"=%
MTRY.E"]2](:T@46S:P>)%$$JHPWNJBYN%&5.00TNA1B6+PY*0`3^8`U<`0X"
M80+^(")"@#N:="C*0P4T(`]^*-=NKQ7BH.12001RH0URA0("(5^"Y!HD@`!F
MJ5.YDQW^R]0ZN[-'6&46C#47UL,NY!1&_6`%3&4F.E1`_@"1`@%F&&(%MJ8%
MKC77E($C<B($!`0AM(0-'B806(H@`J$%G"4[^!-3MY,Q.34O_I,F/_5'-D)1
M*F(55*")<@THZ@`$B0%"2JY+5.'OP&9^,H!;2"`7+$HE]`-=$08#HD:X9`(C
M>,(#-*5+BL0G590A;!-%?_(+6=1):S`7*B(.WB0IO"(/5*`\LI5.\L!JN*4%
M1,H%5`$YV"!7LDL_Q/$TZ@-R^N`#!J0CM6*O\(U&=FQS[I5O!\0#5K-',E(`
MFA,OSA([QW)S[R)A&39XX$D;F),AB($$N"I!=F45`"0/!A?^*M)`!%0`#CR6
M&T"V!70C+V6,;=Z`5?+@&@HKK>+#^O(C:?P@<?J`>Z(4,2W5/S<5.W=6+P@T
M61DC0;G!#RJB22^*#2@T1[T",KC%!48JRCR$>9;+.+)(&3!`#OXN5%I`/XHF
M=BN7&%SW`_)`FR2G#BZ32-(H;;$(6='6>J]R;=%4TI1!-Q#&0G;D%?R@/$3`
MIK@A+M*@#E2!VC2`&%I`%6#"%4IN0%0C:=R,!=8%.E3!)(A!OR:"&/:*&$X`
M6=R6T3P`QW3E.0)6(Q?6)$4W+W:XDGJX,4!&%3(G#L3V&O0`$M\@*7(A1M5@
M%O0CNW*%3.H@52S&M;A!!#97>*?^XP]88*3BXQI$H%K6`%:L)5A>X0_BX(+M
MH(":UT=<80``]"X$U#^?=T![]D<^8".V%$:<A$IW)"JDY`]")#MF@0WL(!"<
M1F&`KBY8N(0RH%4"`596P`Y`6%=(8&9V35?<%$+Z=VS3MB$_>2_(UK/F%@"R
M"SAKZ0WL8/<B:K7N8@,L<!5$Y`3L8!8PM.E.X!38(A`H!C,\0&CIMF8"@965
M(0-.P`3BX$'<9P)60`7@@BG8@X05BP1^*U0NET<$MBM)^6#'43MYV)M[I"C`
MIKG2H`6P*N+6X,)FX0.P;D/4(^?\`$)8P@]VHD=/`0-`:D4M(`T^@!A\Q8BO
M@9JAR0_^G$4AHN*9ZL`$A+8-0C!(YM@D'QHO=A:+JA=(J&(-EJH.K.0N\H!V
M;4\5@&T"GC4.$(EY)*`%3*!@$#&!&<($7J-C9+D.;$\$JCD$A`9MW)E,/`!:
M!L1(SA:4";@N!%@O#)@'^0<2N4>B_6!Y`T@OM6&%=J=[@"-Y1+088H9.U&>%
M^V`SL.&#5&&ID6=YJ:-\2@@O4>B&!P!T[:)S11*<=?@Z4=DN5$%'?&>K[T)2
MY(-Y"@@O-T@B^K*$@H-WNF(5E,'>5D$/Z((8D($Z=,=+*H,O40M@_@<Z7H'A
M@*12X]@N<!8[&3.S.ZFBXYJ+`D%$'4A%4R&KG_JI]1JS3F'^J9M,?AI;*W3D
M?\HZJB6"+@@H37[J%%PA38ZM2$X4BY85-T/98(OZ(OG%,$*;,)1!`K1Y0\U)
M+.&:*#^2/&C3*\;RQ%00.^4%,L>PD3:;+Q(S#$.),H-Z"048+*_R;+N(O<>P
M*SJR#EIT":GHD;9(BI;;,+BR+!46.]F23*=;2+H(BM*LH/+[,#0U9S7;9B_5
M+'[HARH:E))[PNLEN/-BN!MR`$#5)`WXP)&;=+`1`4*@`3MQ#3:``,;4(P=@
M!#:FQ'4RA]GP%1"``EBCQ%7@`':7*%WA`&B\$P7G!(+IO)$0A[31Q]-`#2@`
M`82<(3H``52@Q1EQ#4A@`-CVP^/^2!0'X!B1<1;9\02<\1FYW,,?KMD$X!:1
ML105JXM\\1D!(!AU$PZ+4<M_41F'L5,Q0!?9/!H]U,KC2!M&:@ZX$=#1\0TX
MS2Y2@5L"?1X)'11!:@X$7:4>7:3D0&SU`J12*M&YL3V0TPKY@*0%_=$C/0XV
M_2LZ7:0BO0XB'0XNB\]9O=5=_=6)\,6J$`T-?))DG9*H<=9U_8!U_=8/>,AM
MG;P#@Y*R\+UA_=B1/=F5?=F9O=F=_=FA/=JE?=JIO=JM_=JQ/=NU?=NYO=N]
M_=O!/=S%?=S)O=S-_=S1/=W5?=W9O=W=_=WA/=[E?=[IO=[M_=[Q/=]=4`NO
M\@N/ZKO^:;/?/1.,Q%S?#=YTT@X*]^@5'N`!#@#&\V(6K"V]IJ8$."`6X$`J
M@,X5**")KH$"%F?1#G[DVWT5%&"NI\.$2D@H\D(#7D$%`"";Y*`-^N``ZF`\
M>]L5&(`X=J,RKD$!=&05/$!J"I[DC=Y(M.')*J,.1OU$_`"9M;*,FJT!GD=1
M*H`!."X``/:5V^`$-"`.0(`/+*`%#H`#3$`")B`$=)X#%&""+*`!6E$!VA0"
M'*"GC_[NC>BE2J`59BI;(0<\D&<B3"T0TF!`BIYT:I($,$-KG;@.K"TO3$\_
M.D`$B`'D(.#;5(`8&D#N1LXA7,@#M,$!YC,ST`[O31_&;&+^,F5YFDC`:?Z@
M`U9K#7[Y8^GY&OA`&:)$CYPM.(XS=1U_.^U``#(*`A;P`;C,.W(,`L;M[W@-
M&4`?([A"\7_]]*E_7E)UQOY`7C4`QW1L#6#+BB5CR<=(@0P`/-3``D1@/!Y`
M+W)!`%8K`:)DJS!`!3K@5!+@#QH+T^)@K*1FJSA`!0`BPPEN!`L:/(@PH<*%
M#!LZ?`@QHL2)%"M:O(@QH\:-'#MZ_`@R9$1B(`BNFE5"61X5'J[-\M"&FYP/
MJ0B>^,--&4Z1/#<JJZ.-X+4W;[2]RL-0FYQBW/*\DJDL59P^IZ[5(5:GZ5.B
MUZ`J6]-'%;>@/<N:/8LVK=JU;-O^NGU;MD36$WI6U&G!;0-6;'13K5)!4(\(
M;GY(<.L*-['BQ8P;.WX,.;+DR3US>>`PL,4K$VK28%-#(@TQ$B3T%$S#@<.K
M:VDHHR5+=F'LH+0-UH9=$+?KW;Q[^_X-//C%V;F%&S^./+GRY<R;OT88V[GT
MZ=2K6[^./;OV[=R[>_\./KSX\>3+FS^/_J.V]>ROL7^OS?U#^/398XN>/K_^
M_?S[0[QF0002#"C@@`0..$$#ICF41@,3%%@@!!(4.`$#2/F'888:;@C>-0T<
MH``#(3)`HH@E,B!`5O@AM((`)XY((HPI<DACC3;>*)PR$A`@1T[*_`BD,DRM
M`,"%LG'^TP(`/0;))#=$(K4BCE).2665/5VSHXH)!94DE`UU.=:6W+```!Y6
MGHEFFA]=DXHR!,6GT"R(R?E*;<0@]F:>W-PY5BX$Y1+4+`;EXA=^MX5I&UK7
M0""`'8@>Q&61CT*'I*11!D6FEVINRFFG"@55QP8#<5-''),21,$*!$T@AQYN
M!G5"(`S%2E!,LTAPC3*J%L0!""3@%65B6#9Z))A)56HDI<9ZRFRSFRKS`3<D
MB/6!D=%Y8)@R$-01B$MI:,,"&W*LEX:CI/:H@JS<G."**Q^\$DB/9(5`##<N
MW)E&G774T0>I=9A&C!IUFC9+LB$I$P$!C@8[IJ7%`K"PF)G^GNILQ1;3F$N/
M;:R21QT[(72"";FH`H(=)*PBPAMIJ+#"&W#(48<<</A11QZ!N+!3'JO((<<?
M>6CZ01LJ8T-"'QND,H$>)@22-`FNL+$*&]>T4'!65THP@,&)@LDP05POM.S%
M8H^-82Z.QMQ"(&P4E`<+9)W`\Q]IQ.'"SS:YLLI`2J>1!@DMXVQ2"VP0TT(:
M?A;DP0ILK)"*::KH40(W*MAA@N1Y;,#&![/$VX:@5T(P@)8*)6GND626KJS#
M9*_.^GG*="!Y&BN,H!=!KO1!%@FSM&!'''3G8=HK):RR2@MY\)%'&FWPFTH+
M'Z?18QRM&40O-R;PW%0>AJV01^3^W*^@BAS(Y$)"CV5AJ;#IJH.]/D)?MPY_
M_-^UD8<:@9JV(@?7>-!''6V<H`JZM.!DJFB9&MB0AC[`@5LKP$E0./`&R44N
M#HC9@`E.L`%EJ$`/*EB%!]95A\&8X`]J"(1HN`&"")9%6\1B6-C$],*M24I^
M-*PA=I31AWH=QDW%(4B=E*$-8A!#4,3H@TNN<40]S,)-J3@%-Y98D%SX21F"
M2@597,$'/=3K&GWPTU.6^$4D\N%P:5B%6885L=2ED7VH@U3#UFC#.,J1/UW[
M2/?.@CZKL4]3,&S?06(XQT`*,CLKJJ-#B',L;JR"A^<#75;<LY[[1+)A6G,C
MF1Y9GZ[^3,R0@^RD)SL9%"PI0`(5H``%*E"!"9BRE!6(@`'@F)`6&("4IRQE
M+6OI2C-]<I>\[.5A%""`8`ISF,(D@)(H5AP5`(``Q&RF,>7ERVA*TX;:*!7/
MKHE-.<2!9V^(Q4,"\89L9G.;<NC<-,^)SG2J<YWL#"1NUA.F=T8$GO&L33PA
M8\^*<%*?$]EG._\)T(`*=*`$I<PJ6+`"%=3+GVQ+%G[V=:J@J(*1!K';-=;@
MI^BPZ5%L<")#"PK2D"HF*'(0``D\X+D>-D0;$8B`&\/$AK7-IBNS>`!%"R(!
M"!S&`&(12E<&.):W\0&9(BVJ41DC!PP4Y"4;X,8:(#`]AOS^(0,9\`,W]#"!
M%G3N`110AAK>T(8,;"`F:7"`'-(@@!`@9*H8D)4$,#`!*7*@`D@C0-L08"H1
M],$$'L"`53]ZU,`*MB-U4,`'\"(!.9C@#2W`P%..I`)M`L8">MC`"OR0!PRT
M0`4J:,$&ZO"`/D0@#G#X0P+4E:?(QD%5#*A#"5HPNS*>=!5@30`W)C`'#JS`
M!108K&]_6Q:23H`8RB`&[.36@L@Y9`(@`$$%B!&M$IS@&B3@P.):L-E<-&`T
M$6C!*AJ`IX(P]P,5\-`L5.%="TP@%2J(7-\PH`T,Y($#P*L`<.^+7X_$80(%
ML<`?6-`"%@RF:ZE0`!_XP``_4"#^#AA(PPGJ<(*$KF`%)IA%@F<&`3\TH*=A
M*G`?$*SA/+3`!'GPPPE.T((0Z*$#J;`M!>J``3OD00+YK;&-^]D4M09EQA]@
MC0L<LH9=M>P/&[``"U+!@="XH`UM4`,Q-C`+#8B*&R(PC$'6P`*ON8`T'E!)
M!3;0AUE,`,(GG4712N`'/Y3DQFQN<W#',H++M:8K@%7I?-R,YSR;10\4,$%X
M-Y)//0MZT,\AM*$/C>A$,Z>0>FH./=73:(_4V9V*KC0H:8/IH-X3(O#L]&T"
MO=)/8_I0EFZG,N"0TK%T+`]Q$%1TB$-%)SH%4L1PQ4V/U(I7]5`9JWC*JQ,5
ME#_(2AO^_:L#(R5JIYKXZ7"0R@,C9Q&'CMDAG]%)Q9^7ZKE9>,YL<NC7(95A
MZT=-6DT'1LCAHJ,,9*SBVG^X]C5:T:Z(-IJ*-2$.HR.-J%7DPA6)RLDL^*T;
M1&G[4X2Y-KX-0D5^)XI/=FYXI'^-D&MP^*7B[C=!!IZ;8*/VX#72!@E`P^QK
MM&$%H3%C4O(PBU3,X@2^+HC*5?#71'(#S0G)A1]B87*':!`GRI@`&T[P08-T
M0(=/5,4K5+&Y4\EL!8A91=]:UC4/+#11;5@;-YA,$#AD(`YR(:I$7P%SMQ`C
M#6N(:4S+OH:RLT'M)W1('=*P]K.C/>YK;X%5'5(\LYL][7O^7X/RQHT0.0#]
M8X?1HT'"#(*I%T0/UR9&"/#VD&ODP>8=$0&$(]Z'/RAW(6R(2;`8;_&%</$/
ME7MU&T-"%N-J)"@QG=0U5$!X*RFC-2:X>Q3[Y0JZ%$3PLY`#";#"*NV)H$>N
M,)4V.G`"%0#8/6O'DQQ$X":_2RX5N3@![DOP!Q=L0`YM6@$<N`%W-1BD#BI0
M1@LTX";'>TT/VEA!CZ`?"!.\HO<GY8`(KL$&-="9&^%L0W2Z2"K3U0?]TAJ"
MIPPBD`;BIROFPPUP8"H-^'T-&$&N@!=91P)/$0?0-Q8>D'PMX`)N\@?L@A:K
M(``&```GB((I>((#(`!F5$<6``#^`:"",S@``#`J1R('`%"#,YB"`3``"G!K
M_.0'Q*`*XD<6UZ!$+)!`!$$,%=`W9)<3+-`C<K`*73<6=4`"-Q$(RN`!0]4'
MNE,'%98*%58'%=`J3O5CLZ"$_1(;?B!_:KB$/E0MZR)B8>(')3`+9<@&H=$O
M)C8+Y&,UH:)_'Z8-K1%@I)(*+N`"_:(,4OA$_,,-&<A#<F`!>[B$;_![=0`!
M-0%^;)`'?8`7KP`">I`+6:$'0\4-:O!@X,<"/W$"RG`*H>$GY'<-@5`"=O!@
MRG`-XD<0@D=<+/!]</>)>+&`!1$J&$4J*V!^&8`,$$8,VG`";8!_^B<E7*AK
M%V=$(F#^&2:'8GVP!M"R"O^2+GZ0!GEX(7EP"BI`/VKP+_%"$(&P!JFP+WP0
M",D#BE\1"R+P!\;3!T+C72>0!QW@C>933GX@`JX0@>K'?W+`!J_@,=_S"B&P
M$H'`!YG7*JD`37YP`!RV8U;1!B9&%-H0`B'8!YGC!^S8D'5P=W"@0D1!$'%0
M?LIG.VEP#2*@!VR0"BID,XHC8AIT#2Y@<"#A"@F@`&DP!SQ#3DDY!Q5P`(_5
M$!Y@`&E@3=J$37%0!Q9``,#2$'D@`"!@34F)E+AX`+CB$;D@`JG&1:I0`;GP
M`9/H"AYPDG60DB%H!QE@1:32!E\(!VV0!JZ@!JLPDFN`8OO^.'NQT"HLT`9\
MT`9K\`IKV98NIP*O\`%\@`&6P4,M,'9ST`)UL"OL]0H=X`IR$`@:,`LB@%[*
MP`9^@`&J$!1QX#0L$)*6)V-[!6.6,36QX#$MX`IY&8\QP0VY$`>!D`%F]@??
M^`&[B1@8T`</M@9SP`:Y()4M,#6/Y5=M8`=>V08S`S<B\`J7U3D\`P)_H`(U
MHPIK0!`F5I+L`I`>H`</Q@9RZ9`[X9K=^0>=LS$=TP9_<'\5`(]4`4TVX@$J
M-"A_H`RFD0J<N`*RLH\<,`M_<`HM$`NOD`KBHD.GL#O$XP)LL`$D8'7@9P*$
MPP$A<%8!:0(V>2'G90>I^41]4`+^2J%"?"`H*.=MRJ!6_`<')Q`"H\@]8O$'
M;_<*[1(+J,&AMK,"?1!VBZ<,?B`H?M`&<G`-=*%P'Z`4-YJC"^*2$D@0=3`!
M*\`'>/)?'(`,;"!_!*%RWE4\8G8")!"$0ID`":!P"]$!`^"4#,$!!#"G">$!
M`:"5!(<'`+"G;I0'`T"6'I$'OBD4?9`*`Y%X!,$'Q"`"4XJC'Z`'FYEE0<$'
MR*`,)[!-[H*H=]=!L5`!:4H,?I`*+.`'2(2H*,`-'T!T!\H-/9IEK/HG;>`!
M=>`"=9!EW."J>O`*?Y`*JEH:&'!B=1$F+,D-)3DN)/"D+9"I>:`J;1D")/`!
M?;`*<ZC^BH_%18FZJK#8`AV0"T82`EQT#3*C#6S``7K`:@(:`L6U5URTI-EY
MK`Q6`G,S+B)`.'7`B;-F%2M:`N(J,S@*`A=BK'P`!\+*`@WZ!S&:"VK%`ATP
MI#<2;37G![IR=>IR`KWV+9KCH%0S42(:)A;J7>B5G[.P(+G0H`>4L#=S%Z,G
M?GK@!^'89,<:AM@@!RK4;4A"LDQ8HR00""N0"X&0CGD00>Q8CD#*!@F[((61
M%ZU!%HS'+T[5I-H@%U95!R#@HN48".IRI5L;0;&1B-H``B?1L^^X.ZI0/*_0
M`M6TIAT1%$.9`&8D2?;T0'9*5&'2`00`<)KV'MS0`7KZ$'G^``!9A@WW-$EU
M(`"#NA%V0`RQH"I'B*@#\0'($!B.>K6;DXYV`!@D=:IPTSD:%#--<3+%4TVC
M&@@M\`;:MC&0JVN!$!/L"!BR*CFHR5B<^8XQL0(-JJTDD#S:H`<<Q`V#ZS*I
MV`9Q()*O4`S:M)FOJT$I]P>+=`(J-[:'\;C24C_:\`'?BCC^JC+(L`9U\!*V
MUV/]XV=/^U6F`CURD*3A!+;K\BV]B!,P*;.OV*4UZP*S<`I:&XP\HQ(I!SQC
M`EU($@@Y:R,])ZW*(`=OF@L$R%B(H0*J@`P>X'O*@`+A8K_28GS<H`K2A3>Z
MN0;YZ4,>$%FK<$`4>`K;1)-KP%C^*,$]>H!E9C:E%R<XQK8@RF`!))`!JE('
M*C,+%>8"1'$*]1L"J4`"?A!3.W$-*Q`T:AHF?:`,N1`N=F"6?;,[XM*B,-,'
M;Z`&GE.&(4`_%1`"+].U2_4!,!D((-`R!)'!++<*JK*9'5H6;ONF"L$!<OH0
M=9JW"I&G%;B5?MH0AHNX&M$'?(,3:N`FV0H8ZYJE*D`"2L$O6#P+WQ,FC]P"
M<(.K[65^1+$"3M3&ZR(XJ^`":6"VATPH0F&Z<,!>W(#(L:,"(F8'N3HU;V">
M*/9C9ZD&/)..85*&=6-F#J8'(7`"?F`\JA*N.2P:R7>Q(!S&LBPMIR`"KDE=
M.Q&N1@3^,WRSRMRPFF'"`2;``N1#12VP!KWKA'E`##WL!]A3$C\7R2S0O7G`
M!E2CK-+<R%F<I190-^,L!\XVA.%2!]>@5G_0>;''(50T"]J@BP9!9ZM1$$"T
M)X#"#<6@B]HPN%23&[GP*C25:LA0)[\I*)"$T$;1%11-4VY2R'A2#)X3&P)-
M&U!4R'4")[EP#<O&;(=1)^$%3T-T<<3E;SEQ&%WQ"HSD$K/PC-IV)XW'T(L+
M&Q0]%BL->!+AMCE'*75ZIPIQMU%]$![`QPRS'H#[IXG"E1`0E!;QATQ8$.[1
M%0I]&#B-1-S0TSF1U@4A1$CD'FM]#3/=%7,=%,3UT8*"#77^/:X)S=)E/=:Q
M0-9M+=-W7=!*#2="@7%`G=<[7=9!(=>QD'X#[=:'O="&31"%?!CQ(2?QL0*#
M2Q`<T"TY$13*\!1MT(IWO=&`/3,(EVU,H=EIO=9O@G'(X$V'D=,ZK=&>\E&,
M=6<$YW`0)Q'WMGH4`5C4=B0<Q[;<`,<-`=5U/`!QC*=^>RQ:C4Q!80<"$`%?
M/1S=?4@4I]P'P12A!VC`_=WD?=X-X7X&T0:W%A0#6'$%\0>+C-[)G7'A#3]1
M4M")L=0XTMQTBK=U&]ITRQ!]N]4)8=T,40<$\,=OT=]B@M^2UANI]^`^8A;$
M?2:!0'0%L4B:UF@!EQ,`9RC,]FC^Q=%N$QW?Q8%Q43(+MZUM)RYNB%3B\O8C
M>7(;&?52S3BXVH`,KB"Y"O$'/)-JC89QKSIL$0X1_[T0S^T0=RO=")&GN7HD
M";X07-G@(3$^=XP?':XG72-Q%[<326=Q3;P3(*Y2M<'EH.9P3'A>"X5('TXI
M>O*,+E'9X-UOB%3C\M9#;TYM@B(GD6S0O(8G,F[C1EXE?A#308%]PTT8FW<0
MJ\")<4X0>;!_D/X0G4<QK&=U0M,F=K2FEKX0<2`U&!P+8??F*I`&WD5P6)<3
ML,>F;EJW=OP04UVW!B[@31&XUTTJ`Q`!:\L1HU<Y"Y$!80P1JB<3!.`F;:!3
M42+.J%C^$2.$$2%X$A9Q*5E16I$<51?A;!)NZ4Q7$'$0<V%VO1*Q<U5B!ZJ0
M@*92/!G@"M7W!^UW$VI]$U-3RX?Q!A_P8YTA$VO`K#D:*+K;B#TR=B40"$#A
M>R01K@A$*F)H`OR6"VO``58CF%DA?GQP"I5%D]I$Z9IG<LI``M+8Z/S&-T9A
M?:P1B8'0&3KS`.CH`=;FS7/`#1X`?20@H*]P$ZD@`5#"@9T%E-S0?$)A)-\R
M@+#<&@\?\02Q`N@'8=<0BP!-$4HNU03NW%*/QWZ+U;A^X!7%X-R=$215B7SX
MJB(H40I/CI@I-RLPJKC3&A/V(S4*8_RF`AR0C$S!F6P"`?3^4_9/`6%&>*P@
M8&TL4.^>G`$]U0<?("MQP._$T".O\(!]X`&R,A0?`!:QL'*GVAIQ4*JDQ099
M)@>UK`HJP'RMH88ND`IYL(G2R9;]`@?,MO2!,`(\EU!6E7NF05UUH`H0H#+6
MQ]PE[\VF8O/MIE5!_GVYUR]RL`8?&`($OS89F"LJE`M.&!KF68RIKA)H'X#+
MZ.L9`BN99?/+&66EJPQMD`H6`':EBPQMH):QH#MKP`?M##R!P$%K(&(^0Z85
MX`JWRT"N(`(W6J@8Z0=!#A!]_NA9L2)0"V4NM)5X12(.-VX8_+2I,T(;13TC
M7+&0`^=$(!*!5$!DDRI/BVL>_JC^8<-&3AL5LS[T^<#M1!X,KTK\D>,*)8D^
M%AJZ\K,R51M7W)21F.4A%9Q9$//\6<$F3YHZ>E+)@<A-A8H6VCQH>_-FYIHY
M*UPYA&CRI9\3<CI$[5K7[MVNVKBY2I!@%3>]VO0")LR!P"N\=PTG#=R8<(<`
M+!+;S0.@!>#!@@%?XU9'@`3.DT6/KIM+3J`,LT2D0NDB=)M5;9#)">$J;HA5
M*LIJ$Z&G3D-E(2#6$2%'6<$^;6:]^:,\#;<VJ4K$$='J9AL_&"!>6W$-J-`3
M>D[,RI!*:?<0LU2PT9.FS:NLYZ^E5]-GC0L7=<;/!&$S3X9`0K!JC:K>:.$J
M._0()`_^5RK(!815XG!E#9M>N4P.KCIKHX^X/(A%*0E>68$/%&;A8!8V`FE#
M%3E6F6"6%3B4Z0^A3/@#H14M4*6#5$ZX41DUE#F!O1;^X*D55]1(Y0UN1%`&
M(@D]\$.-.MB`[Q0/ZJCCC5GBL`,[$EQADC0RRS3S3#33)%,O%O(H@9L5Z@C$
MJSPX,"&$/]Y<A0\.2A#!CS=/2(4/;@))8XT-BG-AE558F,6\0E?@Q@,10HCO
M#3E4R(4-$W)9998T.+"T!55FH>`$$8C)@YNR(`KA&F+Z*.&:./+XDIL^7')A
MJKJND4.$-5[1`R(XGLQEV%7T(`'./$RP*94^M'DEC0[T</;^A%5B6247$M[@
M+)=53UFEC]!2F:4%1EM@@P,2V"!,#3WZX"8$;3`\H5XVY'T##HAF">2/J"9Z
M:#`U(>(+@:1$Z^`PPD1;;#0/!+A,-+TJFW@R.SX+K6`RK^FC1VY(T`.#$TAX
MDIL/2+"`#SOBT.:$..1X&4-MA,OCA!*"(_:--O0XJ0X,2,`*`Q-.X"8/]6)>
MJ`]B=#:8VF:Y84%.FTYY6H-STUUE#3F(N=J58?](PZ4YDWVS36=5<$65--)0
MY9575'%A#0Z*RVW>6?XXQ6@_1+"#U3'Y"+B-A[A!1KA5>$UE6Q':X$8/U;A)
M_`_)E66V@SL![4SJ/##W(!=T&XW^)985*$_C!,0^0`8BID6H-XX30@B!CUF!
M+J&%/J)"6EZ".?;]=^"#A]..9>-4PZLZ4.(C$!&X\5)YYFU:A0UB6&OCCU@"
M62'=6:PNU.A.`SF(FS3B4*%4L5]Q)<57`F%!%9^TJ>,X;N`8$X1K_*B#!&W@
ML",/)J5A7RVH`U>,0SY5^*$%KV!2'E;0M#8\YPW$H].R!`6PD=S$@JMX!0>5
M421NY$(RT=%#:$YQ+E6LH@77F\6P`%.'KGB`&W*`G:_><+Q6<>-1>2"4&G+X
M.U<H@`$K:$-+C&C$-;2A`@=(V&@X<``6%/&(2%0B`2[3.[OH)6,<>,,4D?@&
M$B1``B?^$QY>/*8*HY'@*M>8'S>DHXP_J*`CV("9RT[P!I>9(`]RR$4(E-$?
MZ-0A3ZM8`8:4T0<,L?%H29/#->+B!V+(D!O$R&`>BE>'XWUDDB,A@852N(*:
M%4X9G)Q>]5S`!DRR:G]>H>`)5)&*-+@@%7!3Q0H!]@<T<@,$>=M;H9;B*\?-
M4%YKR&$QA..EXY7D%==HP;]F(1S_2="2PV/!-98W@LVQP`[5S,-QTC4Z%IQ"
M&=F3U`>\]CABN$X.;TB#OU)!`C8:!Y'R:D$+RWA/?.83+VTRF@J6I(8-K`(.
M<EA#+BJP`I2T@:"14P&C6'""-*R")2KD7@?T(I(9PB$-Q.C^6P7JP((_@$".
MJO%#2WQB-0*ZJPYI^$"&,+<"91C(`_&J`.[J$(<5G(N=$&D#"L8&IRZ*+0U^
M*$M85I"&F5[+%1$\01M.("NO?$IH):,+,<.2A]"@\02N4.&$V$`Y;EQC57II
M0PM`H)]ZU8$/+K!4O_Y`#!:P9TO!6X4`"@``O.95KW@=@`#^@L6[6"```=AK
M80<``*,!-B^=`8``"KO7``Q``1O3)T1.T`(7X`TKP53#JKCA@ILXDF8DB(70
M=B*"-\"T>:I\IW=`5:M<N"!FY#LJIK1A,A-\0)+7`,$;GFK!I[!A`ZH(:PC`
M.(M%V29DA9O/<56Q@A.L(0V!L!_^"[2Q`C5T@'9>X6K;WM9!=*V!#8P:B1]/
M4,"0L6!9=2"N#ENP!M^,21D58`%*U@`'2:D!5<J0;@964$TVL).AJ8B9&B('
M0W\.]#D-5>$L2&"';75`-]PXGE[JH((2I%4/`C99+LJ7!Q&B\I#:H%!E37QB
M-5WC&D]ZDC9FH0S!+%,96..,M#CSI&OHY<6<F454<JP-'D-$&R>+13$ZHPRL
M``89B-%A"'VLEVNX(C`[A@@'`H'C';O8QRL.ZRNP(>07ZT49K]!++J)B8Z6$
MF3,Y5D:;9P%D%I?Y&K,X)V"6&=:\Y*+%3^IQK[HR9V6H.*P\#O2?E8(800-/
M&6V`0QS^8N9H&CH:TG%H`QE%DP<W3%K3D8Z#&[PWFE=DFM.2CG1';(OB218:
MQU*&2*&54F@5WUB'N>`Q,01S,D'+FA@?FB1=E$%K06M#%8%8Q;):_68N_SC,
MQQ9,CI7"C7IV11FS<'8NO&:CO;"8VER&,9"=W6P=;OG9M&9#5%X!XS0$AAO%
M$+=2-O!B.[=X%KD(ZRK>7>,[QQG-.`YKC''<;&T08Q;'(P9B]/=G/0^:&^=^
M]B29/,[M3!+5$Z?X:!3;:G<).9]R(`$,ZY(9C8<<+Y5N6!8_;B:0BSPOBF5Y
MQ5W^<ICG\^(Q;T@[@P>'B]U%+W^XESX31QB3C&;1I!DZP6;^CJ8XU#GI:3IZ
MS)W^=+PTG329J7/)H7YUWTE=>)IQ#-<=4R;!-$;=8]>ZQKV.&<R4'>O`.[JK
M@4<,RN*ES94%\LK7+AK*QOWN>W^Y-I#ABM6EO%\K:IBZ"=/GJ*O\Y%;?2R[F
M='*"*4-++5X\K2'?E53HO>3*D$-4.$^7NO3!A7R05UC;VP?/\EWUJV=]ZW7N
M>MC'7O;Y5$4L5."'R:AANI,AJ[MZIW:3AP>LDRG("8RF<FVD/C$<\)K1/VZ"
M%0C'J:LEC!R,KP=7J,`#<ZJ#!9QW`A5X?/;C)W_YS7]^]*?_=V(!/V9SS(8U
M#$8.%DA0R)CDBA+(BP4C6>=P`LW^A@_BBE<(@55)`Q8XF5?P$6;B&LEQ@0WP
M@WA)@P7JC.C:C@]XDC:XAKV9MQ/(J3J``%7@#JY@B3SP@\P2@8Y3"HZ@,(0(
M*QA*@S[`)A(8/E9Y%!5P@5<Z@6OP$^C(A7=B//4+0B$<0B(L0B/4ISS0'JM(
M@P0)A`PQ#0=Z`Q59"S](`_^QC?Z;(3U0A2Z"CT!0`P^K`P'!,158-%6H@`24
MD0W(`Q6``]RXCNP@C#R8@!-`AER`*3;(CEPH@=B`MBOA`/&H$N+(E3Q@`U>H
M@U/X`)(;#H18E3J`E+K(#W+)!29YIJZ0K2/,1$W<1$[L1"$\H=!Y+W;).(])
MA14X'#G^@`\ANYDV')-SR8-B(X$/*"$VR!(5."=EL(#8T9PXH9PX*1^9R3]D
M<)I6:X/MT\7PD!3(614/(`$0$`^/\1784898(0$1``$^.(&J8R8_X(H4L8LZ
MR(#Z&;/GZ*/AV`#%\T1U7$=V;$=WO*=`0*%5<`$6\BR/$8D7VRQNJ$*D@9DQ
M>9ET.P''8PUE8`/SH;=)TL$^B)Y?1)X6P"/1@J0.:+4/T`L"3(-KT`."@+99
M6)7P>:=#DD8=[,9Z"H1W0DA:H3`W>9:ZL!#..!]5&`ESM!#@>T>;O$F<S,E,
M5(6BX:H62)+KV8X^.`4K-`&F"#"L(($(@@-^T0M.F:$X2(/^.TP#%;B9.G.)
M-1BP&P+$%E`:)SD!W>H*%M@`$,C`%L"059"`-#B>$#")&W*P:,20$B"!![*#
MM\R9KK#"R_@2Q_F#P5"!#!"!.B`&-<C*21(.P/2;+M%)QFQ,QWQ,\].&A*L[
MQ-N.NHL%K[F&.Z,SA2.6TL/,+F.SCV.X.)NS6!,T;!BV5<`F,*.VL$J*0+A`
MSF@:;BBR9UNS%6.XVO0:&/LSAI.6)VFD[9@%AJM,+#LW+H-,Y5Q.YFS.V;NX
M/^"?Q1*>F@,]Q7J%#)G.>^I-Y^Q.[_Q.\.P[WB.3N:LLN).YJ0M/]5Q/]FS/
MNZM)?8)/]YQ/^JQ/^[Q/_,Q/_=S^3_[L3__\3P`-4`$=4`(M4`,]4`1-4`5=
M4`9M4`=]4`B-4`F=4`JM4`N]4`S-4`W=4`[M4`_]4!`-41$=41(M41,]411-
M415=419M41=]41B-41F=41JM41N]41S-41W=41[M41_]42`-4B$=4B(M4B,]
M4B1-4B5=4B9M4B=]4BB-4BF=4BJM4BN]4BS-4BW=4B[M4B_]4C`-4S$=4S(M
M4S,]4S1-4S5=4S9M4S=]4SB-4SF=4SJM4SN]4SS-4SW=4S[M4S_]4T`-5$$=
M5$(MU!1=@P>P@`JH``MHU$5EU!`Q5$EU4+U8`0%(``00`,<2@`/`U`0H@+^`
M/?F<5%+^E3T6,``&<`"7>`D($*(&2(`FVHYS@I4RF;;!H$8@+,^I0\A2[54B
M9),"4``(F#/$T`-490"$*;DZ.("HD(,*8+S?XX8_*("$F8",&PR!F!?AT`S%
MTXM5:`!M,)+"&U>K&U5?/=?*8H$"8(`'T`8*```UN(8'2``&@-7%J@Q)@0/O
M,YRXHRQM>(#+4`4":`6)@X@(8)*B,+3MB+MOY88)&)-$:S7`(*-?0U>+73MU
M58`'N(8W``%5Z(,#8`!DC55NL`,"8`#)>]94.``0W$?CJP#BT@P20$<X:`!H
M`P!GD8,$F`!EL`,[4(;;F0`84@4)T`#F((RT9`,&F`!B<`7^"8B`52"&VVD`
M.%`!!8"A0)``!1`!S;M8KSTQ8&6`81TR;E@#(1I9PM`+.<``#3@0#)@%`U@!
M%4B`SC"`5ZB`-Y&_`^"&#8@K!)@#!U@!56``#FB2$L@%`/@#$Y@`;K"`=V,`
MKO!6",B#!O"`:["`K(!9`&"!.```.6`!NL4`F+K%KRW=BFL!`M!8L3"`_N``
M`VB`9-6X.-B`0&B`%OB`.G@`B'@`C63<$BA##_"`IE&`/IB`_\BL/F"`B.`7
MNLP%Y04:;F"`OZB`R)4<Y<4`KF"`-@@$"$@#!.BF!.@Q!>`&$Q``#7`ATTU?
MNI,:`Q!6;,```)``;>B`D(W=KIC^/VXPC(YC7(?-`SU@7!(HPP9X@*3X@`EH
M@,MEDE10`&W``.;5E/'%7P6P&NI%6G#%`!AJ`!9(HCP@@%5A@%>(!7"]!C@P
M#$A47Q2^IXP=UEE`A4EJ`"&R7[V``PG`%0#H`&(P`!HR`%^I81)8%G6K`P#H
MCS207@R0(0I8%A$0R+V5@QKV@`=85ACRUO&M`*.!@!90%C\(@+\Y`+BA6Q68
M+@,@E!0N8[9CWU1=526BUWHEV3RHB4D1#CEX@`?@BCJ0(1:0C+IPA0=8E6L0
M`09X6PI+`"1+`V1XUCR0(67(@!*`@"E>..]C@_!5A0E0@,YK`'FQ@!Y[UC]X
M`-LU8U#^SCHX$0`%R%2\$@`#\%0#^"NH*R1N>(#""659=KHU@(!&M0`,P&5%
M9=0)8#*HDX/7)6`@G&5BKCAS1355**%B7F;Q9&9G=D_`:CHH"YZQ6Y.Z2SSM
M-+G%$[*NC>;T+*-C+E`L<K[7V^:I\U?M5#O#PS-SUKJ+<^>62XQPSM%<L(`&
M>`[<3=O?$9K[14?"L(/=P@#&`)Y7P``1X`!7R(-'YIBA^[/'R^;TU))6&PEY
M/CF)YM;.$#\(;0$%>+=A1A,@.9-K($L.@,7G^!WL+(WVBCF]<`70ZXH3L#3+
MDNDF31E5<(`_R``N6;,\\)I`R(6$Z3$RTX835HJ_X(,):"+^#_`+B/"P9U6&
MVEV<H6ZOCJPQ!EDLKNN*0'@34.$9:3VSGH8(DQ1K7FT?>N.@:V@%,YL3-OR6
M[N&Q.>DS6X.4Y#NG66`!?@$7$JB>)^F#)U&5BS*/&<XIMV(5Q[FR:_@+>@M!
M`]4+/7B`=X+C5(BQ/C./:3NW,8.(57@2<_F+(J:UP;P\@D$&#\`&;6#"D4@A
MU@E5R`$,<ND*?T$,]<F%6.BQ.6D)B&`X\U"?O5BQ>5N%C4D%WJ0<97!I;A"G
M*(L*X1;KJ'#IO[B)HR$C`CR9/Z`W#P@TR@'N0$ML)+T&Z0VA:^``>\ZL#X"`
MMPUD!H`<!O``#`#:!WB.G;,`!KC^&0$XZ570@`[LC`:(`,NE``IH@$"@8YY3
MU?DP:/+Q``G@M<2+(QU"`3AXQ"(JY)]T!=!:A3_H(H0DF8;R@`\(A+C``):0
M@^MF%0M@"?Z2PC]@$).9F!:(I55@IPK(@U?`L(YK@/CR%C58H54XG<>K@PIP
MCX)<$0R1`[-:I_#^H*X%4!)P%FKTC@;P(PM`<!(X@#YHA0K8``L(@?!][`VX
M!@R8``=(`Q*H[Q;8``Q(<H@@AFTM@96:!?&:!3L8$M)+@Q(@ACJ`@PRT+`YH
M`3]@@0Q82Q8`@:EI@9[+@X<H)!?P@#XXGU1@@328@/;ZE9!@`>A*A0@0<S9H
M)K5L'*/^Z8,N6F3HZH-ND8/3&0P.`#\+[R)B,`%5H'05>`],6BHCA;(&B%EN
MB/$\J.$_L`,&^`,)F`7PVQ4^#@0+F..3P0#!N<!M_2P5>`7&[0#3Z(#DX08`
MEP!7:)`XF(#D3;(*:!P6RP-P#W<]D%SC0Z0X4".LZ#$V5X4U\(-<F,4DFY?$
MOAD]DR.7`0%B(.-&NRTY,`$/)P88;`.%AHA2:2IOM`,_4`4AZ8C&1:,J[(,$
M^BJZ\.HX>`,;.4M,<:,ZN)XT^(,2$V?R=1;.B(/"!8%.5H\\<"IB2(#P?@41
MH(XUP%YIQPD[P`!M:(`5X!?`\)EP5V@6JX``A@.A0B6I1)'^-HD#[-$`-((4
M%3@%7R$5MG&;W/"75E.#0,`4:DR>58AZW(,(%5BQ^I.#CR*?D-DFLK]N>-</
M;,"C5-B4/'AM75*&Q!&!J_@H<)^A`M(2*432?YT34EE#/?"^$W`!#0B$",@%
ML&B!$X(`&EFGP;CNX"!&#9@`+7>%5Q'QEXC>5(``XIR`CK#S$+``#6R!R0VA
M%G>!MID;SGBG\V1*U(^H/C`?KA"/&VD;2`&!7\M&94`&.6JDO=;W1KH)$W`)
MZ#BJ\9"*"X.#57D#1'RQWN<--@!#8FB!X\E&L&+*H[$^^'J)87D%/X"+-#`!
MP09Y%1".YI`#=SD!I,Z:!FL`;.#^'PPA`77)A0P`]RQ!Y!.``$1;@Q9O&PGD
M38#X\$H9MS]IWJA(XT?5&S4MN,E1$<C$FC2SN'$[<8I;'A:K5J5)HTJ5BUFI
MN&G+N&96GFO7]*CXF$;-'XS7Y&#\$XA;GSH/ZV3,\Y.;"&0)19;0%J=.JES7
MV*RXAE'$M5Q"0Z9:D>=D'E=K7+"(BG$LV;)FSZ)-JW8MV[9NW\*-*W?N6C8*
M0C"8)<&.'0C7*O0YT"?!K!(F\BC8,,%5A3@?4G)KH>$$B6L;,+I"<'$#"\HE
M./R1\(;!'P6KE$F`0^*/!SD/E(5X@P$.RK1^2-1F\V9EGD`D7JFHHT<.'#EJ
M6-;DYJ'^CPL](I0A(]'FC38.RL3JUA:"3QME;+BQ:?'JP=@/L5;(<?''1)U`
M+?K$;L.MQ,U3*E2=J#,'#FUN;5:_UP8Q=;0!APNJ**0*!]<T0(PKQ-`5H803
M4DCA+`UX\$`:RC#`A@2N'##+":FD@L(L!5S#@39MQ*$""R2D,D$==500"`-O
MM/;`26H1PT%M?:#7QRIZM*!''2RP\0<+0%[SQD7<J-"&'!&1R`(+J>`W2QIC
MY9$!-VGD40<<;\C1Q@HL^#&6":NPD<8*(NIQ`D3<A%"'G#AMH`P++`7RF)1_
M1.0*"1!R@P$?+O211BR]D>#'";.$,%^8/NY4H:678IJIIIO^CA4'"ZY`-,LK
M<7"4AAU_Q*&,'WU<PV(#VN"7QUC7J*&&2[)RHPI.W*PBAS9IU-$'1VOT,4L<
MN7"3R@EV<(.0'@6MP(948VF3$F3<S")L2JJLTJ2LIZ3QAU-K2*O,&[@JIX*P
M+5W3![<<<;,&LJFLHHVL>KP!X2Q^**,M-^"*>TT<<H":1QQ^K*(*-Z\DR9$+
MJ5Q#+D'<N.("'`3IT=U'U\#Q[#4MR9K'DYR27'+)JJA@1THP*2SM'\00\X<R
M\LGZT:\N*%/'*['@1"P?*NR*4;5"0_;Q6-E"A).6>LRB)6VQ-)R2"B+(Z@?,
M.A&#S!_7I#'M*BN@-",WQ+#!U!_^(RL3Q[.JM#$+,6F"JL<K-:W"D3;FALRK
M*Z_(D4H+Z-;A`A_<X`TO0Q<%LG>]09O<N../0Z[6M;5-7E9*;%2P0:1D#2VT
M69U?"UGHU*)EK>C6<DZZY*2#0)#HI+^N.DJH5UZ;YZG?;KGN9W5N.^6VHT[Y
MZZ#/[CGQQP^?O/'*_S[\[<$[#[STR/N>5N^3CRY[]=H;3[3WW&,O>TH:28\[
M-]>8,'CLN*^O>N79;U_]Z//KSKSIR^,O_/3V%Z^__OQ3SW_W`R`!\W>__M4N
M<IE"50(52+)K--"!$IP@!2MH0;9`T"VY>-8%.^C!#X(P+G7X@&%*8,(3EA"%
M*5Q!"TS^H,(7NK`$)("A"F.(0AN^,(4GQ*$)>5C#'Z+P!"[T80^!>,,?$G&'
M1E1B#IM81"<ND8E2G"(-CQC%*";1B5FLXA.E*(*1E646)""!"8BX11[Z\(Q7
M5.,)3W`"+A;Q!"O(80QG"$4=4A&+<-QC%M&X1SU>T8IYI&(:H>C'0!+RCR4`
M`5`Z*#4`#`````@```1`R4E6\I*4%(`D.VE)26Y2DYF4Y"<Q6<I0@G*4IA3E
M*56)RE6FLI6<#,`E9PG+6[X2E:S<92QYB<M*FA*6K`RF+GMIS%_*TI>Y="4S
M94E,8!;SF;;\)"65B4D#$*!NNEO%``P`RFH><YG)#&<SK3G^3F&2TIRI;*8G
MS>E.<IY3G,.4)SS?B4Q[;O*>]=RG/OM)3TP2```HB-\$6R``D?PAH0I=J$(#
MP="'0C2B$EVH0R=J49U<-*,:C6A%-ZK1CB:THR*%Z$A#ZE&)@O2D)E7I2C':
M4HHV-*8<C6@J,&"`5\3O%0;`0"I8>M&4JA2H/O6I4%$ZU)<>-:-%W>A2DTK2
MI#95J0]%D`!<0%`%IJ0%`$!7"+OJU:^"U5(<(`!.S_**`?@HK&I=*UO;RB4`
M/,21W&`!`)B%#>CY3GG9<U[PRM=7O;JO>\\KWEX%N[^\#K:PL1M@8'^76,3^
M57R.G5YC(_N_RB+VLH-U+/W@UUG^[>DU)6,MJUE>00`?69:QFTTM83&K6-9.
M%K"K;9YK`SNTPL86?[BE76:C=]C=]K:UL^7M<&T+6];>MK:/E4H=X'I5!VJ5
MJVZ=+G6KZ\#1HL45I[4N=[OK74WA`0`L\&!6M_K<[Z(WO>H=RUA!%3[3IG6]
M\ITO>E.2!^=&4(%:919]^^O?ZF+7K-O]+X$+#-;[QO6"Y955?@WLX`<[C@,#
M(&U9X`OA"V/X<2FQ`WX]&-WS9CC$(IY+>^6W,`)T8,0J7K&$[CM>N7Z8Q3*>
M,5L";!;MIIC&.M[Q6Q_28,<M&,0\'O*#;5QA%`N9R$KNKWV=*U>Z,GC)4L9P
M!\CZN1/^YWC*6BYPDWWL8?/^>,MB[BYV:Z?=^(XYS>I-27A?K.#(F%?-<E9O
ME4$EX!2'><YZ_BJ"D^RX#^=YSX+^H)')8N%!(WJM708AH!/M:+`6>BR'?C2E
M/[AH&&\UT)7>M,E*?!8<<SK4%NRSIDO6:%&C6L/<J#*%/3?I5,.Z9)=^<XQC
M;6N2E;FT2+XUKS'5Y/&6>E,IH2NS@MWK8Y\ETAAY-;*;'9=%&WM3IW8VM=^B
M;"Q7.]MOZ3.FI:OM;YLEUZ33[F7`;>[4D?K+43XWN^N,%F:S6]NSMF"0HQUO
M45\;U/<&-[35[>=]QYK5V=VNO0%>Z733&\[>-KBS/9TZTV;^F>'51G@%ZRWQ
M:@N\=O"^.*\W[.0W0_G?'-]TOG<]\F-['-C^+OC)]UQBC0^XY<?F-JWC+/-;
MIT3@`D;SS6U-<0M.N^>PCG1*-BYT3O>[@_L5^=%=;F4SQ[SIHIYWQ14N]5A?
MV^A7=W32J[[T:46/>)3%JP`?2_8#+I:VA_4K;7GK]K;#_>URCWO9B<N_L;-=
M['S->]KAOO:TV]V`9F\>7K-.<+S//?%UYZS@$9_8OK_][X,'/.35?G>^[IWR
MQ3T[`B?_^,WS'?2:SSO=4])<+R>\UEL/M<X?'O754YKJ0!>`&E81B%.D(A"Y
MWWT@=-][WN?>][L'ON^+3WSAZY[^^,%?/O*13R+G_S[ZO'?^])G/_.9;/_K8
ME[[VJ\]]XW/_^<?//OF5W_WM#Q_ZQ3\%[L&?_O&'/_SF=S_]Q7][]J?B%+Y7
MA4U;/197&$`&J,+MY9_W;=\!5I_^E9_ZD9_\,6#\4=\#/N#[(2#Z)1\#LM\%
M+F`$PM_]>1\%&B#\@2#X>6#]S5\#<N`!XI\)DF!/N8(:"`#J59T*```!6)(E
MT1(."L`-[J`.[B`M`6$0^F``]*`/XF`0`N$0]J`0'B$2$F$.\N`1+J$3$F$4
M0F$5*N$/5B$67N$4_J`76N$6%F$3(F$6:N$44J$9,B$5YF`7@B$9"J$;GJ$6
MIJ$<)B'^'9;A#@(3#P:``0Q`W=3.*A"``=Q@)HGA''+A(0[A$^)A&5[A%C(B
M'":A'=XA&SZA(MZA)+8A)D*A)E[B%^9@):%A);*A&1JA):HA*=:A(IYB*5+B
M(Z[B%[YA*5KA#@:4"H"0''@`"8Q`+XK`")"`"(A`,`*C,`;C,`IC+P;C,O[B
M,1*C,QIC,A8C,Q8C,A;C"$0C,4ZC-4(C-E;C&$DC,U*C-EIC+V[C-6+C,V9C
M,_YB.K:C,G)C.Y8C/,+C.$;C-T9C.XHC.\8C-B*C-NXC/N(C,NKC/_*C.A+D
M,=9C//:C.2KD-E(C1$;C!X`16<S"!PPC-*JC+VKC0J(C0P+^I$$*9#<^9$"2
MY"^NXT(B)#$>9$F*Y$GZ(R]ZHT0*I#F:HS`69$2:Y#U"(T&JY$&R8TR6XTZ"
M9#[^Y$BBI$C2Y$DF9#@:)$N>(PET`./`7E5:Y54Z$/1`WOK`EN.1'F0)5M@]
M%MM9WEAR'MZ5I=Z%Y6RE)669V-XQ'MI]'N.Y9>#%5N55'EN<SEJ&7MG1I5BB
M)>#59??@U5D:9N?1G5D:%NS\)5\N%EY^)622I5J696,.IE])9M]]D#(00S%X
M)LP4`S+`#,RP'%::YFDN60L80`,P0`.XIFNV9@,D@'O-19@%6NW`#PB%C_E0
M2&G"A6\"&<Z13(-IV@&AYF]&!@'^,(`")``A$D`"+"<#(("='6=U6J><L4`!
M-(`",$`:N$)H'``#2"=UDD7"K,4U;,3NE">AK,4K4-@U!((?7(0V0(Q>2HBF
M78,?_,$I)!2O((M-[`C3F<4J$$J>_5@#!4)%WB?OU"=!50Y\7DNV0`AP1DBI
M)6AM4@B$Q@5\]M[$."COM&<LD`5\%@M&B(I;P&="D:>D^9]U#IMV&@!0U($R
M*,,$0.=TGD4%,("'&II5J0("2$4#I40#R$<$I00VVDX("``#$(8V"$"`MH6>
M\.BEI(0K-(`#&(`"3``W3,`;U(8J","T(.=8\(&7,D"1;DH?>*E-&("<4*A9
M7,,!*(S^H6W)E:E"`H@I!PB`M^57:0Z-FJ8%'*@/G+:I@*Y%E=:I[JC"`8BI
M6PAB`P"`!+#G6`!J<=;&,))%"!"``B@`J'C`!PC9*@@`!"2``#S+Z_RB_U3G
ML&4I>9P``&``,6!`>.)H6;A"`A2`L)C%&T``KS0`C8X%,6@31N0",:C"?UHD
MVBB#&]7&+!Q`33S`0_B!5.1"1;+G+/S!MC#J65P#3EW#L%X#'R"K6[S"GF*$
M!>"$5"A#<O2!__D!3J5$M8Z%,CQ)"(P`-P3"?Q+HB$[I^;0"X;3HPOA!2H0`
M;J3$-2A`"Q"#Z_!*[>3"?])GHPY$PTH:03!(W7PK1KR!!`C^S;!BRRD\P+1<
M`P/8V8D>S<0$XJ26!;V"3X.&@`@LVY1"0'_L:]$D[,*.1;V8Q<-*FH*2A3*D
MQ!M$0,=:9"J$;%RLP@/$C`-$BC:<#484;,R:Q=/.Z[30*+.FA+-"ZT.L@GMY
M+.$T:BLT@%1P0+E-;$:X:7WBIFFR@`$4:@:$)Y.*)XZ^#@MH3J1<`P8TS08D
M[0&TC0*4@`*LP=A,```DQ3640`.$@`HDE`)D``3(P1^P)E!8Z00H`-C$*P*P
MP"LL[#5T0"[XP0%@P`H\BP:8P`/@QA\D0`)P0"[8U`GP`:BVP$.L``5`@#)H
M0`)$BC)D@`0P0".1J[ER@P9T@`7^8,`US(('H`\$,$""<0,)1$#S<L3D<H,:
M-,`!O($?K*X?:`4WU($`(`"SY`$&D``#G"HWZ$$&@$`#M,`&&,"SZ.TL8`#Z
M0L`#<$`<,">N7,,#/(`$.`!.D4`"8,"XFL!R,HM6/4"];``)/,#B)@"HZ@8%
M-,`L:`/):D/NDD#2&L#@8H#NID0`5X`#3$L('$`%:,.M'A3%D'"=ZH$%W$T&
M$(,>!``"`$4>R"[M4H`#'"P&R(H*#*X+`(`#Q,)@)(`?Q$$"0,!)I$0:',`$
M\P$`'`"Z[&__-@``"S`!&W"N($`*N\!#?("LF&X#H,`K.,`!<+`'/Z\"5,#1
MND5*K,+^V.*K`ER#"AA``L0!$1LQ$D/I"63IX*9!!V1(TS2`Y6(N-^2"YG(N
MA)!+H23`F51O!W#``\"KKU)P!\C)&B@`!.P$&<&9),^"!JQ(!1!%HEIEVQH`
MV'!`>&8I=]8J64C`C"A`M1#&*^`I"CQ`+KQ"B*0!QTX`WRK`=R2`K4R`'"B#
M'H2``<S"!+0K>8R`!7`#!\C)6+"!-UF`,EQ#`JR"!9R`-C0`4!R`'OB!`7`#
M'.0!,1!`*\@!-LM!K_(BEX8`U_@(!N@!8GP,E*Y.N3:2!2@L6;U"`P3"`;Q"
M*G`0KQB`*P@T-T!`'[C"!,1"`A"(!N3"!F2`-LC(*P2`',3^`8K402PO\/EX
M+P`8!`#D`@DX<P+$0BP@`#=4@`K<Q"QL@`9,S,B"`#=H<R"XJIL61`&D`@FL
M`!P0P!^<@`3$*0C,`@"L02H$0#&H@)=8`,PJ0"ZT@8]D0!RXP*^N03SG@:BZ
M`A_(,48,!C$?P`K\`0&<PBP80!Y,C%F[@AU0`)C.01P8P#74`3O?*P60`+)R
M0*0DP"O,@0`$0E#C+@>\<<[,[[(]``O\@0"\]0'\ITRK]`G8--K6QA_HM`F<
M@#(@P`KXP1].#3=(`$Y\<V`H@PJ\QE472E8+P"KT05?#Q1M+A2HH+0I<@PM,
M@#9D@&`W2!T4]OF<`-?T:@G,KP+^Y,$)B/(&1#-&3#.L$L3BU@&CML"6`C<W
MDTJ5-G$"`#2'((-N/R\+Y(%?!_4UOT(`U^A`PQZK)H`'%$H!,(`*;.=XDLXJ
M&``+&)2P*(![,@!$B/(JW+<<!/=)O($S-T#=-`:V"`!0-`#0F.\&>*EAU,9=
MY0*OHO<#!`($"#A.*$`L7(A4I(&.-HT">*\HNY!*DPIQUX$'=,`L)``!?,#$
MC(<$N/B+0X`%B&FYXDH%X$1>Q((#Y$(%"$`%3'*-]C@%.P#01,`)3(!+2$6(
M4T`>Y,&6<FD>Z,&66G9M='<NJ,)]S\'\DFPL+$#U`H`"+'@)S$H"X.(;;$`>
M-("GL''^'#@S08P1X33`'SP`V+PR-SRU"N`&FW-#7K``!91X"#1Y1E3`G].(
MKXJL`HB*`A"$"*A`+C!`HV)`'(0`"]B!DTL`E$.WF-NXY]2!!N0!Q[ZY,A"&
M"J!`+BB`&MC%)%?`/#LY!9#*^2A`F6^`'3B`FD\+'+0YKR@Z4<@W;FPZHL_"
M?F\IB7M`G8BR*L#QK%@`!+SXBTLR1@PVKS"`-N3"!T#`9?"TJ:]!&]1WLX+`
MM7-#B%>`'6P`;3!X2CAX&X`[";3`"N`&'("X":@T3KAQ`[C"+*A`C3``N1S`
MLK8`"\"L,M3W&W5P"]PNVRIG`@R(`(!-!4#G;/K.&AR`!WC^@`+(25X$.T0X
M\QM#A)8+2QK,;P,HS*!K`P0\!(>\@1ZD"@98%0G("39P0QQ`P!*;\`.`[+,,
MNIV+RGT/XX7L/'Z'N[Q7@+EK0""\04VD0ATPP$P3#I0S^3S/,Q^@#HV?*U``
M^WV_0@M+P+6X0@M/@#(TP+G401XP0"YH`TXP*P7H@1[T*D*O/07,Q\MSA`!T
M>,=SPP3'0@-@0WZZ@`"HPAS5!L(.5`MT`*T'0ASD`62X!K8`-:B:NM'BXJ\3
M`YYS@PMH>2ZL0`8$0AOTBBB70-&W@2O4`7FXMDU4,8I?A`>L`#$\NN?$0054
M0"KD0=L_P-L'_;S;CC)DCE69@./^)T`NJ,`*Y$("&,F,CL6JLSU&?+9-Q'ID
M=$`>/`"JZ('BD\<L\,$J//6JN8`+^#I0Y,4K[+?G:\`IA/[H&SKG\('3._T\
M3TS22H6'S$+T__?S"G\"A(GQ&[(#_,'\BWL><,!#``2)$]RT<8L#H6":"=Q(
MN'"Q@9N<"MQ,E.!600Y!;JL:7-OXX`\#/74RGFCAP@.W7`EFR4E`@@T#$MQH
MUK1Y$V=.G3MY]O3Y$VA0H4.)YBS8@D`#`RNX*8MH@`&#!*YN/AC(C<V!7`I6
M<##`K0Z!5:Z^RH%`\8&<`QD/J.(&H4X:`&G6^-$`8HV%:R[;,!A8T%6!#7*9
M%IC5P@#^TCS<#+QZ=8`;!A5Y!,2*)6`D@C<&!D)XP^V-@CH5]`2"D*?"S*"O
M`-2A*2$.XUBN%+2"'<)"S5D0XN#F9@&$&@S*,'@X08#;B0;**,1.<$)%`H-G
M18C06`?`K%=?XTC@=J`K9!(AU+Y:T6`6S6L*(+!)8&<[G`XM:BI3H")#A54&
MV&S`H(V`SF(S+(T$VD@@(P-FL2.!T?B@S)4Z&JS`CO5."($!C[BYYH!5+N*`
M#0(<,T!#FNR30!O[4(@N(LTX>PL.C6@B`0`]N$F%`#8XF,B$!U1QH(430"B(
MI@HXF,4O%!1P:D,%'G`//@/@\(`^$[G*((+?0"1@%A4D6*/^-<9&Y&8.`B*<
ML,($5`A!`6T\<(W(GE8A8(WC],C%@#\^6*A'51H(,@0BR=)SH>JX>:"./`[H
MZR]N`AL,@(%"."&7`$R8``-N#(4@QH+V2T,-!C90AH$@/V#(A%ERW'&CN?Z8
M2\:B9)V5UEIMO956%@QH0*H05C"!@048:&`JF@K*98,_:)K%@UG8D*P$;8C1
M0`YE0.#&CX&N*<&"-#8<(;T3_E##`P\J@(.8$"KP@R87.,@C(R(#V2"#%I31
M1H3T2&BC`M="("9=;DZQH(46^M!4!6(\`.&$V$XX^!HV)JBR!0I**%&C@HB,
MDYM9DJ4)!79#R"67$"*RH%F;XC#^,KU71+#@X%DXX"`0@2WXPP4^N/E#`PV4
M[6.@-MK0"!`-BBD96Q2X24,R$[21V8*,`K&`W0U+Z&,#%VBJPX(1F*3I%`Q(
M>"6BXM+[(,831%:&!0P^H.^:$-);@P(65-+@,S4J:*&@4S!J@\EK\NW8`PSF
MZ%@$C*_QBZ9`-,A`V5D^8#@V%`ZVZ8\0-)3#;)O]6$6##:BJB6MB5,%`@YK5
MNWJ#*NVP@`0F"PH$@\&9Q4!J#4H@0=E_`YXV;PKXYB:0OZ]10>>:--;X)F8Y
MP)VF%O!6X1I5;EYE@PW(KJF%#-I009LWAGZ8FQ8V@->F>3-@@1ANA([HA!4R
M?9_\@B3^YR"#L7?.OA7WA^8\9=<80>_2@RL#'A"!"50@3@JB`@`<P``'$```
M`&``"TK00PM48`C6P(T$Q(9C&A3A"$D8E(*(0#4E3)\`XJ5"!(;0A3$$BAYR
MLP+OR!"'.=2A#N70`1&$(`35&<$/@_B!`O:$8S"TR<88J+R;*-%84?Q#`A"P
M@5S(B(EQTF(3GZA`*&[1B6%4'A1_DL0O=I&+4=1)0=X'0S?&ZHUCS,DK!."!
M)"Y1C$A4HU'PR,<]\D0;=\1B&O\XE#C"<8V);"+'KK&!7;EF)V",51[)N$-+
M7A*3F2P*,69124U^$I0Y?!K&0EE*4]KD&J_XVBE9V<H=,@_^EJX$I"QI*4-/
MUA*7N10*$W792U_>2HL;8UX7;UG&7QXS@9XLYB0KN4QD/A./SM3@,J791VA>
M$YO9U.8VN=E-;W[3F]?(@Z<\M(HTQ(88:6`#&];P!W:ZH&J-2T,:%K,*#S53
M)[,X&!ES$0ME=<Q&DV1F'GTRS)KD0A49)*0?BY)%ADI2D6B<9"YF\4^!\D%#
M2K3G+*^AAO8I(Q=](*7RWC#/]O6Q('^X8DYR\<^"\*&`QUHE1*W)DXT6<D/)
MNT9`&;H1M_0Q%6XIIB`7NA%7_&&DVFC#&MK0@GLV<188JR9-,+I'91###R-M
M7@L@N5,T5@@G><@H3_X04X$2XY_^+:6)'M+#L5FDP@]MQ4DLSAI2@4:4CT&]
MQA%)IU53*N,`-EJ#'$#7AQ:DX1IV<$$+_I`&$.@!#JF(H@D>5H)5Q*&#U2P(
M,20+Q9W^037%Z"Q0`LD-;)!QK#BI:!S4T--([M*+4]V0'D![5VYP8*5-7.>&
M$ID'-3@E#Y([*4Z(L0([5(LG);#H3?PP$R*E8K@1\2M>"UF0W4*1&!R@22ZT
M6],H7A>/CK$M,+'R!A+P53UY^%X=T+O$C$@TC1SC0'1I$MP/Y%8G;WA#U;*K
M$Z1.\K_>+0COQMM<FOS!(C<Z:9RR-0O\'G0Q(81/2@@ZR(6Z(A=^V![FIAM*
M90!1&W+^D(,*R*8-#+1/%9)]`PAO5*45*"L/,8[#-4XPM$!T``[:P%Y&\D`"
MU6WD7:]XPS72P`$YP$$%*EAI'"C`!E_IX15PB)NW:-(&*EWC#1Y8A1Y"\(<^
MB/4$;-C(T)J2!GO]-E%YZ,!B_O"F%0PF#:Y)U($]$!OL03(70TM4'[KL"F^U
M(!`<B!$W\G""$Z1"&R4X`3'T0((T],$$*CZ!7.7@@3Y\N`1Y4(8(2N`:59C`
M#H1#[!LZX(HI%9`805+&*TC``D@RV<DK<$V7VD`D(-;Z%2;11J[I\X8ZI"(.
MK]C`>\$2@DM3P%NYF!@)5L"47-282'9MRD#6`#06M#9;%E#^J!,#P8)KL,`$
MRI##'^+WAE2D9;LM4(&?N;$&9=2A!2LX-&A.H(P_8,`/UJ(RH37@"CN`0`6(
M9@,)7$%CK/#A!-=H`Q"-!8=)1\0#BPG$!T8"\-'F80.KZ`,?<M$5/[2`!2W0
M$!\XL`*JO*'>?H"<70*A#3;D2P^41;1`Q!T'%[!!LBQ892YT]O(X#$T%RG@#
M!Y!1!P?`U<>$+L$IL)(RFJ1!!&-AMIQ)D`$FN>($:7C%WIB]`FT\&^@DN.(?
M)"`^A7_@!#'6A@K:+3<V*`/JJXA%!N3PVSZ4H&:KX``DFZX,%Y@@8<A0-;M=
MD`<7$+EU59[%&U2``F(4(PT;6$/^'5RABC==0R"S8`$%9E&'AQ,/`FL`P;6Y
MH8I,UT<%":^#I3$MYX@3+^)_:,,&0!`;.RP&*PB6M2N)<8(Z^-KA*Y7#%5-1
M,SE0X$+$4(9DN;&"%JAB`ZD@B0LZWP<INP`.:9A%'%(!OA4P:=)RR$,+V*`*
M.11,#H&XBC+RH`H.8+X.-T^%'.C*D#JH@@TL>$,?#N\!9;!!!0*A#5Q!#JI&
M#?I@_F;!^9Q%4T!K%MK@#TY!Q-)`&5J@@-:`R."`^MI`0X)N\A"+!`I-4_*@
M60J"\8B!!/R@#V:!!$9L%<ZK!/3@[>RF*3IH!/1@5-)`#S3`[X"&R#IO%@RO
M!=Z`#]C^X!7>Z_GR0.LRP$V*H2G:CP/<A,8Z+Z`X($+F0.=<H`Y80/#T@`\\
MX`VT@5(`AWA$S@-V:GOLRQ7:0`ZHKPX"2AD^@(.4(24F8U0FP^L\X*=PHK%P
M+@_6(,Y&Y00"0=.B1Q4,3PY83?K60,EBD`V(@0U)0!N>+Q&Y@1B4C"02IM,2
M,7;J$-[D@/*Z*P_>[O!:2P2:ZQ5LCGTH[!)SX?>:2AE.0`Y"8!7TBR903AE6
M0+V(@0WBX`1<004ZKPXH3P7DH-Y2L`]BH07CH`7TH`UR@09UPT9((`[T8"!$
M8!1?0<YR31O2H/NT00V*\`AI@@"UX;'>+P01:SAHH@3\+@_^RDK+V-`-^P`;
M-83R3&`87S`.<HP$],"IVJ`$_$`.S)$$9Z'+O&X%:"S/G"(0UL`5],#5_J`%
MVB`5E'`53(`;1J`.U`#G/(\=76$%QHW\5"'^7$`/2N`!Q\T@9T$%9Y!T9@$#
M:*P/4*"CMB<-"G`?,Q('_0ZR-`45Y2`DRTKG+'!&\B`*_:^5B,$Z3,+S3HI2
M;D2RF#$75@%C6``,R>8-D*Q<\LU=\@!9V@]V2$!#5N$#WM%@=F:>5`'KU*,/
M5&$@0(UO1`"Q:"(`N:$/5F`57H'IQ.H-&`!;;I))S"<$/H,!Q"P5K#(/+F<6
MS"]1V%`WTF#-N*N%X*`-VH_I_@#^WK@AT^S&!`?29.2`V43L&D3J!.Q`;*)1
M%5K``TYR(UA3XSQ`!$"@DYRL#=)`618N@^Q`&ZZ!#[J/&_YE0]IR($!`&4C@
M`S[@<D)`&=C/1G(A#VQD%DZA#P2@GC[@O5*,T.QMI?@`!4-,*Y&3)H@!#EYA
M%JRE^?(`(R,R.6J&8QAR!;)J-`O/(@).I&A"-WGS#U>`#4AB($L3`T*`#>3@
M,U!P+KE!#SC@L@:2!/K@BH++9%QM!?I`^4P&+&K';E0!,2\'#C+B6M:J`\RO
M#0YFQ4X@Q#X#-#ZC#S@G!-H@#CY#S0)A!;&%#;7A,YDM#N)`R60MGK;+1G[1
M%92&..'^@!:U@0^V3B#\0&S$\@UHL2;T8$WRP&YBT$-`P`D3JV/^(!"4,B)P
MU`,^(%O:IR""2VV43Q8',@8+2`24`6A",$KY($EWS0.(;>$4T)[>\QI&TS?A
M\F`"@>V2XQ72H$X/I@_EX'(BP@1,(!=.@89$(!H=]#SE,`2V1PXT!$-7TR)2
M(2]7H"POQ]=282_>@-C2CBE`@+Y"26'LD@#Z8*DVPCI*3[+:2(T&42/TRP64
M017X5.':X!2N807PH+7JP"FT89Q"DBY>P0[,+*&N8J=2`2-)`-X\U39IX@14
MX17:@`52H16\Q020H0U,X!3,L86<BAA@*NMB`2/QT5OD0`_^5D'$B.%C9B17
M6T[LR)$#$NK/ZH#M1,`.V,XCLA(;2@`4E:$$X&#&].`:\-$UWHL8+*(T9V(-
M>JS=\H`I\B"=7.'CTB!+$ZI/+?`5UF`5!L(#JE0/F)4;_*_>;I4FSA!>Z&-E
MP6(DD`RN$NV*`D%;1[.`[B106K165>&?9@$.4\+W9D(%[(`^E`LGZL`/G'$`
M78$-XFPF(LU@HR<6_E1A4N%F?B_1AM%`W\=@HU5-E4$%6/1?YZS>@'8+Q8\.
M:0(4P6)ADR,S\Z#3W,1$+FT%VN`-^"8DHZ5%;S%&6F!M]2`KN8$/P#8.QFD(
MPQ!@@94$LK+>S(N4@I`B[&D@/N#^#UP!)`E-%;3F.;TE#T[!GOHT$+0F!/"5
M(4;QMIPP.;CA]E+!(+4!#NYV^5)A7NMK%GQ/TT@`#J3,6<>I3N+B-TDW!']5
M&?1`&Q"5&UYA%50!65.S#1S#8R4E+HQ0_6C"!%R!!1**_"JJ!=0@_L#B!/3`
M6G*!$#."V(*K#NW`;H*K7<A3W2C"#F:"#236;34W!`.!HMZ5(?:U9$L5E&*Q
M*$O6`T*@_C8*-49@`]C+1%V`/2.B_>8)[E2`L=*`!,!GG6*#)E:@!%P@%4!P
M,):V2I*#_+B!!?+`UT)@=LVG!7)!#9@.$!,36`="%C7"S]1@%7X+%%<@#58@
M%J*W.%O^8#$V0*B6QOD:JP3ZE"80M-T&*SG2X&J\!1LBH@[63A4X"%0K!*GJ
MC2YXR@3,+&Q,`'`J(,PB@IW`PM%\:Q7H$!]IPIRHSQ7HH]ZD-80O9ES2X*1$
M8`1$S@_2X/#RV`6T(5%6H6DGF$C68`UBPP].JM#8+E$VF([#4UD\0H]%H`_8
MSJD,SX@>T";<=51>P2%R(7Z9H@6J5<PV8IX\)'%B9QC%$.[2X!30IPU(H`2N
M"/-,X`WR((KKS05T<&E<X!3MI6#6;YYT9HM7H//.*0ZB&",)0@1HV98-,@/@
MS8_?JPXF@`6R"E3&]S=/``-S^1"C..``]`WF`-ZJ!R+>8'3^+/%@GF^)26`5
M3-@U^E$.E'B=ZH`8/B"-+1%`'\U;%HT-7$`YJ4J/L2&1_3@/&#D6@U5P<R'H
MXBUA2$#50,4?7[!I^V"?(7$-8N17P*=C0&!!V<!RU2`7#HLJLJZC.R[KHL=9
M/EJA3^`-V&`5E/`-_D`$V$`-KL$#4F&I;*0@U&`%["8)UX`-B*05<OD45,#,
M4@$#3(`-#C:'.\\%]E$/_,`BZE4C5D`/M'657$EC[K2/[O1.=Y,GE$%#ON9>
M-B2K[Z4@ZN`5?$N@KN&.Q%HC3F^)[L6M>8L%\&LY-Z0@W)JL][H@P':NB02N
M3:1/KZ&L#1NGU".U-`*QE<<IW-7^(Y!A`^HZ101[F%+$)O):C.I:1N!:L,<:
MM*/((\K:6$A;>3+JK_T*K#.&(,I:&Y[8)DY+/;Y&BTIDL!%IKQ':1$JDLIVH
ML7M;L5%)=OI:C##;!.$.]^*D:1E[I@(GJS<$M0DM(S@[)[[:K-4CD(9[ME%I
MK+:Z/3UB-[\[D;@:NK=[K\$[BH#;M(T[LS6DL8,[O44;O7M[L-WZO0F"E$R[
MO#$[NRB;N+?:B"M,J^'+D`@\L5EU(&6%K6:II6&+8ZP:*%2`ITRH**QT0T+M
ME03\A6I%ME1(F<8+)_1`!`**8X)*PUF[PECMN8DBEO"*C.*HP[VKJ$K)H&#H
M&OCNP"7^')QPJ,-PI<=_XL=K(LAWG,AQJ;1**,:+O,B'G):BEM!*1*WBA**4
MY98*(D:/_+6ZR,EO0J6*FZ"(RIHXJ5`/'*5F*9JR'+<EZ</E2(W$2:#N1+-G
MW"8VK"928;1Z8J]45Z<CBI<L#(^(P17V2<"G?%ET1I#<_,558L4%*J4>[";L
M]\!6JLN5B).HO'FD:D,>\<P7BABD[:+X:HNZG+4?,!;B3,9S8LMMR\D-2HTS
MZ*9L(JHRV]&=W,Y!O"8V*H3BY!I"*A>4@25/7,EOZZ3^*Z4L@D@^R]CC>X\*
M`KJ*BHSFJXL(3(/RX!6Z:U:2'%=B_!J6J\Z5P0X6_;6<,XS^Q.LG9@&C5$"A
ML/TF$@L9F(\GQ*FV+-'=<6+;BZH.AKP@C!:*C)8A_BD@=0+>DSUC<%PCE!#<
M>X+:4T*)FOV-^-TFVJ`.['9'@0+:7ZOB=6N4P:L@L('8PE2N:J+BQ0N?=JO"
M[-P5V.\5*"S8G>@YE8$#H8X%6*`;]VI%4Z$#6`##8<U79JUA\HS0<,_*E`$.
M3CX-XA1'GU(W/`"Q7F$$=J\.2L#JL.(5*C(6ZL[0B.$:%BM\/.`5FNO'3.(-
M[&`@<LT%L$$%2(`8C+&`3(,-1J^#*FUP';J#PK,%3$#A4@_K'>+JIHX;_#DO
M0T`'N4KI?NP/.B`.M&$%5I175Q3^&Q3:QCC@\,]>3?&W*4P`!>I/@.*L-B'N
MTA#KE5D2`PB1#6!'L#RDQQYM6H^'&]3`8C4@-2E`EL_>0%=0!3C`#UR@IT>J
MI=+``DYJ]7"/>$`@(YIK4CV`G3X@#9!!\.P^RUQA#4*``"<`XMDFX;X'Z6D"
MUD#`JC&9#9PN72@0`Q=.!P'/^#K@#_X@]+2F+AP:[NRE)H(^2)2L`NW>HTT-
M8]U2VZ)G,/+>_0UB`F(-(.IP2Q/"E9P'@;AQ<W5"S:P*:11>.W&"F!X3*%)Q
MT\9MCH<^Q%1P>[.FPAH0+-AP^T-"SC4/:MJH.L'!!#<X)V9Q\Z/"PBJ%+.L$
MJG`"PYO^-MS6A)A%[`12%21R<<N31UF;:P17K-#VZH2+:Q)5F+@F8@4+KEZU
M;<W3)T\<8BLP".2V:H.>.@]4J=I0YQ6%%B';<.0&0BLW/7UF\56HS4Z(/[,R
MP%$H)X2*4R-/*/.3H0^W:QQ$Q'D#\41FG0I3JU[-NK7KU[!CRY;]2LX?%:KJ
MA%CU)@X)92<"U6D3XJ4R;LKRJ.J@K<,U%+/J^$FCK(7.0&M<Z5FA:HTJ.2U:
MR`ED6AO'.+/TM'B%`9N(/&FN63CNIX^<-GU6B?_3(DZ?5'6PT$8J*J@%%C<9
MK,("'V_`T4(Q+NCFQWW5I2;'+!A,I,<;W)"@QP;`)<1-"ZK^V,$&"[:Y$`<?
MJB#%S2D;7/.82R#HX4$N'A!#PA];K7#@&EA5MHH<N@U9APO1]0''-2[(X>$L
M*N3B(D=\),:!0LI8D$L(KZR0QV0DV*&"''(P),<(W)CPAQZS^(@"1V_@1L(L
M(2ASY0EVI)'+&[/D01E;0[;1`G!"OL'A:KG\0<Q<RJS!30@:7?/!+&RL<H(V
M)/2QP2PBU)'*&FP`R$8+`\:A#0?I_2&@J"B2MQ&6>:3"P34DU+%>&K4I1*(=
M?IQ`IBHAR%$1"->H\6@J>KSB`3<GY(%J"WZTJ!!VVNWGPH`FDJA*"VO4L14'
MJBAT0AW=P<'BH<FE$J,(?\AQ:G3^J96@C`MY^.&*0GTDUM()R"R+G+$DY"%"
MFFMB.%$>*EQ3@J:SD.`'-W*H\0<;\RI#`C<<:$1,"=J(H$I5=;1"`A\LK!+'
M"M'Y\1Y8L=B&6QTBK-*&@\2D(<>??@2R6X.`I5$'"=J\44<>;PRJPF3,2DG,
MS4`VZ0>4T>FAT`:NM&%''6RD0>EQ@0SJH0>SG*>"CGRP04P;3AZWDBLJK,F0
M'FU4.-O<=-=M]]Q8L>%"&J=P+,?)\*XD4@C$?/:?:1]8_,$'N:&=&G&YK(#L
M2FFDL<HJ(J5V#1LAL,$V-R7H\1/AW,RR]QJ#EKQ*&FUH\(&MJKQ2`0F_*52<
M']=@_?#^+'V4<$T>&(C`0FIY;,E-1FUZH$<)W*@@HAW77..'ZJQG$`+2@0R^
MF0HCY-$"-P*9H$<&M*L]2QH>V*$9,;TJ@TP?)GC@@1_S>E`'"E+9Z)EJ<I1P
M,3?$"`'XFI>*5[#``WE801^D\H<V<.@$J>##B.HP%SBXI`^T4@8(FJ>*/W0@
M$,60VD;$H@TYL.%A;Q!6"3DT&(4D2AE2X\BV-J"1/KE0@JM8WO$P0Q5M2*\%
M"4$8V/R0"A;@3GHE^]Q@KM&'F:0I#\/C7"L44@P1K&$6*.B#,I2A@CC<;(.J
M8,$&5@$9`7K))BW80`@.Q0W(K>!R*SCB]"Z7!C;8AEDB<A[^-_J0!C4>BHE.
M!,'V;N2GC0AD%H$(!&I*2((NWDR`"@FC\IBG@E24<8)_H(L>+I81X'###A80
M01HL@L?222T5J^"#-O(PBQ.PR7:+ZY54/E/'O06"8[HKG01'>((J:B.7L_`#
MQ^)`E36@\%"KL-\U[%"Z-'0@5KD@@0<^L+\-$M,.<L#1S;BA"HW\(4"O2J$V
M3&`'#(0`;2SD1BIFT8)30$8%H!3!]^Y&SWK:4S:"RL,$)*6-T9P@<MHXA5FX
MD://Z"$5-O$`<*ZA%\5DDANOH&/)'&('%[A`%9;:"$=6X`I5N<(F`5,)!]2&
M`A/>:17;&A`Q;I,*5WRO#FKSP#7^]'"-T;2@,?W+G4"V.959?*!Y=1`).2]V
M@H>R8!:O$)1>2*6*8A3R#Z8)6$1"X"V(=0@^X%,;T-B`D]\)RZN#LF3"V!"'
MBBA#B_]32!Q@V@&%$..G-UM!5<<EGCQHPP5O4(D))F<CU*3P&GR0D3*6U:Q4
M*,,$N1!A('(QM.'<%$6^DT,Z4Q-,&+J5>3L"H$ALLX*DY(&HL0/5*Y+:`E1^
M#U5^X$\;7E$U$F54<WQ(151MI0Q49BZP:I`#BO+P"A+$P51UPNPIGO;39EVL
M!:M`1B%C@=(TN)94HQV5*D[!+7"60$00?`4;0D6,0C(1H1W*$\9LJ!";V"$/
MIT#-6I7^40(XO$$;_MH8LWX&NE0D9EDJL)5GB4J@A*P5?$T!74("G`95Z&&5
MK1R:-MAP`H:>(BJ/:X$>)J"-#VC#O3?-PS8#L2@X^,ZFJ\QI&X;6!A>T$2G:
M.+`);$B"S7D*2@Q]J`>"=EXV!`)34@E$1%H0U%?-3!LEH*`V&(1B;BB2!8'P
M0U>(9-5[.OG)]N3#%4W#/`JV0'IUQ*J\Q-4"E?AN.J/$6+BX00L0C(P-JK`8
M!^KHBE>L@1@_`5\)U%`'ES*+&'H3I$+6P`<][)BU#JG<+-2@D>WRM,%_R%VL
M*L?%+=8QAMQ0`PN&YX)3J,"YMQF11NB2!B2IP16N"+0:XIS^"A.?8!4BR%H?
MC.6GBK2!K*E)PPI:\`<1@.`K'PC!E?V@!NJL8=;3.XX(3D"QA^JL#1%!CFG\
ME(9`K,"Y[=M;*C0\(NT*!@-JDP/T$LT\YX9@)B18P[MV$@(2O"(/=:`3!L#S
M2_1"&H"!D%YJ3"#K>]VDUQ"+"3%L(D;KO*+3@U:%C-B0,!6T@$\6S<6G76%B
M$3*KR]Q8@1XHY@$3S.4-)#A!*PJD@@\$N0Y`!ET:HK2&H[0@!'[H["IZ'6>?
M9BH[KM"316>A"A.<``YHSH,+/A#G-'#`WVE0PY@?KI)3DX`-/LJ40OC0Z6O\
M89:IZ%P*P\<8>J-L5&!K@PJ&A]S^/+5AW]P8E05&\(%4L$$-4HM#&D`09SFL
MP5%2\T,N5*",RJ66T9IYE1X<$E7P+9HZ"O%#N551H*&EHG*Y4P&[T)V*%01,
M(2NP.3=$$(@VF.44?&A;KPL'.O#I00]Y4$,C!W/V/.CG54+63.5.06V.K(($
M*XC%&YY=]S5@,-E0SKWN8]-"QJ1&&6#A2`NO,9C!`!\YF9/(<3C2%ZR:1YV;
M1LZ!A/\9XJNFA<5'SO(EPGG?K^;X2U0;8Z:_$;7U'DOB?]46KZ^YX+-?&]TO
M/T<X\(KYUQ]+!U(&]<O/C<2VG_W7=QPX\AG;]RH<$7.OLAK"IW_\]QE+Y'YO
M4'>%)'S^Y\<:VI!^%YA_'`$6H:-^Z1<]$F%\&)@[_V>`!*@:RH`-'/$']F(:
MOG>!C&$>YH=^JG$-!<@1ZX<<U.=#V`>"VE>#V>>#/BA]K.&#YP>#\K<1!_)[
M^^=#QV>#3)@:%WB$)TB$%9A]ZK>$U9>`^(<EV<>`OX<-#JB#2DB$WN=[8%B%
M5UB%JV%]/J1\$K%[<CB'LU&!L^$E`*@0J.8NJH$-6DB'L&&'=;A[@O@:=7`@
MT'.&@?B'=^@9@D@K]N9D'+%)#F<W=GA^KQ2(K7%^C$@WR%`":Y!^@#B'A;B)
M]E2*4LB%<X.*KX&*K#B*BN@:KZB*L%B+MH@WL=&)M[B+O*C^>[.HBS4HA\#8
MB[9H?<1XC,B8C*FHC,S8C(3X?(3(>Z1(B_<TB])H@<Z8C%@XB+)AC<]GC=FH
MB;X8CN18CN9XCNB8CNJXCNS8CN[8CM`(CMPHC?((C^]HCB74:[.4@+'0&K,P
M2[V'?70A@)E$)1?X"G@39[&!'6D@-8&%C0H(D5/A?J6CA9>#AON8&A>9BJ[P
M$P%YC_4$'A*4B*6H##I!A:NQD;`Q"VM@,RO!>=;X=+((&[]#C:G8CWDHB*BD
M#;F`.Y$4+KVG##VYA+UWD?L'DDB9E$IY3\I0`7FP!AO0>[G@)^?'`O$GBVP@
MAL+T*C&B!P_%A0*Y$8,B&Q3!!T7^%0)2$99UDVA2.!>OP@9%=ABHX7O;Q7YU
M68]+.16A@P&ND`K#.(ES&1L6,%G8^`8?X24JX(BFV!HE\#!$*8U.)QOD53>K
MT),^-4NLQ1IL\@%7^98JH8`4"(N<TUGP@I(2$8FPH2,N`ANY4`(F4`+$<`V$
M^9&LX0</LXV7F!H1*!NK`(R"&(&SL`IS\0H"<90159RLD2MJF9>O00P#,Q!Y
MX`H<X"XK4`&Y("RHD0MIT#$^\P8107"V]QNY`"0^]U(ED"%Q@&:1%@<:,6MT
M84=T(0>I\#"MV#R9I&%TUP<DH!$NL)]M!#98,980Y0$0I!BC\0<EH`)\@!<B
MXE(8$)W^?"$[@'$";%0'&-`"]_(&#>9%31$J'+*=+B"*S*D:<`E]<9,')5`<
M9M%9?\`!=1`+%<`"&08?)+`T.:%W5"4;[L5->I,*L5`"?C(+($`=RA`")J8*
M0/HJ*B"<2O9X2$I3(1!DJ1%`H2AN;V"D>D`1J:`-%!$Y&J`&@94&?K`!?^`*
MCX<<WQ.*=9!;%PI[G848:3!I8)$+$]"?9@$6984:%HJAVM`&<Y)4S2.BNO<'
M)@`<'/(36Q0]4%@ZQ]%#YA$]RQ=_'M`U;KF,T](!O+,"=E*%RL!YQ*`VX!=V
M2"$5QT>$UU`,6OBIW,01L0FI8&&2_<<&(*A_4+BHR/$JT>/^"K,`!UE*@/5G
MJ[D`!WUP*<'7?2P!C;1Z'+8ZH@J!#"$`)Q;$)'*@#%5",?-T%]I@G5QR`EU"
M)&O`']H1*N`Q"RR@#!A0#&]@=MH9"PZQ!FW@"G"@"F_@"NR).7GH>Y>F"ARP
M'7VP%7Q#(WG@.4331(<"(]?@)9CZ'K,R*6[Y&V/B$OL!-74@0G!`=RJ0!U^'
M-G'0,T+C"B(`J,S:&C(RF).G<TUY#6/4("[1))`!`OWD&_81@?.D$(9"C=3G
M&Z\'!PV9,'KRHMX3*N328+BB*V%"*YLS$YL3"!E0'9M&(M+A*^02+!7A,(FQ
M%'_@7D`6!RO68FJ`D&TT"R.0&VG^$`>0X0&NP`;H]@8QXT`*D0>TX`&M,&*!
M8*T*4;'*L`)D\@H"%`<L@#33""S`1W-:$Q=G%Z5]Z0%I$'4EP*VKTP84L`IY
MX$JODA`U6XC9HVS*(`(+I@*N\%8K\`?`(0+$$`LJ`"0T.S07H@+&X@HKH`;:
M$`*WEITJL!171P(:\`<9L`)787-Z(`<6T&F/DKE@$R=C-E:!`'J5@P%LL`%'
M8W9*<0)C)@<5P`8<L`*.4@<GL#^K,`%'<Q@G4`*O<%.G%K)3^IR&PB0(I`R!
M`#QEH1!M$`>$,4`J\`HNL`JCI1]_`+E&AB0)00+?P2R\,E^IH`HVHPU_4,"G
MX()RP`'^(0"[(3"=D.<!;="/XH,!M,-$*C`K5WH^&K!&TR(2WS0\0-I92^%=
M`H$V3,(!T$0"B[,_-<L'<6`]9'5"I>,'Z:F[R$F^FM-_"-0"IA>\FOLW*;S"
M)?15[#L\X70H?Z!&(``"(>`!\U0'&4!HW,`">>`!(3`I"Q8"\=$YBB$"'^"U
M+6``L7`-&2`"E!<:['(Q`^Q6(\`&6.0'GXH"7O2Z$..:N0`@IN(K-V/!(."U
M6),2=4`DJ9`+FKM61',IDK5T.M)/O#([G743'`)Z4B$0JB``PPAE=6`!R](U
M;9`>%I4?!1I4LQ`+):,*%J4<+99W"C$+&N"ILQ#+LGP<JF#^`7&@`B$Z+GI2
M6JG0"E15!Z>P"B90&W-1!Q(@$%PB!Y%K$)_5D]M$00,\+I/Q`9_%#1]P"ABT
M*7\@6]:L0;,@!WJ2.;8AIF\03<&D"@/3*="V"LSS&2PB0"&P21/!-69$#,.C
MS*_P`?"KPP#T4Z_+$)L3!TZ'34TF3LMR,R?@4JK09JJP`LS$O[=2LH`0=K7#
M!BTF(S>C0?#[!RB@?#9H@Z5:5/&"5501$2`0"*Y`P-Q52*["8R)1*R(Q*874
M>0YT97:T3@EC233+(>(!<GU@*#=E!W:`SJ<@`5[+SQSA*Z+*8RJ1(2X[&BRP
M.?)))WVJM=?`9-L$)X?BA,#WT5K^_2H./3QY4#-DA!M8H5]Z@),7.\RFT0<\
MLD<L,1`B@D&YU1^LY%NF4@)$HD%Y+`=+TEYY+9<*`0L>D`H6T"Y3_:QQ(-1O
M8`+]="AZ$$!!4P=\<#/;Q+9UU7EU(*5X.1O$4#APL`)=XAD';#D*4G>@J*O4
MD[BN#'M+*#ZOD@8?0#LB($V9)"NL!$#-L@$E(*N6=S%K8&XG4&[/HP`W0P+E
M9FG)+2_(X'#!#26B\T3#0SAVP`(@,`O;;!J")`*_LP'AIH<NT`)!UR'!Q,UX
MTI*7DSF`17B@TP<=`'M<(Q*L%*2>(0!#1[YF'`+*RPTN(*.>4=AML`8BY`IV
M@`W,XR?^+1`+:[`*L8!4Y,0-K=`")Q`1G48"GVQD_G(*_J+4S'(S]6&3K^("
M&I'4Q)!7T]HYR!6EK%0Y<;8*$N`EIR=Q$=%B"X,O+2`"?*!U+!!!;=.2G`<\
M1H05:R`<?V>2OK.W"JG#L;`!!#K/;"`"V&8:0Q,G+(!YB!DP@U)[E<ADL3$'
M-P,6R!6PQK+9/J,;OX$U:R"&U38T`>LH)D0Q1,$&@_$&(W!J*H`-*N`!'Z<6
M49<UD@)5,CK(W)">LLH8W'WF>0!5A?=YMO)+VZ0^A0=RC]:V%A#D>P,9$;%B
MGSF'<3!C=B!TNML'6<,">L$"B=NOK\`??^`]I67*-Z$VI++^K*V!H*_2FMBT
M2BFT)2Q2!V\0HH'P4';$`JJBOLZF#*<0""(P"U[4MHUSL2SP"AL0N9,'3AO`
M6%"E#4O[`5YU$Q(!+K`W7GE@EI,'SCO.SA)1![U#&%@5!\?Q!P)TZ,KP!O6"
M=/#7V>CXT5'X&6S(WS-XE-R@@EU8?=!(;5.Q32LP2P?/[]W(?C:X@0>RJ#FX
M$@.C@D>Y@2U4JF`(%LB@A8NZJ#A(?A;/SZF!#2FH$,19I(_)@&^H\A)1#!'9
MC0()?_DW\TGH?6!!#(-1.,00(UI8JBSX4298JF`1/=`(0!^Y?\9H@@GXAKZW
MK!VOK,'']'38`@2J#?0:<2(0(:7^+`>J8.%R9P*88\5U\!.V(D$;10(?M)@+
MD4YU-Q(MT`K1U`;1F7&QS#H'H@=/`P>QX`(J0;\J@<7OI1!FFA.RBKT?8,.1
M!B5J(-"?6V(^H@;'@6Q`F13?'"[Q$70"P0:K?B&S4&0M0&<#\3LNL$NSX`$J
M\#`QETTJ\0:\(:A*F9O>1WU$-),YF8J<<ARO(`*1[RAMI!*,!>)K"(!J^7SI
M`>(OK_1+'Y$5;_R;R(J%6/3U*8MX>80KH`(G>?P0N8W8O_V:2(7%MT1S084Z
MH@;(<*^T7S>N^(+93XO.7XUA!R"3\?R6Z._F7_]'#Y$<T)FIX0IKD`N7<C<`
MH8W;0(+^!0L*-)C0($*%#!DJ/+@0XD2*%2U>Q)B1HC:'`QT^E*A1Y$B2&$$V
M+$GPI,B5%P5R3%FQ9<:9,;G5C+C1HTV>-7%65*:B3\F?.WEF7'4-HL`X:Y2N
M+&KQ9]2)5(]>-7A-V5:N6Y%U!1M6[%BR9<V>19M6[5JV;=V^!:NT:MFO8>O"
MQ9OW;EZ^??URG:F-K#:M?PV_+4SV&N'#C1W+Q<JSQ8$&"A@HL,S@\F;-ES-[
M[JP9<V?+GT&'YGPZ].?1HE.K;DV:M6G8M&-GGBT;]6W7HEFCAOWZMNW?IH?O
M=CVZ`8(6-R&Z4M#@M?#<JW^GCIV`.NG>P8U?KPXZ/&[=OG?^%[=>7CUY\^W7
M;^]=^=7$:Q*X^_[./;_Y\=U;CR?NONM4N\^STM:S;('WL#/N//7<&PU`!R%T
M`($\(K-)(!8&@&`""3X$,4011R2Q1!-/1#$"%%=<4446373Q11E%C)'$&DN\
MD<83)W`1`@%8H,@5RG2<L4@CCT0RR2-S5-+&%QDXP!7Z'DB@22NOQ#)++8MD
M,L08(YC@`0'J<`[#E%H`@,S%.&*S33??A#-..>>DLTX[[\0S3SWWY+-/I>P`
MH+F3!'J%``YNZC-111=EM%%'&>6&`P*DA.B:!QQ0!M%'-^6T4T\_=1,;;E@`
MX$*KS%2)&S0O1+555U^%-5:=\@C^E*)"#Y4U5UUW=;6#25&RU`'(>"6V6&.E
M4K748R%:M<QE97K6I6AY%8A609\CH(-IM^4V5H%\G:_2!C#MMEQSKQ((33N<
M73;=4D\M]IH,VCB7H%<F&`K>>B\"%$B4;MTW8($QDG2^E:YQX(%A!V:X85)9
MY;99?7,5Z`UE]RU!@'`;/LI:=@LJ5%N.1QX8W"F%)3EE<]V%.%J6!T88@X`+
M7>%CE4WBQN.)7,G6YIM_+E922A52)N&%@49:UY<GQE!#`-9E&M:*`="C7G?]
M2%JC:FL=E!N><<TZ;%T+GK*!H\5&VTR)(U8VZE@Q4"#3>J^!0.:TH<4#`'\A
M"OENOU'^%=IG2Q7^N_">DFWYV9<##D2`-7R>UF(^#)_(XY8`ICSSDLBNU&BW
M-;][[6U%/Y>#N/<M6@/0(]*9;T-7A_VBP"M]P&S(8P?=73QNWW7I>AMG@_=E
M_4@3]ZVOE8AGD7%GWB"3.R>\^>:=3CQ:TKE-5X!8`NZ``;EQM]SU0S^7_F?.
M%0KV[/)!O_[8Q<\EYH`0&`_@<?)'WGIOA?I>OWFR01((PJ+7O]7YSF6($YZQ
M7"``57#O=,;+&=?$1T#FS0Y]#WC`]RC(OJ=A;U1M,Q<Q$C"_<Q%*`&E(X-\`
MU9R=]6R#L+-@0JXQ+O6],&T&G%;[%,<-.0`@$`%+`P.G%T'^Y$4$<S;4W/\N
MB#(D9NYA*?06`E=F`0C4,%JY2``(I'<\6[VNB9E['OJ,]L7"O6]T(.P6K<AT
M/[4)L7RT`M+EO$C&POEJ:#*\E!7I^#,<6@^-W*(`!-AH)A&*H'P"R1L+$T*H
M.>[Q;N=+B#)JIT='WDR'Q6+9((_2!P#,P6H1K)HF.<9%.6I+E)5\EAT%-TE4
MBJV/S[HD)KEQ`@/D(F`5J&+_X!BD1K8R:Y#,RAA]F30S[K!9W2J4"J!(+%K)
M87VDG.`PP[:!7]&.B=)$VA-/.1*G08U;)"C`+&XI`4I2+G]+X0;_L(FT,,JP
M`0-<9\I>N:Q8$LL5!:C9-GFB"@#^P(&"X5/(U^*)-&`69'#E'&B]GKBM8KJ/
M&VP(P"H"9@(#B/.91(2<.A.:,B6ZDW#ZW*B9YGFL>N[*4G:KERL&H$R0,HR+
M$SEB2$<60X-(,H,R)1F:=M=2G)545Q8;2@FY48**;G"%D%,>3DE&4X,*4ZD"
M&ZFQ?"JKDP9L%@1@:?_.^:]>/C5@'4U5^KP*52E.JZ'$VEK5]A4'`&"-@-#<
M7U?'>JYV!A.><SW7,<V*0)Y:Y`,**,:^JOK"UL45;'BMERJMB5#$4NN#WCS@
M5&'U"@"H89E*`^4&$2G!@,JUL=LJ*$$L9;O/FDM=EX75:1_2UZRT0H,Q.:4R
M7,'8=K7^:K41U%]"^L;:TF9$E0#DQFAIVUNIE36R%R-NV@"JV]<AY"7.1=1.
M8.*<Z3Y7NM"M;G2I^Y(R<=>[U`7O=\6[W>N6E[SGM2YZM9M>]F(WO.\=[W,%
M$MJ!"/`IU<5N?LW+WO5&E[OJS6Z`]0O@`?,7)O^-+WP5'-\"]U?`^[V)J/1Z
M1CD(QC$7QG"&-;SALO"P5EP];'*CQ531YE'$!]1FQ`R`P0=`@,4N;C$&82QC
M&M?8QC-F<8YUO&,>]_C%-\[QC&&,XR'_V,@Q1G*-A>QC)C>9QT5.,I*7?.0I
M2SG(/S:`(@.:@`FL0`5?_O(*O`QF,(]9!68F,YK+O&8RAYG^S6U&LYGE_.8Y
MNSG,7E:SG<_<9CWG><]Z3O.;`PWH.O_9T'4V,PLFD(`[9@4"#?ASH0<-9T'3
MF<][5K.D+<UG/VNZSY>.\Z8/+6HQ&WK2G:[TIU7`@@P0`+([/`$`#$``6M>:
MU@.P=:X)@&M=YYK7O09VL(6MZU\'N]C$'O:NA7WL9#?;V+9F-K23'>UH^]H`
M`$`!Y%8A``(`P-O?!G>XQ3UN<I?;W.=&=[K5O6YVM]O=[2:``"1:*04(X-WW
MQG>^];UO?O>;W`,H7K=<D0<]%-S@>B"XP1-^<(8OG.$/AWC$)=[PB2.\X@Z'
M.,8?KG&*5]SC'[>XPB\.\HY+/`_^\X:(,A;.!SX8O.4MU\/+81YSFM.<Y34O
M^,US7G.9NYSG,9\YSF<^=)_OW.@_AWG/=YYTH/N<Z3JW^=*)_G2B%UWH5J]Z
MU!'^VH/T8>53ESK.F[[TL)/=YB\_.-31?G:GASWH:D<ZV-F.=;H?/>M/+[O6
ME:[WL8L]#Q8]<>`%/WC"V]:]WATO>1&\8,8G&/'O57QW([_X`TO>NM^-?.,U
M[_C)6Q[SCP]OXM,++>>*WK^67[#I*W_XS;?^\N#M?.@A__K#JY[RKF\\3BC_
M^=S/_O2L%Z_M8<_YU7M^^+@GONQY7WSE'[_RL"]\]*4_?>I7W_K7QW[VM;]]
M[G??^]_^!W_XQ3]^\I??_.='?_K5OW[VM]_][X=__.4_?_K7GY@=D<ATH>\L
M_$?DMK<UB@`T+\D+0/T#+G;YKP(4P(/XO_[K/Y5@DU0!0.U"+9G0/ZT9%*A8
MB`OTB-4J/0G<P$7BK<@X0/^C0)9(E88HP04,B9Q@00ULP13JFA1\09U00!:T
MOQS4052:F!$LGV'0`BT8!FY`@RJ@!(+8!C((PBQ@A(%@A"P0`R/DAFT0`S'@
MB#&H`E/@!DJH@B8DB"<,`RT8@VW80BC,`C1PPBL0!FXPA2H8`XXX@RKH!><8
M!BC4@BPXPFT8`RT0@RS0PCI$0R#4@C5DA"KP!.>@PB#$`C3^Y(8G[,,\K,)M
MT`8R\,,M[,*"0`,[)`,RI(0LN$,O9`0U;$0I-(4KV$3GZ$0^%$(V]$0^Y,0I
MF$-AN,,A+,0C/`H@M((I>(2JX(9)``:"L(8S4`(MH`9$%,9=3`@TB`3GZ(4J
M<$8E(`6"Z(4@'$)N$(8I<,8J.,.!H(8K4`)DY,8LD,,RV88S@,6`.8-H+`AA
MP()B'`AA$`,R1(@RF((IN,,JF((ST`A&L`9K:(1M>(1'``6"H(1J&(A>$(--
MW(9)F$(T_`5**`5&.`-J\(6!F(1(H`0RM`93$`5&F`12V(9J^,A2*`4M:$*!
M$(5AV(9&:`11T`9'B(2!-(4YY`;^8)@$2L`"6Z2&/10&2A!(4W@$1IA#:IC#
M2>B%22B#(Z2&26`$3Z"&1R"#->0&:[!%4SB#@8R$,PB&7B0#+41#7_`$3ZA(
M--B&84"#,Z!*,?!"2J`&4&B$1Q@&2'@$41@K7Y`!&:A()(@!,4#$&Y`!&Y"!
M(1B((?A+&1@#;J@&&["!;=B&')"!91P#&$"",B',&I"!&S#(,"A,P>0&))"!
M.90$&<@!QG1,27`.7Z"!U#1,Q+P!U5S&7@A,;H!-O.0&(HB!PQR(;?!+RYQ,
M;B!,P`P#UKP!TGQ,;HA,(M@)PDQ-S.0&S03,WB3,BAR"O>2&2!!->31.&:@!
M&OA,;@C^3<#,`8.,3-.<S3FTS<-TFT:H@2EH!#'@@2J8"%.P@3D4""4H@BB\
M@:WLS"`@@R.`SX*PR\,DPT>H`3'0@BP<"#.P@4;(`ANH2&%H13&0@2M`S"&H
M`C'0`3(8"&"X`2,@`Q[0QZGT`0_]`5L\EQW818;X!1G04('HA1H@0X+(1#'8
M@1WH0S2@BBD0!7:4AH&D@J&L@HKD!D(`AD;XA6"@@FK8AB`0!E$H`Y?T!#,H
MA2DT380H!2UD2U&@AFK`@J!TA&$@`W?4@D^HAH'4`DJ(1H$XRX$HA25X!&'0
M4.\D!5&(A$\@B&`82&L<R#"(A"D-TX%81E$H!3@5"%^H`B7^C<=&.`-/,$NP
M3,)?0()A$`4T6%,JL(9)&`:K=$HRZ(5M&$=*&`9JH$NO*M0:J(&\E($0G4H=
M,-4:Z$TDJ`$<H`&^K`8<P`'&Y`$:8$@)58*"@%53U0&#%(-8==6!@-6*G`09
MX`'&W`$:.$*!^`53E55:955994C4G$Q?,%54;=%5K8$;*-;.C-5914Q;94P=
MT%5N(`,9Z$UC_=8:T`%KX`8QH`%P?54:^(7.E`&^3%8>D%>!H%<<`->BI`$<
M@%>#7-<CU-93U==N30EJH(&!%`AAH($T/8@J,%@A[07F-$XIX(9@"-:;R(%E
M%(AM4`(>X$N!^($4)0AJN`$AM0+^514(4]"!K2R#WNP%'#!(+>#,7\"!-3P#
MG%W,>OD!DCW-[51'7[@!>8V(.T0M-""%46"$:J`",9A(;O`$24!&A#S"1ZC3
M;2@#8(B$29B$4G`$-!V(`XW'7B1#4+"&266$+GV$:53'4@A(:I@",4"#7W!&
M1J"&MUS#4@@#4!"#?+5&,OC'`]4";1#5@1B&/;W(7B@#A&#(C&S$-81)4:B&
M0^2&'1T(4%A#4/@$1O`%28@$3_#%,+7%,EA&82@%4HB$700%:M@&;%15I=)6
M&D#5E)U*@]W.>YW6WL4!;=@&'9"!796!)*"N7XU58=5.&GA5VIP$&M"!<W76
MTZ0!4R7^UUK5WFME5]DTU3E$`G(M6=^%7F/-WNTUU^)-5PGM38$87VEUWM:\
MUWSU3'Z5@>IU#GIMU3F,A.R-57D=@^,%WQH07Q:%+77]`:,(!G<L"&#02AR@
MR6T(!N(U3BIP7(WD`77DAB-P!*<EPR!X!+05"%(P`@JFANRRAAQ`1D;8`3*,
MA*'5@28DPQ]P!&ZX`BUP#AXPT7)968/H!1TH@]$$WQCM0&[0QBG4B&WP!$J(
MA$@0AD8@!60\`THH@V(4AFI`4S2@!#2@AJP]W8\4!DF=0B/]!8&8A+:M!E(0
M!FK0@J"LAFIPA#7T6C2@4SJ5XP;NR$88R%*H@FT0!D8@0V'^L`92H(1)^(5\
M?5S'-<TQH`1)Z`4'9LA',,A'H%TR\`0TD(9EI`9&6$-@H(2*!`5/(`73I011
MZ(38C<N;.`.&)`5/:`1*>$,M]<=@T,^G0DT#;ECGL`:#I5_TW4Y:75]T15[E
M)8CQ!5>=G==Z#5?/1%;JM=YGY89HU5YA;E7O-0)NR&54/0.8Z&7M!5[UA5'V
M1=YV[4P`5F;^;69\U5?\C=?]!6!=GE[Y55<"[H7LW=T*W(DKR(*+($/=I,^=
M\`4;R%>!J,,<.$GO7.`LZ&=KO($I,((?*()BU`(EP$<>L(*'"-J"((,?:%!U
MO(+_'(9T_0$M5%F6]6%P/$B=#8+^?GY1(RZ(++""R]H&49@$,B@%8!A(3@V&
MPWR$0SP#FRX#TSR#3^B%,Y!BRQT&H12&1TAD@7"$8O2$:M!2:NC21F"$4C@#
MQM3A7L""*44#L@6&81"#.`[.4J`"-"@%1J0$2*`$4)@$7U!DNA2(,PC*)G46
MAOP$-``%??2$&R8#7U!&,B`%I(9+,2"%J-3J1YA34L@"+7WB1Y@$2?"$+"B%
M,N`&QC:%4'T$6WZJ4F78^T5"WVUF4]W7<KU5<I[7[W6.^&W>96[-;#YG9,W?
M<R5@T`[F<OW6=$7-;'Y1&CA@OM1(TI9M(ZAFU+;M<BX3YDWGRSQ??<WGZ7UG
M@&U5X.[^169N[B/\[;RD@3@E"FY@:.$1"&NX`9ITCFAEQ)L8!DK0`AVH2&H(
M@B%,8FLDQH'@@>#4S(&D!A!%1!V84I0$44^X3S:5@3<>5H:T[I->&6[X889X
M46VXYU((!AB5")F^+.+=!FM@3'FM!I5<0VHHQFV0<!"W1MK=<(,<B%\PA6H0
MAIDL8;JL!N+E"!"WAFH8U"G<2FL(!C*LAF``!E/X!6&0Q*W<!FH8AE)P1VWP
MA3D,AIF\"::=0E,H1A1'PA1?<6X@<2'?!BG_V%XPZ%(PR)`4\PWGB%Z(Q5)0
MR2'<4DG49B"OR^W,Y_$VWU?=;6M.[M4V9^865@"6;6>^[NK^56TR7-C<YE[+
MO%8:\.UMW>6!^.;?=5?+%.;A+-[BE%!CAE]TEE=UOM?HSM]_7>;^[<565>8!
MUN[PW>6HR8(I<)9?$-*$L`:&948:0$/L)(@Q"`)NV`$MN%(D0()?1(@!]0%N
M.`,*S^Q@%XA/V`'N0H(XI08=4$=2"((?^(4BV$4D0$,%]\&+X`%P=-$:0%@?
M(`4<@/*8;NC#,9-MX&!7`K]</N!N;?3SU098;4V^[.74)F8\WPG73F=F[G/=
M[<7:9E]I7MAY1TQ6W<Y#S^;<Y59>)NW>-&Z"KW?K+69?%?4]_^79;N<_QTYZ
M!5?KGMYD1E@9T&Y\SGB;*`5V+EG^&S`#F]D&77;1(N#<@3"%;GV$6R\#)>QH
M'F@$V20#IFV$!7Y1%'>$(G".+*!0@OB!0ZSA&Q8%FK0&']C*D!Z(8+@!!YX6
M*N#<!B<(;8W1(0B"=XZ(\#Z5!W1!LN<_K>$=#G0O=%HD:&'[$'3!MN=`'$PH
MT([SWFW5XDY?8;;W]F7M2Y?63`?@3?]W0$=7@:]N:SYX;3[?%]5EST1/W395
M.B?T6)5X?#]F=-YS4^US&;#?TTY6_078>";89,YTD0=??_?,;G8;)>AU;1B&
M,+@!J4P(@!8(:JB!,"7)B@P&U!\&'8AY@0COCT7]9E=Z'#A,XR<('L!LA#B#
M\*S._%3^UZKG!BSH34J@@34,`W.>%EY?XQH856DD]E\H6)@F"+'G"3;/38I0
M_X*(4<:41,:\"?.W>O=OB0FL\H.0_Z6@=8,8][8'"&X"!P[<1I";MFT&#Q)<
MR/`AQ(@2)U*L:/$B1H:^:M#PQ0V)##(#K>&HP1&)0"0F:8CA5@T'#H4Z9$3B
M)D8&RH$J3>*H9I,&1R,I9?3B-HF&#IDT)B'DY@MH#1DM7]:XL=0I#92]3!8%
M*5(;MVTE3PHT0@,'2VXD8V[3<?4F2FU@D4#M^1-M3KH>0;8\JL-:4S%0:10]
M>J.&W3$R*'';6J.KU*89#U;+4J,*#B3!(F[CX9$;FAHZ$-?^R"D*1Q4=:`8F
MY*9%2]/3J5>##68$B>JFUG1\'ICEQQ0=HGP#USRP3!$E/(!-;H[16I#1JUES
M^Y5T(*,=#@6"?=V\VO1'HH:-*<J-4IE'U$AQ._-KFTA2C\X4]<285!DTP2B1
M$14)$B7!-/+((^U5<08IPS364B2@]#*?>;TP(I`O6DQA"C=E;/.+2(\XR$@6
MO;`'WB3#-39A+R*1,=\4/E6#!3>F,"+*(V5((Y`GG@A4C1A5,(6&+]K`9@H:
MGS"BQ2\8<M/())X81,T9YTT"7REG*-&;<UEJN267%FWTV$<T?*766#0(Q8T1
M*[5$T@U*,753$@3199(./MV$5TK^'1DE0U)M+=;4EQQ--58-3/62%59Z\B57
M6(0B`999@KH$DTPRO"E#G#J9A)B=4)U)UR\?1>:706")L2F81]'I$QF6-@84
M9&-RN0TUVT'DD$*Y;@.60+0"QA"C!5'S*VO5V&JK0-90PRMWRC)DC;%=2GN0
M0I(U1%!K#P6;T2.P46.$)Z4`@P:M47HB"BC<7-&++UBL1PTU2X"VVAG:F#)<
M3908)(R.6$S2R#:3!).N+TIL<X8HI5`CC;S<2#*&3Y&8XDLI+_82C,%H)$S-
M,&6D*XR)8#VLS2](#'/%:J8TP@TU2@S,2+JBP#:O0*5$0@UC8WBBS1$OIUM*
M&:6$Q=C^0*2X*TH5P5PABC#"1#DMU%%++1%83]6P5V1@B;527E6E]1);,UV:
MZ5QU=6I27GJ2VA8-C%6]:5HD5>6J+S((Y1C648(E-UD?F109V&[:A&E3VM!U
MF%V"!344UGTA!9BII!%FE-G<M,H8WJ**U"6SS$Y-=7.>3R3ZYZ6;+A!3D&3A
MB2G4B`*OB=2008H1ODP""2FB_!"B,(XX\DNZO#)U1G*]3#%%@4CW0LUJOC`"
MC!F]Z*X%AMLP$@E[UIPAQC:>0")),,^;<>\CC)"2+C5((-&2]9'T,DSY6J`A
M5TW4,.)+))Z@$808FP7C^V:X\8@L#*,4CW"$,.X7B4E$@A+^YC-1%8I0!8,X
M(A*?\,4CT"`&46Q&$L@Z'0A#2)&-*"HDNBG)83[EM4'%I!IB&UQ<\L233EDE
M+S+PR-K<XC:GP&U07F/*4^[&%5&U)%F.2LD*R50#P<%)3IO"`6`$@Y>R-6Y/
M?PD,5%(E`\2QRE5;*:&L1"C&,9(1=&44""6@="!24`,4REI9*7+G&DHT@A2-
M\$0P/"&B!5*B0+\0&E,FX9-AI+$1U2C*(X0AA<:`H@SN$P7PV",A4:RL%QOJ
M1!UG)(HS2(P4I;#&-B3!C6'HR""3C(0O,*@#1SAE9<(`!1H>\0E!/B)4GI!$
M_K@1C&!8`Y>@\!`I&"%+@6UC&.G^VD9-GH0@#U$C"U-@X\'.*,TQ6JTK:=$:
MH81B.*!\#3%,Q`EK=L*IGQPF;1ZA!)\JQ92W)9$J)@$B.)\"QA-R+4]68:$Z
M!T>V,,WP)VC+4ZCX0KDKFFHPA7FB3Q2#.5@1<9H.?2A$/^>D)4T"&+,3B"/.
MH)_AG$$+.D+#&11"A@G*;I-D$,9YN)$_4OR"/8^8Q!DF\8AAU*07OT!8+Q0F
M)-`(#3:DX"0C5D,),4!)%+TPA8*T@0904#)A[<'0[#Q2!31,H@HH%88I%E@*
M'05#)&*H!H]T20:9BL0760C&2TL!BB=I3$"B&$X?01/28&1!/G6-*%ZEQ<Y8
MT;-O*D'^"S[9=JF<S`6A_LP*%0>J%,88)%!?&XU5@&@F'H+)*TUQ9VF0&)5!
MM<E/@W5B/V]20\8U=!)\@APYAVB8<;;*4!QIW+;R*MO9TI8ZDJD5=W`+EH08
MI%IA\4EKAM6KL`QC&+M"""A1.C')>,Y8QSTNO%I3+48QRQK"@)8PJ!$6K?%*
M(</P"7>XPZMJ)$0N"ZG&,,I;7O$.A&,*R6Y8>KN07<&KMO;-"`FQ-B:^(2I,
M-P`<I3P+0SE53C#E'$IATLFV'5I-4NZD&S@S)U!LUM-P25S+-PG+SW$:.+-A
MJJ)?4*LXCA2FP']R#&3T=M\5L_BAI"/=06!L$6WT0L8MOC'^CD5HM;PQ:FM^
MY29G\PF7\,X),5&D00I):]H^Z1!0/9S4#[&BE2&"9`Q]]?!.NAFVMQ"N*46N
MDS^Q3(.`C@HII;()JDJ\*FXHQE!`V<LU<RSG.9NN<\#"B(TSDN<MV7C/>]8S
MG5F\UX8:A&\U.%.:'!Q@MWQ64Z%%LIAQ:&;!`FHP/N2(9*=<61-2F"S;!"R9
MMMQHS7*8FY^Z86D?%QBXJ9FU)WZMYJP5Z%G3^E9:8QDP<#40],HW+#MBF3#.
M;(U@!+M7O8UO-80!7NENHQK``.]V>Q6,7C_7)<'PR4*H$0SM(J2WYK7&,+CM
M:]YNNR#S57:O;IVK<O-*VPKJ=GS^MPO?6D-MMPCAU6YC.T(JF]"(]?3;/<G4
M64;KD\!KOLE)$KOD2C'XR>Z\RE-0(D_8@@6S:5-TV%PUY*9$JM1X^G"J"1KF
M5%7N<HWA]^;HK7*53^&[66">*#04EK.&A0Q:R,*25J8$95>A&D%%`RE0"LQ?
M.:)`2*#&OX8ZP1A508`O)049WBT&]H!F#'$B11A<HZ,I4(-`8BA%49A'"B61
MHB5:$(4OQK#))"@H?3$BP[G.H"0"H8X,2`C5U[>!DE*0`120H%[US$<*@PRC
MZ9`(:19$@08E4)W/*X?:Q!NZMS*E#=2!\U--FNCE`D/:AB5F<MN<K"8H1[8Q
M=COYU43^I6(?]S?+@27XQ@O[Z'^"7*!+%K%!*<=%-I_XS9)_//#I//5>E(&0
MZI+DV4>IH<&C87YB&(4ORO!*;C"B$=J=A'`1`E)MB.$_&N,&*'34"RSXG!(Z
M.L.$AD&&FEBN&H./Q!BV02!JA`'IW-!?J(S_JT>(P1J1F-T&:0,P3$@U7,%^
M.(*3R$Q8G$%(@<8O+`^/3(D!>H*'<`/0F$)"1$*S"83,!$,IA,C9U<K3!-]D
MM,$)K(`*J``*JN`*K&`+FD`>R-J=?0E?55PVR=#7W("H#1BOB%/B=)["35J3
M@<4O;`J`;0H\:1IDM$2G(1;`18;<9)C!<=@6M9X,D%E?G!;^%FU*J]F%R7T1
MC_T9"8ZABST"*7P"&E0#$B@!T3Q")!""0/1"X@T@(_0")>0.(T#)(W@"*6S&
M&2!!$FR&\]0A*4Q"%H@'-_"+4SR"A)""%AC!=-"(&6C7,&B!]3&"([Q5N)1!
M-9P!@9A"V*F/2(!')I8")6@!PB@$4W1=+TR"`Q5!_U4'(]R/2Y2!E9&"(SS/
M(V15'Y6/]`A$%B#!TL62)/2")Y#!!G70!V&$";K`-<R:!0B``10``1!``5!C
M-5XC`1P``)R`EYA$%?4*"F'9W_B0%'*'#])0Z^D).C&9J["3HLV-9`G1/.T(
MY=G3URR:QH%3#W+>@=5>F8E<ATW^SB08ED*AWA+*8$2)H8O-6+WY&1EM@^(A
MS"\,1QF$A7XP@K(-AR28H7S\5!E\`C#H"#<PC<,XA"20@GR(@@LAHADVALQ,
MPB>DRQDHR/U(@M`PQB?D3R]D8B2$`2@(`R6`Q5$EXB<T!2E(@B\@H-ZIG3;0
MB"Y]@AAD(F-,`H9@3U+>'S>0PH,8H\2(@?E0@D],7\`,1/B@E23P".-IVT5N
M"08`@`(\8Z!U0`(T0`,PP%WBI5WB)5X:0`LHI$;`VH0URJ:H4,!1A9"!T^8=
M'#?9D*2!'E,TEL.52:9AQ::IV,-US69-RL#11,%YF6$ICA/J14-%@IFM&A?J
MGFATD9O^;5K*T1E#DJ%>2<LV@*(>"4-.]N%J>$*ZH`$C4`*YP$<O&&,O8)5`
M!),H,!#VM8>Q7%23`.?F^,)^')70F,(CP$<K"1!5-4)1G$%0HI(P4%WXX!$C
ME`CU=2=3&!`E:8%/4(,OB`)7L@>4,&<U7"0:,D(PF$%UC`'(Q&>AE6<P1$(#
ME:2./`+`0(D!90&6.(<''(`$R"6=<<`!,(`"5"B%5BB&*D`#%``+4$35,)1E
MV6"%J43`81BE;9P,46%)F),5+9;H'>9H8)I3G)Z$94U80%9F65B)+AJ798H]
ME=H_@DIIJEKDK$2"]=-!UF@8:4D=Q*#HJ$$:2$8:1.E!S`+^!E1`!5!`!<0@
M09P`"1!$'7QIO1D%T41$*12!:BQC>^#`#_!`$/Q`NCQ$:O``#Q3!#S#'0U2#
M%N#`%`30K40"$A2!DDA$+XR@""V$OL78KF0+8*IIC%T+8&++?.69HP)FHFI+
MJ1Q7>%&+M'"``3P`A,Z9A%(HJ2H``Y3JJ7+H-Z;>8+)>3D1*/NZ@YI7-[$5:
MBRZ8Z,6CC!X*/88AE-'>X<2--YVH8I(:%(49B]J>%A94:II6/[76R940$W+)
M'QR`'#P$"7PIHV2KK*V"M=9!':2!M1*$,AQ`&PA$*AA`'T2J<Y!"#=2$C`G#
M#2`,%30=1%AG`RE&J#P$C32(%-S^`+$<1!4@`2SM0*C`F!;H0"DT@@R8"$18
M!VS$YNAL*L5J"[;@F6U9B[U=[)TQET-"A)WUV:/B6T60++N6+%AX*@0\H\G>
MV`88`*E2Z`)D*(4V``'\Y9]%GF79X[^YWJ1D7.9UF;&>S62)RN<)SH>6(^E!
MW.G1(*$1IE\A1JR>(ZT"Z3J"&)&&&4%"&IC=Q$*Y9I>$@`0P0!UH+#>8@`F$
M%]HRQ"HX`,MRPPE8P$'P`0',@C8\P+E&36H4"LB69$Y0`U%0A!*TI41LPP[$
MZ4,4P6=0P17<63#8`+?%$F">`4Q,ZS1);)W)9I9X:@2$JIR-*H:BJJEJ*`%T
M:)X-&EW^C$EFEL7HL0G5HDEHGL75WNI,--SH859E'@K8BN.F/`H_3:V`#5D_
M\D04R0"PHIKM9>V(I8I!OMH\8>Y!*$/98L"U,L3:-L7:DNPJ-,#;K@`#V)D(
M;$`(?(#45$--_$"!%"Y8>`(2+".CH($/J"FCU*OZN@02..Q!@`(5M%$IR.^4
M:(&];DDPR,5FB,B[C=)`5*1V@55UU$9C0-.^E$+_[HA/,`>\!(,HX*EUL8RV
M<5![99L'T\HH^<1F`$,?3I>(?(8(3]LV9!=7<L=F@-LPO#`%)PO:"01NQ7"X
M<:4V@%=+F8<VM)UV*9LID`+F7L,J)'$KK,(K8,`!/,`IN(+^*JS"$BL#CFW`
MA)JJZ,9LZ:YJ%6E-C+9>.^ECHU7M#P*KV@AAZ,%CW*`0Q"%*?OT>?Z7-8?+H
MJ%G8HXT60&;A=13486SM[D$KBC44EX!%!5RKG66O0%PO0:R"`KQ!'$0R`R#R
M06"``A3#U(`%^D8J6(!"$-A`XT'$;K!'GOE"#HC;K4S!#32NZ'3'#ZS/#_R`
M_')#%N`<]!X$$OA"-51!UPW#RZF%$H0*CS3"%+1'E.3R+G<=*,"=@CR"="X$
M`W)#$0!#)*`!!7*=!:+$+'J",(B!>:R.0*S(HR`--V!!@;2<&8J!'HW23*$4
M^#5=%E!"+P#E(TQ!V!6!-I2=)XS^"]%$<\XI05%4@2ALPP_DLQB`@CZSA_SM
M$A'&2;=L@T`;8IEZ*#>L@@$H0`)D=`)@J$9OM`"4[8V-ZH6.;JF2+LZ.$`T\
MKQ(!ZQBW$.P5ZX;]H!Z#Q&.Z*!O[T']5IM.&Z$J3XXXN$;'ZZ(9U+50DZZ@L
M*YHUJ_&Z6FM2G.-90/52Q_6"10FDK>>X0@)@@`5@P`3D[4&\P@,00-G>,NAL
M\D0,@T7AP+Y"!!H,P<12@95-Q+")0@X8*D'<Q&<@@2U;;"V?;$6<02F80DTR
M@B]C"'[H")0$PR^`!QIH3V"C@3%1WTP)T-@9!&.#!X$`G04RQB^,@?W02#"<
M`23HDB?^"@1]^(+\U>0D2(+ZX8Q*T>(P<.=GU,@K]5U_:(,P%`@U],\D]'8O
M2,(H-I]/B,=["(,C\<A^Y!(IH('0;`-WUMAYD`&[:($CFN1T7,0J2*,!;'<!
M)`"%;C=X`T!4LQCH;C%)J^K$[G2<;4V2;9.##>L+">_0IA:+MF,^L5,=(Z&4
MO0JK1H:__=A_O=X^QDD/AF85I@T6#I2(L9IJ=JWSYHU?6P14RZ`)>".C5#C;
M<J]$7(,"K$$<),`L?,XFRY@U,`L5P(B,(<'*Y)DU[``IW\JB6N`2/>HC+!%8
M/((/1`18]#59]TJ)@((A54$\"T0LD0%8J-\D%"J",!4HY.'^&31"$6\&&F2!
M%BB71JFD)TQ!(PQ'9../'95=%4R(43""9[O$+(8V&MQAW#&/APPGRU2!_'"#
M-)`!([`.TJ2B-H@2-:1D_A!S_,4(`V*(-DP"&5B#)S!"&=@A*>0/@40"!@O$
M:W!/>Q1=$6M!&)BD!V$$,;!`"W1Z"[C`!-3E"GBZ"ZC`*N`8Z%KH2&OQAG9H
M1>PTIZWT:$KMZ_4HD7%>PH%<#H6>9-ZN&[N94,3Q8%J<9@%89XY:3)^-K2JK
M0&;102'IJU566DC+A%\L"7B`9$R`58=7VUIQQ0J$"&#`,VY`!XAX@<A8(T0L
M-TR!E<'8-MB`>4B$+[2)1`R#R1S^IPY`Q$:XLQGD!%_CW)9()!J,`2D`PW!\
M537H9RWYGP#]SB^8097,#C`<)?AMA@8.A"/XPB_`C#;X0"8*YP-7`27,9'L4
MA1E4@R@<Y80X$!LQPBQA`0>1I(@D8O#<W^M<#S?`N2A8PTLEHB/6$5-0`F,T
M@L:S$L!\PL*N!R'T@A:$Y;[H2#6(4AQ"@C84W3:@`1($W29%N$2HK.?>&%A@
M\:F2--F;:A?G;$KKUY71,8!EW-B`%A4&:>`N'*XFK:XR[:/`^IBX*D*0:!O+
M*C_.MX%9(=;VL=:66"#W7G\O:99(`!S(X"PX@`GX01Z8``.$^$&H0@)\_4"\
M`0%XNS+^$(`*<#U&[$#Z0@0I+(7\[0`J4X<GU$#K/^H8[,#H_(`25(,O>+Q"
M:D,02,%Z*.Q$7$'3]3A"_$(P]`(PN*<%*@Q3J.28+[I"/`(P''_R[ZLO;+DH
M0$(D#'?T%X4G*5[Z;ILI"$,J):*^K$PP,(7B?0(>J10;E<*V?49N4P)-10)<
M63Q[8+`I9-23D/\O``-`]-JV+9*V2`,?<>O%*!*U2-R$-:+6ZQ<P@=P(1A(&
MZM$D;J5(<0-%::`D7X_*4..VDF5+ERVU:>,FDX,!",IFQI3YDF=/GS^!`JW)
M0$%1H@J()F5`@$70E;YJU.C%#8D,,3,QXHA*`\E*)#1JT+C^:@T'CH$Z:'@4
M(Z,K5B11:^"HQDT,C1LUC'B5X8O;)!DZSM*@A!5JC1MBN573&M:C+QIY>T7E
M^_6JS&TZX.:E:A>QXAMG9:B5D:3EUZARZ=JMT;;J9*M]9?"PAK4NW*F35..8
M32:TPJA3JX[!ZA2H"3T]7V'0@`'#*YZS/%SK.0M#GY4R^V2819P[MRR@@(KZ
M4:4(7Y^>LC@]<V9XSVI*IA1!\U.;%B1%/`5=WYU_?_].=_I/P`$'#)!`EFJ"
M0+H#&>QO@P.4,@JIHA1H@(`6VN-)IL)<(P,KQ;9JRXBMKE+,K,MZ6ZLMK\"*
M:ZZUHF*-!K[\`NRRM`AKL3.M#FO^3(:\H)J1*AD\E`G$L&0\K,2R`A.MJYU,
M<Y$N&6)DT;6K<--A-IGJNHN&VUI$;0P9!HM,JB&+;%#--=GLS\`VX613IC=C
M>NG-#*_+$R8`[61IISLU]-,E0`VD<]`]#Q4TT`-KDD`Z0.-4LX,$&FB``4L9
MN-322ALP`$.G..1&"1K2O"RNU;PR;,<3>:!!DBF5R/.MJ+1,32L9::3!1K0&
MVQ"NSC##`4?'NBH,.!J$,Q*S*JDZ=<D3T1*--+?@TN%%&FYE\9<AL?QK&]JP
M_:VO<*WEAK<R)4,STCX%A'1=^O!\=SAW$Y77WGOQS9?`#09X8$%]&<0```,(
M**!@`A#^1MC@`P`X(=Z7?)%!AJF&@$&XE;8YC`89AEAI"!ELD$&X:FZX09N,
M98"$FS%B6)&;CT.^8:XQ0^[XY8FYD42&'`;*H;<-::`AY)%O`%F&AWR)H>.(
M]^*&B!B2Q:CHFCTV.HS$;+#AY!QB>&@,&%R&V:Z9C;;Y8[Z>OCJ2G;=<60:A
M<=8YYIEA>+47B?GZ.&J`^>[;[[\!#USP!D-@H()_!^?.#SOR8)SQ/!I_'/(Z
M5"&NFDDFF8N42*:Z#I1)*)DD)&Y(`9WSF3SQ)"90(@E&H4=&7ZET2BA172'0
M19<]<VZ"F20_;5@7YD/0*3D=>-HG<;V:2$*Z?/?-.T<=^='^9Y]D*FU2GXEU
MUWMAOJ7J;>\%=^HCT?R1J8*)!)0`Q4=^KMY##_\1X9W7')+H$\]?__WY[]__
MH*X1P/\-D(`%-.`!$9A`!2Z0@?Z;4TX@"$%ZV2E`=8*)H2JH*#TAJH(6W&`&
M#^7!.G5041[TDP@CF"$2#JI0*00AGD:8P19>YX4-M.$-<9A#'>Z0ASWTX0^!
M&$0A#I&(133B$9&81"4ND8E-=.(3H1A%*4Z1BE6TXA6QF$4M;I&+7?3B%\$8
M1C&.D8QE-.,9T9A&-:Z1C6UTXQOA&$<YSI&.=53BG^JU00W:D8]]].,?`1E(
M00YRB7(X#C=.L9U9O`$.J[C&&[CV$8@ZV"$6W/B#).4@A^T0DI.=].0.]9"'
M/_1!&1EPQ35,,(MKM,$5(EC%"KAA`NNPX0TDR,4G<9E+71)0)GHH1C&.XX=9
MI*($W'B%*F:Q`0M43@5^X,8;Y'`"$IP@%;NTYC6QV;<\S((8>8AD+%Q13&6$
M(`\DF`4)M,&"/SPSFGD(!#&R&4]YSG--J[!#&P*!R&J>P`5]"$$@0L"-.K!A
M%B50A0O&"4]Z+I2A#27.+"K'#0%R(Q5_*`8W-OD*;;@B$(J<H$-!&E*0?E2D
L)37I25&:4I6NE*4M=>E+81I3F<Z4IC6UZ4UQFE.=[I2G/?7I3X'ZQ(```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g64853bgi002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g64853bgi002.gif
M1TE&.#EAJ`)P`_8```,``0D%!@L'"`T)"A$-#A,/$!41$AD5%AL7&!X:&R$=
M'B,?("4B(RDE)BLG*"TI*C$M+C,O,#8S-#DU-CLW.#TZ.T$]/D,_0$5"0TI&
M1TI'2$U*2U%.3E)/4%524UE65EI76%U:6V%>7F)?8&5B8VEF9FIG:&UJ:W!N
M;W)O<'5R<WAV=GIW>'U[>X!^?X%_@.H`@^L"B^P)CNP.D.\QH?)5LO);M?-A
MM_-EN?-IN_5_Q82"@XB&AXF'B(R*BY".CY&/D)63DYB6EYF7F)R;FZ">GZ&?
MH*2CHZBGIZFGJ*RKJ["OK[&OL+2RL[BWM[FWN+R[N\"_O\&_P/6`Q?>5SO>>
MT_J]X<3#P\C'Q\C'R,S+S-#/S]#/T-33T]C7U]C7V-S;V^#?W^#?X/K"X_K(
MY?O5[/S=[^3CX^CGY^CGZ.OKZ_#O[_#O\/WE\_7T]/CW]_[T^O[^_@``````
M`````````````````````````````````````````````````"'Y!```````
M+`````"H`G`#``?^@'&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@
MH:*CI*6FIZBIJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*R\S-
MSL_0T=+3U-76U]C9VMO<W=[?X.'BX^3EYN?HZ>KK[.WN[_#Q\O/T]?;W^/GZ
M^_S]_O\``PH<2+"@P8,($RI<R+"APX<0(TJ<2+&BQ8L8,VK<R+&CQX\@0XH<
M2;*DR9,HU;E)R;(E2C=G7,J<2;.FS9LX<^K<R;.GSY]`@PH=2K2HT:-(DRI=
MRK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ]@PXH=2[:LV;-HTZI=R[:MV[?^<./*
MG4NWKMV[>//JW<NWK]^_@`,+'DRXL.'#B!,K7LRXL>/'D"-+GDRYLN7+F#-K
MWLRYL^?/H$.+'DVZM.G3J%.K7LVZM>O7L&/+GDV[MNW;N'/KWLV[M^_?P(,+
M'TZ\N/'CR),K7\Z\N?/GT*-+GTZ]NO7KV+-KW\Z]N_?OX,.+'T^^O/GSZ-.K
M7\^^O?OW\./+GT^_OOW[^//KW\^_O___``8HX(`$%FC@@0@FJ.""##;HX(,0
M1BCAA!16:.&%&&:HX88<=NCAAR"&*.*())9HXHDHIJCBBBRVZ.*+,,8HXXPT
MUFCCC3CFJ...//;HXX]`!BGDD$06:>212";^J>223#;IY)-01BGEE%16:>65
M6&:IY99<=NGEEV"&*>:89)9IYIEHIJGFFFRVZ>:;<,8IYYQTUFGGG7CFJ>>>
M?/;IYY^`!BKHH(06:NBAB":JZ**,-NKHHY!&*NFDE%9JZ:689JKIIIQVZNFG
MH(8JZJBDEFKJJ:BFJNJJK+;JZJNPQBKKK+36:NNMN.:JZZZ\]NKKK\`&*^RP
MQ!9K[+'()JOLLLPVZ^RST$8K[;345FOMM=AFJ^VVW';K[;?@ABONN.26:^ZY
MZ*:K[KKLMNONN_#&*^^\]-9K[[WXYJOOOOSVZ^^_``<L\,`$%VSPP0@GK/#"
M##?L\,,01RSQQ!3^5VSQQ1AGK/'&''?L\<<@ARSRR"27;/+)**>L\LHLM^SR
MRS#'+//,--=L\\TXYZSSSCSW[///0`<M]-!$%VWTT4@GK?323#?M]--01RWU
MU%17;?756&>M]=9<=^WUUV"'+?;89)=M]MEHIZWVVFRW[?;;<,<M]]QTUVWW
MW7@+_$8<>^\=[QM]\^WW+H,G4G@HAS.2.-^$+%Z)WXXC$GGCBA=R^.2'+'YY
M))M/`KDBF"\2>>*D9RZY)IT_4GCIE(L.^NNG#^+XYX;+;KKEAH3>NB2C6ZZY
MZ[93LOHO:K"PPO'(MZ`&[(RC'CLDNC<2_5O3FU5](T>@@/P*+9P`12O^(0!@
M``$&&```#XSO$,01$U20P4I)E!#'%AZ\T80$$CPAQ@9ON-$"XSS801R.<(0X
M:,$#<7""_.*P@B1PH`(0(($@G+`!`_;`@!B`P`_>@`$,:.!]<>B!`--`@C<X
M80+Y$X,$-E`!%%RA`A:`0`M*4`$)*&$0)[CA%78@PCBHP0-=$$075E@!%3A!
M!'&X@A#2@`$(2C`.2E`!%"JHA2$(X0$>@(`3=B"!&FJ!!#5D`1@P``8UN.`-
M'X"@!UP@@2PV(0YPB,,)(,`!-XPQAD$01!.P*('U=?$!4%#!#>/P!!@V0`CL
MDP`*XE""&_)@"V[(X@D22,4@,-&)@MA;(2_^(`$PN&$#$#`!%!?HA@]8P(:$
MH!_@.."%0?A``A8(X@;>R(+ES=$#RPLA'2'PA!44<`=@.,(?!ZF"&N8QC2O4
MP@;P&`=3/L`'<0"E**%`@5,Z01`[$"`))K"!#/!@DDJ8P`1N6((+]D`+F8Q#
M$"HP`5$6$H(M\(`%/M@_(.H1`AL`@P\$>(1!"H($-_0"&?V'QE.^41#%;&,<
MA-`^"?@``QFHP`ER&`=@'H$",#S#$S1@0&CJ,HM/4`$2XL`#,!1A`A9XP$&+
M^8`+QN&5%0`#%+`X@1:8,@,9>$,0('"!(&H`FNL$0QS<``)VOE$+&;S@.BF@
M`2540`-%?`(2PXG^RA)`TP?HK*@0B"!!)23AG]RL@!9`L(4XL,`-*V@?!()8
MRAIN0`L:\"0+?.@!"0@A#B18`N/N-\XX=,$"$X`"%`R)2`I(8)*"(&H-/[`#
M42+!"2T8Z15:,(1J`E*0>Y5`7XL)`2)<H7TM;5X"Q4>``A@@`!)8"2N^`($%
M-*`!"``!(4+`/0HTX0@K<0,#M%""$^CV!Z]<`@/>\$,XXA6)/H"F"@"@A34\
M0`U=<``4$I"$)CQ!$$=@+F_C0`$4'*$!3H!""!J0A)5`80)Q($(%U,"`Y$)`
M"TK```6V0`0&/$$)4&"`^AP@!D'T0+8E.)YLD0``(@@B#4=HXA:$(`'^0JY`
M#`90PA*NJTX,-$&[)P!##Q*P@C18H`104`(8&.""^!(X")%\@P)\X(3P!H'#
M0HW##[2X@0P;@`A#L,!*ND"$!WS@#"?`P!6.<(8*Y#$.0V@`%(X`!A14P`D*
M4$(&?H!7+:!@`TYX`!$NK(4KK``,!J@NA0517R4,X0TEP#($CH"$!@]5`>IK
M0'_WM@+FQN$`67T"`Y`09#<<0+;\"X($G,`!),8!"S[@<!J,C-<MK,`"0XYQ
M!41P!`1<H:4MQL(!B"`$#)Q!OT?80IJ=L&8E)*`)-ATJ`BQ`2!8<``D[J(`;
M&O"#'S1`#1AP@!R_-P@3/+G4]DW"%8[8@`+^)J'`<0!#`X+@@0R0`+EYW#$`
M)KD%`*#X`V](P`YLW=\X5"`$4,``%!Y]!6''5ZP3R",)'!U8$/S`"=I=X!5>
MO`(U,'K=Y&:R("A0`BUDH`M:8,`1@LSC!X1`"TT0`0-:+/`^*X`!<<@``,JJ
M!@6(D`%ND"@2&,!N*)"@!$ZX0`463(%9)_?6&&C`K@41`A7L```ZI3(A6Y``
M(8A!`>BL(P9`C(0T^'#%3GB"%JS]R3B$P`-#"(`6+G#D,S3@Y&X000F2D($@
M*)G)*)B`$QR:V`7XH`E0,$$`W+`^(B"0!"IH`:2)7(&[QL'I/K"U&BY`:0?,
M\0E(R"HA4'"`US+^@..MV-L0#-"`!1C@"G#<6PE:X`+Y#2X(#)#`&XB``4%D
MP-=N2$,(!H$""S3A`P4$@0A4$`</)$$))!@Q$I(0XR0$X`17<`$8'+"2$DB0
M"*P>!`7`L((@)*'RWLYC">1'!"TJX0P/0&<%AB`(,$S@DU=@@?QZB\!>$_\!
M2CC!#FZ^^A@/`<NOO\(B9XU.#)S`"5<@?QPFX`,&6``,)'##,Y6`3C<X`)U[
MJT`!M?"`*ZA\Q#&Q-Q=@8">0`?<5!Q9@8`.D105T`J)4`4D``B"@!!OP!!-0
M5M_G!.'7`C>7!*R73KC'-_975D*P`4E0`8EU?][&?#X4`B2P`G&P6X+^4`*D
M-VN#E0!>4`)ND(`^=`5^HWX8(`)-D`%@T`(&V`1^<P$%U`!7X%!*X`5=`'&S
M!P80@'AJ\`!E%00FB()M%@=)0`(9@'@!EUX>D&""H'\E$`!0L`/?`SAQ8`+R
M4X)*H$5)X'.4)P@F<`(()`0H:$=!U@0@8&![LP-!]@9=<`"Q%'\-H'PL:`',
MAP%$L`,9X`1*L!(F\(#,=P)=L`(2I`(E\`33=@6DMS=`&`)+0$9&>%]^LW-7
M\`%B@`(UR`!8@(`*J%YX-7[2-0$,``89<`!E-6M@,$10``$K00(LX`(2M`(?
MP$CRPVQ'D`%G>`1I"`4NP&N+%P0`@$AYM#?^6M``_?,`+I!@;J`!Y\=K\N<#
M2M`%7F``&-`%.K@`Z-0%;@")@C`$T.AM`U<!3W`&0L"`<B0_0X""0S5_8/!R
MB$0$;I!:&Q![!GA#/+A0]ZA_'F!@BJ1U29!+A'`&#O!P!;!(K[`&$J``!K!Y
MA+!X/<``2,<XL_8_0>`"@K`!)O!\FL<X*Y``&Z``37`%^40!9L4"+'`$8G``
M%=``@V2/)J`"/K`%)#E\ZL1J?K,!1/`!)O4_<<!T>"5!1V``-80%5>AM"O@&
M$]`$'#51;C`!8G`!0J5X6'D`&J!?05D!#E"498@!1^F2[(5.&\``$>0&$#`!
M!L`"6C`!)Z`"*B#^?Q+@``*D!HLX"!Y05DUX!0S@ET<F"!:01RJ0`-44!QC`
M@D<@E`]P!CM```K`DQO0`!G@`$\``LOCC'2I`CT@!@@`ES?D-T>0`&OT2:MI
M>@*IF(A7`0KH!$"$`6J@@G(T4FD`2.;G@'-770.@`:IUE]%DF@H@!CMP`!2`
M`:JU`0=P`"+P!@]PF#X`!@DP`03`?`^P`2&`!1^P/$+``:8F`0EP72"0!#WP
M/Y"97AMP!%1I`4<``B20AXCG-R8@05JX!%HI`22(@F!0`6*P7D?`:BM1DWE9
M0&>X!2#P!&!P6(0Y:[VI@*"D`-"X`K$IG,SH;7=U`ENP`PS@`+278";^L`(N
M*0C0N0$.D`$+0)U"B9TOV0`AZ08J4$"*R8ADAH(G,%)7"`46P`%Y*`'H=(4,
M0`!!T`4D20(MT`,+X``/(%2VITX<H)_1Z((`.H,ML`,>0(.":$`89Y@U%$F1
M1Y*&Z0!!X`4:6IB+29DLV))G:&`E0``[D`1""0%HH`)(M$Z"X%P2<$@L4*8J
M0)$4&`<M()07H)DL*`0QRI\BL)TY9``Q%$2'XP($P``*$$2PH`0&\)FV4P(N
MT'B4LP+?0P3HI9DJ(),(M#<G(#\_@`0^<``ED`!;D*&=U`4-H%ID]E8&\)H*
ML#S_B63`AUT04'GLDZ<E.@3`IWX48&`KX0+^!L=(+``%!%`"#,!\M"I*.18'
MU"@&&$<(0^`!2+`!6V``_V-_Z/20\J<%(N`#8I"E/O8&Q#E4*K@WE9E$50@!
M"SJ;=LI(DR2`M5AY>X,"(``&0L6#*O`$7?D#ZDJLX7FNMG.'0\4`B,=L2I![
MU%H$@D!SW@H%3"H()R!!:<"$3)I%FIE'3:``J@6O")B)FRA*A(`!.^`%:4"S
M!B2P%G!-BZE;'<L!2$!&61H'#N!!E=>-9!A.^^9`L.:+Z52K,N8!'PN"*)@$
M!E`"478_!C1PHA0$;G>(("`!8H2OV+:8U2H(2DBQ;WBP>/B`PK<%+(`")HN?
M[1JC0[68CBA'7<#^`C@["'\;`@&T>6D@@P]IBR>`1+R9`2C``"M``?7W`$<0
M1%VP`,LC`JGJ/:GUAG%H>J]*`5);G67%2"[0`BNP!`-`L-WH!F^PF"'@!AF@
M@(F5?(*@!0+K``@D@SN0!K6+73R)CUM`7`V09HQCM4$0J7V;52;0`DHP`%_5
M`MF:AXQ#CP,TO!.0!!_0`D%T!,R+"+@V`&<*"QHP5Y_3<BH@6X5#`M>5D!_P
M`0VV`2!P=(PC`K*U3QGP/2@@00\``08T`,\F0.H$P!4@0?)D`@N0A0#\@P`@
M/_`KORL1`LLH!`30N%;G`1(\"$/'?!^0LE1FBWL3`K(5!`^00"@@!@+^,,""
M\`,8<`0G;`$2I`8',(OBU+]=P*LCUID,U&`(X`%YV#]X-E1QT`0-P`(0$`1@
M5L0`/`@:Q$@*H`(?X&\54`*(1``JX`%/8`*;MS=/+`):\`,.4)-#=L(M)`8!
M\&Q!L$."L%/I\P"7"05)0``HT&\H65>Y)0'?(\5T)`)*(`8+<`(6L(P%X`5-
M,`!QL`0*L`)G^X,&@$Y?K`4K$,4@$`6"D,2)99N+%P4'`$4/D`9#7%$/0,;?
M%0<J$`+Q]09G``%;T`4%@&0`+`$?4%=QT%EI``!@D`0B^X8+4)-R/``H$`(&
MYL95EUZ1.LH20(C+V`,>I0*BU(1/@``]'`?^"!"_GUO+=Y4`XY8`I_P])!P'
M&[=A;E`"LE4!/@##""A!I%C#M9Q'(N!HW`P"B.=M$[`"<7D&"B#(U8?)!>Q7
M"V`"%@`"V48$!^`$'.M#0[PWIG0""I`&Y`RK1B=;/]!@LBR_<2`!1)`&2B<(
M'T"8FW<`X&I`!P"[CQQ-N#8!*"`"0J4&"<`!BW<%!L!``,P"%;`""_`&%L!O
M/?`&;631+&0"$B"B*/`!3J`"BQQEB84`'$`"9"I!(&U``,!\7BO%_M9./,#3
MUGS11S8$=/P!MS69C(,$P3H+6A!CZ70$3:`$%$H('VA`PX=.7Z0"/H==!31D
M/;`2&B9C;R0&*I#^LBYU!=!T!2-U!H)Z34GD49G4`J<K:B5PN@1D0"?0OT3@
M`W!XNH(@!BP0$TA`!"4U5#R02X\-V'%@R&K0UR3PUT&@!1>$!2/E/_T5!)=8
M`@4I5"TI0&)P9H1(@X##@9FT!CM@?FKP16*@>03K`XBG!'D(QD1@>ZF=AR'0
M!$M00'O3`XB'!$*U`R&01Z)]!978UR(@!%#`O%?@4GR#W<RG!1,EVSU0JZ=;
MA"M!G808`@64<'+MJ*^]$D00`BTPUWS#V]0]0!J5W/-LW(F5VU_6`H##`EL4
M8V]@WDET06+0`M"+75!0/`\^/\-75CR`>$*P!CZP0-E'`N<=V91VV&;^U5]N
ML`-NT`5,#<X%!`7S_-_JM$6JC-OL/0C_?01?-U$B@'B/[3\D\$:AW0)-0&7E
MII+^[>,!WKCS'`0IJ^()-'IS3>`F'N7U[0)?4%+;-U0M8-9I(*A"7D!8L$A(
M4-<7Q%O]%D*(-P0QAM9-8&!*,,]Q$.%[P]L(201YF'I#9>!%..=WE>+KIDXI
MBSZ,C4Y?'@)7L`61C<IA)^*RTU@DX`)$8&R(!P:9G<C)K07+30+H@^9E)>/H
M'<RWY7:$H`:\UA5@X`&#>0(A(`*L+@(DL-:J``4'=0K7HPMQ=`1ZIP]QY!6A
MXX;IA#O!'CR,,SR-8^S$+CB9\P9Q%#C"+EK^T)Y)PP/L@]#KE^/LZ33MEC`X
MSM[LQ3[LN=,\J^,W/5L[V?[MR0XXW)[LZ!X\I-,[VKX[?M/KPDX[AM!M@N#M
MTL[NLH/LJ=/NN(/MZVY<X/X[E!/OT([LXGX[Q$[O_F[ONT/OX+[PQX[N$K_O
M$`_LSL[L]4[LZPXY`Y_PC'/Q>5/R)D\F<23Q<-#K*T_O*5_M+D_P*<_R!&]<
M++_RA(#S-E_M,E_S<!3S-._R*J_R/`_T,)_S05_T^5[S+\_S2R_T2?_S/6_T
M^3[T3W_S2`_S5*_S3]_U4H_U6'_T8K_T59_U56_U.U_V8]_R2B_U;=_TB=?V
M:1_W8M_T-#_W<,_^]7D_]5=_]G*O]SZ_]60_\TZ/]WSO]82/]U1/]FZO]H[O
M]GF/]C]/]%[?^"F_-WM/^8^O\XG/]9;O^8L?^7UO^"1_,C>``S50!7&@`S9P
M`S;0!FU@`SA@`SH0!U50`SB0`RN?`S>0^G%@!;AO`V80!U-@`S8P!7%@!K)?
M`V,0!SE@_#D0!V.`^[[/^JX/^ZU?`U9@^S5P`[H/![SO^\`_^\-?_+3/_:C?
M_#C@^C@@_<$__*Q__,F__-M_^]Z_^[VO^M;_^K'O^K5O_X"0`P>7<U-3%6=5
M@V-C%J=C8Z,39V:#4S,6AW-CDQ,W5I-S^&AIT]9F66,55U5S(TAHB*C^R.@X
M%3G%NH@95]CYZ=H8=VN36WFYVOHZ6#@*R7AJPYG;>IG9/+LH#"E)F9KLZ@EZ
MB7C+&8VLNQP[2BM,3+V;R7B#`TP^C.MM"+Z.G:@MVC1=UGK)`E@K7S%OZ939
M&^>L%+INU6#]<^>(VZ1*AJYQ$A<JXL)CJ@A:/*CH'"I&DZKQVM1.6\9(&[^I
M`XE/1\"5%,,Q0QG,ECZ2UR+A'`5O7TEE)V-"0S70I<=?H#C-'&F3Z4^DTDQ!
M[<DH1@P8-^+0@#&V3!FT,&AH0BMCT(RQ9:FP)6,6K5LR,&3`0"1CK`Q6?6'8
M.^M7;6$J<6R@G2&7;AR[?O&>;1OG1F'`8@?^5REL&0;F,8LS/XYL.&_:M6/=
M:HX!&<Y<LI-!J][+EG,,SX7+GEU=^G7LV64_CPV-&<?F.('[$O:;Z3)NOXR%
MHS[,5G%KTWXYTZ8,([IHMZ2IF][]//5O&-IA5#\-IWG=PN*3+P^,_K-?W^/C
M\#7_6ERR209>>VXIUQUS!-KVVW3NG<?;?JJQQYI]NZ$VWW%Y8<;76(C,%B%M
MTGT2''S$U9;86GZY=I]DQL&`G(/OY==;7BFRQ2)L&*(8GEG;_?>7@C3ZA1V'
M)5XX(&TO*K;B6PDV%V*,_AT96W/8`;>=<F(-,D@<7,(1AY=<BMDEF6!^&2::
M9J[YY9ECDIGFFVC^JCEGG5W2*>>8>-Z9)Y]EV@GFFFSJ":B9;OY)**)^+BKH
MGH<&6NB@B3X:IZ*4MMGHI)52*BFCF#J:*:.=7MKGHZ1JVNFFH4*JZ:>EK@JK
MJZ*""JBIJ=Y*ZZ2<1EJHK)Z^ZJNJN9899K'&'HMLLLHNRVRSSCX+;;323DMM
MM=9>BVVVVF[+;;?>?@MNN.*.2VZYYIX[;J#HIKENN^Y6J^Z[\LH;[[SVDEOO
MO?KNRV^__OX+<,`"#TQPP08?C'#""B_,<,,./PQQQ!)/3''%%E^,<<8:;\QQ
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M?_WVWX]__OKOSW___O\/P``*<(`$+*`!#XC^P`0J<($,;*`#'PC!"$IP@A2L
MH`4OB,$,:G"#''S7&S[HAC>X(80D%*$(23A"$YXPA"=4X0A3B,(/@K"$,#1A
M#%_HPA2VD(4XM"$+9\A#&OIPA3D,8A%!V$(9]K"&-$1A"8FX0R`&48<[%&(3
MB3C%&1;1B#[\H0V_",,:0E&,2TPB$+5H12<>,8HKY&(8D6C%*CYQB7/480R5
M:,<XAK&.1IRB&^^H1SFND8QV-.,8S\C&,E)QC'I48Q8324<T\A",0\3A(PDY
MR45&,HU(_-<.&C"!"4A``J(4Y2A+2<I3IE*5J&0E*5MIRE&N$I6QI*4K75G+
M5)IRE[*\92MU.<O^50(SE[!492^+2<Q@)G.9PXRE,H5I2V#B4I:V_*4TJ0E-
M:?XRFL,TIC.UF4UD8G.;W70F.<_YS&FJDY?'3&<WK\G-:@H3GO04ISK?R<YQ
M]O*=^#2F/NOISGB6LYW,7&<X#\K.;]JSF0W80;_>$`<4`.``!2B``2YJ``)@
MU*(7Y2A&/PI2CX+THR(=J4E/:H"2HG2C*!6I1U]ZTI):%*8L56E(5TI2G,+4
MIBSMJ$EY.E*@]K2E&-6H3X\JTYNF=*E#/:I3.5I1G#:5J5-U*E6AJM*DYG2I
M+E7J4SLJU*U.U:9=16I6O8I4JJKUJFAEZDS%:E6:1E6J:]4J6N5Z5KC^NE6M
M=F5K2@\``!3$`:+\"D(%-I"!Q"IVL8QMK&(QX-C(1A:RBZ5L!B"K`0U@(+,8
ML&QC/:M9R8IVM*0MK6D3BUG-9C:TIVVM:U\+V]C*=K:>A6UM9XM;V=[6M;O-
MK6]_JUO<]A:XO]5`!8+0P>1>C+#08B[`G"LMZ')+NLS*5[&HFRSL/@NZV@U3
M=P>KW/"*MV7?%1AVOTM=PI[W6-P%KWO?"U_O-E>^R"IO=(T%4>DZ5[WTO6Y]
M^^O?\:K,OOJR[G^59F!E$3B[`@Y9&KH`!C!T`0W]0L,6W.!=,'BA6&Z(L!J0
M)08O@$$,V>T"B<.4A@O'(<(L]L*)PR2&+F#^.$QNZ$(:C,7B'+]!#5OX<)@B
M?-T(>V'&Q>(QA3.<XQM#-,8B9K%S:WR&%<O8NS+F<92+%>$:Y]C&2`8#AR'<
MY!%C6<-$#G&.C\5B(C>X8RL80`(,<(`'$(&]\F(!`)!`8P8T`,-NX$```+`!
MYL+A"`RX:`..H"Z(;F$`&P!O"P"@A#@T@*(7#0`&L-R``C0A#AA.`@!8P.$%
M$.``"3B``0(@!A[<.<\,("$/X$P`$]RX6"0`@`@X/&E3$\`!1PC3!N!\40*T
M6KZ>!O4&`/"#,'4!`$W8`@!"`%XU+$`"5R#U10&K@C"I8`"C+L&'B3#1!)3:
MTG%00PE,78`-7,'^UP5`=P(<&B8A%$"C&_#RFC<&4180X+`5N&@7`+PNB#XZ
M"31VP`,^+(3`'L$`<X8HN!^P`0PD``!%.%87".`!1T,Z#@]0`&4K(%B(1H&B
M)0"OIUL`7C=X``,02``%-E"!-.Q@XYQ^P`,P#.X);,`"`2AYL3!@``:<6`T0
M\'@&-J"``:S[UY3%@`?47.PX_/H!4>Y"`"(]@6''H0D`:($8#`#QQ%+`!W$8
M`@`RT`,)`.`$6Z\`!A;`@`Q8P`01!8#.-1#T*&_@`)#=P`,`,(0X7&$`$/!!
M!LY^[XV!:>"#)<$`D,MG>\?A#+-.0Y3Q&,+KJCE:`@<`P<MM\S7$(0C^D':#
M`;+-Z7Y#(4Q*0$`%U'SQ1G<^T@VX>;)4<(`*V#X.)X?OHR/=>8*+\`$."&'6
M2?P&#`3@WW'0P@$L<(!><]K@,R:]L0FP!09'?0,(.(!#MQ"`7J-``*N/P\RU
M``9&(RL#0E^Q`R`P8S?8?,9=4,`#3FSV'D@=^V&"`@$:O6WKY@89<`#9MV")
MIS"_%R8G=P8*X`,5(`$8M@((D``6X&4DH`!XY@$-<`4F``%1E@820'?6PGC3
M9WM=D``8\`$#P'Q:,``:8"P9,`!:(%];@'$:1WN[9RQNT``DP`(S&"9(T'7N
M%7R<%@<E*'\-L'4`D&T0I07K)G`)L'`K0&/^\[>``$"%&\!_RJ($0[AW"+!G
M8!!^<7`$6!@F!'@&8$``'(!?<0`"#*=DLV:"F5>&31@':<``$!`''L""RF8`
M&6!^`N`"8``F:G"`"*@P=M9K:O`!`$`$7W<`%)!M*P``'(`"!C`!<2`&?->%
M)#!Z`-!K72A\`4:*S"5P`Y`!(0`"(&!_,^8!<.8$X.6"R$58)T``S*=H!P`!
MJA@"%3``!.<`"@`"(1`"&U!^4```/8`%``!OO>=?C)=OJ$B,(+``#A`'71AX
M]44!#J`&$V![;N``#:`$3O`$?K9Z>[<!Q+@!V6ARGR9U!R"#02`&8R@&#'!I
M8J``C;8%NLB+'N#^95>040\@`N47)FH0CC-V!`%0?A"%@7M8`$)`CA*%7&+0
M``/``![P>8BX7''P@Q!0=`!P:5V0;F%R!@;@`6"B:I&F;PK0`/\&!J<740?@
M8]7"`G`6``/@9A#P82M@``C``%?P!EY&>I^'84<@`/]&6%N0``H0``(@``E`
M``3W``DP``(P`(ZH;0'@91!``5>(<LZE@/D&9T[I9@]PC<L'7A\4)BY(A3L0
M`.NF!E,9``%0``R0;.]X:E?)=LS5A2CW:U=``1``!0.`9U)G`&?@:7.F!4LY
MEP(``#1XC0^0ET+`80<9)B7`?X&R`@4`!A]P`%?9;BHP8UK0;XZ)>AK^63%B
MN0`6H`(HX&4VR(9D.(1Q8'6]=@820`"4"5$:<',54`''L@(9P`$;L`'#29P;
MX`$;``)$]F@^T`5:``4-8(U0(``;D`0#8`$>P`"T.0`\X%Z.AXMQL`4%@`%;
M@`5>8`(;UP`<J`5/>&-NX)%*``484``TV'O\%99'"`#."9WK>8W,UH;F-P`[
M<`5N287RYP!-X`$$X(EAP@$%D`1;\(22YY52-P!B8)0D$'UA\@.@Z`*<*9[D
M:9Y:@`5$I@9-<`(,H'4(.F-)$`";YET5P`!OX`$0J@(&8`%JY@97P`(2`(2H
M:3&/-F?&$GO*5@"@1IMC"`:X>6MA,@0#\`3^"@!OM`8!OFFEODD!%3`!&(!A
MLU>%2A@$:+F9#-I\!&`!S5<";H`!`Y!]Q7)Q&>>EM;=Y4$!J````%X5R98AR
MQP*-^DF4#Z"$GG:@'.D!-P9]5QD`!Q"!X%A\>XB5^\=\=+9]+/@&$(``!%"8
M-B@"$(AA%Q>;1<8#2,J1!+!N<Q@F9;B7DZ=G-,I_E-B$1'`"/I:0T@>D%*.`
M;@`'$-4%`H!<G,8`T#9Z"KF'SR<`L1@'4(``%)``;4J"GC=8/`BFQ;IBDJE_
MR4<`3]`%#2`!'N=<G@I>=I:#:;!"<;`"&+<"*F`"KO>?H/9#?JIQGQ>7#O`&
M8K``%.!E8*``!O#^8(JJ`BJP`A5``*M7>S?F?Q2`81L`A"_D7WVY?]GW`Z:&
M9[N9``6PIT7Z0A@F`0=@;R)@`/;&J#,&!@W``,SG`SW7L"O&``KP;[7V!&%2
MLIMVB+7Z7.Y*I&,(42X``"30`R.)!0,0`EY``("8>D%[+47(:2(+!UTP`!7@
M`QAP`$_K`KR7J"H@`@1``+T*7C8H>_H9:0Z0`!`@2P^@!12@`#/I`0'@!4T@
M``\@2PQ`<'9&<!B&A);Y:`R@`FH':C@[9QC6A50HG3,&`H%EF&!+2@P0:<4R
MJ=FG!A(0`!$;!RK0;J6ZCPP@2U4:K!*P`Q@`:,6R!G\+7CA[D?U6@"?^:WZ(
MYP0&L``L``(#<'`R*S$0Y9;`YZ91F98D<%$;D'VON'K;UJN/QG8)QBRP>W4T
M)@'P9W[==P`GH`0$<+A"8*D)4`$08`"ZJ6P'\`&?^Z)Q``$JR@`+P)(_D`!T
MIY9$$`!#X`0'X`!PUP`&T&LM,+P8%KO$:[QOT`(-@``*0`(WA@$,X&40=08/
M8`$A:+S3*G0AD``JN@#KVVN$I00!@'(><`#,1P0#(+M0D``2<&5=D,#<^[4?
MM@,4F`"XFW+%2V3TVP`*X'+&ZIG,YP9XMVE'L``(X'K&ZKH2XP9GL'EW^&1J
M8(B<=@8]_`9IX&/N2\/6X@9HP%QJ,&L[Y@;^XMI\S.4&2OP&6]``0UHL0LQA
M3JS$/,S%-ZQF.Z8&3<S%2LQG3DQC.'S%<EAN4HQB,UF0XJK$QD+&8KS%:?#%
M=EQN<AC$IH@&,QG$8\S#5\S#T(7%Q]+%16;&G%;(:K`&>%S#):-=6J`$%*!U
MX:)=T#5"!!.S#V4LP!M?T[+)CYPQ#G>GLHLMZ`5P`5JTSA+*D"S*0>,&6,"L
MKTS+M<P[^25?^87+NYR61#A8,M3+O!S,N)R6O&S,P8S,OYS+RDS,:LE?NMS+
MP[S,QJQ>S\S,O@S-QWS,RHS,NZS-W9S+U3S-PNS-X/S-U[S-V0S.URS-YUS.
MY%S,YCS.1/C-SUS^S_-\S];LS-B,SM/<S^1\S_'LSO\<S>J<S@(MS_H<T.\<
MSO),T,W\T/RLELELRQ5]+%N@!$V@T1O-T1WMT1WM!!\MTB--TB5MTB<]TB&-
MTB*MTBOMTB\-TS$MTS--TR_=TC4-TCBMTSO-T3<=TS[-TT$MU"@-U$-MU#"M
M!`;8+Q)E`-QFM4\-U4_MU%%MM5--U59=U52MU5IMU5A-`%X]U5X=U6"]U5]=
MUF)]UF6=U6H]UE=MUF4];VXMUVS]UFG-UF*-UE(]UVW-UU"=UV1-UW6]UVL=
MV()-V'VMUW=MUUP=V'GMUXJ-V(\=V8DMV8-MV(R]U7]MV87MV)>-UH#^K=8&
ML':<[`)?:W/$=]JIK=JKC=JL[=JG;7"K'=NO3=NO/=O26=NI/=NNO=N\;7.]
MK=JX3=O`G=NZ;=R\;7#$S=K*;7/"[=K.?=S%+=VM/=VP7=W-S=R_?=V`FMVY
MW=VJ_=W+7=OAK=W;/=[F[=W53=[@O=W0;=WH;=OJ3=LMMZ?]<L-*G`;YK=_[
MS=_\C=]HH-_XG=]U+,3X37D#WM\)KN`"+L0-7N`!GM\`/N#XS</^'>$0CN$2
M[N`8OM\$7N%IH.$?_N$'WN"41^`(3N$";N`!KN(7KN`O[N'_[>`I[N(;_N(P
M[M\TSN$3SN,=7N,,_N!!'N+]+>,(WN$Z/N3^/G[D/6[D+,[D-[[@/V[A2=[D
M0`[E3=[C'X[E0:[E-L[E#`[D(F[E5Y[A._[E4D[F"1[F.K[E8F[A%+[A.6S1
M<]XM[24N=KY=H-PL]H7*]Z7*K%SG>SXN>'Y@I#A??[[*B`[HBF[HGQSHP4MG
MUD+HD=[HB'[)E`XND^XMFM[H?5[I=`[JH2[JHT[JI6[JI\XS^VPNK9S*>5XN
MZ;5?K3S1@:Y?\,7JC*Y@#-8N,3OKD%[HNOXMO>[H[%7KF-[JJ%XVMS[J3M`"
M/>`#.W`$<CY=0=`"[!@M'W8&+$"KU[X#/B#MVY(&+6#%8<+L.W!E3N`"YBXM
MF=P%+-"RWG(%Z4[^H6GP[#L`F>%><=GR!C[@`^6U!2I0Q.+)`FI\+9FWYSL0
MBP1V!BVP[<KR[P&_!2M`\.#E!#N@[,CR`T,*43QZ9<H"!M4^DVZ`!#M`H;RW
M`T2F!"WP[L(#42<``(X)``/@`<3L7[,N:/VU7W'P`W^VE^ME+$)PO5H`D@"V
M7F4X``F/\Y5N\P&F:$,O7RX?`&17=S_ZR<X%!AF`!7$`;N)+\TP/[#^F``!0
MMASF`7<:``S7?$,O[/F2\P69``@@>K4.477H)>!5A@;H\]H%!1HPDVS/:0,@
MOL9>+,YV:<4NFZ@G0K(YRT\_`%UJZ8)O+%QW:<3[F,MR!0U@IQ-`8BK^9Z?\
MZZ8&D``SU@*.*0!42#RCKP))X`,-$+"9_K@&$*G)DB]B"(A;8)+4L@)/>YK@
MT@6W;RPM0($EYP83H``*D'V>[*``D'U@<`2+GRU;(`!DA\NH*@9!D%(==H/9
M`I^[9UT0Q;#3/P`;IBS(/UA>Z_C+X@8+8/J`;OL91^G>/X3,=9VQ+U\K4,E?
M_RQ7L``'X/XJ=P#&#PAQ@H.#&09!/`$H<4,`*CT!+H)@$@@2:G%;`1E*&P%:
MA*&BHZ2EIJ>HJ:JKK*VNK["QLF]Q+0!*@D$`DDAG4$%N<6=$1*!I1TV85TE:
M5TZT<5!/A%L?#$[!8L17@G!-7EX]9X-$!A7^6EH$'FH]SX)O3C[<HFX0&146
M<7!Q6DW1)UL$]?L7$-X36OUHJ7G"(@B83`0VQ*%%BT4!!0_<N'G`($'`.%V"
M),$D"(L/;''`5$`01,W"AU"X'5$Q;J(3<5>@B((7Q$D:84$,N!#S+LX)`E@$
M]0"!!LR`=2>A@5FB8N3$)EVZ\!@7;YZ;!@_.#$$23-"5($J(QDD"H(6@+CVP
M*`G0)8Z;KN^^A5-SYLA)DH.@,'"0)-BP8O02L$CC8]H^-T>"U`W5Y:F:J((.
MUV3K%F0/+7/K0B.T(@$M)^ZV^#M3&,R):8+6)`GBA1`M,`<6')`8!\0`!P@^
MTMO`NP*%."H.G'G^PZ""(`D&&#Q0E@!)G"L!B$R4Q;V[]^_@PXL?G\I6$D%'
M`.P``T!#@`<I(0`((&!(+0`LWB1`D(8$`%#LG4#(!`,P\%\:\@4P@'UN&$!!
M`@+4I`8""AR@P!4(4"#?+H+8$D!;^A!R!0!''/6040=`$D`"H)AP0"(K!H1`
M`I@<%<P)`"00@`1N..5!*"P8`$$#;BAQ``H&!*0%`@``(,$X2'P(@$0E!.#`
M+4X`L(@$%*@PGP0_V5)`!<V)LL)\4\9!!``/`%#"=FL%8$$06T"SA8,)NO4&
M!@`P^:,;!U"@0`!J[("F6U\Y4$&3']!"A``?2O`09_Q`N,`&2=[W(0O^=CF8
MP`!;4%!``P!@,`@M%!A`ZA9JM$F?=J-]A<$"``C0F0?S!7`$G)D$FF<<:4C0
MY`'<4*J%CI<>(-RI<93VAALSUBA`'.GYD```!%CW!J[T[3K:$R=<$9%='V#A
M`0$%C>+&3VHX$$(<&S#@QAL3,/"&&"!L\0"1@J@13!(!.$'>P`07;/#!")_2
M0@`M7''$`P-<`08"#/3T1@4&'+$%Q@]5X`".040#@'8]$,`--&*(D,`5;EB0
M\<8&@/$&!`>TT,0:@RAA``9@:'&``TU$P8"I8!A0PAD[''#B=BP`L$66(=<R
MP`=@[)!='"P,`$+5),;QP'3-+A`,!>_J,L3^&0-PP&P+`KA@@!-*-/`#NKTM
M@`X"/7A]`1A*$(`-QKLJP2$'!*P`!@ETJ7$`!FD@H0ZSNI3`M0_4#K##3X2$
M4&L"&]2UQ0$-."&8J6<H0#F..M'<PA,^DX#T`6*\\<`!0VR!00+7!8#!%D<$
M\,%:((8P0!-GB`I&&D:_+C/-*S@<0,@M;$V(%@TX`(4;@&]<P-)QK`&!`41T
M4<$!:6#7`QHA0``-+9\_T(1@%\31PP!*@#'!CY0*3WRJRQ;EK.P9:1;NE#"`
M<QR!``)R0@!ZD(80/&`TP@`)`=3F$G@18#*F.!,NI(,)%2C@#6IXE@,"B#*.
ME"5A*$RA"E?(PJ+^!,D`\[&<!'_$CP&H0!""V]41#%"`1L5!#0SX$0D2<$):
MK``!-;QA'`1G';"<\"WCVL($!8$!4[U@9-?I&C3J<1PW*"`#'>K:%@9@G::=
M1Q.X`$L'%1",9ZFA:3LX@P#4YL(`\&`!10"!!IH0`#"((2(NJ<`&GN"(-X`A
M`0+:``%`@000;0!4U`J`&+1PM3A4`(R$R,`"V`4!4W4A`.<1A0]N)P`)&'(`
MO*GB.]2`A@^`,@Y.C(.AM#.B78$%9Z5IUB<$X8$!@F@"IHI#$0)P!A]@$0H!
M:*(#@H$=#`RA"Q"TBP,:D$0<:O$Q#W``)MBBA!(,0">-6%9EZ(@!#7C^[0$/
M.<$!E@@B"03S"`/`8"B<Y881=A")@D-4`E9@P2@P(@#I&H04:<A+NI&"%NF1
MB!LX*,"R;&29A-A`UUI(T8I:]**MJ`@JAZ`%+-"B"^.*0R,[TP4!G&<-&`#?
M=DZ0`"\T``2V00X2*94)^L&R`8!A'RIG2,5\K*``"PBJ`<X#C2>8@P0A:(!'
ML"9&73%U5Y1,(]@\R$SH+,!R:"-H&)NP@0I(8`5-`(`8<+,`!3#``"3H&P/,
M:@"W9&"1P'.+(D'1NS/T``"A5.4^NC="G,5!E9KPUCON%0PMD$``70##X_X:
M3"2<=0$%2"-.FT6`M9XUC0[XB0IPI\B/Y%+^<''<J4@!@+0"L56RF'A#"00`
M`!N&0@T-H"9-2XJ+0;AA`2(0Q!8$T`01&$`!"DB``L094@QD0';"[0A\0(LV
M.AX!L;QZ`RT\*%T':!,YON24&A1P0TR5-;C+^FA(!4$XT?!J$!A2`"CVQ*\0
ML%$0]0R@(,X4@FAB]+[XS2\+;8&+?7QT`+G]X0'XF44=)D!(:$#/`(*0`,$.
M@IX#-LLK&3"!)Z9D-Q!)9?S.=`0X^`N"*B!``>B#@`*$S(R9<"J*/RG58&SV
M60J@`&L`L!4!\&8[MG#"W(:7)3"`(0`<6%<PTI,??P5#!)!D"Z<Z&TDQ?-(^
ME@SF(%A:%GR`))G^H3B!`]3"%B*@+96FHF0(W,#?.#"`1\TB$0B#\5!<(K%W
MDW%1')8`HDL*(DI(4[._[-(`-'<O"BS`@`!PL3X)-.!9$<Z=@[]286K=0GA:
MT$@1>?I7,()%#$9FIUOL3"WH#F('ZIN9O.K)K\UJVBX)N.%;L2#I48#TQG$@
M7/\(D8;!/&2ZIKFMGS?"+S4Y0K_`#K:P"V8>7E4FE''0$%%$`+LX2.`!+`@`
MY5)2H;"<=P5B2S8$B!("Y;Q!`00.!6`+0,,,F`J9/Z#6!N9AEWHY`1T[E$B9
MQ[BK8H]Q@P\4@Z%'*XF[BN,IVZ&%+:#0!`*H5X$/F8`$XB`&#S#P`+G^O<(&
MBB#2)#O2`(P4@!\+"(8A"("@M-#%KA28[C$2=3MG<HL7/#``'R_6W,C!:QQ$
M$`!<[%,0Z*96!I+RM6#D$CN<PDUNV2*)#20@*1[8'B4I=X0,<./F:H+`-`A)
M\=&LX+W*CD,($J`66KA!`G[3NM.($(!I[,`#W.L"N04!<Q(TNP0D.+71D7X`
MT1CQ%F=`@*F^DI$S[#N?J+[A#\HN2P^HA1H&^!$TDBZ:)\!F.R880`E`PXT@
M!.`*:C``I[S>\Y0\0`%'N((2:C+LTIO^]*>8KA:WLX6N!:,)`T!`F]RBBQV8
MN>Z"^(!HF76"`;Q^``F8O5T0>-Z_ZFY$P9S^P`1XR2;@_^0T`(#I("P``#38
M`JI81$'7M```BD>;(P?`W9T61RH6G*%4\[R%4W"7'E"P90$&THXM''```'!C
M30:`0I9NR">Z.FWF`:`[$@!&L5(![T$`$(`)K;<KA'`&U'=6`/`CK9=\"]=(
M0V,@NS(``D(+N`(Q-`(M-&(4!'!D`.``!^9_BY`>T?$IH"!1$!![F$!\_"``
MG&-PM5$4VK<`8``%`B![(!(K!S`!$,```1!WK4(`;2)ENH5^<:!PF5``"'`E
M)N!H-Y0>![!6`@`*@]`%!F!PZM$A[\$`X0<\-^0&&OA##X"$3,@L$T@(_?=#
M!(``@%$Z!#``3;+^<+`5?ID"7PD0@KI0?TT"*Z@WB(2(>DG@`4G1@"'`;DM$
M`B)`!""D`B3P$$K@`0QH"],6"D=@`M"@!")``D=`$27`@*&@!"%@."20-[)D
M>PQW`G"GA8*0!!]P,K10B?W@`=P@!HM(+;C(<+M(9A]`!)MX&DAU!2O@`[JH
MBH-PB*!P`@*B!2&@%D%``B00-63FB/[`<"@``EJP!98H2R+P$%<0C>A!`FJP
M`4HH"&)P`B1@.)FQBZ&PCB90`CV`";HX;3M@>V]`!"(0+J`8!Z,X".M8`B(`
M"FZ@`BHP9"7`9BW0CUIH+J$4!"&P`U!`C@-)`@9I`J2H!2?PB>LU/=3^2(DA
M`(K1]`8F@`1$\`$M4!:&50(G<'CJ*`+XR(I*0(TK>1T>8!UQ()$428Z$4),D
M`(GPU0+!B`1QIP4><!YNH)$"00(N"9,"*9.$T`,BH!9.20B'XXPJ4`+3YHEI
M10@'B0+!P(\G@`*2R(B%F)9JN9:I@`*0Q)9LJ04F4%L5$#]P>9=X20I*,(7V
ME9=^^9?"UI<E>5ZQHB89L#A[M1.V`4&)J9@3,1J067R2N3[,4A26:9F029D'
M=9D01!&#X%^A,!J-"5\,!T,9(%'IIIB=60J>>9DQU9KVM9J5.9N$67RR29L[
MD9BM&0J@&9I]&5VA&5.5*9BCH)DA4IN_Z9K^<*(&$I"(S+*;RGE>H)F<@%F=
MUJE"5^``AG>=J*<%&$`!$M`#%L:=Y!EL@%&>Z)F>ZKF>[-F>[OF>\!F?\CF?
MPDF?]GF?^)F?^KF?_-F?_OF?`!J@`CJ@!%J@!GJ@")J@"KJ@#-J@#OJ@$!JA
M$CJA%%JA%GJA&)JA&KJA'-JA'OJA(!JB(CJB)%JB)GJB*)JB*KJB+-JB+OJB
M,!JC,CJC-%JC-GJC.)JC.KJC/-JC/OJC0!JD0CJD1%JD1GJD2$J9U)EZO;E"
MTF4*2[J9U!FE*.29H]D*NAFEOTFEO)DP@QF=2!JF8CJF9*JC;B`"'B`"(>`!
M[\("_+1%'A`ROTG^!!X``AYP`O+$'6_``5$CF71JIR:0IX,0!!XPGJAP!!O`
MIR>DFR%@'V4Y"H0:#-P3G&*P`3K!I6!I`B#P`1L`#,49`H+XF>107W'``Q@0
M;JX)!B&``0(S",OQ!J`JF:'@!B7P`1[@`3[P1+$9G-LQ!"!@J(1@JDITIFQJ
MIR)0%E=*FQ4$IF4:I&Z``=^C`!+@'%X%EA*@CXKI)0H7``V`.<6YF?1PK9-I
M%#M"`3/RD46Q`W[&J\&9!`0@`<+R.^?E!L1WJ\`):K60CJ*P@.!:"EZ4`.`)
M`/(*06Y0`!NHF$<!+`>@`<H8G$$P`"8@,`B5$6]`?$NZ!L$%G@$@?9C^2@@G
M4`"Z&@IGL+`\`%\7\#T+,*W`2@I:P`#H^JW-"J1>]*9QD`%@!(O4L"S[4!K!
MD`C:\@9:Z`9:>`9M9!<R`Y:DH`90$$U7QTS=MQU0611=X*T^!IPH\%YN5Q95
M:Q?@MJ_>*@@5(&5O0'K"X&.O!$&1QBQIT#^W16`E<`!E0;3PI0!N`8MO\`23
MD4M)X&F$,+6#8%Q9=@#21;?\0`A1.[."X")^);2V\03]D[:@T`+O16OFA01\
M"U\+$&X(4;2\(C'H`0#F=7BT(+?H-:DQ:Z-N<'.TL`$00'UQ]W4]L"<$H`CS
M1$3\$`!-X`2W"@#E(P$"``$L4P'OT@(5H`;^)$!#;&I;XNH""@``$S`9N%98
MN)L2%G``#Z`3ZKH6'N`"5@(*1&`AZ7.#TT4`7J81$[$#"&``8Z8?-^0!OW,&
M&5``"6![+7"J"7``D@`%LU,!,-$`!O`!!J`M@N`%C\0`VJ$&&1`$#3``)?L.
MJ4M@)V`O;M!M"Z`=7V$!$"``MG<%I")#*M``6@!_"'!R:E`"!1!A;D-A9:$$
M,_(N#8#!,@0&%V"].F%;4'<"AQ8-!"(!.L'!]&%[6J`!)@``3^`#`=!)$#4(
M1]``!,`X8&!6(PPG#ZQ;&P`R$(`++K!P6N"[Y`L&9;5P5S`[%O`0;@`"%J(=
M6QP`AW"Z.8JXJYO^`$Y@*#I1`#OPL%N0!!5`MD<D.@;8#P&`JW$``1*P!1L`
MLD\0`$EC>SU@`/-B`)3C=6WE!H@L!A@`*SN;>"+```'F`1``!AY`32I0`,##
M`E"``'%W`"'0!02R+%K0O(CT$(1$D9(7!ZEF2<[1`P6@!2LP@J71!>#Y$`_P
M`5X``3]B`1+0!1\@<X,0`@9P!4W##=**!=UV>/4D`6MZ``*S`\V\`]MC9A)P
M!;Z5!BTP`6=``@NW66[`S4.`"?M@3$>0'D*@!A!``5<`#6KP`4?W!GT&S@:@
M!@Z$S`^T'=6\IF\S$1(``83<SRWP)"2P?.F``3N`'1$=?$6K6-S8`!/^\`8N
M4`#K#)90)T40C05=@R1Q\`$/@`9G]P8M0`"[\@!H1\RRM,T$T$!AD=)L?*.I
M>T.T@`'Q4U+G<0`[$%8J``4Y)35V2`!OLK<!,1>@H`7YIW4!4+PID7]0$#,V
M[!8)4`%',*E!HG`2D`"X<``"T@AB@+Y+1!=_9:D1HR;QQ"M;X`+49RI=)0@J
MD-&UK$H5\"9@$!"YE`'Q0TG:80(NJU*4),!.<<`50\M5"%`"O2\24"\5\*SY
M4$MQ@`"+K05C^P3HB!SK%!JGP@`"\E?OHDJD81KL6SE7`-K_!(L;<683T``4
M\`9\U-0'L+2^L`%@5%+UI@`_<0+O10LND`#^/W$$@NO9'JU$NIT)`K`KIK8"
M`L`#6(`)4>)C`."H!O!7\3,B2K`#EL,R-XW37;O3859S<1!A+6```<``7=<L
M"!`3'Q$E`?$H=;%=-P0);T(+%U`")G`<-GQ#3B`L"P8GZ"P(]N`U?=@`#/`Z
M9QT0%?`!@A,0<$8(6"$(/!`QFRU2B]0`-V0!QZ5Y<-+7^;`%PI4`#.!T3J4%
M`B#`E)17$I$`*=C6?$A@4```34`"%]$`"N`/EAU)/:,`%Q"V,A4GP@$H2G1U
M-2NVV#4O"K`(1#``6C`!X5<]&#3%(O,$8140:C"_7>#C=A98<6`""K!&1>O;
M"A@P6<*V4/=)N[+^6[N"`J9AO`,@)W'B8Q9"XA4`!Q[P6VO5!&Y``G:(`1W[
MW27JQD<.$H-&R_P4:4Y@``1F1)-+"Y:K)"S-#[FLSPR``%KH`_BP"%ND`)R2
M6&B@`?*"<I.K2CM^!4N`-0,D``&!`1O@%+LB!&WM=5E=6+?``V%N%!7P;?QG
M*H!;SET0W#7[UT[5!)B7V%=@4@+-`#>D!@L@!(I=.>:%N+>K!!R0#UZ0!&G`
MZ]2R2`_P)D+@')\UZU2$21>06Z3]8!_$[0=$/8MP!7QN6UV;8J,W`%!5V]^^
MD\Y1&;M"!,)M%-F&4+FL)L5]N5Q+8/Q>4]91`O*RMF^@"T^0)6/5-:+^PU@I
MD01HH`:8'03*+N@S"BB<;LN9(',$L`/I$02](Z=T#;=%D1X!`0<6D``]<-"R
M=``MBP'!``7[4</PQ>AO(``9L,7.L1TJ\!2<&@!3"`(.<`49``'((<ILP>#Y
M4`$*X$#*0@AK4@$D(!UN@!W;&P#I9@"+0`'.H0N$"@!JL`+7K4BV)P'KQ@#O
MXEM'L"@.YDTM@"GC(/:.EBZW]0`@``*^JP6R[@0H<``)9@`"LB8MZ^`(^/3`
M`[UQ(`0`<`(F0'A6YC\!<`)I(-:.!@8ET`!,OW#+[O<@\(+<4`$R#Z^I"P)]
MLW!=T#6X\0$/VVO"H``3T`,)`%/I85[P=0#^2L2OK0<"/U``#!`'_N$$W/LT
M4V(_&L#![U(RA`^R)4#CW'LR'A^C%Y,WM*"FGC<-%'`Z^\**V]$#D4T(3H!.
MZLBZ%*`%?B<)2;``_E!/C69;%I`W<]\`&0"3/O#8!TT"V:`!@/`P<16W0Q'G
M]``6%R(2I[:QX4.P%6=IN0,A@4$8EP3Q0/+V5L'#Z%CH4'$4UU,1I_1P\:8U
M\;`A%J=5`4$BT13W9NE6\@#!ZE:Q$[>D>.FV02$QC4SB\(!LL=ST(,:ML0)Q
M%C01]^2P>%EHO'P:?*DEK96QC9Z6(=@YO#%-;7FV(5^<([?"@3G3P(FE'@XL
M?,C@1MVN6[FXI7O^5J&')3`/%,;AP:"$"PMQP(!X@.W1A@5-O$AXH"&7&Q(H
M674!`8J5NIT\>_K\"32HT*%$BQH]BC2ITJ5,FSI]"C6JT5'JA+E)L.*=5*!N
M5BQ*$J#+5J+"QIH]BS:MVK5LV[I]"S>NW+E*RUX2YB)!`BU#[3IUHT"`!`,;
M>-KU&Q0QW9UP$B_V>9AI8Z:*+TV^:_BQYLV<.WO^_%G8D0U*Y()9\6&'&M"L
M6[M^#3NV[-FT:]N^C3NW[MV\>_M^6]EM\-_$BQL_CCRY\N7,FSM_#CVZ].G4
MJUN_CCV[]NW<NWO_#CZ\^/'DRYL_CSZ]^O7LV[M_#S^^_/GTZ]N_CS_^O_[]
M_'4/[U_4?YBU)F!Y!0*(8(+;19;;@?<QJ&"$EW31!1A;@.'&:E4EE4:!;J0A
ME&(@6O+&B$6E$=%8:#CXSQ9=G"&4&RE>HL:,<8BQQ85`>:&%C4]]:)B%6T2D
MAF)JN"B&@&]06):)0:D!HR5I.$FBA5W,6):,1D7I5(W/^.@3E>J@Z!.0P>32
MDX5@7D*F)2NRN2:+;/Y7&9=`I5&).AFZ9>918%PTC(9-=1BBG45YV9H;*H0@
M00A#$!&$5E.1&`<*A`BCF#!1J*!5ICV%,&(:(>R$*:5E":,"%)+V!.%/PH#Z
MCC!I++'J)1Z$L($"^FPH3!"1EIHJC160<(+^`T.PND,&)&RPR*F9;7&IJW%`
MP>E.6DB``@82=*6J7RMD(,(!1-1*(PD>>$#"AZ,.2.D[1$!0E@DFK'JM"MKF
M4JH0/ZQ*%11BJ0/K47X)8^D[OO+;[AFC.OM.P8I%@8(E6C#@XQLE>)"!!\(H
M82*JW3("H\?D.H;9"=&2K#!0F&Y00HI:;''$O@.3&AQB,U-Z1<1R@E'*)6=`
MH<4)(QL5`AH(JX/&NNTNW6FEN[*6<AQ!'+N:,&*L61675Z^@*AHF`HEA,&5Y
M@26:-\X(AAHD1"GJC<^8'8?1;J!IJ9:"[N3&16\`"L:IZ<RHQFI0S!O'&53"
M&@^(;OS[3T1NE-7^M]/OM%T2!H;&(00&$?V0P3`@IJ&A&NGXL&])=ATTS,^<
M^K6I)2WTL`,46C9,R!F<_&1""9:4@((;($AIXAEPPP)`)6XP4"VE4$0<APM9
M%;Y:$$+$8>+5NZLJNB4AP`@Z4&)P^8;96ZL:T<$_A9WB&UIS2SV@<5Q1[<18
M3HL*!TG$L0&,<UM2=T2@$CJC,Z0H;SQ9G#H$:(FM16$GD0N&%TZG+K>1*AUG
M^-TE>G"$)$1*4-:S1.`*A[7]!2H.^WO<,$QXMF&X;R,1@8+0RO*$%70A8F9+
M@]&"DJ2-J$U_<(/1&:*4(C!\S413NL3XAK:9J!$A!";`P"*(@*Z+;.'^6&GP
M@1M:T`(*N*`D%E!!!K:@A5L1(@B-2,($,"`&,(PK"!=@@16Q6($M0I$$BWA"
M!5BP`0VE@0-9'!<80@`"5APA6UH0P0=8L8(3W$IJI=G"N"S1A1!DX`1I:,$/
M1#"N'OC@!%MTPPE"X(,X^.`-5V@!"2J`!<ZY`0L6J(!"RK(]2["`"&H`@09(
M,)`68$P-4%"("SP0,17H@W)OL(!8G%6"CWT@"3LXP0:0$`(,3(D?D2(!+G?@
M`16L!HH88`4*/%`"%FP(?I:`P@I\4((/A`!8JHH#$H3FD_Q)B5FC@H(8*W<"
M%31K(!68WA8VT()5D7-:N"3"!TB@AB.$H`3^&7CB0<6@A@S\`"`3B!0($GH%
M(I1&"X^\Q!`\<($DO`&.RP!#%S>`!8--3QA$X$L3%()-#X@A"&YP`0OB6)(+
M>!%:'L!`.\H9OP:@T!)7\,!&+$2!)H@!D(@\@3K?0`(68$"<0Q"#$G2)BSCX
M(GEQB*2R<HFQ-)SAI"F]!#95(",3;$"F'_'`!\#@@194H*,D_*1&E%`!O@2#
M!"L0@@A*X,0XS#$-5V#!0H^@`1$@YC0_^,`5WL"##>P@#2``01+4L(,W0*$'
M8#C61^D8!Q%(@*N%`,$*W."##)B-!Q]0P@=60`%5/>&>'M2(*-40!!=@`)=0
MJ,`*-I"W$!QR("?^T(`3,!#;-X32CBO8@19:@`()L,*>(2"$256@`;VZAG)'
M8(`[7>"[KBYL6KH3PP?>8(`FG`%>'@#&!;!P@BMI;`(M<(,%W'`%*.1,#"11
M`@;BD%XQ4$`+N-R"8BN0Q@IH"#!*<(/&5@",$(`A6W%0081/T[D5*$$+NE-!
M:831`X6(H`D,4,@&WD#?.+R5",M0P1%$X`8B)*`0*NB"T+([#H#=,`A'(()"
M/K`%>ZDX"4<8PA;F=038?4P-&&B!#T004+QMP$3@4L`9?K"`.(!@"RTX5BAY
M?&1/M.`-0NN""!1:"*%=YGW;<T(%H,""SK5@7`3K!+7(I04+DK`!2A#^FH3?
MX`$'`X,"T2+""CAUA!9L<2=7:',%&JRQ*YP`"=Y%`G@#'<8XQ+?+<=B7":"+
MB'FIX'YE00.GNJ"Q`RAAO8*.@P7X(@PA_"H.)GA"*XC0!9($X00M2R^KV^MJ
M+>Q@$1H`D3"VD``(0*`!$`!3)DC0B1"X@06TDO"WXK"")&P@*QZ8<)#_ZP$D
M*&%>00C91W[<!2%_@`@E*(T%4BH,%PYD!T^(E`MP_8H@L``"27!PU:2VC!4<
MX0T?H%00D-"$+".AO@77@@IDK.+"8."&\!B`Z$"`7B14^'[=%H):KP#?\#J<
M"$(K]SN@@,LA[,#&RFO!&0Q@H5']V0,:.H/^4?'G!@IDQ97,`D,Y6'!A%'1N
M`UHX0Q'4$&@+I-$"3X"Y$T@B80<#&A@6>!IH*$>$WT&A!6"0P`E$BR9RBB%=
M%%A$"-26"PVSS`0/N`((@-$"TKS/!5N@(=D788(F6.#K$R"P]D;DA@DLXJ+J
MC&ZBE[&!$!C>!:S80BA#(`81W`T*/Z#`$\[>BG%70H,M4-463B"*(Q0<"COX
MO&`Q0`0G%<T2!ZLW!,30@F7\0`E(.$(3*H""Q*.@G8_(`!1$VQ,U5.`B'MA!
M85`-"RWDFK-2LWT%5-!3ZB6!!"6`U+1T)A%L>6!<)EC&P2(2K#A$X84\P<)_
MI?3N$PB_!":`P!7^3)`+%2RP5T,X@1A6@(2L^.5:BAS7\EP'>M/2`J87!R5P
M?R]C`<RW`0#`%VX@`I%W-]2C!.F4<V:'=A7V,=)#0MBF*CZ@!#$C)7?'"!=8
M,$T@5Q$A#$657T'@`&L"!CS@?EJF!H4G72Z@<5IP296@!$Y`=['7:43@!AFP
M`GER"5`0!*_'`MXW!"B0"PXC6%T4?1PU`4X`@B0D>"#S#B?@>;U3<)=P<$I@
M5%O7=2@@`AC@`HZ`!!$C!,-S!:BP>PT5!QX`(TJP#`^P#%#@`EWW=82637G2
M*QMT`DZP.N7$=:^0!C!6`>P'`>UTB-H##<"0;?!T=H5W##Y8!*@7."3^0#EY
M]U]ID"X58`(GT';P5RGSMUWKTGJEIXE@T`4:(F]G@%#K<G8B`",:1D>LZ(DA
M4PLM\%QA!HN;B`0FD`9_L@6R.")1,XM8(`:MR#4JI@7+J`8KH!#DI`)!4#K"
M8'SPDP2Z$P<M$`4EL`A#8&FJ`@8EX`C6]P0N,$,;@3$ZMCM*$`09\'Y=X`*V
M-GM'@`3,E`9><`8F,$SKD@$KA1DC1B(AD'^%\SM:P!=GL`(-\`9#D`1)X`)J
MX`4O`E"">#!WMA-W1A7!HH'@UPE!\#P]`8<E<5$(U6VLJ#`P$BR]@@3Y1P0Y
MLRJM4X35L@,A4`3F4'KP=`)>X`*JPI`/D`;^*I!(EJ`"^K(3D-`"3U`"2:,]
M:D"+DM,K`KE[C*1!P<!AE#.++)DST!:51!54/C($[?0$CG!1(J`%K*@&*C"-
M+0".<0"1=%>/4C,]N+4`T9*-)D"/MC8U]H>!!C-98"`&1(`!3K`#'_@K!O9W
MEV`R-U(":K`NO:($\*B3!K:/:;`#T_-_2H49DA8,*(`%N*1E1O,$`?4`G$)Z
M6["*K>@&07"7!O,K**`$(SDM*R<T8X=T:?0B_V!!9T<":7<$W#B+5R`&7A"-
M\P=74Z:)77@"29`58Y<&,J62L21,L'$&71@$R[4"PM=5J/`(&H,$FG-S@79F
M<>!^'-`%!)<T(!+^:2*`!=HT`5<&7#<G`E?0.0;F!A=0(0^0(C9G">1Y/R+0
M!2M@:R"@<2&0;IU3`I'B!`F@<66A`3`B`5#@`$B0<V^``9SB1$$0,2?`;FXP
M!/OB!`/H""(P)/?U#F^%.?\5H7&@""R@$#YP!#UV!8619,TH#/[95160(=J%
M"`Q@=B3`83=B5%<`!C_`"A=P!D(P!$4U;XTV$!L`!86A`KIS!3,B;U1Q`GP9
M*0L4B(APA=:5#MC(HSG7`X`6!TX$:&I0`CYP!@X`:U)#2YR@!?-RI2?W0L+`
M,Z1$`D.P7-I4`6^`!1J@55H0!.."`5U`1R'`%TZ``$J0/<)0E@,!$>/^Z08A
MP`H/$*?9^0BY%`<9@`0U2EPHD`9=&&B8&@<2`(9QX`4/\&_RI@L*X`8]\@Y'
M8#D%&$IY1`('FF[_57T>D!6)N@+/%:-'8$Y:Q0K"D`$P`@&G$:-$@`*9&J>K
MFF0FH!`9<`2B>@2\9@D?8&PTIFGCP@&4T@-%D&3FL)VOX'"D8P[SPC%I=`E;
M`'-:D$<WAZH:T`4[\&0;A@)J0!)UAP3B1`+)"@N%$00#."\P-*SS(@:_HZ8?
M@"]:=2$M"`*YL*4;4"$-$%H!.J"VAI9NX$2C@@%0T%M-0$-&I:;DR0H0D)9B
MTAE#:0DS^C[+8%`88&MFM0$BH$W,<P)Y(P+^(L`L6"!)QT*J<)D!&?`$]"A^
M&.`!DE<MVB1Z2#LM'R`"F/<(U=([8$`"X%`(A*"H&<`IN[8!Z?((%``W/F"&
MF.16J*=E'`!0U/-;HH`";T!D[Z,1G(`%&;`!MK4['-"TN=`#9O@!1D@(/D:%
MA>`!4]8#VK66[P!A72!.=A&/33NKRY`&$:-\`+$!0J,%3N0#B8LA;G63:N`#
M'_`!H125PB!LZK`#A2M2N-0#&8`K>A5ZLT9"<0=0;Z`&$0,%0TM"(M!3<8J/
M<3!\^:I5)K*Z=E$$()"H'SBS@@4"OC<0(;`%B2LTO8,%RZ`&VW($LT99Q6=M
M_..SP'M,S&`!RW+^!-``M,"`34#6`HVK:>/K`5O``AJP`^@)#^VP!1CP!L*H
M#BMP`1SP/,ZCM4(H-<[4,BU@+P&5AS]`"#*+*]YZ"6CK`H,;!(7+,8W@`>7;
M5KC@!#K5IH@+9,^C`D04MR7"55J0&O=S!33[`1B@!<[;PN;P!D@P:[L0O5=:
M+5_;`UZ`2SFSNC4+!6\`M!)\08FK!LDK):FQ+Y=K#KY[">%9`B#0%3!2>BI,
M`E2LJ%R[`RGU!!JP`3_@!C2T5A[@!*:`!KP;3=.CJ$![!K'3(*SB*G8Q5'=1
M*E.D"X61&7>!-79L&#?35813%5;C"+!D)V_0QZ:2*0-C%3]1QY`!&4K^,C\;
M."!6419!,#Q]`2974!HTPR]EX0.KX5A.,1Q4T2X5TU56VLDD4BJ&`2:C8,J'
M8<JL0L=,H\F\`LB4[,A[7!EK,B,F-$`Q(BT%-!Q70&KO,X@%)#9,,U2^K#)_
M#,VTK"=R7%LDE`%B@LBQ0A5)8'6RP3!]@10@0`(CR\L!0A:P8`"KS!,Z^I^7
MTQ1R0AFV'")[S&CQ'*^&0B>"E0$?0%I)`<\V@\X;Y<YS`<_4?!:54<IU$17'
MQB50H#N>8L^;81<KD+@".12T&AYOH`1$^!9@T,UWX:-#(B%%H07`P!D>/=*<
MH0:,\QPDF])I4="0C!8Q?1LU`\ZA0<\TO=#^=/'-2)'/]:'3,DT<B>S/2D'4
M+ZT.:U;4?CS,BY'-SXPWFBPCK?(,P9#(L^S*`R,C1XW*B#P[NOPXB%S+>N(C
MSCP55O'59[T<!=(8-H+5L@P;=D%..FQNE\`#@?4.7.<#^@#05-TT[#(@)"!M
M2^,LK=LTQW9%A!"G[S`D+7`R\DPBNY++I7(&E=#3E#*K('T&S$,J8T(!C-/*
MPJ#4IM*UMO)((,O!2Y/9:Q,K)+,#>*T$&Z`!1M5C(S,S3MS9NZL.1<L@EZT5
M)3#85[!H6W!?4%5U[Q#;MR(H,QP'6_`*MU>U4FH)&W`_`Z$34QH)1*<$CX0$
M-Q<$D3"2)_`\N0;^O,,'"Q90M1K03FHP+W-F">?D!/J';?&=>$U+"Q[``1:0
M!F)P+AO``>.R5(G+%Y!P*Q-:$L`[".JP6;J0QI!=$AL-5^HDW:W<V2W0!40@
M+UN0D_#P;W*]#!`B&@2+&3*;@C]U-!NR`@$UV;6"6K7JHY>P`KL5$4U0?)=P
M!'J5.=TV&P3D`8=X.7*X$R;`9;S'-#_=V4?.SK8L#%KH$R:S(N^W*B;S0;K\
M$Z4*V!!MC9!=%H/#)F=G5(`L&A`P/3[-/ZK2&!7P"M,2`'GBUBDX+^D9S1O2
MSAX$PW%(!-TK*0C]#P4'USHJ#"`0)0=BROZ9@O"D!3,FDOP%27TG-1K^4TZ&
M/F-"$$I3K0L2\#Q9OH$_4#KF(P02,!#2]*GCD@880,7B-R^H57"<2NF%8U0G
MX)!:14FB:5^0N0A:X@&E<9.6\`0OE'.1\@0-$+JCT`074&'+D`1I+@PE,"0@
M$)WT_#Z[U@7GM>I'GH5:<`4\$"E6JV*!KN#8Q\H&9[O+_`.SEJ57WA/4-\]Z
M\A`QNQ=-<P2XA`+'$J@[P`HRQA=Y*UCP]!E=L$!.(!8;K05>4`%-8`)"L`$"
M2=Q-T`2KL01=L05P?",V;*(E(2]GH'R>4".LD`0>$$I7(`09@%D2<"P3W%JP
M4`%$2`02$%`-%@=-X`;Z*@)9T06R?249<,'^:?`#'J`%MN8&'&/SQ-EIRZ0+
M[P1Y.X%7E=!8JWSCN@`,07#K!:@[6ON6'M0"&!!*/3!EEN!?3T`"F:,0:8`:
MN\("17`"B*Q!&5`:'R@)B+`(5Z`%;R!5H52=KQ(3`Z&IHA1NEK#QH>0#>?0$
M;M`$B!5*8.!3_1;%'K`OSFW2.JH%4'`$1(EYC49T@%\"B_M:ZI(YMJ8&+<"H
MD-E5/G5V70$""W0%0<`!](JOZA`$0J\$%I`G,JD+&BMI1"!.6F4*K]).`S4Q
M@A7NOH("BW`P92$$8RYKED`$)"&/D`0,/+@#"J&18E`.UK<3E%4(#7`L[(<_
M7D`_6'@)')`+9T#^!"E8+;W[#IJD99=@`6#`EB1$2QNQ\B-+`D%0F'`+`M&B
M!13M!-RH]1'A!&=P!4@`"!\J;FX>*R%:7DI7<2M-<7%;%4IQ21]!<6]Q5R4^
M&UUQ8"4E8)EQ1"LJ(6IQ42`J<4*801L[+*9K+2&,4$@@*VZ0IB4J6J57QDDG
M(6)Q/AY(PG$_*"61)22,TG%-I3]'33UQ3RIGV(S(<5`GIMON[_#Q\N]@&W$5
M)F\M3]8;:1DFQ'P`%:>0&`_-2&AIL<4%%$A:`H"Y$B(.B29;2"B+8P`)F!U@
M*@8YLF*"F",GU)PX`TF)"8M.TGC0%$>+!S<LM#"SN*4%A30DG)QX`F7^AT4M
M)ZY<67&%1!PQ]DH@U<(OCH@K20Z(>@E'&!@/<918([$$$I(5%I%`<2H""A$>
M%J^<$1$LSHX?<31LN?(2$A@0:AH$V0*VAQ"+!-6(B.-A2YP#0Z`T>%.!%`,Q
M*IS$X4%DB(^\8%H\U'0"11*[)+:0:P1%3$4A0SC%R:"F,I@'5S9`P<*`5:2;
M.^!Z*`6I104>CH\P`--#'`<Q5V8>\.$EQ!DH:!D$L6G71R$HUC`HA1"GQY`X
MJTY4`/,!RA.C+<?&G`GQ@0</&!X$<P`6TB=3*A!1WWT8-'`*"4\@H80F)*31
M@H!!8&)*$(?%<<0#'W@@@0=J?""-)BU@!4O^;DU$08)10P1UQ(*0I`%"(T?0
MIH)3*F"RPQ&,":'$$5B<0@%3PD"!`B0\?*8)$1BXH8%:.RQV!05!T:3.2UX`
MIAUAY9U'`D'"I+%!$@HRUHP(6ZQ`P1D5(*'"#VE`H$4FFEP!RQMO>'#&5V[L
M`-\6!T"AA%,E7"$&79`0L1P/XGR01E%$'*$%!G&8P(XF._3@AC_JI5'!>9`P
MV((CFZUXP*`K1`$+J#2=49$F*CSDCB8@8''$9]%!@H*KP037SCR\]NIK03N(
MD4%L/6PQY`=N9(#C":ZBIT8)S:#0!4,.061/I%<L%D<+0Q"QQ01N-:'$!D24
ML`$*(V+0A&]Q,#O^#@MN5`3)&1L$P9((S9PP+5YN^1!"%ZR<L,4.6BS4Q9"J
MMMO0%BP\Y`0/262@SI!2HN&ANZO%<098(;BAPA/C\'#$817X\$,#KJJ1QA46
M@(&4*7.]\0`H''ZP`A$2X!6'$R"XT4D<#SC6\P;+=K$#R$&<=P;+H35[PA$M
M&.W"0B00D<$*29!K[A5##HTCUM98Q=(TF(#A5`AH2+,.`UL<`:F0<:1QA@\?
MR"S&HT*X\``8$CBF*+ZGM*`"&OVM`@(+0TAPA`M#MB!"%\&0]M`3\+X(D04^
M]'!"`VZXX`(&.Z+7#&DZ:X$Y#YM;F($/E8:B01H_B'083;(4NL$//G#^L$$A
M4OJGA1.0FAX$`_(2<;L+/="$QHL"$\'""DX]@18(S7B@0@\M:%93"PY4R#4D
M),P>QQ`<O(&Y!1+0!(8/$E`<1Q`M:$S7S'$H^@'B$GPFC1H8Z.G#&R3(U[2&
ME+031(L1-($"+"#QHMJ9+4[VT`<8,."#(#1`&U93!PNZ8`'X5:`%._J,`H5A
MI_<EH04$%!^#5M`#S?P@"4UXFYY$8#RG""-AD$C*J\KSD@AM0F)Q0`$"=W:M
M7QGQB._8P0G.HB\M'`LHS5#!$%=AG79-:V"N^EXC^*&)".T`:R<81+F<H(0M
M!`H270C!WFSUD+FH05XM6@$#G!!`*U9K"[#^.(($G"*P%A3,C^P0`_-ZTI"'
MB.$$1,!$QH2QO#BT2F.6<R1*@FC($W0K#AM00A*@0)PC4"`((.C"R[J"A@;)
M:Q4T5((3WM2("ZC@/F^$!"I+H:\5(.T(3Y!`$#S0!1=$01B/JQ$4&*(G)71C
M""<@X^]@`9@ZK@`)?:GB^R0$`J"D`2*NRD@BU0&+$'@@""10PXNN\`$G).$*
M7;#A*NH8G16DX92*(8(JQ;`"5R5ACP!JHPC>&:0%:D$"3O#0$1*`%@Z<)V"_
MW,20:K*`\4GH2!(X`0DDX%`X31,2M3N%!>(@`59V@0=:@$`)3K"WEWE!`J6@
MD#L:*43&6``6SWK^`CO0,S:-G:8@&&`)W"SDE&"HU$.4`1F.&*B-&VDLG/!,
MY1,<(PU^"N,#+!&8"Y`V!!24HJ7",)4I0/"&(5!3IPML&`@TR4E(^/`]7?"`
M$Y#0DQWA935=J2(47'"T:53(#6\R@1#V,0U-XL4)P=F!*K71HE4Y<C3;"$(&
M@E'!<2Q4BI"``DJ12%DD:@(+$]A"$"[@!BP,B4-U?"0#<?*0EK&@D!!A@!O`
MH`'SL60#:CC"!<Y@@A<=P1I70(7#!!0"3K'0+C]X`U!#890>L*"N+3O$MBAT
M!C50M(\%&T1%H"`Q$Q!25SL@0A+X!8LSI`HLURN/.#1QA`90(KS9/0+^)C!P
M31<T(R_-T(`H)Z4Q*LHR7@_Q`2/<D%-(J#5LZXQJV_!"PQ"4(@--VZH;8N>Q
M@>'E".;$+1&NP(X/*":*3=@`&,10@;H<83%TK-_8H&"!8#3!!-M\CQ8\!(7=
MO4@+]C@#2.35LW*VBP@G<(,%TJ`&"KPA!/GM0L/BX`(>3\`WX>T!7EZDB9U>
M`0*Y>8,;""`.*$`J"298X,126U&:>$`;04$")FCBPXO&H@+3L.%QE0R)'^R@
M"S/=@5-\V+LS>`@%0@5`_)SA`4K0](:3G6`PY`0)-4!`,[?1@AL\Q`V)78`2
MEV+E.IYBWSCT#,C.&.*\5A6,1UX`#%-]WQC^XR">3FV"OC-!0D6<$#8MJ+8>
M;V#OMMY;NR>T0%@:"T(/5%D1']"7`YH1`19"7>8S0"HU1\!+"/PZ#O_%`0E#
MA00:X`C9-UPS3I""Q!4@U02T4%)C%WAO9<?]J]N<8@+<M,H*2L"2:J/'#5"@
M``H<$!HL0L0!'\B`@(8`@@V@10D;'45!2$"""BSD(1,4`8+]`@(29*"Y<"Q$
M"#"`A2M,@*3,X4`(8(LD$+RD!R0X@1:<JX57>L`>/@CYR#U`@B1Y-=W[[)2R
MTO`!AXN;;ZSX2LO5$(4C'^'D<W)D+2#P!#5,0!MOJ,5,.Q:=#`5#"8MA;&ED
MJ0821%4+FD(!!)3^L(.A7V$'B`W!&XZ`9I'+1`08*(4("@Z%-$Q`"R8`RM6W
M0`$-4*`N/B/!!1@AS49(P`0EWN8P^7<"$Z1=6[JXP!`6?=_HA(`$(3D%RR?P
MABMP``0<8,W[+A`"]X7$X1#O)T0,M`(,;,`%'76D!$H`@0UX0=O^9("%+DYP
M(B!+$TI0@1(N_@$(2:C,1$!SO$`0@H[])PY=`,$("V*!,R3AXB7X@#;.\"+(
M,F:F6TB2?SU0`A&P0SGJR:+[/`EXH_!3$Q]H0A<:4`(,B&_2E]I!--T0'<S7
MA9%PY$8%,$YL(G1A`R?@)J9F5)I0`FB!#:46!UB``2VW;Q^P`4'G0W#^<P@6
M@`1%@`DD4`(7@!9-]@$AX"&/I%(,@@$2<`8<IG5/D`0B!"\;T'+$45CY=%3"
MH`+M\V6-L`$:0!R/5`0,L`(>$&WD%H3QD`92EC9NP`JKI0::H(1=XA=@<$UN
M\`9,N`DJH`8O"`9<<DUJX!MOL`7-H`9UH09>*`UNL`77%#=DN`7$`09/2`AJ
MT`5G"`9;$#E/J`E@H(1=T%R9<(>:4(90&#G7%`3BE@9?N`7LTB(TX8=^$0Q@
MX`52XH=NP!)BP"Y6Z!M$&`=H,(>%QBYOH(=HR(1@J#%P2`AFJ#)1V(21&`>A
M6(:^489C\X2LP(1ND`9-0`@;4%-=.#9GV"G^<AB+D<,*8C"'8G"$PM`%Q'&&
M9W@&FAB'=RAMFAB*H:")PB"&EB@,4M@I[\6&:+B'<W@$XI`)7#@Z6-@%><B)
M1#B.+$$(D*".!9$V!4&.45A3F$B,\T((XP@P30B-6\B+76*,:@@)8I"'UGB(
M8C@VUUAH+'$&QK@-)7!-A&B)FJ",]S>0V\"&1*B.ZG@G:3"1*_""JU406X"+
M5GB%CB@,ZGB07E`*)QF2ARB1JA@,[*B*7I",HWB2L3ARVW"0+PD)R5-HX\@*
M;R"0A0:3Z"B$1GF4.?D.X+$K\]`[\N"42`D/O4,34,DB4ODK4!F5EF5JO3*5
MO?(!C*-E'Z*573G^ED:4E3M$EI6%EFIYE;["EO#0!-$`EV3Y,FA)EVQ)E6U)
M;FKP"'OYEW_IE7X!,DT)F&9IF&HIF(6)F$+H!B9SEEI)EVY)EGC)*Y)IE)>9
MEI3I#FJ@/9L)#UH@CTRIF5&9F:.9E(R9FFWIE'1RF*CIFG"I"9=IFA\BFZ?Y
MEH"IETB9E:9)FX7IFT%HFWOIF\`YF9^IFD+8FESY#E-9G*Z)G-#IG-`YG<Q)
MG=9YG=@9G-FYG=S9G:DIG=X9GN*9G.NXB\)`!!R`6)G@:W6A:B\H#70F#-(C
M#&7F#C]G`MU7"JRYB19EC<))AB<@`B4``D'0!*<A)0AJF3<TD:KX!M[^LBMY
MN8XFP`-_X@./H)S]F:%IR0,D4&<[HQF*Z16/1P(BH)^OJ0D^<(C24`0<`!_2
MT`4"H@E)X`17<*'6.)9G<']0F08KX'$,:I8)>J/QL`,&5A!O>!Y92:0ET&=)
MX!C_J9OT\'CMT2F"N8_+>9MF52%;9`IZ":5<2J4[8Z-C^9\FR1+[B)9F,U0A
M4:*=<E,\"A\^DV.+2:9JH#^O*6[/Z:6:J0E;D`1#\"88*J1D:FHA*@TYNC.4
MT)IB<%-)&:3C*0W;9)M8L`'T-$0JL`-.``M$$`(9X91N0`&11%X`0!RK%P==
M<:.6%(R0<Y4LD%!&-!$9`(<%<Y16MRLK4";^ZNDK4%`1&U`PK$1N:$"IVR`"
M;R`$1C(/Y*2,J\HK)3263[`!TX8CM@D%+Q$G8$`$^L.6M8J6(=`"(1%T43D$
MI%`":J`%!&,-^ZD;+O,&[G)$<0)5/<``KU>=]029)X``2T@`,4INCYF91X()
M];J?;F!PC[0!!IIY=@%$F>1#*-`#2.&<&R,/3J660F(,QVD*M?H![QD'T!(/
MX(F8CODX[:)EK`(R/X`)4.`&A((L(M<NA`41*E`,II8$"0`RSG4+[V!]Z^@#
M(IL&)Y`2A8`)3F`";Q*,)]`-*@"$-R0O/*:0V>4&*#!41*`">+H-Z6048&`!
MS5(0&X`$+>"U`E+^$R;@E]NP!<GT/H^3`5>@!BP!!C0$+#L0##Z+`BHZ#BW[
M!!F`IV!@<+,R!#N@"4/[J\)`:++)2EKP!A-A`@^ALD7`;DE)!&\2G[`',Z?@
M`T/@`A&I`DJ#%$[0M5#`I^89!QQP35Z`%FF@>VQ8"F*H,2MP`M>T/D(`M6'[
M#CMA`E=P!"&0J4K@NNX0`M?F2(P@4QYUM*'`"1,9)PM4`B`C%*Q$!%]V*8=Q
M!C?S%%O0'%`)(FND!0H0#1GQM^KP@Y#P<XO+LP21!!PR*T)@%&]8$&]2!![@
M*H$[LI=R'D0ZK\+`=1IT!I@0L3^P`=;0!=;@1O+2K.X`!;TGBM8;"B'^<%L%
M#`("8F4;*[TI$0E#>X=.`+K;``4@,%1K<;G$*+T"LF%Q<X>EVPVL!@9E2`1_
MNP/_LS,M&Y`]`!=[BP5:\!EY\B\7U3MH,+UG`'<;RYV=\`08\`8[L&>F,+;O
M8P])0'/^Y;;1XF>FL`--<`1&<:I'0`+QTP0EX`),R2I$((>ET`E0<`&.)`38
M8VE-H`7X8@)@<`0+\',6T`0.$`W;@$,]``X)T`09\"7I`S4`+)H`B0%.%#\9
M(+B6Y@3&$5"*Y@%>L`,'VB4;0&'&Y+MYZT-'U[79-6F:>\92$ATZ80ROTU0(
ME@0.(!9-R@Q$>Z/9TL-B(!/^Q3\AD`0*X+;^WP`!/VIJ)3"[D>4^/4`$3[``
M?W(8('`%W5)>/[`%'+`%;`H"+Z@)+O`E9YA^+/`!QFJWL]$$0B!V#6`"45`"
M;O&-[C`<%I$]4L$`?NMMTJ!\+A-$6D`86@`"BJ8!?.$$)4$$4*D%):,"=>/)
MH:3&3^`!0($C'Z`$/3`2"A!#Z+P-<H8)0B`"2:!C3A2WNL%+V?*L[.H#3[!1
M#>T$&N`#6U<"2:`%3C$H36'1:GQ(U1L_(.`$J(`$VF(*/\`O3J$)40`65CA=
M[&!G8H"P:?(.SUH/3Z`$"0`\\5,!B*P!V_#3'*`$8)`!H6NP02!V#.`"/O``
MZ%$*S"P-/YU)>ZO^!2VZ`IK19SP0!-BZ,QV9`#MP!0Z`/!,0!0E0+A*@!`:G
MS&#`QD>@`,!S"Q@@!D.`%T&P`A\6"C8D#0,]UN7E`X"<G4$9"A*S3=+0!!#0
M!"1P+4Z5`4*1+T8A)8KBU:86(2:@!C>2T-*P`AFP#$;A&$WM,]X15;WD`FG4
M`DV`;MA@9DTE+T$`0^@F9X[T1MZ"`4BZ#6+`$D'0-2S1%9H@+=#C#"M")CR0
M;1.""27W,F`Q!$J@!*;;N4UP!3-S`I:RB\<M5'_+:.D\=A0P#BU0Q.E$7Q`1
M42&0HJ>4+)B0M#8$`HFM"4V0?TT6@=5M#UK``_^G!4>`.61L::=P!&;^\PY'
ML`$-4#`O`08!@K)H`0H!]0;RN@6]F@3Z`:%V@0'`0S`L(`8*((7B34(?8`(=
M<ZNAIE[)5A.I@*[NH`4/,''@)50_T&)GP!(H4##LX+,^L%$4UL4P8@)NT`)D
M_0;-\`/N5`%FR`VW"(:@(&@?\"8?@6;8<3!/<;2WV&Y1TZW;%2F:50*SN`VU
MPS)]N`%,17T*I8H2@`8B(`)*H#BCV8P@'=OJX$?6\!<5&3!%(%S;8(4[,Q,,
M\"8ST2@'+@UROB/B`%@$\S(J81CF+08+$(4+#A,.L#,;U0.]%#4B`-OH%@7'
M0L28X`)@SA(NL@T_SN/.+9Y(4`$J`"DOUSO^3^`"W#(OEN.[(H#C6[M^("`"
M#@`*7>2-2N`#F0KDHJ4)JZX"M/$&*O``XB!R3:(GQ&P4Q"NYTF;;29`$1C%I
M2C`7*]`"/K"UTD`"'A`":`%5VR!5E.`#,UH+3PN?8T8"),$8Q7KM.J,&&5#$
M/P`*RVZGD/!(KC&Q).2@<`%8/1`"P0'%^0TSC$9%I0!&FN"[\)!+/_P]/I4$
M2H`)0_ZL1:P$+:`SU>3@1*#+JFBX'M`$L.#@$C@D.X`!RZ`&8+&`.^`"]@(/
MWBAR"Y$1E,:4:&,*^E(M8F`"K[ZDX"YZ=A$<(!.Q2D`!]E`,)0<).^`!A[%\
M8_DQCB`$VR0"'B#^`FBA!1E``8Z1]!OP!G*-[(KA7;&0Z#NP!2_A&F%1`1+C
M.-`N!'AQ*\[P`'T!TR@[),FB,YCX(G##]F]00:3P#EYB+@9J%&@52/D7-_Y+
M-'RNT"Q/%_31,2"_KRW2^`;Z5WK2S@O5=3@2Z^FD,743*1N1,%?P$2(0]W"Q
M&HJ2&F8E4O65P0OT]+\=GFDPQ$G79:8`N>7Q4&G'&&X`[^WB*I0"'WI2$._C
M*&/E1#NDL[=/)QS@!@\-!N0A+2V`(\BP370O@DVE+4%0W2@+"TKP3HZ1QDGY
MUY4`"Q[@CCR/6M^O!+<`!HRJ"4*P]<7P65UE\4,R,!UC(6DP_8`@H1;^1QB'
M0A1WM/,64ECX$4<4%/>TLW,4=_7DF*D2]Q;G)N+FIN%&(A:WHN1!NI'&20B6
M@<8)>N4)&I34I$&IT@42I_;D@Q@7DO9&0G+&V57A%NK1)*Q%XM02Z=+%$;<5
MHM9XU:AV)!WK`TNBI=72A1)WUL@9X@R*TM6">!1TY*E%!0LHL6YYBK,CB`M^
M/<!LVJ"DA98M'H:=Z"$D#I05GQSATY(DQ)8C2)!X2L+"#:86*QS&\;#C@YLW
M'-QXT!(GR0E$4%J<*1%'BX@N!"&ZP'1%BZ0X)K1<Z1)G`A9"H)1`@A*/Q#%"
M:1J!L1"GJQL?A#C`\ABGQ$HE2B95`K,A:$7^JFDQ+8P#B>Z5BN#$$4JVK%DA
M4&KCM&`;C\@.%Q,KNBFA.-&[>&=$$#J!4MXX,"V0*IT$Q5/%I4V@3M!BD]/>
M4!>WQGH-.[;LV83<;.C1(H$;)1C0$8*"8<<*-VI(1-)P@N,5#"LL.\*`,^B%
M.,:#3%+0Y0I0$F<[G@#AP\6.+AYP)U##PD.+1BM.8,G`0T(7(CVH.XGCXT?'
M0F?F^CAR1'U/`(6$&DEXX,($;FCAPGZ)<$`$!I"4Q\D**YAPGP^38,##!4,X
M>,9M&"AQ31QQ61='!CY@@,4.))P0EPH(TM,1%AOX4`%J<7&R`1%"D.6$"F!P
M*,$5#D(!U!N@L!#^P@H*N/%!*NSP4((*"B2""2B@G""!$"I$5\@5$_BP0A,_
M%-&$`SML@`D(+&RP`Q%DO<1#'"Q,\)H+$@2!P21N@K#!&Q7X(($*8F`@!`D5
MI#&7FQZ<8)B1C@3!00OU;=$GI&+,Y8@']U"G11<:X*AC#Q8TL<)]1&#BR!5[
MAB#!&UJH6$$76TCP`P9BN(B,"Q[\0!\E)L1QPB".E(`%&%<""T4&1V`P2@5K
MEH;K!GOUX()N1ZAG0GZ4`,7!"AYLH(4$/F0`QA;P2;"%$Q48ID*$/FS@&R$@
MH,"!%F`8@-N'\LRU0@@A('(""2I@LBHG+8A`1`.KUOG$L""T\`%8CBS^3(0#
M9%6@A"-:(*IH?X1XD$H+>'+BPL`._/#&J!*TL`-!$W^@304]3+!"B2)3=X2F
M<5VQ!:8]R#>$@$#U*&<<0F!P;B<.(M."!\:0!0IM5E]M-2A;$`&&%JDTT1TA
M5QP!RX)B'V'L2*D48G8AJ.$$1BI.D`+5%547`@8222AQSGQ=.]/$$:FHT40<
M8A"Q11Q@@!%'%X,L'DO;8)QQ!N-I0(6&-$JE(D9]=\?1A!)G&`G&?8ZHX<06
MCS-NCJ2<M!X65'"S?H2D3YSSB1-'?(HWXJ&`B3<4E0\#%1B^OPX5VTA`L<4;
M6TCC>!Q.0('3%:XUWD021S#NB!NAUSXY&EO^)$'0)TH4+@;WI>=47T&Z1T&5
M$DX8U\41^F:R^Q5I)&Y^$Z#4;HO05>T*5V!<VSQVMR[`PGC\@YT",X&(NWE/
M"4E8&P,),1(C$:XJA8.<&A+G@[45PG%NN(\8OB8Z@HCA"*;30A&,M+6N,4XI
M:1B>&J!RAMHE+H.R\-T;FJ"&W4`0*I]3"?Q0IX3E424Z/_1?*(ZP"0@Z2"50
M$(/7+)>X-RCA*9R@HAB,Y!35Y&]_A$!-3JC6O2-448-(P((:5F`D+3JQ?OIR
M0^+:MH4S$!$G:GB<[^(6.\4!#5(03-PNGB9'PW$/:XQLI",?"<E(2C*27NC8
M)"^)R4PZ$@JNTR3^;(YP&JSMK)%)6*0G90,*3IZ2$T2HURI?><I4=A*6M`$E
M\&CC@?+1DA,[,.4IC+7+8.[G<Z^YV^>4A,J"T`:95=/28)[YM&C&AIBV@&8U
MI6E-M,"FF=.D2S:[.1MC9DV9WJ2F-[>IS6]VQ`09,2<UU8#&86:3F^2DBSG/
M>4U\8M.9Z12G/O_ISG*B,YWV%"A5_%G09-[SF.K\!$+_:5!R,O0$DQ@H79#D
MFX="%)QHT4+AD.D2BPISI"0MJ4E/BM*4JG2E+&VI2U\*TYC*E*`SK:E-30J'
MF^ITISSMJ4^#><^?\K2/IW/E&T@QR<D5DQ"#"!M7&$F<55Z.$TXM)AC^NH!5
M5\(&F+0DSANX&IL@SJ:J([U<$;7J2*1BLQ!J".HTP3J;&U(U+&[%)%E3ZH8N
M'!.8;[@K(Y4AU,!J4@EPU2<U^7E-9V;G,OP#A18\A\'Z3:*N\NS($R:`A*6>
M@01^*4031.&,93J-GAOMYAL\4`)T*$$4(D1D4"1@`A*(P)0$M4=#?[-(4"R6
MH<^$@@NV`"FTT@5%AVW"/*I)3%#D-+$T+<@&2E"UCBWE#<L5[3.)2U!\N(ZT
MK@V-:Z/I!@Z8H%[)$(Q&USJ;+:`F+Q`-Z#P;B8\-K.T,4=!"/$!QW&3F\R]^
M%:Q_W[!(-XA0#6OS%"'$T,S6BO43IA3K&=#^X8;0<D4:/R#+%3BBN*J%(!6@
M^$\2)@%,,4@#%%%],%N-A5U'G`$6FTV#,`KQ"A&<H:U4:6UM4N%="1.8K=)0
M0W?2X-0WS)>]+TE#,VA\8$Y$X2"P<4-WQ*`&&3L"P=4T`4%V'(<*,]@W;JA%
M*-+@70AW!PQA0^8PN'H&$/A%PA%^C8Y-&5H)F]@CW#L#D0-%A`^%F#9$'88;
M4&2XN[45P+4!A1K@?#<1]G7)^W%#@%MK9ZIP+QR""71LT!!D!1L+%#^8!"3D
MK-4T2",-@X`KE9_J:+96E=2$^$!W-K(%RM3FP&!--5<6*58P@-:_O.ZB"X(P
M,,6)(`29#9$$B.#^!0JTQ0<FV$$H4``>C;A`43@Y`85\&P*U:,`K(@`!)A0Q
M+C"<P#(^(,@.)!`.A+!J&2M(E`ET%0G4BGA>.VB"!TC`."@(#"?,<"41/&"!
MU8K`+XZM0!-(P`(,L(`U4J.+L8]`D150P$A/`($%?@"&'7!,"QX(@9&N8($*
M;(+$T":+$B@0'2UPK`0MP(`VW&#M.8GMOM(KG!9VUP(53``34*A`"UY1B)AP
M9#[#"$(:1H6&#4C@0R2`[@X\@($MB*$%*-AY'%3`@1+LX`Q(.$/.)<#S"JS`
M!>AP0E):0.U"\,8)-*,`(L#0[<Q6[0<[P(!QH%"Q.M&]3QI'Q+]+$&#^%(3`
MY#DJ(P6B<(00F"`#9WA#S!WANRVZ@P06P,F]/U"$./C*$QG'0!%4``%/'`$J
M'6?!%8;@`@Q`%^8-OWK6%PX*,(0@`\,R=D8(<?)J1YO2L!#ZGQWM["8\I0(B
M9QL*/D"6GE!^*I\HP0DVU8(*^/T#@,>;QIO`<9%`81);</;33Z("#*3!!*'/
M1,?C*+9]=V$"22@$#SY@E17DZ`UD`26Z\%:""X#F`_K/^,8G\";]U6L\=50&
ML`D9H`J8X`&<D1%D$0)N,`':L(!'H`TH$#H)`"]*X&PM<($O$1>]P0(=(P)B
M<`+3X0%[0Q8B$"J^8#\:$5QQ$`1(T`0,\`;^1T!V("`KQG$`2B`&(>`\EB$2
M:H"`0S!9A9`&*/`&7N`!Q=%9]N(&S($,8*`("!%!Q/(A0:`%!]`UC8`"C.,!
M3G``.#%;-A%>6G`&[:0T#7(P;_!B3@B%(2"%SG87H(`%%N`#+-`$00`DAA(`
M8-`$&!`'%K`X%6`L5V`<0K`#6V`<8A`7)Z`/'U(?05`$8,`12<"'?N@!2B`,
M+2`1*"`&`N"'&``'@@@&$&`L_Z$$&,@K^"4";Z``26`;JM`Q[%`($,`1$S<>
M*0*!+:`&`P`%3F`";/B#'2$$:G@$;T!D.'@$#5"#/:"!FE>%)K`)/7`$J6@8
M*X`M>)$$6P`4B@#^!@(@!D(0#S[@>%I@"29R!!G@"1-0/W6"ATT`"2Y`<SMP
M'QZ@#XA`CH209C!HC">0!J-@B##H`RJ`!4H``*H`!A_@-6BH$(;0@;PB#4'P
M(0F`!&X@$B0PC(Y%`,TSAB$@%/C!`UW0C0,Y'4(`*4$@!B6@5Q\`3$%(+^:E
M$3Y1`%W#6:U@`6X0!1T#"MWR$E[0`EYP6F#8!6Y`BH0X@`.8!C6!$$I@`JF`
M!#_0!1>7"FHF$CD1!"U`$.YP!)!0"6NR`A;``D@`"4<0#T+@8B$`>A2H#3]`
M09.0`:D0`B1@-QJ1"S"(!*P0DV!0*"0@'XNR!1.@`B0@%<[A`E"`!$7^:(1-
M8`)JQEDT@@RVT3$G8(X;L`*JUQ%7<`$^H`8J%Q:-X`9/T`(9\`2`J`86<`(G
MX`!7P!MDXQU9>0)NT(:/"1'$L@4NL`'AER1Q8"-.4`2?00DN``;O@@;<00_)
M0`B=9A%!HAG$T@X7QS@H`@9)`"?!*0\J(`1N\5LM0)W#V5DB<!:[L`05X5U<
M,0H3P#AJ]@%HN2<=,9LH8"1.L`,4\`8;4#@>Z0:]"9A\N38GD)4J`"6.\`%O
M0`1780F4:9F@H`($\0.\()Z6L`D+V@1B-RY8\"YPP0(XD0^%"8.)%YE=8)LJ
M`)9'H!_C*39!(!]:X)Q&*`PG`$8HP!V6<9W^87$(VT<"7:`"-8@!:.,=8-09
M5^$)$8D($,`X):`$%N"B$K`VG*D&%7":#V"(:?!\1U`!,@(")^!L<-$22VH"
M)_``Y9-?.Z`$)R!A/0$&%!`6`]<(;S(WC\!F3N`"&0`<G<E?1]EK:$`/6%D"
MSK`1AH,"#U`<1I8*1(`$6*DX*[`472DX"H0B6!$'HB,"!>0X*Z"@>S,)YJ4$
M#,`3=;D+2J`?E;`%,M8%7M`%E@$%S=`%5T4/0="6G+`&&\`"3E`"1M:$R`"H
MQ*(/B9H\^G@"%9`$'-&#U/&H)M"KAK.`HIH*Y(&`VF4XL>J8WBD8CM@9Z9.K
MN!`*68:=7:`IG)7^%\8)@Y.%`B9A.,+@GO*``@X0"41P!A40!(H1:XJC`BCR
M!-D)#X;#'=L:6JKZ8739$9O56>'@<5>U2+;EGBK@<>65"N/J!$*A1]%#+$:2
MDK,*"8=J"40@!EA5"/R9912D'_#I`IN`KS[1!6*@G*'@`PD`!BRP!2W@L4/@
MB;9Z%!6;!HLZCQL`!1A[!B@``6>QCQ@K!LSPCV]`A)]P`O/#`T,0;7#0#;Y`
M""A`$&`0+Z!1ET*`""\FK&**5<:28PN8+G^V`\."B.)S!B8@*6/1`$HP6Z(:
M9ZE*EI\"!>.1K9TE)O$PIT%4`B)0LTC@JR_&K70J6&Z@`$KP!O(I`IC^L`%=
MX`]Q@`%=$`X8X`F)^P.>@!E(`"2_QA$NL`1'0!81TZC%,8M;P`*;X`/:XVPE
M<`6_^@/QX%V@0(V8^PNEV3B`!PE@,!VC^H3/\RXH@A.@\`2-D`09(`YJ0&2>
MLF%,L04_H`T[\"&@<`DO\0.^ZIT(&)5*\*,8``;(J`8G\#PW20@NP!$[\1)T
MP0%VF@HF4+P+A[P=4;/5^I$6PHWA&HB+\P#HT`3>0`3Q4!%*\"[L\`.8<`%B
MX`]#X&SL"Q0IV01QP;XKT+YB(`P60$#Q2P@^4!("`BGXY6IST0HAT'XDH$M1
M<G5;&0=>$+\@,+X$H01?T3@^J+R02P2GY0C^])(T\1H$YEN%%)@B?#.Y0>`)
M&9`$5^`-2;`#6@`4F2$"37"A06`<%7`$U5<"Y:MY2?`$!IR;C!<'0GJXT$$(
M:%`1W&N%_OB`!1P)D*(B:.``A5.C;A`-A+`#D,LW$MP1&L+"<2`"40"]K4@(
M41!<U,N&!+8`)E<1F+L"FY`9)3`$"\@(:_,&%C"4-VE;A/`$7P(4E2$.;)@)
M<0$*WI863U`1T?NC%N`%8!"_Z<.W@:4&&``"&(`(BJ@!0[<!&S`L.4<"JZP-
M:H!UC7`$F7<%/.!X&T#+B'`%#>($:0`&)*`!GK`#1E*-P>D&+7`?*[#*.%$F
M'<%Q.]!^5^!L0_#^`1@`!3!'"`.*`??A!+.7$22!#$;X`30#ARR@!G(+"BZ@
M`BM0"S_\!BB@R\`$%Y1)S>1*+'`R,.WSS1DP"4Z0`1M0)UPA(ZV8SH[`SBS@
M#(SA!O(\<#7B;(5``A[@`4'`&6$!*4_P`2+`DE3Q=!O`.+8I`L.RE13!RD$!
M$5F'`CGC;&=`S!]0T5W@`V#0($>H.!K@`;Y+"$?0!$[`RPTBT2X`U"C@!E[P
MRABVM+UW!6^R)B?K##_<J)'P`1E@.F&!=08MMX3``F#*R\X&(P_-%1L@`AIP
M!4W`R[A\`B$PF[ZR`6=@CL,@`AO@`6_``T;"`AEP`8KPU%J0RZ.`$"#^0"&J
MBP&^X@2,N`&$)*-6S0&CH`*R#`L\$&Z&D%D3D#@`#2<=D08J(-98D@D-XE@9
MH`48]II;2=4030C?W"?VDKL??08]H$%JW0I0``+^O!^[FP&(@`(_Y@$\H!]G
ML`+7"X,!W7ZZ10(9X&PFH,])0PD?,-%Q4`15&,H]]8_56AL9]3FV)4'D)%R#
M(5R:HPVA4#4K4&:O,1.18TS$E(]4,6+WI%5P4-X>\=[>-&+U<E3<;0O;K57U
M/1OQW45:%=___0E<%N#8-!/F!$^AD`$">%`%L=VS9F;D34W;?5AHQ=_=8^'F
M70B^LP*(J=X21$SE#6'NU-V\I=[W'4X0/DW^[!WA5:-6\+U-[&U4S33?W4-9
MT5U3HW3B'"!AZ%57-1Z2=`&:S<51TK29]512E%7C*)7D(O4:*O`!&U!1D%3C
M2WY;X$3E]'1886(!)=`*DU1=2\52;L5=I:525&[C.G5`5L/7)@4Y>-/@9P[G
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M[4:.3]9.6O2>Z`T_&_EN"\I5$'U^[*I.\16/\=;%Z4^0`2(`(PM7?7N1!F)0
M>R(0+A($;<CW;!\``B40'6JP)OYI&`WB!B9P!$3PFIF0;GN1"D*M.,/"`EB`
M!4AM)[ITF>7<<`WM`4^.8<O`*E<0C#!_F]+`S"50`AB0%$L_U4#3<2"0NXYP
M!!AY8$==+QP'Y3O=<=6W+>4,TD&AUAT#!D!Q!4B?IESO`;/-]2'@];+^X0_B
MP/:,`PJ=00@J&PI$P`&HP`GS\@$?U_53X08RPO2?,`0;@&]*DQ%/-]MD`UV@
M0]%@PHF*H\N+V0B$#P;R/"?!S#A@,%ZU<0*,(YV9V"ILD@D<D%F&L_ABDYX>
MB?9_OQ]P`0*B;QB;``8>8"35I]F(WQ&0#0+#$0>0+3"%\PE$0/F<XP'P8X@_
M4/E@``+)\_G:;R0Q>/-JD%J%$`2W-V4<[0',#]DP_8#;"]0].T.OC`E!D`$O
MXBS_6,[.(@XA`'\.LBV``@@K<6]#'B)B<6`D'B`J8'&0<4<>(26/1QPA(4-O
M<6H[&RIN<6XH(!\^D&]$AHAQ8B0;*Z.O'U?^D&XFCYUQ/QL>6H.1;[J1D%<>
M9Y!$.Y!#0W$[C"N\N"@<P<;:V]S=WM_@X=UP<5HM'P$D16X'MT0`8%T&<1X-
M.P""G6X*(1,!/7$0F/!@H(&:.!L*H&@@(<X0`&*2$'"C!<"M"B$@B2'0)0T`
M"G&@$(@C(8F2!ZI(!A$6B<B!'AL".`DH8H<*(9$V5(`$8@-"A0S=$&G!H($C
M)`9VM$`!YHA`!`BZ:-L`H`DD#@UXX!/VQ@&&%0".Q"$A(02!AB<<[%BQ0HV7
M="2J=AGITL6*9A*0+$G:XD33!"8.(-C"K5.($V(&K&BQ0ADD"PH.0E@)MD0%
M!80[-0G0PL*!.$3^$I0XD`#,&P0U55`FL.-!@[$9)V38<0+*EGE)\&4@$"Q-
M@P%BU+0P$<!#*@C0BJ(XX"'.EJU:#M!BM^7,`!(B`$CM=`2`BCA!O$/JWAPT
M8`0)@I6PQ]8QI#/#BP.4\*-<V#@$P/@@P$,!!F,5;!!3;!N4@(`!P51V&6$0
M_%<!"6\,L-()#4&R`P31`+#2!BBH8,E$PH@@`DN0:$%`"R($T,P$&*RU`R\[
M('"0#PLX-X`%)0S@PQ,K5&!`;7,M!J0!)C@@@!(I%<F#:G&P`(`)%90V%PL7
M#."3,"5``,(`$\1QP@,K,!"`6`DM)($;;B30CXIQ**A`,!MDM94D`'S^`(D:
M!P2C&6=15A.'"P!D(XR3S<2!0J!Q:!+'!`("`((Q&F`0IY_B5&KII9AJD\0`
M4KG10#!'`.>%`VDX(!81W^'"0#`M[/1I'+F!<84!CYQ1@%@/],,#)!Z4<,4!
MCY#"P!500+#`&2MT$$<%32RQ4R07$,%2)T18`$D%*,2QJC&:)>#&&PD0,6NM
M!H@51P89+'-!2D3\%P<&CT8"1@,/F$!*`Z?FX]Q@?Z9B@KU@T+I""<:<<*4(
M08#!@"361L*L$@U3VW`&&753P@IB,$"+,1]HN.P1[%@5QP/?=;+"NF*`<`82
MUG:5G*!N+&!5%Q6HH8*]%4C;B1:O8>`"*1C^6*4$`P_4%T<7`R3QF!)#-#`*
M%`*``<8!D77A-"X-@-'$`IV48-4H2020K@<`_)RH`Q(\4BTD&31GP@G?(*UT
M'-':B"0#8'``]Q4AK`&MM$U\E@$T78SIA@$B0P"W$P2$^<@.$X"!P->28&@"
M`\VMJH(*8ES=R0EP#U..`Z.<L%/=?H*17AP69.1!>3YXV^8"HVA!>B1:/#"*
M"A5V\K8P8AP@\@,M=.XW"P?X_3G`P*Y@[SXKF/B(&`4HO>T.-2,>!QP0",+`
MJ:F&\$#:I#R@9YO_G1'"=M$D\&HD;E3P@`:CM```"7&4@+.TOSZ!B\I3(TRF
M!DC``HKN"`$@C*?^3A`$$10`#%ZH$0<(`(*9P(\!,Q&0MIZ@!0\@(`XJ>``O
M,)`M)1A``@>)PQ4:`(%L12($+&@!""R@!!2,:`)*<!9++"`M;1R!`3[@G6D<
M<`(?1$]>!'C"U-*P@@:0XUTNQ("[?N@#%S2#",\B0I>$T0,,'"$!!TD("$2&
MBP<HP`39.$%&CD``X4C`!RV0%LD&4;N%_7`(.Y@)#IVP@!ZX8%=87`9(MM$U
M%9PA`3[P@;D@L8$)2.`-%4A"$P80+!3\IQ-)$$`%?*`,(IQ)"P6P2@.*N`(P
M/&$`F1F%"0@&+V:X80L/V,(!Q((F2!RF1Y#8@@#,50$D<*`\,5,"&!S^``$7
M*&PZ#>A"P"#0@F"-IP$84,0<SZ``)S0`)T/(8I=0,`$X]E!T6QB`N=H6A!4,
M`$D*``,/`J"!(_BI16WJF0_`H(*H*0$XD+`D)$I0-DBD00(2T(`QSL``*%1`
M!17H0CI5@(*,C<)W]O+3%A30@@LA"0/&88%5.O$&>V@+20<HE"R#H0(PEH.B
M/&B!&KK`@(-H80$I-%0%\'@&B51R`U;K@A,DX"Y(F&"-;5Q!"-+@@P`TH06O
MZ<0%O#<3#81`"?G)YW_$:$$U**`)#9"6I\Z7R0K\(`W&"((6('"^.$2A`4]`
M$`@E@#<5X&^FCUF),:[@`$H9\*YX[08F!2#^%34\P`(>L`"M6(HF%B0``,W0
M!P02P(`"0&%D"QA``Y0V$&%@8"=B\$\U2'``1+RA$R+P4!!4X(%(+JH)2GA6
M)W)&(DDDX`/R>\(;'G"!TLZ$%Q4(`A(P=(+F=.*RD)#B>!#@@;:!)HO_>2(&
M>K`&[0GGL"TPAB((,*8V$>`!!AB1"ACP@:^\X0#Z*L?"[FD``,!MC\PQ[MH<
MTC*[EL"0!BCONH1Q@2!L<@-*:$)=(;$"Z42B"10`P".AZH`#6,L-M"VM%I0`
M@,SXCF`;&$`!X`$&"%RANKQPP[!^]8C"S:V7'H@N*1+`@@HCH0$G068PM+`!
M`>1)&$3(P`9,D('^#]B+"!CJ"6@:EDT0<A<#)1.=AQDI`0]@@`#6"T80'E`G
M8VS@``X@0"HTD(#XIH((NN.O?\,#C5$$(0"/A=]D*Z`%"9B@2^]U:"3^M0TM
M)&`#&6#`AB#P`0O(U:<BZ(*WWL``D15.6BA0P"BV\.8-8.`,A"V'Y^+0`A=7
MY22\"-,5%-``36;#9`5P0`'PMP(#)&``V4)!>=YU@=DF8`&\@;26T=2"P[(`
M-!@*@4^VRA(`"QBLJM#PI;UD)PE$EP1N?2_!*-!#'K(D#0\`B%WSRFQFAZU3
M#,"")`(0CP<TY;-$0``RG9"&1VCX"D3(&J.U#0D*I`(%$%"`6"3FPP7^`"L)
M%M@6#E-K#&.++I!Q\$&7MK6-'@"68"T@=QS,'5QWK7<9#0O"%H^6@`=00`"B
MT%EH:+$%I;F!=W'XJ1O`<!#]L01;D%`B2^-0!`JL(3C+6@*]8?PLA1<F?X9<
M`!C.@.MK*4$)#7!`$Z+08$B0H&*2D$IF\RN!;A]$#:_:F0$Z)983$&R3&Q]=
MQLR5!#<P#@(2"`!.=/GA)(3@66I(SS%U@L([,:`+Q/($!O#7B2%L8`<<\!#!
M/F"`"BQ``6\X0LO1'-%N#'E9T-A"`.Z&A22DX0VS.E\%=K#QU0;A"@F8B1(2
MZ/-'I2$"%'A`"GGVT$@01*`@J,!_@*UFB+;^EO,A^0P&H,&MD-3KD@IP(184
MH(R2UNYJ)3*("@4="35&?3,"%($E%"`&TVTLXR#8^$%,(((S-``@R*-%;K7E
M!#0\8@D!D$H<1$`"H6`;`6\(P0$NTU(^"^H(4E&8SK`&LPDHP$<[*0%3&/(=
MUBX*&HJ]4K/WS_]-=>I5H2(&7B`!5W`?.Z`Q['=!A-$`/B$&""`63Q`H6A``
M5T`"&*(NVJ`%!O``:5`X%S`*#],RD%`WD4`.Z\4"Z?(^VC`O!^`_J@.!`>`_
MYY(N.\8NUG(&:B$,09``20`%%%*`8G&`M/`0A/$!Z_([G^4EH=,).T`Z8><#
M8E`C1]!3*:=#,);^/A[5!=IG#":`,;A7;])2`8,W,H*P$:G0"0_P'P'C!!!C
M#`@F*''0/9(@`!>W/\+`,XGB$Q-X!2H``4_P!!L@4.$T-S04'<'0`P/@!B,'
M!0-P)KBP`,4G'6X@`=\Q"H7`8#W``B<`+BMP!4=@`$^@0\X77240.I"@3,;@
M!4DS@EMW)''@`+/R'4U@`)GQ+CVD5-*R`2T5AX(`!@4`$"*0-@9@-+:S,2;S
M)"`$`*EP,:6GA*>793]DBZU%"A8P`$;3&F`E/B9#.Z.S,9SW!K^0$J##$G((
M!@0@!!GS"@+P:L(PCNUH+RZ0?6GP@''@!`#P6$D'"1%0A@0P!&!@@%G^HP`K
M``5?A"3YV"!'0X\99C[","M!$`4^8`!,1#`A``#196Q%`"PZB&17D`9G`(?\
M%Y*8PAT]QPZW4`3PT`72T0(!(`']I`\O!I.W``4`@!,L$``3@!J+LA,5P7I"
MT!#5D`8)8"U"V3`/<`3V.`$0L!,8D``4H`#-,`I$$``5\!M(XCX3T`!`=R^X
MQY(Y.2*0,`%;-)4`I0!7P&`50``;4`UE`0E@,'@]$``08)'P0Q!&(A8A,"))
MB`)<`@$.8!IFE``8HH$.<8&=``%(T`0`X$@*$`5H:26C\`%VP@N&@1@&T'F1
M,!ET(A9(``#&<@$'H70-8``8,@08DF$*P`#^$M``CX($+<D9B9(1#[`22O<&
M\O``%*0&!&`T#'8&_V@NFAEA$Q!2Y>!?&.!?I)`G")8`"A"3X%$!_]@$H#-Y
MN(91:*F6I<,EJYD&)/`HO/`<YB(!*U$12!`'!;`%V`<!`C!J<4B;D*"98F``
M^..:;%4!%`$`@":1Q7E\FPD:^!D'('`"9R"7JXDL`T`!6GF'C3B7T14E2FF?
MQN`!U%9&"2`!"8`D7@(B6C``$.!^/_"6$]!PK@!:(_(M<<!@$,``%?`&T7$0
MX2%MH)4122@"&>$&%-`0+$D!"%"C[9`2N2$!"F`!8,4"C:B,1R``U9DNE#8!
M"^`$\C":92<,['#^/B2`$H.`2*9@']D2)1(@`-^D800P84UP!`H@DF8Z0&*P
M!`\%!0<A!DJ`)O[S!E"@!+=@#$\04R$1FDZ@)W-Z"VZ@!*YP!74J*]L@J,=0
MIU=`<_FE!#.!!4N`6H(B!DV`6ML!!9.J!&&&.X(BIW0Z5W5Z!I/:!$E`<Z$:
M4V_0!.P#!8CP!$H`DFK`AMJG!0)TBLV"6FV:7\J@!OXC!IEJ5F>`!J$ZJL`Z
MJ10WJ[C3!6X@6X7Z"&K0!*ZP8,IJ#%W`J`=!J,-@J:@5!9"`!9BZ,X1Q!<YD
M=9TPK4Z`)DK@&%:W!F[@K,?`K&PH0&N@K%O@!-5PIZ_PJ*[@EK=0KEO^H(7T
MJJ^@V@3E2JNHI31'D%BX<*[M2@H*:Z\+!@5^`JYS%:AA!JV=,*_Z`*B>$*WP
MH[%_B@BR:G67NG&+6J>>X`20>@R/RJBI8[*O@%KYJE.=\*J3F@3(BK(*:PRR
MFH%*H*RZJ@]-X$Q;8*P[>S1-T`E0D`0F^P3\:;&JT*?E\*^)\%C8F@0=1JW;
MP*:1``6WL#-:J"=.\*VHY;)RZ@1/P&UGX+)GNK9LV[9N^[9P&[=R:RG+)@YU
M>Z;+QDF9<K=SV[=^^[>`&[A]NVR40KC>X"?54+=\.XV4F1)VA;A<`0X<]0V3
MFQ+:H+AZ)3J$M+F76QB56[B4*[FM]W*:VWK^H#NZVT`.?&NXJ-NYI?NZF'NZ
M;\"?T^BZM1NZL/NZI,NX)%*YH@.YBVNYK0N\=+N[F2N\D,NYJ&NXB6NWQANY
MFQN\@CN]U%N]UGN]V)N]VKN]W-N]WON]X!N^XCN^Y%N^YGN^Z)N^ZKN^[-N^
M[ON^\!N_\CN_]%N_]GN_^)N_^KN__-N__ON_`!S``CS`!%S`!GS`")S`"KS`
M#-S`#OS`$!S!$CS!%%S!%GS!&)S!&KS!'-S!'OS!(!S"(CS")%S")GS"*)S"
M*KS"+-S"+OS",!S#,CS#-`RWTCN]-WS#PAL..OR_/7R\[OO#SQNX0ES#ZUO$
M1DS#IYO$3!RX/O#^`&)Y"RT07?JP`0"5H/482Y'0&@_0#%YPHVQ5*&`@`2+C
M`@3S!!C0`"*`)A;0(%5Y!D(P/A+P`.R#"U;\`"6081;P,TJP`*+W`"(`CE>\
ME6X`3X91*!_@!%<`Q1`P-UO\`,G&$TJ#Q@[P`83A!1,0#%N0`1MS!E\R`74:
M`F83`HXL"5D975;#(A*P$R)0GJ,BJ./C?ES+R"#@3.4P`0^P`<KP`4^`!8P\
M-T\,4'3,$CU0,Y#0!!@`5DDP(G><QP6#=1(`$&Y@Q:M9`B30`!>``0L`!4]@
M)]N'/]1<`6+1!9E\-!@P'7?<?;TP/BUT$%O@`0Z0`=ZF`1GP6>@2!T_^T*$/
M$+10C`$3P,ISTT5@=0060`LN$%VB;$MS,S1_/"(80!A-P(%Q+,Q;V`18)\M0
M8`$'D02/XLD.)VV;?'Q'@*`N4#NXK,MQ8-%E.<M*6<HT(P$3`$1H(`&:O`&8
M+#*,42PKW<UNN`-S;"Y/',7Y)L?#W,3:ZSL9T`/I!@?6+*5]-*9A=@(`P(X;
M*@0^H!U3<P1*<`2"0@$RR@!"<#@;<`0/8)].<`3,814G@`%/D`1)@*>D`)4F
M,``$HT(!P`!O(*DK(``^H`7[T`-0;0Q0$`"XEP&=11(WYP!"8`$"H*TE(B%7
M+6T20`2'@P%.4`&?T07W<U*=)P(',`0YXC_^QXD($]!E^"P`#&0`);"N7Z8"
MCS4!XPD`;(A!20`R1X!B(2"?'Z<!LS(B$)#80U"-CU4";.W6QH@!`#`WW;$2
M00`2<DW7*5$!)Y!-`G`+"@#81\"U*EUUGG0MZX)(%R(=_T@P6L![<;T#):#;
M)9`!2!`3*R$!$'`$5"8&;Y":;Z`Z98IE0>`9F-K:CT4!K`<&`S`3#_!JG4`"
M^',!AUW:;MD$YM37^W`+W8$L%O`$2)`$R@,:#>`$M?VG'A,$#1$""@`%$:8&
MA-9Y3A``)B`$NET!&3`K&=$T'&[;#Q#<`]"UY9``6GT$$`0`Y)T`D"2CZM8$
M?;;50M$EO%!4.[#^`WR=/TEM+&^@`A5^X7!MU-=[`O;B@&`P,&(&AVH@`1E`
M`:.`!+PG5HFF#3XPF/G1`A>H@<$`/3YEBMM`:U`0%8;B2'/C?_<"DN3`.R7!
M*U,]</GU++$@#$E0YH]5`5M=(6#`>%,#+%9#<010IQ=@+QQ`EZRE5&#Y17XC
M-X\A+8+'JJH%&O.E`8,D+-("!2NAZ$U`Z.GB<93",QC@S9F$$NT2!Z]2YUMH
M;(4C%OP6"1E@<`V#`>FR+;FA3`<`Z0BXY]'0$!X'/4Y0`&`5=F(!`12HF!A2
M!`VCF5H@`.7).EJ5<1QPZ*&9<?9"-@UZB[#"5YZP+0B$!A[2N>NU5[;^?LX)
M<`MGL-J1#BV;K@"EDNHK@6_L-A8"M3.+M@4(H.S@,9B4A`2COC;ZH`!R=0)=
MPF;!L^5U;>7=>P(:T`4L8`!O@`($HP\/0#$9('GF8P"/I3`&L`'^XV8>\`$;
ML`LA,0!G,`0-\2"/6!]A)PAMP@"RYO-NN"VZANM*\`$5@T`*5/(AD`%Q"@D/
MH`24P$@;P($7<'.#A&^)T%@;$&:]%`+6@G9246884`)G[A2.@7$"\@!HD`$]
MY`8((%>W\5C=;BZ-)`(1Y@1.<``@P`B5`P4JD!0L$1<0X`.=0`$WITT^AO="
MSV@>$#B(@$42,`3PIBUOGH]?H01/!I@F+X/^PG5<P250#/`,2ED.#5("7K#L
MGB)6=.8E'O`$(E#=+-`0Y+!V)#$X,=809*T%1##@SE%=X"X,8/``":!LY+!*
MY[(!I((!.L,=E.=7&B`"1W8&+@#TLI`27]3WCW($CC0$[9WBVV'PTY$`<L\;
M*N"9/3`*7Q0"?E\$6?0LSI$`,;\!:-`%IQ]!-7\&W;W^F2`)\&\B@'`5%W=T
M\+:2T<52X-;"$+*Q,CA)66EYB9FIN<G9Z?D)&BHZ2OH6QW(@P=`25U(29^KV
M0+)S(ACRX0:!,IC&PB``!9:PTK(B-NG6T'0B$E<A&>>FP"*=H#*H`K&C$@1+
MJ:P5I\8`IG4@YL/^H!:'%+`U/ELK/GB5D+[^?!2IH:14,8B(!4J^&`Q0HH\#
MP!(``H#I`N$)`R(0W`1L8#&.B@5Q+NQ;L6'((#<+D`SJ,B!)G"T"5,;)L(''
MB0!.FBAP48R0`0@!5&2<I,1"@!!Q*"Q90B$@0!42N'F;-*&'F`-$X@39<$2"
MCPQQ&(A3TX!>G`T*%"1H(FV6BQ/T,&`(.#".VS@/'!2`($Y+Q(D/,JIYT``"
MWC@K#C08\"/."0V3,&QX,Z'$A@TD)L11LK.!"%-=!)B,8Z&J*8WY)IEX56$?
MBY"4D`CH$H\$CP\$SK38UHW2D04X61'!*J&'!R4!8(_6@C'6`I=;4K;^$PJ"
MT`)CON,*_+:%6`L5:K9`@+)@2,4XRTX0)<*@=QPB`$UI20"/4(`T.PRH8L5T
M!PIOHTGY_P]@@`(.2.`H)I@`BRD'?N.&`^+`(0T$"CB02AQ#5!4'!RB(P<!/
M@YAR0@80J.0!0'$,(\XTT2R(23@G(@`&#P0\P``!:!U1G#1A6<+"C#6B-4$2
M5RR@P!/_#,)#>Q9BZ($S$R@1!`0G0M'`0PK$(4(#$K`3QQ,!T`,""7%,@`06
M"C!PQ"0/G##($PJPTT4`+ED@TA8!0''D).S%X0%CDX#A4QQ-'`":/R;NL!""
MDYBRQ0$,.$``44,,9$$#'G0E#HK?I*;&`6G^@B76('.M%Q<&8BX`QA4'Y,7`
M&R0PL.5(.[YA2@D([A('#P=D!$%5#Q#QP0=$/+">B:-U-J=H<"T:QVEC"GEF
MFJ,E\9J.XAP!@!HJO$*)*==-,NDS#7PP%3QNN/#&%AA-X@";<3@1U@H6.4'H
M$28N&P>BDR#W$W)8:LG."1A`D&:X>L85QQD$I!E'#Q*T\@JMS2I:8,467XQQ
MQ@0JJ"B((;QQQAK*/*$&&&\T80`4:C@Q`!@M?-G%`3V`H0`89X#AX14SIA$'
M%@:D6<(![+A!S"#-N"$&,D\XD4P#*F_PU@,HI`%&!<X<4>W()?,,RYHE5R!F
M!55M``">$KP!!57^WZ@@@!9=),`*F6``(,1E+=,<AQ8$C">J!V@#4!4%56D`
M@$K>KNI&!7'%.:=(6@!@Y)8W%YMW`#M\TP4`Z(K`P#--+'%VVG6;$`+28HRV
M`P-=I.%#O4D1`8#?#$#AQ@8(@R;2"02`T17)8G`]*G%*I)%`50J(4P&Q6W"D
M-]\N?N/*>@`X\08U5@$@3@-1//!`%`T0<B]G+0UB@0\@LV.P::A5E4'A'\:1
M1([*"()C&BN4+L89_1%!@1J3[PF[2U7`;RT@@!NZ4(XT((,(B*,`!N;F`C>$
MH'-$F`#2>%=!M*G-/0DTF18ZUSQVZ`P":"B6&L2`00N>X0R*@4#2#H#^H.A]
MPSQO2%J7F*:Q'.IPASPD4/1&LX(!.``!EWJ``AI@@!"4X%X0D,0&#)`*-<2,
M`4ADQ6C$D``Q98,`5&08T:*Q`BXRX`!G,,&E8N$`!2#@`6JXP@#BXX,$P.\=
M:3DB`C@P""B\<1`^N-(%ZM:$LCE!``\8`#:2L8$#($`"O*.`2'90%@*(Z8,6
M"8$"+&(*>YBE!!:I`"`!8!)3O&$#!5#`!`01AS@QK`)U@AS+&M```C@A"9;)
M5P%8Z*T"+,``57F2EPIYR#`V@`'P&02N$F:`)]`R0AL@SP(.\`!D3(*5.G)&
M`^QX*;F\11H?.$`"(*"_!61*`$,`PP(J><[^D7CE?3+T`+&(P,4$7,X-J@M!
M"+IP)?Y5(G,,2Z0##"")(80/8D41B1-`"0L(X<A<Z\36&78@QF*:X@@#@.4`
MC&097;Q%DP6HRCD8,$9X/%$!$A`$/,<H$GC"4I8L`R8E&D5%`O``#!V*@R4M
M(@8$:)&B*ZV)`*[Y`)!!(`$*V`#O2!"Q00ASC&DH073ZT\.H2G6J4DT#"R>!
M!C"`X0O(T*I6;R;-.%A5&EK%I%?!P+5)B(%+L-`J6T_$-:IY%7YU^Y!7V5&R
MT;B!=WLUJU>OJ@8OC.8-O!.#10[H!C=X0:M0)2O.!F'808#5KJ:@6B4F.XC'
M]A4<95V4%S(BAC7^2..S>]4J::6Y6;7:#+*)]>IHY-I9PJ859TB#;%>URK/^
M1#9AO#NK-&UH5S"P`PXFRZS^>"=6Y+85JF@HX3AX5\/59O8-:F`'7\-JUXS<
M#+?CP*Y861A::73!0WL5I69-!MO'CN2LB?WM5<%J7J\>MK.0E6YI']):^@;7
MK83MA7+7NE[YWK>X)2NN6-.:7-=6EZH,;K"#'^S@-P3AK<QZ<&,;ZXD+9P)"
M`,(PA$'A81V&^,.B&'&%OT'B%*MXQ2S6V(@]+,H,5\+$'99Q5&D<(!Q3@L/=
MHJJ.>\AC$&<LR)?X<8EGW.,B(QG%FGCQ)HS<XBA+><I4KK*5KXSE+&O^><M<
M[K*7OPSF,(MYS&0NLYG/C.8TJWG-;&ZSF]\,YSC+><YTKK.=[XSG/.MYSWSN
MLY__#.A`"WK0A"ZTH0^-Z$0K>M&,;K2C'PWI2$MZTI2NM*4OC>E,:WK3G.ZT
MIS\-ZE"+>M2D+K6I3XWJ5*MZU:QNM:M?#>M8RWK6M*ZUK6^-ZUSK>M>\[K6O
M?PWL8`M[V,0NMK&/C>QD*WO9S&ZVLY\-[6A+>]K4KK:UKXWM;&M[V]SNMK>_
M#>YPBWO<Y"ZWN<^-[G2K>]WL;K>[WPWO>,M[WO2NM[WOC>]\ZWO?_.ZWO_\-
M\(`+?.`$+[C!#X[PA"M\X0QON,,?#O&(2WS^XA2ON,4OCO&,:WSC'.^XQS\.
M\I"+?.0D+[G)3X[RE*M\Y2QON<M?#O.8RWSF-*^YS6^.\YSK?.<\[[G/?P[T
MH`M]Z$0ONM&/CO2D*WWI3&^ZTY\.]:A+?>I4K[K5KX[UK&M]ZUSONM>_#O:P
MBWWL9"^[V<^.]K2K?>UL;[O;WP[WN,M][G2ON]WOCO>\ZWWO?.^[W_\.^,`+
M?O"$+[SA#X_XQ"M^\8QOO.,?#_G(2W[RE*^\Y2^/^<QK?O.<[[SG/P_ZT(M^
M]*0OO>E/C_K4JW[UK&^]ZU\/^]C+?O:TK[WM;X_[W.M^][SOO>]_#_S@"W_X
IQ"^^\8^/_.0K?_D;S&^^\Y\/_>A+?_K4K[[UKX_][&M_^]Q??"```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>j1264854_aa003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j1264854_aa003.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`)P"Z`P$1``(1`0,1`?_$`:(````&`@,!````````
M``````<(!@4$"0,*`@$`"P$```8#`0$!````````````!@4$`P<""`$)``H+
M$``"`0,$`0,#`@,#`P(&"74!`@,$$042!B$'$R(`"#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL?`F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M``(!`P($!`,%!`0$!@8%;0$"`Q$$(1(%,08`(A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M``P#`0`"$0,1`#\`W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(3M
M+LS9'2_6G8';_9F?H]J]=]6[+W-V#OK<N09EHL#M+9^&K,_N'+5&@-(\=!BJ
M"60JH+OITJ"Q`]^Z]U0EL++_`"`W/\Y/Y;'R8[4WIW1UOVM\V=T?(7<,_P`1
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MEJ:F?#[2Q>8R\.#V]M+:>5R^4K?"8:+&XZ>5SZ55O=>Z-1_%<7_SLL?_`,6_
M^*_\#*?_`(M?_.R_SG_%O_YO?YO_`!]^Z]U2W_,:I_F7\8]D;R^3_2'SI["K
M.R-[?(+XL=,]'?&7L+J_X^Y3XM4E-WE\F^I.H)-LYS;^#ZAI/D;O#)8O;F^<
MQE*C(XS?V-RU1'3V!6"FCC3W7NCZ?%?Y);K[:CW-U?WOUS_H.^4_57AB[/ZM
M_B8S.V=QX"JJJFBVUW;TENAEC_OYTAV)]G(]#5Z5K\+D(ZG#9:*GR=%,C>Z]
MT;_W[KW7O?NO=!YVUMC>^].L]\;4ZU['J.H.P,_MO)XS9W:-+MC$;UGV'N&I
MIV3%[G3:.?EAPFY?X55:9#153K!4`%'(!O[]U[I6X&#-TN#PM-N7)8W,[CI\
M3CH-P9C#8>HV]A\KFXJ.&/*Y+%8"LS.XZO!XVNKUDE@HY<C7R4T3K&U1.5,K
M>Z]T[>_=>ZIW_FS5+=SY;X.?R[J5%K<?\Y?E#BI.[L0\9"9/XC?%G#R_(7OW
M&/7PUE/58N'>&6VUM7:U1(JE9:3<<U.&66:%9/=>Z4>R)ZGO+^<MW3NN&*.J
MV3\#/AQL[X_4U6Z&U-WQ\P]W[?[Z[)Q\/DC_`'*S!]*=3]=S%XR!%#N)E+.9
M2L7NO=6R^_=>ZJ<Z^^3'S5^9^[^W<Y\.I?BUU-\5^N.UM\=/[&^0_>>RNTN_
M]R=^[IZJEEV7VEE=B].]=]K?'C%;=ZUVOW/BLOMZCW#5;RK9<W_!JBHI\:M*
M]-53^Z]T-_\`+I^5^Z_E[T5N;>N]Z/9-3NOK7NWMKH'/[_ZHH]R4/2G<.:Z>
MW%_=G-=H=+4^[Z[+[CAZ]S&82HHDAJJ_)-29/'UM,M;61PI4R^Z]T;#MSM?K
M[HGJWL3NGMC<M'L[K+JG9>Y.P=^[IKXZJ>EP.T]I8FJS>=R3TM!!59"NDIL?
M1N8Z>FAFJ:B33%#&\CJA]U[JJ;XR?&JO^>.Z]C?S%/G-M3*96.NJ(M\?"+X=
M[[FH,OU9\8NL*D)5=:]N[TV`(:C`[I^7F_<+(F>R&8R;5TFS5KZ;%8M:6HQ\
MM5+[KW1P.I?G)L'M?YN_+?X+4NV\U@^R?B?M'HO?>3SM;7XNHP>_-K=X;5EW
M!2UFWZ2&2/+4-5M"NB6CR$<T31'[JFDCE)E:*+W7NC<[OW5C-D;9S.[,S2[D
MK<7@J-JZMI=H;-W?V#N:>%'1"F&V7L'![EWCN*L)<6I\?0550PN0A`)'NO=$
M#[2_FH_%[J2JP]#N+:?S%R>0RZS2-CML?`#YN9G(X:"):1TGW#CQT'3UF&6K
MCJU:!)D$LRJS(I"D^_=>Z"FO_G)]+O0T.3V7\/\`^:EVCC,ACZJK@R6P_P"6
M5\NGQOW]'D\GBY\"<ANOK;:E$^4CGQMW>.1Z&(3(DE0DJ3QP^Z]U6?U/_-^^
M9OR%^<G9G;?QY_EM?S">Q_B;L3KG,_$:JZ>SD'1O7#XGY@=<]A[IW#V?O#?5
M1NGN-MH;)RNTX),-M&:`5U3(L<]=-4RI44$..G]U[K8G^,7<^[>_NFMN=E[\
MZ&[4^,^\\CD-SX7<W3'<=/A$WKM/+[4W-EMLU4AR&V<IF=N;BVWG3BAD,/E:
M&IDILEBZJ"==.LHONO=#_P"_=>Z][]U[K5O_`)X]54]R]M]I[!PV/J,\?B__
M`"R/D9@\1@:.<J=S?*3^;=EZ7X"_%C:@20&,YQ:/&;MEHD1)I:ELAX5"M(LD
M?NO=;(/^B+9O_'#(?\RP_P!$7_`^3_CS?^.'Z?\`BX?\W_U?X>_=>ZKN_F.2
M2;Q^1?\`*.Z'&8AQ%)V'_,!D[2S/[4L]7DL9\5/C!\A/D'CL5#$DU,$I:W>^
MS\*LTNN\1T721"Z-[KW6;^8WF9>H>\OY8'R0Q<\E'687YQ[:^+6\G25ECR_5
M?S2V/NWJ:7`5=+'+"^0C/>E%U_DHU)9:>7&B<J5C;W[KW0H?,SYG[UZ<W?L+
MXS?%OJ:C^1GS<[GV_F]V;`ZLRVY)-E];=;=9;=JXL7N/O[Y$=@0X_*R;&ZGP
M68J8J"AIZ>GJ,WNO-.N-Q4#,E954/NO=(W^6%\VNTOF!MCY1;3[YV[TS@N]/
MA]\K=^_%CLRO^/>Y]W;JZ>WCEMH;9V7NA=T[.GWQA<5N;"+356[JG!UN-K)*
MRHBK\)-.TD2U*4M/[KW1B>FOF_\`&COK(?**DZW[*P^3Q_PZ[(S'5??.YZRI
MI,=M+:FZ=M[2QN\=TNNX*FJ%#48/:]#72TU?7$QT]/78^LA+'[=V]^Z]U*^%
M_P`R>C_GQ\?=L?)OX[9;-9KJK>&>WYM_!9#<&%EV_E:FIZ]WQN#8>5JI,7-+
M/)#0Y'(;>>JHF9O)+0SPO(D4C/%'[KW0,4W\TCX@;AS'PVP_6^\MQ=M2?.[M
M;M?JOX^5FP]HY7[/<'^@W%;PR/;?955_>]=I5DW4.R:C9[TLN?QT.1IZR2NI
M*BB6IH))*R+W7NB:?+7O[8O37\X#J[?W;^&R1V#\8OY0_P`Q^]MNY>*3[JHR
MF^-_?*+XD]9S;0Z]PU3445)DNSMR4&%I<%044<AJ<O6;CH:-%\KPW]U[JP'X
M#=%[DZ;Z-GW+VA2:/D+\C=\;G^2WR/K)VAGR$7:G:LE+71;%GKJ>EH8:_%](
M;!HL)L+$RI3TZR8C:],YB1W>_NO=0/YFOR.W!\2?@!\M?D+LZMI<9OSKKI7=
ML_6^4KTI),?B^S]QTR;/ZRR>2CR-)6XQ\;CM^[AQTU0*N/[0PHWG9(M;K[KW
M5<'0FU]Z=D]+]3_RT/@CG<IL/XB?$C'[;^./S(^;<`RNTL]VCDNO,2<1W-TW
M\.JRA@CR&4[0WMO2FK:??/8L<F.H=GRY*J&!J*W/(7Q?NO=7C=3]4=<=%]:;
M&Z<ZAV?A>O\`K'K7;.*V?L;9FWJ<TV(V]MW"TJ4F/Q]*CO+/,R1)JEGF>6HJ
M9F>6:225W=O=>ZJ]_G7;87L3XU?'OJ/<U$N1Z1[E_F*_R_.L/D?1-14M2E9U
M#N/Y-[$DIL=/5U7_`!9:'+]L4.UJ.KJXP76DJ)8^%D9A[KW5P2(L:JB*J(BA
M$1`%5%4`*JJ``JJ!8`<`>_=>ZU]OY6/<_5/R=_FD_P`ZSO384%#-)0Y[X<]+
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M[D>Z]U<]VUWIU'\?>LLKW!W_`-B[)Z3Z[V]0T]7N/=G96ZL%MG`86>HCU18N
M?,5]='CZO+5%1>"FIJ:2::LGM'3K*[*#[KW00_#KYV?$_P"?VP-T]H?$/N+#
M]R[&V7OS*]:;FS>*PNZ]O?PO>.'QV)S%3CWQN\L#MS+5%'/B<Y25%-70P24-
M7'+^S,[)(J>Z]T&7;W\RSXZ]6_)+'_#O`8CNGOOY13+L+(;CZ=^/73V[^QJ[
MK3:O8U?]GM_?';V_6I<+U#U5M5*4&OJ),[N*AJH\=HJ%@=)H#+[KW5.?5VT-
MP?.3^>Q\XZW9]3M?*?$?XJ=G_`?,]U;F>JPN5K=]?)+XI=3]Z9[JWJG:D,/W
M]5'B^O>X>\(MQ9RKF^VDQ>X-@0TD`;[^=U]U[K:0]^Z]U3Q_,0R&(VC\]/Y)
M?8.X<YA<)A<=\NOD?L&2;.9*EP]++F.T_@C\B=O;<BCR%<\=)]U5YFFBI*:G
M)\M965<,$5W<`^Z]TF?YBO8>U_D-\F/@!\'.HLA'V1VQM7YO]'_+?Y`XS862
MH<S5?'CHWXJUU;VK%NWM^IH7K:3KR/L/LFBV]M[#T>8^TJ-P1UE='CQ)/3DI
M[KW29WMU+_,3QO\`,-^:E9TYUKB=O]<?+_8/Q'V+L/YOYS>'763Q/QIZKZ6V
MOV)#W!@L5U,F>I^T]T]Q3[K['RE;LFFGQQVJN7RZY')5DM+13XV?W7N@ZZ7_
M`)8WS.^*G:?R(Z&^)W9'3?3GP8^3>_-D=B[L[SAS^_<U\U>N<9@.CNL^G]W;
M)ZTPV5P%;L&H[3WW5];R9";L;-9>NJ*6HSU3DAC9<G3Q++[KW4#H+^3?VGU3
MVS\L/CM!N[IWK?\`E+]N]\[1^1F)Z5ZFVUG*/O?N2JGZMZRV/N7XX=P;XS&2
MJ<5M?XY87+]34E5D*?$P5&Y-[QY"JBK\M3TM=D:*?W7N@V3XP?S/]Y?%SY#?
MRO-H=>T?QWV=E.U/GMN?=7SI_O\`[,J-N=S=2_)?M7N?O_K'K?HC:%#/NOL;
M8>]-][E[IAVWO?*YW#FEV?M_$Y&3%SY7)UM":3W7NBU_$?X@?S<O@E\H.CN^
M.V_AGU_\R=I=0_RY-D_"3X\]=_$WOSJO9&/^-46V]P[$?,G?=3\FMQ=6UF[]
MZ=E_W::MSFZL+'E0IJ)J=4BHHXHO?NO=#EW'U/\`(';'\T;^6C_,._F5[:^/
MPV7O+<6ZOACUCTQU5CLWO?;WQ"[H[;-1OSXT;RWUVQO*LI)>Y.QMX[PQ%7M:
M?+8W:NWL%MW/#%U%"9))8ZH^Z]UM)>_=>ZJ-_G?=8;I[U^`><Z#VWL?L3>^-
M[P^1?PPZW[%'5W\1_O9M7J;)_+?IC*=E[OB.'@JLK!B\;M/#U,%;4Q12)0TU
M4]54`4L$[K[KW2'ZD_EM_.#XD[0V)T=\+_YF6'V9\7>JZ.@QW6_4WR7^$FP?
MD/O';N#AJVR%=L^K[=ZW[>^+^0SNSY*R:9:3[C%?QZEIYFCDRM0RQ21^Z]T+
MV^ZW^=E@\_)C.LMM_P`K/M#:U/2TRQ;UWWO;Y:=#Y_,5NEOO)9.L-O\`7_R-
MQVW*4.!XD&[\JY!.IQ;GW7NCQ]S]*;/^2O1&^>B^ZL.M7M?M78M3M7>E)@J^
M6FK<35Y*BC89O9N?:`5N%W-M+.QQ9'!9:)$K,;DJ.FK(2D\*,ONO=$'_`-EA
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MRX6&GQ^0BEH8WIY?=>Z'SI7^7/\`%'H+Y+]Y?+CK_8=<O=_?F:.;W)G]P;BR
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MV#TOB:Q=M4&9QVUZ#'[ER5;53S&&FIH<C[KW3Q_)_P#A/_,_Z`ZUW-1?,GM[
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MC)#`R]IY#'X.JW(G7>3SCZ(F>H@HUFJ5"F`2Q^Z]T'O\O7:_\J_:6WNR\7_+
M!J?A=5X&3-8/(=P2_$+=_4^]6&7KAGIMHQ]B9CK;-9ZNB5(3DQA:7(SB&GA^
MZ6BC1/*/?NO=6*^_=>Z][]U[KWOW7NO>_=>Z][]U[HN7RTVK\:M]?'WL/97R
M[R/7N(Z"W=2X;;.\,MV;NK$[%VYC,GG-QXC&;&R&/WKE\EAEVCOJCW]4XR3;
M.3I*NERM#N):*;'RQUR4[#W7NB42M_-:^*.V=O\`7W7O7_3/\S/:F+A&(V]V
M3VEW[5?$#Y"8;!8Y#%BJ?N&9>HN[>NNY]Q?9+'%/N?%C:M37S(9*G$F5Y*E_
M=>Z/;T'E/DIG]MU^?^3&S>G.LMS92HH9<'UET]OG=W;5)L_&K01&LAW-VYNK
M9?5,>\\Y6Y"1B8J#:>*I,<L?C6HR(<5"^Z]T._OW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H&NWX/C_`%%1U1'W
MNW4RUJ]O;2GZ./:51M.EK_\`3M2PY2IV6O5<FYY8JINTFH8J\4,>))RDU(:J
/-%:%IE/NO=#+[]U[K__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
